1.1 	A bill for an act
1.2 	relating to cannabis; establishing the Office of Cannabis Management; establishing 
1.3 	the Cannabis Advisory Council; requiring reports relating to cannabis use and 
1.4 	sales; legalizing and limiting the possession and use of cannabis by adults; providing 
1.5 	for the licensing, inspection, and regulation of cannabis businesses and hemp 
1.6 	businesses; requiring testing of cannabis flower, cannabis products, and hemp 
1.7 	products; requiring labeling of cannabis flower, cannabis products, and hemp 
1.8 	products; limiting the advertisement of cannabis flower, cannabis products, hemp 
1.9 	products, hemp businesses products, and cannabis businesses; providing for the 
1.10 	cultivation of cannabis in private residences; transferring regulatory authority for 
1.11 	the medical cannabis program; allowing Tribal medical cannabis program 
1.12 	manufacturers to distribute medical cannabis to Tribal medical cannabis program 
1.13 	patients; providing for transportation of medical cannabis by Tribal medical 
1.14 	cannabis manufacturers; taxing the sale of adult-use cannabis; establishing grant 
1.15 	and loan programs; amending criminal penalties; prohibiting the use or possession 
1.16 	of cannabis flower and cannabis products on a street or highway; establishing 
1.17 	expungement procedures for certain individuals; establishing labor standards for 
1.18 	the use of cannabis and hemp products by employees and testing of employees; 
1.19 	providing for the temporary regulation of certain edible cannabinoid products; 
1.20 	providing for professional licensing protections; amending the scheduling of 
1.21 	marijuana and tetrahydrocannabinols; classifying data; making miscellaneous 
1.22 	cannabis-related and hemp-related changes and additions; making clarifying and 
1.23 	technical changes; appropriating money;amending Minnesota Statutes 2022, 
1.24 	sections 13.411, by adding a subdivision; 13.871, by adding a subdivision; 
1.25 	16B.2975, subdivision 8; 34A.01, subdivision 4, by adding a subdivision; 97B.065, 
1.26 	subdivision 1; 97B.066, by adding a subdivision; 144.99, subdivision 1; 151.72; 
1.27 	152.01, by adding subdivisions; 152.02, subdivisions 2, 4; 152.021, subdivision 
1.28 	2; 152.022, subdivisions 1, 2; 152.023, subdivisions 1, 2; 152.024, subdivision 1; 
1.29 	152.025, subdivisions 1, 2; 152.18, subdivision 1; 152.22, by adding subdivisions; 
1.30 	152.29, subdivision 4, by adding a subdivision; 152.30; 152.32; 152.33, subdivision 
1.31 	1; 169A.03, subdivision 6; 175.45, subdivision 1; 181.938, subdivision 2; 181.950, 
1.32 	subdivisions 2, 4, 5, 8, 13, by adding a subdivision; 181.951, subdivision 4, by 
1.33 	adding subdivisions; 181.952, by adding a subdivision; 181.953; 181.954; 181.955; 
1.34 	181.957, subdivision 1; 192A.555; 245C.08, subdivision 1; 256.01, subdivision 
1.35 	18c; 256B.0625, subdivision 13d; 256D.024, subdivisions 1, 3; 256J.26, 
1.36 	subdivisions 1, 3; 270B.12, by adding a subdivision; 273.13, subdivision 24; 
1.37 	275.025, subdivision 2; 290.0132, subdivision 29; 290.0134, subdivision 19; 
1.38 	297A.61, subdivision 3; 297A.67, subdivisions 2, 7; 297A.70, subdivisions 2, 4, 
2.1 	18; 297A.85; 297D.01; 297D.04; 297D.06; 297D.07; 297D.08; 297D.085; 297D.09, 
2.2 	subdivision 1a; 297D.10; 297D.11; 340A.412, subdivision 14; 609.135, subdivision 
2.3 	1; 609.2111; 609.5311, subdivision 1; 609.5314, subdivision 1; 609.5316, 
2.4 	subdivision 2; 609A.01; 609A.03, subdivisions 5, 9; 609B.425, subdivision 2; 
2.5 	609B.435, subdivision 2; 624.712, by adding subdivisions; 624.713, subdivision 
2.6 	1; 624.714, subdivision 6; 624.7142, subdivision 1; 624.7143, by adding a 
2.7 	subdivision; 624.7151; proposing coding for new law in Minnesota Statutes, 
2.8 	chapters 3; 116J; 116L; 120B; 144; 152; 169A; 270C; 289A; 295; 340A; 477A; 
2.9 	609A; 624; proposing coding for new law as Minnesota Statutes, chapter 342; 
2.10 	repealing Minnesota Statutes 2022, sections 34A.01, subdivision 4; 151.72; 
2.11 	152.027, subdivisions 3, 4; 152.21; 152.22, subdivisions 1, 2, 3, 4, 5, 5a, 5b, 6, 7, 
2.12 	8, 9, 10, 11, 12, 13, 14; 152.23; 152.24; 152.25, subdivisions 1, 1a, 1b, 1c, 2, 3, 
2.13 	4; 152.26; 152.261; 152.27, subdivisions 1, 2, 3, 4, 5, 6, 7; 152.28, subdivisions 
2.14 	1, 2, 3; 152.29, subdivisions 1, 2, 3, 3a, 4; 152.30; 152.31; 152.32, subdivisions 
2.15 	1, 2, 3; 152.33, subdivisions 1, 1a, 2, 3, 4, 5, 6; 152.34; 152.35; 152.36, subdivisions 
2.16 	1, 1a, 2, 3, 4, 5; 152.37; Minnesota Rules, parts 4770.0100; 4770.0200; 4770.0300; 
2.17 	4770.0400; 4770.0500; 4770.0600; 4770.0800; 4770.0900; 4770.1000; 4770.1100; 
2.18 	4770.1200; 4770.1300; 4770.1400; 4770.1460; 4770.1500; 4770.1600; 4770.1700; 
2.19 	4770.1800; 4770.1900; 4770.2000; 4770.2100; 4770.2200; 4770.2300; 4770.2400; 
2.20 	4770.2700; 4770.2800; 4770.4000; 4770.4002; 4770.4003; 4770.4004; 4770.4005; 
2.21 	4770.4007; 4770.4008; 4770.4009; 4770.4010; 4770.4012; 4770.4013; 4770.4014; 
2.22 	4770.4015; 4770.4016; 4770.4017; 4770.4018; 4770.4030.
2.23 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

2.24 	ARTICLE 1
2.25 	REGULATION OF ADULT-USE CANNABIS

2.26 	Section 1. [342.01] DEFINITIONS.
2.27 		Subdivision 1.Terms. For the purposes of this chapter, the following terms have the 
2.28 	meanings given them.
2.29 		Subd. 2.Adult-use cannabis concentrate. "Adult-use cannabis concentrate" means 
2.30 	cannabis concentrate that is approved for sale by the office or is substantially similar to a 
2.31 	product approved by the office. Adult-use cannabis concentrate does not include synthetically 
2.32 	derived cannabinoids.
2.33 		Subd. 3.Adult-use cannabis flower. "Adult-use cannabis flower" means cannabis 
2.34 	flower that is approved for sale by the office or is substantially similar to a product approved 
2.35 	by the office. Adult-use cannabis flower does not include medical cannabis flower, hemp 
2.36 	plant parts, or hemp-derived consumer products.
2.37 		Subd. 4.Adult-use cannabis product. "Adult-use cannabis product" means a cannabinoid 
2.38 	product that is approved for sale by the office or is substantially similar to a product approved 
2.39 	by the office. Adult-use cannabis product includes edible cannabis products but does not 
2.40 	include medical cannabinoid products or lower-potency hemp edibles.
3.1 		Subd. 5.Advertisement. "Advertisement" means any written or oral statement, 
3.2 	illustration, or depiction that is intended to promote sales of cannabis flower, cannabis 
3.3 	products, lower-potency hemp edibles, hemp-derived consumer products, or sales at a 
3.4 	specific cannabis business or hemp business and includes any newspaper, radio, internet 
3.5 	and electronic media, or television promotion; the distribution of fliers and circulars; and 
3.6 	the display of window and interior signs in a cannabis business. Advertisement does not 
3.7 	include a fixed outdoor sign that meets the requirements in section 342.63, subdivision 2, 
3.8 	paragraph (b).
3.9 		Subd. 6.Artificial cannabinoid. "Artificial cannabinoid" means a substance with a 
3.10 	similar chemical structure and pharmacological activity to a cannabinoid but that is not 
3.11 	extracted or derived from cannabis plants, cannabis flower, hemp plants, or hemp plant 
3.12 	parts and is instead created or produced by chemical or biochemical synthesis.
3.13 		Subd. 7.Batch. "Batch" means:
3.14 	(1) a specific quantity of cannabis plants that are cultivated from the same seed or plant 
3.15 	stock, are cultivated together, are intended to be harvested together, and receive an identical 
3.16 	propagation and cultivation treatment;
3.17 	(2) a specific quantity of cannabis flower that is harvested together; is uniform and 
3.18 	intended to meet specifications for identity, strength, purity, and composition; and receives 
3.19 	identical sorting, drying, curing, and storage treatment; or
3.20 	(3) a specific quantity of a specific cannabis product, lower-potency hemp edible, 
3.21 	synthetically derived cannabinoid, hemp-derived consumer product, or hemp-derived topical 
3.22 	product that is manufactured at the same time and using the same methods, equipment, and 
3.23 	ingredients that are uniform and intended to meet specifications for identity, strength, purity, 
3.24 	and composition and that is manufactured, packaged, and labeled according to a single batch 
3.25 	production record executed and documented during the same cycle of manufacture and 
3.26 	produced by a continuous process.
3.27 		Subd. 8.Batch number. "Batch number" means a unique numeric or alphanumeric 
3.28 	identifier assigned to a batch of cannabis flower or a batch of cannabis plants, cannabis 
3.29 	products, lower-potency hemp edibles, synthetically derived cannabinoid, hemp-derived 
3.30 	consumer products, or hemp-derived topical products.
3.31 		Subd. 9.Bona fide labor organization. "Bona fide labor organization" means a labor 
3.32 	union that represents or is actively seeking to represent cannabis workers.
4.1 		Subd. 10.Cannabinoid. "Cannabinoid" means any of the chemical constituents of hemp 
4.2 	plants or cannabis plants that are naturally occurring, biologically active, and act on the 
4.3 	cannabinoid receptors of the brain. Cannabinoid includes but is not limited to 
4.4 	tetrahydrocannabinol and cannabidiol.
4.5 		Subd. 11.Cannabinoid extraction. "Cannabinoid extraction" means the process of 
4.6 	extracting cannabis concentrate from cannabis plants or cannabis flower using water, lipids, 
4.7 	gases, solvents, or other chemicals or chemical processes, but does not include the process 
4.8 	of extracting concentrate from hemp plants or hemp plant parts or the process of creating 
4.9 	synthetically derived cannabinoids.
4.10 		Subd. 12.Cannabinoid profile. "Cannabinoid profile" means the amounts of each 
4.11 	cannabinoid that the office requires to be identified in testing and labeling, including but 
4.12 	not limited to delta-9 tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabidiol, 
4.13 	cannabidiolic acid in cannabis flower, a cannabinoid product, a batch of synthetically derived 
4.14 	cannabinoid, or a hemp-derived consumer product, expressed as percentages measured by 
4.15 	weight and, in the case of cannabinoid products and hemp-derived consumer products, 
4.16 	expressed as milligrams in each serving and package.
4.17 		Subd. 13.Cannabis business. "Cannabis business" means any of the following licensed 
4.18 	under this chapter:
4.19 	(1) cannabis microbusiness;
4.20 	(2) cannabis mezzobusiness;
4.21 	(3) cannabis cultivator;
4.22 	(4) cannabis manufacturer;
4.23 	(5) cannabis retailer;
4.24 	(6) cannabis wholesaler;
4.25 	(7) cannabis transporter;
4.26 	(8) cannabis testing facility;
4.27 	(9) cannabis event organizer;
4.28 	(10) cannabis delivery service;
4.29 	(11) medical cannabis cultivator;
4.30 	(12) medical cannabis processor; and
4.31 	(13) medical cannabis retailer.
5.1 		Subd. 14.Cannabis concentrate. (a) "Cannabis concentrate" means:
5.2 	(1) the extracts and resins of a cannabis plant or cannabis flower;
5.3 	(2) the extracts or resins of a cannabis plant or cannabis flower that are refined to increase 
5.4 	the presence of targeted cannabinoids; or
5.5 	(3) a product that is produced by refining extracts or resins of a cannabis plant or cannabis 
5.6 	flower and is intended to be consumed by combustion or vaporization of the product and 
5.7 	inhalation of smoke, aerosol, or vapor from the product.
5.8 	(b) Cannabis concentrate does not include industrial hemp, synthetically derived 
5.9 	cannabinoids, or hemp-derived consumer products.
5.10 		Subd. 15.Cannabis flower. "Cannabis flower" means the harvested flower, bud, leaves, 
5.11 	and stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower and 
5.12 	medical cannabis flower. Cannabis flower does not include cannabis seed, hemp plant parts, 
5.13 	or hemp-derived consumer products.
5.14 		Subd. 16.Cannabis industry. "Cannabis industry" means every item, product, person, 
5.15 	process, action, business, or other thing related to cannabis flower and cannabis products 
5.16 	and subject to regulation under this chapter.
5.17 		Subd. 17.Cannabis paraphernalia. "Cannabis paraphernalia" means all equipment, 
5.18 	products, and materials of any kind that are knowingly or intentionally used primarily in:
5.19 	(1) manufacturing cannabinoid products;
5.20 	(2) ingesting, inhaling, or otherwise introducing cannabis flower or cannabis products 
5.21 	into the human body; and
5.22 	(3) testing the strength, effectiveness, or purity of cannabis flower, cannabis products, 
5.23 	lower-potency hemp edibles, or hemp-derived consumer products.
5.24 		Subd. 18.Cannabis plant. "Cannabis plant" means all parts of the plant of the genus 
5.25 	Cannabis that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol 
5.26 	concentration of more than 0.3 percent on a dry weight basis.
5.27 		Subd. 19.Cannabis product. (a) "Cannabis product" means any of the following:
5.28 	(1) cannabis concentrate;
5.29 	(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol, 
5.30 	extracted or derived from cannabis plants or cannabis flower; or
5.31 	(3) any other product that contains cannabis concentrate.
6.1 	(b) Cannabis product includes adult-use cannabis products and medical cannabinoid 
6.2 	products. Cannabis product does not include cannabis flower, synthetically derived 
6.3 	cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, or 
6.4 	hemp-derived topical products.
6.5 		Subd. 20.Cannabis prohibition. "Cannabis prohibition" means the system of state and 
6.6 	federal laws that prevented establishment of a legal market and instead established petty 
6.7 	offenses and criminal offenses punishable by fines, imprisonment, or both for the cultivation, 
6.8 	possession, and sale of all parts of the plant of any species of the genus Cannabis, including 
6.9 	all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted 
6.10 	from any part of such plant; and every compound, manufacture, salt, derivative, mixture, 
6.11 	or preparation of such plant, its seeds, or resin.
6.12 		Subd. 21.Cannabis seed. "Cannabis seed" means the viable seed of the plant of the 
6.13 	genus Cannabis that is reasonably expected to grow into a cannabis plant. Cannabis seed 
6.14 	does not include hemp seed.
6.15 		Subd. 22.Cannabis worker. "Cannabis worker" means any individual employed by a 
6.16 	cannabis business and any individual who is a contractor of a cannabis business whose 
6.17 	scope of work involves the handling of cannabis plants, cannabis flower, synthetically 
6.18 	derived cannabinoids, or cannabis products.
6.19 		Subd. 23.Child-resistant. "Child-resistant" means packaging that meets the poison 
6.20 	prevention packaging standards in Code of Federal Regulations, title 16, section 1700.15.
6.21 		Subd. 24.Cooperative. "Cooperative" means an association conducting business on a 
6.22 	cooperative plan that is organized or is subject to chapter 308A or 308B.
6.23 		Subd. 25.Council. "Council" means the Cannabis Advisory Council.
6.24 		Subd. 26.Cultivation. "Cultivation" means any activity involving the planting, growing, 
6.25 	harvesting, drying, curing, grading, or trimming of cannabis plants, cannabis flower, hemp 
6.26 	plants, or hemp plant parts.
6.27 		Subd. 27.Division of Medical Cannabis. "Division of Medical Cannabis" means a 
6.28 	division housed in the Office of Cannabis Management that operates the medical cannabis 
6.29 	program.
6.30 		Subd. 28.Division of Social Equity "Division of Social Equity" means a division housed 
6.31 	in the Office of Cannabis Management that promotes development, stability, and safety in 
6.32 	communities that have experienced a disproportionate, negative impact from cannabis 
6.33 	prohibition and usage.
7.1 		Subd. 29.Edible cannabis product. "Edible cannabis product" means any product that 
7.2 	is intended to be eaten or consumed as a beverage by humans; contains a cannabinoid, 
7.3 	including a synthetically derived cannabinoid, in combination with food ingredients; is not 
7.4 	a drug; and is a type of product approved for sale by the office, or is substantially similar 
7.5 	to a product approved by the office including but not limited to products that resemble 
7.6 	nonalcoholic beverages, candy, and baked goods. Edible cannabis product does not include 
7.7 	lower-potency hemp edibles.
7.8 		Subd. 30.Health care practitioner. "Health care practitioner" means a 
7.9 	Minnesota-licensed doctor of medicine, a Minnesota-licensed physician assistant acting 
7.10 	within the scope of authorized practice, or a Minnesota-licensed advanced practice registered 
7.11 	nurse who has the primary responsibility for the care and treatment of the qualifying medical 
7.12 	condition of an individual diagnosed with a qualifying medical condition.
7.13 		Subd. 31.Health record. "Health record" has the meaning given in section 144.291, 
7.14 	subdivision 2.
7.15 		Subd. 32.Hemp business. (a) "Hemp business" means either of the following licensed 
7.16 	under this chapter:
7.17 	(1) lower-potency hemp edible manufacturer; or
7.18 	(2) lower-potency hemp edible retailer.
7.19 	(b) Hemp business does not include a person or entity licensed under chapter 18K to 
7.20 	grow industrial hemp for commercial or research purposes or to process industrial hemp 
7.21 	for commercial purposes.
7.22 		Subd. 33.Hemp concentrate. (a) "Hemp concentrate" means:
7.23 	(1) the extracts and resins of a hemp plant or hemp plant parts;
7.24 	(2) the extracts or resins of a hemp plant or hemp plant parts that are refined to increase 
7.25 	the presence of targeted cannabinoids; or
7.26 	(3) a product that is produced by refining extracts or resins of a hemp plant or hemp 
7.27 	plant parts and is intended to be consumed by combustion or vaporization of the product 
7.28 	and inhalation of smoke, aerosol, or vapor from the product.
7.29 	(b) Hemp concentrate does not include synthetically derived cannabinoids, lower-potency 
7.30 	hemp edibles, hemp-derived consumer products, or hemp-derived topical products.
7.31 		Subd. 34.Hemp consumer industry. "Hemp consumer industry" means every item, 
7.32 	product, person, process, action, business, or other thing related to synthetically derived 
8.1 	cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products subject 
8.2 	to regulation under this chapter.
8.3 		Subd. 35.Hemp-derived consumer product. (a) "Hemp-derived consumer product" 
8.4 	means a product intended for human or animal consumption that does not contain cannabis 
8.5 	flower or cannabis concentrate, and:
8.6 	(1) contains or consists of hemp plant parts; or
8.7 	(2) contains hemp concentrate or synthetically derived cannabinoids in combination 
8.8 	with other ingredients.
8.9 	(b) Hemp-derived consumer product does not include synthetically derived cannabinoids, 
8.10 	lower-potency hemp edibles, hemp-derived topical products, hemp fiber products, or hemp 
8.11 	grain.
8.12 		Subd. 36.Hemp-derived topical product. "Hemp-derived topical product" means a 
8.13 	product intended for human or animal consumption that contains hemp concentrate, is 
8.14 	intended for application externally to a part of the body of a human or animal, and does not 
8.15 	contain cannabis flower or cannabis concentrate.
8.16 		Subd. 37.Hemp fiber product. "Hemp fiber product" means an intermediate or finished 
8.17 	product made from the fiber of hemp plant parts that is not intended for human or animal 
8.18 	consumption. Hemp fiber product includes but is not limited to cordage, paper, fuel, textiles, 
8.19 	bedding, insulation, construction materials, compost materials, and industrial materials.
8.20 		Subd. 38.Hemp grain. "Hemp grain" means the harvested seeds of the hemp plant 
8.21 	intended for consumption as a food or part of a food product. Hemp grain includes oils 
8.22 	pressed or extracted from harvested hemp seeds.
8.23 		Subd. 39.Hemp plant. "Hemp plant" means all parts of the plant of the genus Cannabis 
8.24 	that is growing or has not been harvested and has a delta-9 tetrahydrocannabinol 
8.25 	concentration of no more than 0.3 percent on a dry weight basis.
8.26 		Subd. 40.Hemp plant parts. "Hemp plant parts" means any part of the harvested hemp 
8.27 	plant, including the flower, bud, leaves, stems, and stalk, but does not include derivatives, 
8.28 	extracts, cannabinoids, isomers, acids, salts, and salts of isomers that are separated from 
8.29 	the plant. Hemp plant parts does not include hemp fiber products, hemp grain, or hemp 
8.30 	seed.
8.31 		Subd. 41.Hemp seed. "Hemp seed" means the viable seed of the plant of the genus 
8.32 	Cannabis that is intended to be planted and is reasonably expected to grow into a hemp 
8.33 	plant. Hemp seed does not include cannabis seed or hemp grain.
9.1 		Subd. 42.Hemp worker. "Hemp worker" means any individual employed by a hemp 
9.2 	business and any individual who is a contractor of a hemp business whose scope of work 
9.3 	involves the handling of synthetically derived cannabinoids, hemp concentrate, lower-potency 
9.4 	hemp edibles, or hemp-derived consumer products.
9.5 		Subd. 43.Indian lands. "Indian lands" means all lands within the limits of any Indian 
9.6 	reservation within the boundaries of Minnesota and any lands within the boundaries of 
9.7 	Minnesota title to which are either held in trust by the United States or over which an Indian 
9.8 	Tribe exercises governmental power.
9.9 		Subd. 44.Industrial hemp. "Industrial hemp" has the meaning given in section 18K.02, 
9.10 	subdivision 3.
9.11 		Subd. 45.Intoxicating cannabinoid. "Intoxicating cannabinoid" means a cannabinoid, 
9.12 	including a synthetically derived cannabinoid, that when introduced into the human body 
9.13 	impairs the central nervous system or impairs the human audio, visual, or mental processes. 
9.14 	Intoxicating cannabinoid includes but is not limited to any tetrahydrocannabinol.
9.15 		Subd. 46.Labor peace agreement. "Labor peace agreement" means an agreement 
9.16 	between a cannabis business and a bona fide labor organization that protects the state's 
9.17 	interests by, at minimum, prohibiting the labor organization from engaging in picketing, 
9.18 	work stoppages, or boycotts against the cannabis business. This type of agreement shall not 
9.19 	mandate a particular method of election or certification of the bona fide labor organization.
9.20 		Subd. 47.License holder. "License holder" means a person, cooperative, or business 
9.21 	that holds any of the following licenses:
9.22 	(1) cannabis microbusiness;
9.23 	(2) cannabis mezzobusiness;
9.24 	(3) cannabis cultivator;
9.25 	(4) cannabis manufacturer;
9.26 	(5) cannabis retailer;
9.27 	(6) cannabis wholesaler;
9.28 	(7) cannabis transporter;
9.29 	(8) cannabis testing facility;
9.30 	(9) cannabis event organizer;
9.31 	(10) cannabis delivery service;
10.1 	(11) lower-potency hemp edible manufacturer;
10.2 	(12) lower-potency hemp edible retailer;
10.3 	(13) medical cannabis cultivator;
10.4 	(14) medical cannabis processor; or
10.5 	(15) medical cannabis retailer.
10.6 		Subd. 48.Local unit of government. "Local unit of government" means a home rule 
10.7 	charter or statutory city, county, town, or other political subdivision.
10.8 		Subd. 49.Lower-potency hemp edible. "Lower-potency hemp edible" means any 
10.9 	product that:
10.10 	(1) is intended to be eaten or consumed as a beverage by humans;
10.11 	(2) contains hemp concentrate or a synthetically derived cannabinoid, in combination 
10.12 	with food ingredients;
10.13 	(3) is not a drug;
10.14 	(4) consists of servings that contain no more than five milligrams of delta-9 
10.15 	tetrahydrocannabinol, 25 milligrams of cannabidiol, 25 milligrams of cannabigerol, or any 
10.16 	combination of those cannabinoids that does not exceed the identified amounts;
10.17 	(5) does not contain more than a combined total of 0.5 milligrams of all other 
10.18 	cannabinoids per serving;
10.19 	(6) does not contain a cannabinoid derived from cannabis plants or cannabis flower; and
10.20 	(7) is a type of product approved for sale by the office or is substantially similar to a 
10.21 	product approved by the office, including but not limited to products that resemble 
10.22 	nonalcoholic beverages, candy, and baked goods.
10.23 		Subd. 50.Matrix barcode. "Matrix barcode" means a code that stores data in a 
10.24 	two-dimensional array of geometrically shaped dark and light cells capable of being read 
10.25 	by the camera on a smartphone or other mobile device.
10.26 		Subd. 51.Medical cannabinoid product. (a) "Medical cannabinoid product" means a 
10.27 	product that:
10.28 	(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with 
10.29 	cannabinoids, including but not limited to synthetically derived cannabinoids; and
11.1 	(2) is provided to a patient enrolled in the registry program; a registered designated 
11.2 	caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer 
11.3 	or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical 
11.4 	condition.
11.5 	(b) A medical cannabinoid product must be in the form of:
11.6 	(1) liquid, including but not limited to oil;
11.7 	(2) pill;
11.8 	(3) liquid or oil for use with a vaporized delivery method;
11.9 	(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;
11.10 	(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and 
11.11 	sublingual tablets;
11.12 	(6) edible products in the form of gummies and chews;
11.13 	(7) topical formulation; or
11.14 	(8) any allowable form or delivery method approved by the office.
11.15 	(c) Medical cannabinoid product does not include adult-use cannabis products.
11.16 		Subd. 52.Medical cannabis business. "Medical cannabis business" means an entity 
11.17 	licensed under this chapter to engage in one or more of the following:
11.18 	(1) the cultivation of cannabis plants for medical cannabis flower;
11.19 	(2) the manufacture of medical cannabinoid products; and
11.20 	(3) the retail sale of medical cannabis flower and medical cannabinoid products.
11.21 		Subd. 53.Medical cannabis flower. "Medical cannabis flower" means cannabis flower 
11.22 	provided to a patient enrolled in the registry program; a registered designated caregiver; or 
11.23 	a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical 
11.24 	cannabis business to treat or alleviate the symptoms of a qualifying medical condition. 
11.25 	Medical cannabis flower does not include adult-use cannabis flower or hemp-derived 
11.26 	consumer products.
11.27 		Subd. 54.Medical cannabis paraphernalia. "Medical cannabis paraphernalia" means 
11.28 	a delivery device, related supply, or educational material used by a patient enrolled in the 
11.29 	registry program to administer medical cannabis and medical cannabinoid products.
12.1 		Subd. 55.Nonintoxicating cannabinoid. "Nonintoxicating cannabinoid" means a 
12.2 	cannabinoid that when introduced into the human body does not impair the central nervous 
12.3 	system and does not impair the human audio, visual, or mental processes. Nonintoxicating 
12.4 	cannabinoid includes but is not limited to cannabidiol and cannabigerol but does not include 
12.5 	any synthetically derived cannabinoid.
12.6 		Subd. 56.Office. "Office" means the Office of Cannabis Management.
12.7 		Subd. 57.Outdoor advertisement. "Outdoor advertisement" means an advertisement 
12.8 	that is located outdoors or can be seen or heard by an individual who is outdoors and includes 
12.9 	billboards; advertisements on benches; advertisements at transit stations or transit shelters; 
12.10 	advertisements on the exterior or interior of buses, taxis, light rail transit, or business vehicles; 
12.11 	and print signs that do not meet the requirements in section 342.63, subdivision 2, paragraph 
12.12 	(b), but that are placed or located on the exterior property of a cannabis business or hemp 
12.13 	business.
12.14 		Subd. 58.Patient. "Patient" means a Minnesota resident who has been diagnosed with 
12.15 	a qualifying medical condition by a health care practitioner and who has met all other 
12.16 	requirements for patients under this chapter to participate in the registry program.
12.17 		Subd. 59.Patient registry number. "Patient registry number" means a unique 
12.18 	identification number assigned by the Division of Medical Cannabis to a patient enrolled 
12.19 	in the registry program.
12.20 		Subd. 60.Plant canopy. "Plant canopy" means the total surface area within a licensed 
12.21 	cultivation facility that is used at any time to cultivate mature, flowering cannabis plants. 
12.22 	Calculation of the area of the plant canopy does not include the surface area within the 
12.23 	licensed cultivation facility that is used to cultivate immature cannabis plants and seedlings.
12.24 		Subd. 61.Qualifying medical condition. "Qualifying medical condition" means a 
12.25 	diagnosis of any of the following conditions:
12.26 	(1) Alzheimer's disease;
12.27 	(2) autism spectrum disorder that meets the requirements of the fifth edition of the 
12.28 	Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric 
12.29 	Association;
12.30 	(3) cancer;
12.31 	(4) chronic motor or vocal tic disorder;
12.32 	(5) chronic pain;
13.1 	(6) glaucoma;
13.2 	(7) human immunodeficiency virus or acquired immune deficiency syndrome;
13.3 	(8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
13.4 	(9) obstructive sleep apnea;
13.5 	(10) post-traumatic stress disorder;
13.6 	(11) Tourette's syndrome;
13.7 	(12) amyotrophic lateral sclerosis;
13.8 	(13) seizures, including those characteristic of epilepsy;
13.9 	(14) severe and persistent muscle spasms, including those characteristic of multiple 
13.10 	sclerosis;
13.11 	(15) inflammatory bowel disease, including Crohn's disease;
13.12 	(16) irritable bowel syndrome;
13.13 	(17) obsessive-compulsive disorder;
13.14 	(18) sickle cell disease;
13.15 	(19) terminal illness; or
13.16 	(20) any other medical condition or its treatment approved by the office.
13.17 		Subd. 62.Registered designated caregiver. "Registered designated caregiver" means 
13.18 	an individual who:
13.19 	(1) is at least 18 years old;
13.20 	(2) is not disqualified for a criminal offense according to section 342.19, subdivision 2;
13.21 	(3) has been approved by the Division of Medical Cannabis to assist a patient with 
13.22 	obtaining medical cannabis flower and medical cannabinoid products from a cannabis 
13.23 	retailer or medical cannabis retailer and with administering medical cannabis flower and 
13.24 	medical cannabinoid products; and
13.25 	(4) is authorized by the Division of Medical Cannabis to assist a patient with the use of 
13.26 	medical cannabis flower and medical cannabinoid products.
13.27 		Subd. 63.Registry or registry program. "Registry" or "registry program" means the 
13.28 	patient registry established under this chapter listing patients authorized to obtain medical 
13.29 	cannabis flower, medical cannabinoid products, and medical cannabis paraphernalia from 
14.1 	cannabis retailers and medical cannabis retailers and administer medical cannabis flower 
14.2 	and medical cannabinoid products.
14.3 		Subd. 64.Registry verification. "Registry verification" means the verification provided 
14.4 	by the Division of Medical Cannabis that a patient is enrolled in the registry program and 
14.5 	that includes the patient's name, patient registry number, and, if applicable, the name of the 
14.6 	patient's registered designated caregiver or parent, legal guardian, or spouse.
14.7 		Subd. 65.Restricted area. "Restricted area" means an area where cannabis flower or 
14.8 	cannabis products are cultivated, manufactured, or stored by a cannabis business.
14.9 		Subd. 66.Statewide monitoring system. "Statewide monitoring system" means the 
14.10 	system for integrated cannabis tracking, inventory, and verification established or adopted 
14.11 	by the office.
14.12 		Subd. 67.Synthetically derived cannabinoid. "Synthetically derived cannabinoid" 
14.13 	means a cannabinoid extracted from a cannabis plant, cannabis flower, hemp plant, or hemp 
14.14 	plant parts with a chemical makeup that is changed after extraction to create a different 
14.15 	cannabinoid or other chemical compound by applying a catalyst other than heat or light. 
14.16 	Synthetically derived cannabinoid includes but is not limited to any tetrahydrocannabinol 
14.17 	created from cannabidiol but does not include cannabis concentrate, cannabinoid products, 
14.18 	or hemp-derived consumer products.
14.19 		Subd. 68.Tribal medical cannabis board. "Tribal medical cannabis board" means an 
14.20 	agency established by each federally recognized Tribal government and duly authorized by 
14.21 	that Tribe's governing body to perform regulatory oversight and monitor compliance with 
14.22 	a Tribal medical cannabis program and applicable regulations.
14.23 		Subd. 69.Tribal medical cannabis program. "Tribal medical cannabis program" means 
14.24 	a program established by a federally recognized Tribal government within the boundaries 
14.25 	of Minnesota regarding the commercial production, processing, sale or distribution, and 
14.26 	possession of medical cannabis and medical cannabis products.
14.27 		Subd. 70.Tribal medical cannabis program manufacturer. "Tribal medical cannabis 
14.28 	program manufacturer" means an entity designated by a Tribal medical cannabis board 
14.29 	within the boundaries of Minnesota or a federally recognized Tribal government within the 
14.30 	boundaries of Minnesota to engage in production, processing, and sale or distribution of 
14.31 	medical cannabis and medical cannabis products under that Tribe's Tribal medical cannabis 
14.32 	program.
15.1 		Subd. 71.Tribal medical cannabis program patient. "Tribal medical cannabis program 
15.2 	patient" means a person who possesses a valid registration verification card or equivalent 
15.3 	document that is issued under the laws or regulations of a Tribal nation within the boundaries 
15.4 	of Minnesota and that verifies that the person is enrolled in or authorized to participate in 
15.5 	that Tribal nation's Tribal medical cannabis program.
15.6 		Subd. 72.Veteran. "Veteran" means an individual who satisfies the requirements in 
15.7 	section 197.447.
15.8 		Subd. 73.Visiting designated caregiver. "Visiting designated caregiver" means an 
15.9 	individual who is authorized under a visiting patient's jurisdiction of residence to assist the 
15.10 	visiting patient with the use of medical cannabis flower and medical cannabinoid products. 
15.11 	To be considered a visiting designated caregiver, the individual must possess a valid 
15.12 	verification card or its equivalent that is issued by the visiting patient's jurisdiction of 
15.13 	residence and that verifies that the individual is authorized to assist the visiting patient with 
15.14 	the administration of medical cannabis flower and medical cannabinoid products under the 
15.15 	laws or regulations of the visiting patient's jurisdiction of residence.
15.16 		Subd. 74.Visiting patient. "Visiting patient" means an individual who is not a Minnesota 
15.17 	resident and who possesses a valid registration verification card or its equivalent that is 
15.18 	issued under the laws or regulations of another state, district, commonwealth, or territory 
15.19 	of the United States verifying that the individual is enrolled in or authorized to participate 
15.20 	in that jurisdiction's medical cannabis or medical marijuana program.
15.21 		Subd. 75.Volatile solvent. "Volatile solvent" means any solvent that is or produces a 
15.22 	flammable gas or vapor that, when present in the air in sufficient quantities, will create 
15.23 	explosive or ignitable mixtures. Volatile solvent includes but is not limited to butane, hexane, 
15.24 	and propane.

15.25 	Sec. 2. [342.02] OFFICE OF CANNABIS MANAGEMENT.
15.26 		Subdivision 1.Establishment. The Office of Cannabis Management is created with the 
15.27 	powers and duties established by law. In making rules, establishing policy, and exercising 
15.28 	its regulatory authority over the cannabis industry and hemp consumer industry, the office 
15.29 	must:
15.30 	(1) promote the public health and welfare;
15.31 	(2) protect public safety;
15.32 	(3) eliminate the illicit market for cannabis flower and cannabis products;
16.1 	(4) meet the market demand for cannabis flower and cannabis products;
16.2 	(5) promote a craft industry for cannabis flower and cannabis products; and
16.3 	(6) prioritize growth and recovery in communities that have experienced a 
16.4 	disproportionate, negative impact from cannabis prohibition.
16.5 		Subd. 2.Powers and duties. The office has the following powers and duties:
16.6 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
16.7 	industry and hemp consumer industry;
16.8 	(2) to establish programming, services, and notification to protect, maintain, and improve 
16.9 	the health of citizens;
16.10 	(3) to prevent unauthorized access to adult-use cannabis flower, adult-use cannabis 
16.11 	products, lower-potency hemp edibles, and hemp-derived consumer products by individuals 
16.12 	under 21 years of age;
16.13 	(4) to establish and regularly update standards for product testing, packaging, and labeling, 
16.14 	including requirements for an expiration, sell-by, or best-used-by date;
16.15 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
16.16 	a disproportionate, negative impact from cannabis prohibition;
16.17 	(6) to issue and renew licenses;
16.18 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
16.19 	including the submission of fingerprints to the Federal Bureau of Investigation where 
16.20 	required by law and to obtain criminal conviction data for individuals seeking a license 
16.21 	from the office on the individual's behalf or as a cooperative member or director, manager, 
16.22 	or general partner of a business entity;
16.23 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
16.24 	and other documents of license holders to ensure compliance with all applicable laws and 
16.25 	rules;
16.26 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
16.27 	pursuant to the office's authority;
16.28 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
16.29 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
16.30 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
16.31 	of citizens;
17.1 	(12) to make loans and grants in aid to the extent that appropriations are made available 
17.2 	for that purpose;
17.3 	(13) to authorize research and studies on cannabis flower, cannabis products, synthetically 
17.4 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
17.5 	cannabis industry, and the hemp consumer industry;
17.6 	(14) to provide reports as required by law;
17.7 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
17.8 	cannabis products by persons 25 years of age or younger;
17.9 	(16) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
17.10 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
17.11 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
17.12 	adult-use cannabis flower and adult-use cannabis products to customers;
17.13 	(17) to permit, upon application to the office in the form prescribed by the director of 
17.14 	the office, a licensee under this chapter to perform any activity if such permission is 
17.15 	substantially necessary for the licensee to perform any other activity permitted by the 
17.16 	applicant's license and is not otherwise prohibited by law;
17.17 	(18) to remove, upon application to the office in the form prescribed by the director of 
17.18 	the office, any obligation of a licensee under this chapter if such removal is substantially 
17.19 	necessary for the licensee to perform any activity permitted by the applicant's license and 
17.20 	is not otherwise prohibited by law; and
17.21 	(19) to exercise other powers and authority and perform other duties required by law.
17.22 		Subd. 3.Medical cannabis program. (a) The powers and duties of the Department of 
17.23 	Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections 
17.24 	152.22 to 152.37, are transferred to the Office of Cannabis Management under section 
17.25 	15.039.
17.26 	(b) State employees shall not be displaced by the transfer of duties from the Department 
17.27 	of Health medical cannabis program to the Office of Cannabis Management under this 
17.28 	subdivision. Any employees transferred under this section to the Office of Cannabis 
17.29 	Management shall retain their current seniority and benefit accrual rates.
17.30 		Subd. 4.Interagency agreements. (a) The office and the commissioner of agriculture 
17.31 	shall enter into interagency agreements to ensure that edible cannabis products and 
17.32 	lower-potency hemp edibles are handled, manufactured, and inspected in a manner that is 
18.1 	consistent with the relevant food safety requirements in chapters 28A, 31, and 34A and 
18.2 	associated rules.
18.3 	(b) The office may cooperate and enter into other agreements with the commissioner of 
18.4 	agriculture and may cooperate and enter into agreements with the commissioners and 
18.5 	directors of other state agencies and departments to promote the beneficial interests of the 
18.6 	state.
18.7 		Subd. 5.Rulemaking. The office may adopt rules to implement any provisions in this 
18.8 	chapter. Rules for which notice is published in the State Register before July 1, 2025, may 
18.9 	be adopted using the expedited rulemaking process in section 14.389.
18.10 		Subd. 6.Director. (a) The governor shall appoint a director of the office with the advice 
18.11 	and consent of the senate. The director must be in the unclassified service and must serve 
18.12 	at the pleasure of the governor.
18.13 	(b) The salary of the director must not exceed the salary limit established under section 
18.14 	15A.0815, subdivision 3.
18.15 	(c) While serving as the director and within two years after terminating service, the 
18.16 	director is prohibited from having a direct or an indirect financial interest in a cannabis 
18.17 	business or hemp business licensed under this chapter.
18.18 	(d) A person who has served in the legislature or in statewide office is not eligible to be 
18.19 	appointed to the position of director until five years after the end of the person's term in the 
18.20 	legislature or statewide office.
18.21 		Subd. 7.Employees. (a) The office may employ other personnel in the classified service 
18.22 	necessary to carry out the duties in this chapter.
18.23 	(b) A prospective employee of the office must submit a completed criminal history 
18.24 	records check consent form, a full set of classifiable fingerprints, and the required fees to 
18.25 	the office. Upon receipt of this information, the office must submit the completed criminal 
18.26 	history records check consent form, full set of classifiable fingerprints, and required fees 
18.27 	to the Bureau of Criminal Apprehension. After receiving this information, the bureau must 
18.28 	conduct a Minnesota criminal history records check of the prospective employee. The bureau 
18.29 	may exchange a prospective employee's fingerprints with the Federal Bureau of Investigation 
18.30 	to obtain the prospective employee's national criminal history record information. The 
18.31 	bureau must return the results of the Minnesota and federal criminal history records checks 
18.32 	to the director to determine if the prospective employee is disqualified under section 342.19.
19.1 	(c) While employed by the office and within two years after terminating employment, 
19.2 	an employee may not have a direct or an indirect financial interest in a cannabis business 
19.3 	licensed under this chapter or a recipient of a grant under this chapter.
19.4 		Subd. 8.Division of Social Equity. The office must establish a Division of Social Equity. 
19.5 	At a minimum, the division must:
19.6 	(1) administer grants to communities that experienced a disproportionate, negative impact 
19.7 	from cannabis prohibition and usage in order to promote economic development, provide 
19.8 	services to prevent violence, support early intervention programs for youth and families, 
19.9 	and promote community stability and safety;
19.10 	(2) act as an ombudsperson for the office to provide information, investigate complaints 
19.11 	under this chapter, and provide or facilitate dispute resolutions; and
19.12 	(3) report to the office on the status of complaints and social equity in the cannabis 
19.13 	industry.
19.14 		Subd. 9.Compliance with federal law. Nothing in this chapter shall be construed to 
19.15 	allow cannabis to be transported outside of the state unless explicitly authorized by federal 
19.16 	law.

19.17 	EFFECTIVE DATE. This section is effective July 1, 2023, except for subdivision 3, 
19.18 	which is effective January 1, 2024.

19.19 	Sec. 3. [342.03] CANNABIS ADVISORY COUNCIL.
19.20 		Subdivision 1.Membership. (a) The Cannabis Advisory Council is created consisting 
19.21 	of the following members:
19.22 	(1) the director of the Office of Cannabis Management or a designee;
19.23 	(2) the commissioner of employment and economic development or a designee;
19.24 	(3) the commissioner of revenue or a designee;
19.25 	(4) the commissioner of health or a designee;
19.26 	(5) the commissioner of human services or a designee;
19.27 	(6) the commissioner of public safety or a designee;
19.28 	(7) the commissioner of human rights or a designee;
19.29 	(8) the commissioner of labor or a designee;
19.30 	(9) the commissioner of agriculture or a designee;
20.1 	(10) the commissioner of the Pollution Control Agency or a designee;
20.2 	(11) the superintendent of the Bureau of Criminal Apprehension or a designee;
20.3 	(12) the colonel of the State Patrol or a designee;
20.4 	(13) the director of the Office of Traffic Safety in the Department of Public Safety or a 
20.5 	designee;
20.6 	(14) a representative from the League of Minnesota Cities appointed by the league;
20.7 	(15) a representative from the Association of Minnesota Counties appointed by the 
20.8 	association;
20.9 	(16) an expert in minority business development appointed by the governor;
20.10 	(17) an expert in economic development strategies for under-resourced communities 
20.11 	appointed by the governor;
20.12 	(18) an expert in farming or representing the interests of farmers appointed by the 
20.13 	governor;
20.14 	(19) an expert representing the interests of cannabis workers appointed by the governor;
20.15 	(20) an expert representing the interests of employers appointed by the governor;
20.16 	(21) an expert in municipal law enforcement with advanced training in impairment 
20.17 	detection and evaluation appointed by the governor;
20.18 	(22) an expert in social welfare or social justice appointed by the governor;
20.19 	(23) an expert in criminal justice reform to mitigate the disproportionate impact of drug 
20.20 	prosecutions on communities of color appointed by the governor;
20.21 	(24) an expert in prevention, treatment, and recovery related to substance use disorders 
20.22 	appointed by the governor;
20.23 	(25) an expert in minority business ownership appointed by the governor;
20.24 	(26) an expert in women-owned businesses appointed by the governor;
20.25 	(27) an expert in cannabis retailing appointed by the governor;
20.26 	(28) an expert in cannabis product manufacturing appointed by the governor;
20.27 	(29) an expert in laboratory sciences and toxicology appointed by the governor;
20.28 	(30) an expert in providing legal services to cannabis businesses appointed by the 
20.29 	governor;
21.1 	(31) an expert in cannabis cultivation appointed by the governor;
21.2 	(32) an expert in toxicology appointed by the governor;
21.3 	(33) an expert in pediatric medicine appointed by the governor;
21.4 	(34) an expert in adult medicine appointed by the governor;
21.5 	(35) two patient advocates, one who is a patient enrolled in the medical cannabis program 
21.6 	and one who is a parent or caregiver of a patient in the medical cannabis program;
21.7 	(36) two licensed mental health professionals appointed by the governor;
21.8 	(37) a veteran appointed by the governor;
21.9 	(38) one member of each of the following federally recognized Tribes, designated by 
21.10 	the elected Tribal president or chairperson of the governing bodies of:
21.11 	(i) the Fond du Lac Band;
21.12 	(ii) the Grand Portage Band;
21.13 	(iii) the Mille Lacs Band;
21.14 	(iv) the White Earth Band;
21.15 	(v) the Bois Forte Band;
21.16 	(vi) the Leech Lake Band;
21.17 	(vii) the Red Lake Nation;
21.18 	(viii) the Upper Sioux Community;
21.19 	(ix) the Lower Sioux Indian Community;
21.20 	(x) the Shakopee Mdewakanton Sioux Community; and
21.21 	(xi) the Prairie Island Indian Community; and
21.22 	(39) a representative from the Local Public Health Association of Minnesota appointed 
21.23 	by the association.
21.24 	(b) While serving on the Cannabis Advisory Council and within two years after 
21.25 	terminating service, a council member shall not serve as a lobbyist, as defined under section 
21.26 	10A.01, subdivision 21.
21.27 		Subd. 2.Terms; compensation; removal; vacancy; expiration. The membership terms, 
21.28 	compensation, removal of members appointed by the governor, and filling of vacancies of 
21.29 	members are provided in section 15.059.
22.1 		Subd. 3.Officers; meetings. (a) The director of the Office of Cannabis Management 
22.2 	or the director's designee must chair the Cannabis Advisory Council. The advisory council 
22.3 	must elect a vice-chair and may elect other officers as necessary.
22.4 	(b) The advisory council shall meet quarterly or upon the call of the chair.
22.5 	(c) Meetings of the advisory council are subject to chapter 13D.
22.6 		Subd. 4.Duties. (a) The duties of the advisory council shall include:
22.7 	(1) reviewing national cannabis policy;
22.8 	(2) examining the effectiveness of state cannabis policy;
22.9 	(3) reviewing developments in the cannabis industry and hemp consumer industry;
22.10 	(4) reviewing developments in the study of cannabis flower, cannabis products, 
22.11 	synthetically derived cannabinoids, lower-potency hemp edibles, and hemp-derived consumer 
22.12 	products;
22.13 	(5) taking public testimony; and
22.14 	(6) making recommendations to the Office of Cannabis Management.
22.15 	(b) At its discretion, the advisory council may examine other related issues consistent 
22.16 	with this section.

22.17 	Sec. 4. [342.04] STUDIES; REPORTS.
22.18 	(a) The office shall conduct a study to determine the expected size and growth of the 
22.19 	regulated cannabis industry and hemp consumer industry, including an estimate of the 
22.20 	demand for cannabis flower and cannabis products, the number and geographic distribution 
22.21 	of cannabis businesses needed to meet that demand, and the anticipated business from 
22.22 	residents of other states.
22.23 	(b) The office shall conduct a study to determine the size of the illicit cannabis market, 
22.24 	the sources of illicit cannabis flower and illicit cannabis products in the state, the locations 
22.25 	of citations issued and arrests made for cannabis offenses, and the subareas, such as census 
22.26 	tracts or neighborhoods, that experience a disproportionately large amount of cannabis 
22.27 	enforcement.
22.28 	(c) The office shall conduct a study on impaired driving to determine:
22.29 	(1) the number of accidents involving one or more drivers who admitted to using cannabis 
22.30 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products, 
22.31 	or who tested positive for cannabis or tetrahydrocannabinol;
23.1 	(2) the number of arrests of individuals for impaired driving in which the individual 
23.2 	tested positive for cannabis or tetrahydrocannabinol; and
23.3 	(3) the number of convictions for driving under the influence of cannabis flower, cannabis 
23.4 	products, lower-potency hemp edibles, hemp-derived consumer products, or 
23.5 	tetrahydrocannabinol.
23.6 	(d) The office shall provide preliminary reports on the studies conducted pursuant to 
23.7 	paragraphs (a) to (c) to the legislature by January 15, 2024, and shall provide final reports 
23.8 	to the legislature by January 15, 2025. The reports may be consolidated into a single report 
23.9 	by the office.
23.10 	(e) The office shall collect existing data from the Department of Human Services, 
23.11 	Department of Health, Minnesota state courts, and hospitals licensed under chapter 144 on 
23.12 	the utilization of mental health and substance use disorder services, emergency room visits, 
23.13 	and commitments to identify any increase in the services provided or any increase in the 
23.14 	number of visits or commitments. The office shall also obtain summary data from existing 
23.15 	first episode psychosis programs on the number of persons served by the programs and 
23.16 	number of persons on the waiting list. All information collected by the office under this 
23.17 	paragraph shall be included in the report required under paragraph (f).
23.18 	(f) The office shall submit an annual report to the legislature by January 15, 2024, and 
23.19 	each January 15 thereafter. The annual report shall include but not be limited to the following:
23.20 	(1) the status of the regulated cannabis industry;
23.21 	(2) the status of the illicit cannabis market and hemp consumer industry;
23.22 	(3) the number of accidents, arrests, and convictions involving drivers who admitted to 
23.23 	using cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
23.24 	consumer products or who tested positive for cannabis or tetrahydrocannabinol;
23.25 	(4) the change in potency, if any, of cannabis flower and cannabis products available 
23.26 	through the regulated market;
23.27 	(5) progress on providing opportunities to individuals and communities that experienced 
23.28 	a disproportionate, negative impact from cannabis prohibition, including but not limited to 
23.29 	providing relief from criminal convictions and increasing economic opportunities;
23.30 	(6) the status of racial and geographic diversity in the cannabis industry;
23.31 	(7) proposed legislative changes;
24.1 	(8) information on the adverse effects of second-hand smoke from any cannabis flower, 
24.2 	cannabis products, and hemp-derived consumer products that are consumed by combustion 
24.3 	or vaporization of the product and inhalation of smoke, aerosol, or vapor from the product; 
24.4 	and
24.5 	(9) recommendations for levels of funding for:
24.6 	(i) a coordinated education program to address and raise public awareness about the top 
24.7 	three adverse health effects, as determined by the commissioner of health, associated with 
24.8 	the use of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
24.9 	consumer products by individuals under 21 years of age;
24.10 	(ii) a coordinated education program to educate pregnant individuals, breastfeeding 
24.11 	individuals, and individuals who may become pregnant on the adverse health effects of 
24.12 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
24.13 	products;
24.14 	(iii) training, technical assistance, and educational materials for home visiting programs,  
24.15 	Tribal home visiting programs, and child welfare workers regarding safe and unsafe use of 
24.16 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
24.17 	products in homes with infants and young children;
24.18 	(iv) model programs to educate middle school and high school students on the health 
24.19 	effects on children and adolescents of the use of cannabis flower, cannabis products, 
24.20 	lower-potency hemp edibles and hemp-derived consumer products and other intoxicating 
24.21 	or controlled substances;
24.22 	(v) grants issued through the CanTrain, CanNavigate, CanStartup, and CanGrow  
24.23 	programs;
24.24 	(vi) grants to organizations for community development in social equity communities 
24.25 	through the CanRenew program;
24.26 	(vii) training of peace officers and law enforcement agencies on changes to laws involving 
24.27 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
24.28 	products and the law's impact on searches and seizures;
24.29 	(viii) training of peace officers to increase the number of drug recognition experts;
24.30 	(ix) training of peace officers on the cultural uses of sage and distinguishing use of sage 
24.31 	from the use of cannabis flower, including whether the Board of Peace Officer Standards 
24.32 	and Training should approve or develop training materials;
25.1 	(x) the retirement and replacement of drug detection dogs; and
25.2 	(xi) the Department of Human Services and county social service agencies to address 
25.3 	any increase in demand for services.
25.4 	(g) In developing the recommended funding levels under paragraph (f), clause (9), items 
25.5 	(vii) to (xi), the office shall consult with local law enforcement agencies, the Minnesota 
25.6 	Chiefs of Police Association, the Minnesota Sheriff's Association, the League of Minnesota 
25.7 	Cities, the Association of Minnesota Counties, and county social services agencies.

25.8 	Sec. 5. [342.05] STATEWIDE MONITORING SYSTEM.
25.9 		Subdivision 1.Statewide monitoring. The office must contract with an outside vendor 
25.10 	to establish a statewide monitoring system for integrated cannabis tracking, inventory, and 
25.11 	verification to track all cannabis plants, cannabis flower, cannabis products, and synthetically 
25.12 	derived cannabinoids from seed, immature plant, or creation until disposal or sale to a patient 
25.13 	or customer.
25.14 		Subd. 2.Data submission requirements. The monitoring system must allow cannabis 
25.15 	businesses and Tribal medical cannabis program manufacturers to submit monitoring data 
25.16 	to the office through the use of monitoring system software commonly used within the 
25.17 	cannabis industry and may also permit cannabis businesses and Tribal medical cannabis 
25.18 	program manufacturers to submit monitoring data through manual data entry with approval 
25.19 	from the office.

25.20 	Sec. 6. [342.06] APPROVAL OF ADULT-USE CANNABIS FLOWER AND 
25.21 	ADULT-USE CANNABIS PRODUCTS.
25.22 		Subdivision 1.Definitions. For the purposes of this section, "type" means an individual 
25.23 	product in a product line that may be sold in different sizes, distinct packaging, or at various 
25.24 	prices but is still created using the same manufacturing or agricultural processes. A new or 
25.25 	additional stock keeping unit (SKU) or Universal Product Code (UPC) shall not prevent a 
25.26 	product from being considered the same type as another unit. All other terms have the 
25.27 	meanings provided in section 342.01.
25.28 		Subd. 2.Approval of products.  (a) The office shall approve types of adult-use cannabis 
25.29 	flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived 
25.30 	consumer products other than hemp-derived topical products for retail sale. The office shall 
25.31 	not require reapproval of a product type if the manufacturing or agricultural processes and 
25.32 	final product unit remain substantially similar to a previously approved type of adult-use 
26.1 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, or hemp-derived 
26.2 	consumer product.
26.3 	(b) The office shall not approve any adult-use cannabis product, lower-potency hemp 
26.4 	edible, or hemp-derived consumer product that:
26.5 	(1) is or appears to be a lollipop or ice cream;
26.6 	(2) bears the likeness or contains characteristics of a real or fictional person, animal, or 
26.7 	fruit;
26.8 	(3) is modeled after a type or brand of products primarily consumed by or marketed to 
26.9 	children;
26.10 	(4) is substantively similar to a meat food product; poultry food product as defined in 
26.11 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
26.12 	7;
26.13 	(5) contains an artificial cannabinoid;
26.14 	(6) is made by applying a cannabinoid, including but not limited to a synthetically derived 
26.15 	cannabinoid, to a finished food product that does not contain cannabinoids and is sold to 
26.16 	consumers, including but not limited to a candy or snack food; or
26.17 	(7) if the product is an edible cannabis product or lower-potency hemp edible, contains 
26.18 	an ingredient, other than a cannabinoid,  that is not approved by the United States Food and 
26.19 	Drug Administration for use in food.
26.20 	(c) The office must not approve any adult-use cannabis flower, adult-use cannabis 
26.21 	product, or hemp-derived consumer product that:
26.22 	(1) is intended to be consumed by combustion or vaporization of the product and 
26.23 	inhalation of smoke, aerosol, or vapor from the product; and
26.24 	(2) imparts a taste or odor, other than the taste or odor of cannabis flower, that is 
26.25 	distinguishable by an ordinary person before or during consumption of the product.
26.26 	(d) The office may adopt rules to limit or prohibit ingredients in or additives to adult-use 
26.27 	cannabis flower, adult-use cannabis products, or hemp-derived consumer products to ensure 
26.28 	compliance with the limitations in paragraph (c).

27.1 	Sec. 7. [342.07] AGRICULTURAL AND FOOD SAFETY PRACTICES; 
27.2 	RULEMAKING.
27.3 		Subdivision 1.Plant propagation standards. In consultation with the commissioner 
27.4 	of agriculture, the office by rule must establish certification, testing, and labeling 
27.5 	requirements for the methods used to grow new cannabis plants or hemp plants, including 
27.6 	but not limited to growth from seed, clone, cutting, or tissue culture.
27.7 		Subd. 2.Agricultural best practices. In consultation with the commissioner of 
27.8 	agriculture and representatives from the University of Minnesota Extension Service, the 
27.9 	office shall establish best practices for:
27.10 	(1) the cultivation and preparation of cannabis plants; and
27.11 	(2) the use of pesticides, fertilizers, soil amendments, and plant amendments in relation 
27.12 	to growing cannabis plants.
27.13 		Subd. 3.Edible cannabis product handler endorsement. (a) Any person seeking to 
27.14 	manufacture, process, sell, handle, or store an edible cannabis product or lower-potency 
27.15 	hemp edible, other than an edible cannabis product or lower-potency hemp edible that has 
27.16 	been placed in its final packaging, must first obtain an edible cannabis product handler 
27.17 	endorsement.
27.18 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
27.19 	edible cannabis product handler endorsement.
27.20 	(c) The office must regulate edible cannabis product handlers and assess penalties in the 
27.21 	same manner provided for food handlers under chapters 28A, 31, and 34A and associated 
27.22 	rules, with the following exceptions:
27.23 	(1) the office must issue an edible cannabis product handler endorsement, rather than a 
27.24 	license;
27.25 	(2) eligibility for an edible cannabis product handler endorsement is limited to persons 
27.26 	who possess a valid license issued by the office;
27.27 	(3) the office may not charge a fee for issuing or renewing the endorsement;
27.28 	(4) the office must align the term and renewal period for edible cannabis product handler 
27.29 	endorsements with the term and renewal period of the license issued by the office; and
27.30 	(5) an edible cannabis product or lower-potency hemp edible must not be considered 
27.31 	adulterated solely because the product contains tetrahydrocannabinol, cannabis concentrate, 
28.1 	hemp concentrate, synthetically derived cannabinoids, or any other material extracted or 
28.2 	derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant parts.
28.3 	(d) The edible cannabis product handler endorsement must prohibit the manufacture of 
28.4 	edible cannabis products at the same premises where food is manufactured, except for the 
28.5 	limited production of edible products produced solely for product development, sampling, 
28.6 	or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

28.7 	Sec. 8. [342.08] ESTABLISHMENT OF ENVIRONMENTAL STANDARDS.
28.8 		Subdivision 1.Water standards. In consultation with the commissioner of the Pollution 
28.9 	Control Agency, the office by rule must establish appropriate water standards for cannabis 
28.10 	businesses.
28.11 		Subd. 2.Energy use. In consultation with the commissioner of commerce, the office 
28.12 	by rule must establish appropriate energy standards for cannabis businesses.
28.13 		Subd. 3.Solid waste. In consultation with the commissioner of the Pollution Control 
28.14 	Agency, the office by rule must establish appropriate solid waste standards for the disposal 
28.15 	of:
28.16 	(1) cannabis flower and cannabis products;
28.17 	(2) packaging;
28.18 	(3) recyclable materials, including minimum requirements for the use of recyclable 
28.19 	materials; and
28.20 	(4) other solid waste.
28.21 		Subd. 4.Odor. The office by rule must establish appropriate standards and requirements 
28.22 	to limit odors produced by cannabis businesses.
28.23 		Subd. 5.Applicability; federal, state, and local laws. A cannabis business must comply 
28.24 	with all applicable federal, state, and local laws related to the subjects of subdivisions 1 to 
28.25 	4.
28.26 		Subd. 6.Rulemaking. (a) The office may only adopt a rule under this section if the rule 
28.27 	is consistent with and at least as stringent as applicable state and federal laws related to the 
28.28 	subjects of subdivisions 1 to 4.
28.29 	(b) The office must coordinate and consult with a department or agency of the state 
28.30 	regarding the development and implementation of a rule under this section if the department 
28.31 	or agency has expertise or a regulatory interest in the subject matter of the rule.

29.1 	Sec. 9. [342.09] PERSONAL ADULT USE OF CANNABIS.
29.2 		Subdivision 1.Personal adult use, possession, and transportation of adult-use 
29.3 	cannabis flower and adult-use cannabis products. (a) An individual 21 years of age or 
29.4 	older may:
29.5 	(1) use, possess, or transport cannabis paraphernalia;
29.6 	(2) possess or transport two ounces or less of adult-use cannabis flower in a public place;
29.7 	(3) possess two pounds or less of adult-use cannabis flower derived from sources other 
29.8 	than the home cultivation of cannabis plants authorized in subdivision 2 in the individual's 
29.9 	private residence;
29.10 	(4) possess five pounds or less of adult-use cannabis flower derived from the home 
29.11 	cultivation of cannabis plants authorized in subdivision 2 in the individual's private residence;
29.12 	(5) possess or transport eight grams or less of adult-use cannabis concentrate;
29.13 	(6) possess or transport edible cannabis products or lower-potency hemp edibles infused 
29.14 	with a combined total of 800 milligrams or less of tetrahydrocannabinol;
29.15 	(7) give for no remuneration to an individual who is at least 21 years of age:
29.16 	(i) two ounces or less of adult-use cannabis flower;
29.17 	(ii) eight grams or less of adult-use cannabis concentrate; or
29.18 	(iii) an edible cannabis product or lower-potency hemp edible infused with 800 milligrams 
29.19 	or less of tetrahydrocannabinol; and
29.20 	(8) use adult-use cannabis flower and adult-use cannabis products in the following 
29.21 	locations:
29.22 	(i) a private residence, including the individual's curtilage or yard;
29.23 	(ii) on private property, not generally accessible by the public, unless the individual is 
29.24 	explicitly prohibited from consuming adult-use cannabis flower, adult-use cannabis products, 
29.25 	lower-potency hemp edibles, or hemp-derived consumer products on the property by the 
29.26 	owner of the property; or
29.27 	(iii) on the premises of an establishment or event licensed to permit on-site consumption.
29.28 	Notwithstanding clauses (3) and (4), no individual may possess a total of more than five 
29.29 	pounds of adult-use cannabis flower in the individual's private residence regardless of the 
29.30 	cannabis's source.
30.1 	(b) Except as provided in paragraph (c), an individual may not:
30.2 	(1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp 
30.3 	edibles, or hemp-derived consumer products if the individual is under 21 years of age;
30.4 	(2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
30.5 	consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;
30.6 	(3) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
30.7 	consumer products at any location where smoking is prohibited under section 144.414;
30.8 	(4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
30.9 	hemp-derived consumer products in a public school, as defined in section 120A.05, 
30.10 	subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all 
30.11 	facilities, whether owned, rented, or leased, and all vehicles that a school district owns, 
30.12 	leases, rents, contracts for, or controls;
30.13 	(5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
30.14 	hemp-derived consumer products in a state correctional facility;
30.15 	(6) operate a motor vehicle while under the influence of cannabis flower, cannabis 
30.16 	products, lower-potency hemp edibles, or hemp-derived consumer products;
30.17 	(7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp 
30.18 	edibles, or hemp-derived consumer products to an individual under 21 years of age;
30.19 	(8) give for no remuneration cannabis flower or cannabis products as a sample or 
30.20 	promotional gift if the giver is in the business of selling goods or services; or
30.21 	(9) vaporize or smoke cannabis flower, cannabis products, synthetically derived 
30.22 	cannabinoids, or hemp-derived consumer products in any location where the smoke, aerosol, 
30.23 	or vapor would be inhaled by a minor.
30.24 	(c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other 
30.25 	than by smoking or by a vaporized delivery method, possession, or transportation of medical 
30.26 	cannabis flower or medical cannabinoid products by a patient; a registered designated 
30.27 	caregiver; or a parent, legal guardian, or spouse of a patient.
30.28 	(d) A proprietor of a family or group family day care program must disclose to parents 
30.29 	or guardians of children cared for on the premises of the family or group family day care 
30.30 	program, if the proprietor permits the smoking or use of cannabis flower or cannabis products 
30.31 	on the premises outside of its hours of operation. Disclosure must include posting on the 
30.32 	premises a conspicuous written notice and orally informing parents or guardians. Cannabis 
31.1 	flower or cannabis products must be inaccessible to children and stored away from food 
31.2 	products.
31.3 		Subd. 2.Home cultivation of cannabis for personal adult use. Up to eight cannabis 
31.4 	plants, with no more than four being mature, flowering plants may be grown at a single 
31.5 	residence, including the curtilage or yard, without a license to cultivate cannabis issued 
31.6 	under this chapter provided that cultivation takes place at the primary residence of an 
31.7 	individual 21 years of age or older and in an enclosed, locked space that is not open to public 
31.8 	view.
31.9 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
31.10 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
31.11 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
31.12 	manufacturer, medical cannabis processor, or lower-potency hemp edible manufacturer 
31.13 	license issued under this chapter.
31.14 		Subd. 4.Sale of cannabis flower and cannabis products prohibited. No person may 
31.15 	sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
31.16 	consumer products without a license issued under this chapter that authorizes the sale.
31.17 		Subd. 5.Importation of hemp-derived products. No person may import lower-potency 
31.18 	hemp edibles or hemp-derived consumer products, other than hemp-derived topical products, 
31.19 	that are manufactured outside the boundaries of the state of Minnesota with the intent to 
31.20 	sell the products to consumers within the state or to any other person or business that intends 
31.21 	to sell the products to consumers within the state without a license issued under this chapter 
31.22 	that authorizes the importation of such products. This subdivision does not apply to products 
31.23 	lawfully purchased for personal use.
31.24 		Subd. 6.Violations; penalties. (a) In addition to penalties listed in this subdivision, a 
31.25 	person who violates the provisions of this chapter is subject to any applicable criminal 
31.26 	penalty.
31.27 	(b) The office may assess the following civil penalties on a person who sells cannabis 
31.28 	flower without a license issued under this chapter that authorizes the sale:
31.29 	(1) if the person sells more than two ounces but not more than eight ounces of cannabis 
31.30 	flower, up to $1,000;
31.31 	(2) if the person sells more than eight ounces but not more than one pound of cannabis 
31.32 	flower, up to $5,000;
32.1 	(3) if the person sells more than one pound but not more than five pounds of cannabis 
32.2 	flower, up to $25,000;
32.3 	(4) if the person sells more than five pounds but not more than 25 pounds of cannabis 
32.4 	flower, up to $100,000;
32.5 	(5) if the person sells more than 25 pounds but not more than 50 pounds of cannabis 
32.6 	flower, up to $250,000; and
32.7 	(6) if the person sells more than 50 pounds of cannabis flower, up to $1,000,000.
32.8 	(c) The office may assess the following civil penalties on a person who sells cannabis 
32.9 	concentrate without a license issued under this chapter that authorizes the sale:
32.10 	(1) if the person sells more than eight grams but not more than 40 grams of cannabis 
32.11 	concentrate, up to $1,000;
32.12 	(2) if the person sells more than 40 grams but not more than 80 grams of cannabis 
32.13 	concentrate, up to $5,000;
32.14 	(3) if the person sells more than 80 grams but not more than 400 grams of cannabis 
32.15 	concentrate, up to $25,000;
32.16 	(4) if the person sells more than 400 grams but not more than two kilograms of cannabis 
32.17 	concentrate, up to $100,000;
32.18 	(5) if the person sells more than two kilograms but not more than four kilograms of 
32.19 	cannabis concentrate, up to $250,000; and
32.20 	(6) if the person sells more than four kilograms of cannabis concentrate, up to $1,000,000.
32.21 	(d) The office may assess the following civil penalties on a person who imports or sells 
32.22 	products infused with tetrahydrocannabinol without a license issued under this chapter that 
32.23 	authorizes the importation or sale:
32.24 	(1) if the person imports or sells products infused with a total of more than 800 milligrams 
32.25 	but not more than four grams of tetrahydrocannabinol, up to $1,000;
32.26 	(2) if the person imports or sells products infused with a total of more than four grams 
32.27 	but not more than eight grams of tetrahydrocannabinol, up to $5,000;
32.28 	(3) if the person imports or sells products infused with a total of more than eight grams 
32.29 	but not more than 40 grams of tetrahydrocannabinol, up to $25,000;
32.30 	(4) if the person imports or sells products infused with a total of more than 40 grams 
32.31 	but not more than 200 grams of tetrahydrocannabinol, up to $100,000;
33.1 	(5) if the person imports or sells products infused with a total of more than 200 grams 
33.2 	but not more than 400 grams of tetrahydrocannabinol, up to $250,000; and
33.3 	(6) if the person imports or sells products infused with a total of more than 400 grams 
33.4 	of tetrahydrocannabinol, up to $1,000,000.
33.5 	(e) The office may assess a civil penalty of up to $500 for each plant grown in excess 
33.6 	of the limit on a person who grows more than eight cannabis plants or more than four mature, 
33.7 	flowering plants, without a license to cultivate cannabis issued under this chapter.

33.8 	Sec. 10. [342.10] LICENSES; TYPES.
33.9 	The office shall issue the following types of license:
33.10 	(1) cannabis microbusiness;
33.11 	(2) cannabis mezzobusiness;
33.12 	(3) cannabis cultivator;
33.13 	(4) cannabis manufacturer;
33.14 	(5) cannabis retailer;
33.15 	(6) cannabis wholesaler;
33.16 	(7) cannabis transporter;
33.17 	(8) cannabis testing facility;
33.18 	(9) cannabis event organizer;
33.19 	(10) cannabis delivery service;
33.20 	(11) lower-potency hemp edible manufacturer;
33.21 	(12) lower-potency hemp edible retailer;
33.22 	(13) medical cannabis cultivator;
33.23 	(14) medical cannabis processor; or
33.24 	(15) medical cannabis retailer.

33.25 	Sec. 11. [342.11] LICENSES; FEES.
33.26 	(a) The office shall require the payment of application fees, initial licensing fees, and 
33.27 	renewal licensing fees as provided in this section. The initial license fee shall include the 
33.28 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
34.1 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
34.2 	Nothing in this section prohibits a local unit of government from charging the retailer 
34.3 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
34.4 	renewal licensing fees are nonrefundable.
34.5 	(b) Application and licensing fees shall be as follows:
34.6 	(1) for a cannabis microbusiness:
34.7 	(i) an application fee of $500;
34.8 	(ii) an initial license fee of $0; and
34.9 	(iii) a renewal license fee of $2,000;
34.10 	(2) for a cannabis mezzobusiness:
34.11 	(i) an application fee of $5,000;
34.12 	(ii) an initial license fee of $5,000; and
34.13 	(iii) a renewal license fee of $10,000;
34.14 	(3) for a cannabis cultivator:
34.15 	(i) an application fee of $10,000;
34.16 	(ii) an initial license fee of $20,000; and
34.17 	(iii) a renewal license fee of $30,000;
34.18 	(4) for a cannabis manufacturer:
34.19 	(i) an application fee of $10,000;
34.20 	(ii) an initial license fee of $10,000; and
34.21 	(iii) a renewal license fee of $20,000;
34.22 	(5) for a cannabis retailer:
34.23 	(i) an application fee of $2,500;
34.24 	(ii) an initial license fee of $2,500; and
34.25 	(iii) a renewal license fee of $5,000;
34.26 	(6) for a cannabis wholesaler:
34.27 	(i) an application fee of $5,000;
34.28 	(ii) an initial license fee of $5,000; and
35.1 	(iii) a renewal license fee of $10,000;
35.2 	(7) for a cannabis transporter:
35.3 	(i) an application fee of $250;
35.4 	(ii) an initial license fee of $500; and
35.5 	(iii) a renewal license fee of $1,000;
35.6 	(8) for a cannabis testing facility:
35.7 	(i) an application fee of $10,000;
35.8 	(ii) an initial license fee of $10,000; and
35.9 	(iii) a renewal license fee of $20,000;
35.10 	(9) for a cannabis delivery service:
35.11 	(i) an application fee of $250;
35.12 	(ii) an initial license fee of $500; and
35.13 	(iii) a renewal license fee of $1,000;
35.14 	(10) for a cannabis event organizer:
35.15 	(i) an application fee of $750; and
35.16 	(ii) an initial license fee of $750;
35.17 	(11) for a lower-potency hemp edible manufacturer:
35.18 	(i) an application fee of $250;
35.19 	(ii) an initial license fee of $1,000; and
35.20 	(iii) a renewal license fee of $1,000;
35.21 	(12) for a lower-potency hemp edible retailer:
35.22 	(i) an application fee of $250 per retail location;
35.23 	(ii) an initial license fee of $250 per retail location; and
35.24 	(iii) a renewal license fee of $250 per retail location;
35.25 	(13) for a medical cannabis cultivator:
35.26 	(i) an application fee of $250;
35.27 	(ii) an initial license fee of $0; and
36.1 	(iii) a renewal license fee of $0;
36.2 	(14) for a medical cannabis processor:
36.3 	(i) an application fee of $250;
36.4 	(ii) an initial license fee of $0; and
36.5 	(iii) a renewal license fee of $0; and
36.6 	(15) for a medical cannabis retailer:
36.7 	(i) an application fee of $250;
36.8 	(ii) an initial license fee of $0; and
36.9 	(iii) a renewal license fee of $0.

36.10 	Sec. 12. [342.12] LICENSES; TRANSFERS; ADJUSTMENTS.
36.11 	(a) Licenses issued under this chapter may be freely transferred subject to the prior 
36.12 	written approval of the office, which approval may be given or withheld in the office's sole 
36.13 	discretion, provided that a social equity applicant may only transfer the applicant's license 
36.14 	to another social equity applicant. A new license must be obtained when:
36.15 	(1) the form of the licensee's legal business structure converts or changes to a different 
36.16 	type of legal business structure; or
36.17 	(2) the licensee dissolves; reorganizes; undergoes bankruptcy, insolvency, or receivership 
36.18 	proceedings; or assigns all or substantially all of its assets for the benefit of creditors.
36.19 	(b) Licenses must be renewed annually.
36.20 	(c) License holders may petition the office to adjust the tier of a license issued within a 
36.21 	license category provided that the license holder meets all applicable requirements.
36.22 	(d) The office by rule may permit relocation of a licensed cannabis business, adopt 
36.23 	requirements for the submission of a license relocation application, establish standards for 
36.24 	the approval of a relocation application, and charge a fee not to exceed $250 for reviewing 
36.25 	and processing applications. Relocation of a licensed premises pursuant to this paragraph 
36.26 	does not extend or otherwise modify the license term of the license subject to relocation.

37.1 	Sec. 13. [342.13] LOCAL CONTROL.
37.2 	(a) A local unit of government may not prohibit the possession, transportation, or use 
37.3 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
37.4 	consumer products authorized under this chapter.
37.5 	(b) A local unit of government may not prohibit the establishment or operation of a 
37.6 	cannabis business licensed under this chapter.
37.7 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
37.8 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
37.9 	the establishment or operation of cannabis businesses. A local unit of government may 
37.10 	prohibit the operation of a cannabis business within 500 feet of a school, day care, or park.
37.11 	(d) The office shall work with local units of government to develop model ordinances 
37.12 	for reasonable restrictions on the time, place, and manner of the operation of a cannabis 
37.13 	business.
37.14 	(e) If a local unit of government is conducting studies or has authorized a study to be 
37.15 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
37.16 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
37.17 	a cannabis business, the governing body of the local unit of government may adopt an 
37.18 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
37.19 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
37.20 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
37.21 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
37.22 	or a portion thereof until January 1, 2025.
37.23 	(f) Within 30 days of receiving a copy of an application for a cannabis business license 
37.24 	from the office, a local unit of government shall certify on a form provided by the office 
37.25 	whether a proposed cannabis business complies with local zoning ordinances and, if 
37.26 	applicable, whether the proposed business complies with the state fire code and building 
37.27 	code.
37.28 	(g) Upon receipt of an application for a license issued under this chapter, the office shall 
37.29 	contact the local unit of government in which the business would be located and provide 
37.30 	the local unit of government with 30 days in which to provide input on the application. The 
37.31 	local unit of government may provide the office with any additional information it believes 
37.32 	is relevant to the office's decision on whether to issue a license, including but not limited 
37.33 	to identifying concerns about the proposed location of a cannabis business or sharing public 
37.34 	information about an applicant.
38.1 	(h) The office by rule shall establish an expedited complaint process to receive, review, 
38.2 	and respond to complaints made by a local unit of government about a cannabis business. 
38.3 	Complaints may include alleged violations of local ordinances or other alleged violations. 
38.4 	At a minimum, the expedited complaint process shall require the office to provide an initial 
38.5 	response to the complaint within seven days and perform any necessary inspections within 
38.6 	30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a 
38.7 	local ordinance.

38.8 	Sec. 14. [342.135] LOCAL RESTRICTION ON NUMBER OF CANNABIS 
38.9 	RETAILERS.
38.10 	(a) A local government unit that issues cannabis retailer registration under section 342.22 
38.11 	may, by ordinance, limit the number of licensed cannabis retailers consistent with the 
38.12 	following limits:
38.13 	(1) in cities of the first class and counties, one license for every 10,000 population;
38.14 	(2) in cities of the second class, at least four licenses plus one for every 5,000 over 45,000 
38.15 	population;
38.16 	(3) in cities of the third class, at least two licenses;
38.17 	(4) in cities of 5,000 to 10,000 population, at least one license; and
38.18 	(5) in cities under 5,000 population, at least one license.
38.19 	(b) Nothing in this subdivision shall prohibit a local government from allowing licensed 
38.20 	cannabis retailers in excess of the minimums set in paragraph (a).

38.21 	Sec. 15. [342.14] LICENSE APPLICATION AND RENEWAL; FEES.
38.22 		Subdivision 1.Application; contents. (a) The office by rule shall establish forms and 
38.23 	procedures for the processing of licenses issued under this chapter. At a minimum, any 
38.24 	application to obtain or renew a license shall include the following information, if applicable:
38.25 	(1) the name, address, and date of birth of the applicant;
38.26 	(2) the disclosure of ownership and control required under paragraph (b);
38.27 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
38.28 	director, manager, and general partner of the business has ever filed for bankruptcy;
38.29 	(4) the address and legal property description of the business;
39.1 	(5) a general description of the location or locations the applicant plans to operate, 
39.2 	including the planned square feet of planned space for cultivation, wholesaling, and retailing, 
39.3 	as applicable;
39.4 	(6) a diversity plan that establishes a goal of diversity in ownership, management, 
39.5 	employment, and contracting;
39.6 	(7) a copy of the security plan;
39.7 	(8) proof of trade name registration;
39.8 	(9) a copy of the applicant's business plan showing the expected size of the business; 
39.9 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
39.10 	applicant and any officer, director, manager, and general partner of the business; the 
39.11 	environmental plan; and other relevant financial and operational components;
39.12 	(10) an attestation signed by a bona fide labor organization stating that the applicant has 
39.13 	entered into a labor peace agreement;
39.14 	(11) certification that the applicant will comply with the requirements of this chapter 
39.15 	relating to the ownership and operation of a cannabis business;
39.16 	(12) a land use compatibility statement from the local unit of government;
39.17 	(13) identification of one or more controlling persons or managerial employees as agents 
39.18 	who shall be responsible for dealing with the office on all matters; and
39.19 	(14) a statement that the applicant agrees to respond to the office's supplemental requests 
39.20 	for information.
39.21 	(b) An applicant must file and update as necessary a disclosure of ownership and control. 
39.22 	The office by rule shall establish the contents and form of the disclosure. At a minimum, 
39.23 	the disclosure shall include the following:
39.24 	(1) the management structure, ownership, and control of the applicant or license holder, 
39.25 	including the name of each cooperative member, officer, director, manager, general partner 
39.26 	or business entity; the office or position held by each person; each person's percentage 
39.27 	ownership interest, if any; and, if the business has a parent company, the name of each 
39.28 	owner, board member, and officer of the parent company and the owner's, board member's, 
39.29 	or officer's percentage ownership interest in the parent company and the cannabis business;
39.30 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
39.31 	director, manager, and general partner of the business, indicating whether that person has 
40.1 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
40.2 	any other state or territory of the United States, or any other country;
40.3 	(3) if the applicant is a corporation, copies of its articles of incorporation and bylaws 
40.4 	and any amendments to its articles of incorporation or bylaws;
40.5 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
40.6 	(5) copies of any promissory notes, security instruments, or other similar agreements;
40.7 	(6) explanation detailing the funding sources used to finance the business;
40.8 	(7) a list of operating and investment accounts for the business, including any applicable 
40.9 	financial institution and account number; and
40.10 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
40.11 	including the loan amount, loan terms, and name and address of the creditor.
40.12 	(c) An application may include:
40.13 	(1) proof that the applicant is a social equity applicant;
40.14 	(2) a description of the training and education that will be provided to any employee; 
40.15 	or
40.16 	(3) a copy of business policies governing operations to ensure compliance with this 
40.17 	chapter.
40.18 	(d) Commitments made by an applicant in its application, including but not limited to 
40.19 	the maintenance of a labor peace agreement, shall be an ongoing material condition of 
40.20 	maintaining and renewing the license.
40.21 	(e) An application on behalf of a corporation or association shall be signed by at least 
40.22 	two officers or managing agents of that entity.
40.23 		Subd. 2.Application; process. (a) An applicant must submit all required information 
40.24 	to the office on the forms and in the manner prescribed by the office.
40.25 	(b) If the office receives an application that fails to provide the required information, 
40.26 	the office shall issue a deficiency notice to the applicant. The applicant shall have ten 
40.27 	business days from the date of the deficiency notice to submit the required information.
40.28 	(c) Failure by an applicant to submit all required information will result in the application 
40.29 	being rejected.
40.30 	(d) Upon receipt of a completed application and fee, or a site permit application, the 
40.31 	office shall forward a copy of the application to the local unit of government in which the 
41.1 	business operates or intends to operate with a form for certification as to whether a proposed 
41.2 	cannabis business complies with local zoning ordinances and, if applicable, whether the 
41.3 	proposed business complies with the state fire code and building code.
41.4 	(e) Within 90 days of receiving a completed application, the office shall issue the 
41.5 	appropriate license or send the applicant a notice of rejection setting forth specific reasons 
41.6 	that the office did not approve the application.
41.7 		Subd. 3.Criminal history check. A license applicant or, in the case of a business entity, 
41.8 	every cooperative member or director, manager, and general partner of the business entity, 
41.9 	must submit a completed criminal history records check consent form, a full set of classifiable 
41.10 	fingerprints, and the required fees to the office. Upon receipt of this information, the office 
41.11 	must submit the completed criminal history records check consent form, full set of classifiable 
41.12 	fingerprints, and required fees to the Bureau of Criminal Apprehension. After receiving this 
41.13 	information, the bureau must conduct a Minnesota criminal history records check of the 
41.14 	person. The bureau may exchange the person's fingerprints with the Federal Bureau of 
41.15 	Investigation to obtain the person's national criminal history record information. The bureau 
41.16 	must return the results of the Minnesota and federal criminal history records checks to the 
41.17 	director to determine if the person is disqualified under section 342.19.

41.18 	Sec. 16. [342.15] SOCIAL EQUITY APPLICANTS.
41.19 	An individual qualifies as a social equity applicant if the individual is:
41.20 	(1) a military veteran who lost honorable status due to a cannabis-related offense;
41.21 	(2) a resident for the last five years of one or more subareas, such as census tracts or 
41.22 	neighborhoods, that experienced a disproportionately large amount of cannabis enforcement 
41.23 	as determined by the study conducted by the office pursuant to section 342.04, paragraph 
41.24 	(b), and reported in the preliminary report, final report, or both; or
41.25 	(3) a resident for the last five years of one or more census tracts where, as reported in 
41.26 	the most recently completed decennial census published by the United States Bureau of the 
41.27 	Census, either:
41.28 	(i) the poverty rate was 20 percent or more; or
41.29 	(ii) the median family income did not exceed 80 percent of statewide median family 
41.30 	income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide 
41.31 	median family income or 80 percent of the median family income for that metropolitan 
41.32 	area.

42.1 	Sec. 17. [342.16] LICENSE SELECTION CRITERIA.
42.2 		Subdivision 1.Market stability. The office shall issue the necessary number of licenses 
42.3 	in order to ensure the sufficient supply of cannabis flower and cannabis products to meet 
42.4 	demand, provide market stability, ensure a competitive market, and limit the sale of 
42.5 	unregulated cannabis flower and cannabis products. The office shall annually complete a 
42.6 	market analysis to determine whether it is fulfilling the four requirements listed in this 
42.7 	subdivision. The office shall hold public hearings as part of the market analysis to hear from 
42.8 	consumers, market stakeholders, and potential new applicants.
42.9 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
42.10 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
42.11 	in the applicant being vertically integrated in violation of the provisions of this chapter.
42.12 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses or 
42.13 	mezzobusiness licenses or the issuance of both lower-potency hemp edible manufacturer 
42.14 	and lower-potency hemp edible retailer licenses to the same person or entity.
42.15 	(c) Nothing in this section prohibits or limits the two medical cannabis licensees licensed 
42.16 	as of January 1, 2023, from being vertically integrated through its existing cultivation, 
42.17 	processing, and dispensaries.
42.18 		Subd. 3.Application score; license priority. (a) The office shall award points to each 
42.19 	completed application for a license to operate a cannabis business in the following categories:
42.20 	(1) status as a social equity applicant or as an applicant who is substantially similar to 
42.21 	a social equity applicant as described in paragraph (c);
42.22 	(2) status as a veteran applicant;
42.23 	(3) security and record keeping;
42.24 	(4) employee training plan;
42.25 	(5) business plan and financial situation;
42.26 	(6) diversity plan;
42.27 	(7) labor and employment practices;
42.28 	(8) knowledge and experience; and
42.29 	(9) environmental plan.
43.1 	(b) The office may award additional points to an application if the license holder would 
43.2 	expand service to an underrepresented market including but not limited to participation in 
43.3 	the medical cannabis program.
43.4 	(c) The office shall establish application materials permitting individual applicants to 
43.5 	demonstrate the impact that cannabis prohibition has had on that applicant including but 
43.6 	not limited to the arrest or imprisonment of the applicant or a member of the applicant's 
43.7 	immediate family, and the office may award points to such applicants in the same manner 
43.8 	as points are awarded to social equity applicants.
43.9 	(d) The office shall establish policies and guidelines, which shall be made available to 
43.10 	the public, regarding the number of points available in each category and the basis for 
43.11 	awarding those points. Status as a social equity applicant must account for at least 20 percent 
43.12 	of the total available points. In determining the number of points to award to a cooperative 
43.13 	or business applying as a social equity applicant, the office shall consider the number or 
43.14 	ownership percentage of cooperative members, officers, directors, managers, and general 
43.15 	partners who qualify as social equity applicants.
43.16 	(e) Consistent with the goals identified in subdivision 1, the office shall issue licenses 
43.17 	in each license category, giving priority to applicants who receive the highest score under 
43.18 	paragraphs (a) and (b). If there are insufficient licenses available for entities that receive 
43.19 	identical scores, the office shall utilize a lottery to randomly select license recipients from 
43.20 	among those entities.
43.21 		Subd. 4.Local land use compatibility statement. (a) Prior to the issuance of a license, 
43.22 	the office shall request a land use compatibility statement from the city, town, or county 
43.23 	that authorizes the land use. The land use compatibility statement must demonstrate that 
43.24 	the requested license is for a land use that is allowable within the given zoning designation 
43.25 	where the land is located. The office may not issue a license if the land use compatibility 
43.26 	statement shows that the proposed land use is prohibited in the applicable zone or if the 
43.27 	applicant has failed to meet the land use requirements of the jurisdiction.
43.28 	(b) A city, town, or county that receives a request from the office for a land use 
43.29 	compatibility statement under this section must act on that request within 21 days of receipt 
43.30 	of the request if the land use is allowable and the applicant has applied for and received all 
43.31 	necessary land use approvals.
43.32 	(c) The office shall not issue a license to an applicant who has failed to receive a local 
43.33 	land use compatibility statement approval from a local unit of government or to an applicant 
43.34 	whose local approvals have been suspended or revoked.

44.1 	Sec. 18. [342.17] INSPECTION; LICENSE VIOLATIONS; PENALTIES.
44.2 		Subdivision 1.Authority to inspect. (a) In order to carry out the purposes of this chapter, 
44.3 	the office, upon presenting appropriate credentials to the owner, operator, or agent in charge, 
44.4 	is authorized to:
44.5 	(1) enter any cannabis business or hemp business without delay and at reasonable times;
44.6 	(2) inspect and investigate during regular working hours and at other reasonable times, 
44.7 	within reasonable limits and in a reasonable manner, any cannabis business or hemp business 
44.8 	and all relevant conditions, equipment, records, and materials therein; and
44.9 	(3) question privately any employer, owner, operator, agent, or employee of a cannabis 
44.10 	business or hemp business.
44.11 	(b) An employer, owner, operator, agent, or employee must not refuse the office entry 
44.12 	or otherwise deter or prohibit the office from taking action under paragraph (a).
44.13 		Subd. 2.Powers of office.  (a) In making inspections and investigations under this chapter, 
44.14 	the office shall have the power to administer oaths, certify as to official acts, take and cause 
44.15 	to be taken depositions of witnesses, issue subpoenas, and compel the attendance of witnesses 
44.16 	and production of papers, books, documents, records, and testimony. In case of failure of 
44.17 	any person to comply with any subpoena lawfully issued, or on the refusal of any witness 
44.18 	to produce evidence or to testify to any matter regarding which the person may be lawfully 
44.19 	interrogated, the district court shall, upon application of the office, compel obedience 
44.20 	proceedings for contempt, as in the case of disobedience of the requirements of a subpoena 
44.21 	issued by the court or a refusal to testify therein.
44.22 	(b) If the office finds probable cause to believe that any cannabis plant, cannabis flower, 
44.23 	cannabis product, synthetically derived cannabinoid, lower-potency hemp edible, or 
44.24 	hemp-derived consumer product is being distributed in violation of this chapter or rules 
44.25 	adopted under this chapter, the office shall affix to the item a tag, withdrawal from 
44.26 	distribution order, or other appropriate marking providing notice that the cannabis plant, 
44.27 	cannabis flower, cannabis product, synthetically derived cannabinoid, lower-potency hemp 
44.28 	edible, or hemp-derived consumer product is, or is suspected of being, distributed in violation 
44.29 	of this chapter and has been detained or embargoed, and warning all persons not to remove 
44.30 	or dispose of the item by sale or otherwise until permission for removal or disposal is given 
44.31 	by the office or the court. It is unlawful for a person to remove or dispose of detained or 
44.32 	embargoed cannabis plant, cannabis flower, cannabis product, synthetically derived 
44.33 	cannabinoid, lower-potency hemp edible, or hemp-derived consumer product by sale or 
45.1 	otherwise without the office's or a court's permission and each transaction is a separate 
45.2 	violation of this section.
45.3 	(c) Notwithstanding subdivision 5, if any cannabis plant, cannabis flower, cannabis 
45.4 	product, synthetically derived cannabinoid, lower-potency hemp edible, or hemp-derived 
45.5 	consumer product has been found by the office to be in violation of this chapter, the office 
45.6 	shall petition the district court in the county in which the item is detained or embargoed for 
45.7 	an order and decree for the condemnation of the item. The office shall release the cannabis 
45.8 	plant, cannabis flower, cannabis product, synthetically derived cannabinoid, lower-potency 
45.9 	hemp edible, or hemp-derived consumer product when this chapter and rules adopted under 
45.10 	this chapter have been complied with or the item is found not to be in violation of this 
45.11 	chapter or rules adopted under this chapter.
45.12 	(d) If the court finds that detained or embargoed cannabis plant, cannabis flower, 
45.13 	synthetically derived cannabinoid, cannabis product, lower-potency hemp edible, or 
45.14 	hemp-derived consumer product is in violation of this chapter or rules adopted under this 
45.15 	chapter, the following remedies are available:
45.16 	(1) after entering a decree, the cannabis plant, cannabis flower, cannabis product, 
45.17 	synthetically derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer 
45.18 	product may be destroyed at the expense of the claimant under the supervision of the office, 
45.19 	and all court costs, fees, storage, and other proper expenses must be assessed against the 
45.20 	claimant of the cannabis plant, cannabis flower, cannabis product, synthetically derived 
45.21 	cannabinoid, lower-potency hemp edible, or hemp-derived consumer product or the claimant's 
45.22 	agent; and
45.23 	(2) if the violation can be corrected by proper labeling or processing of the cannabis 
45.24 	plant, cannabis flower, cannabis product, synthetically derived cannabinoid, lower-potency 
45.25 	hemp edible, or hemp-derived consumer product, the court, after entry of the decree and 
45.26 	after costs, fees, and expenses have been paid, and a good and sufficient bond conditioned 
45.27 	that the cannabis plant, cannabis flower, synthetically derived cannabinoid, lower-potency 
45.28 	hemp edible, or hemp-derived consumer product must be properly labeled or processed has 
45.29 	been executed, may by order direct that the cannabis plant, cannabis flower, cannabis product, 
45.30 	synthetically derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer 
45.31 	product be delivered to the claimant for proper labeling or processing under the supervision 
45.32 	of the office. The office's supervision expenses must be paid by the claimant. The cannabis 
45.33 	plant, cannabis flower, cannabis product, synthetically derived cannabinoid, lower-potency 
45.34 	hemp edible, or hemp-derived consumer product must be returned to the claimant and the 
45.35 	bond must be discharged on representation to the court by the office that the cannabis plant, 
46.1 	cannabis flower, cannabis product, synthetically derived cannabinoid, lower-potency hemp 
46.2 	edible, or hemp-derived consumer product is no longer in violation and that the office's 
46.3 	supervision expenses have been paid.
46.4 	(e) If the office finds in any room, building, piece of equipment, vehicle of transportation, 
46.5 	or other structure any cannabis plant, cannabis flower, cannabis product, synthetically 
46.6 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product that 
46.7 	is unsound or contains any filthy, decomposed, or putrid substance, or that may be poisonous 
46.8 	or deleterious to health or otherwise unsafe, the office shall condemn or destroy the item 
46.9 	or in any other manner render the item as unsalable, and no one has any cause of action 
46.10 	against the office on account of the office's action.
46.11 	(f) The office may enter into an agreement with the commissioner of agriculture to 
46.12 	analyze and examine samples or other articles furnished by the office for the purpose of 
46.13 	determining whether the sample or article violates this chapter or rules adopted under this 
46.14 	chapter. A copy of the examination or analysis report for any such article, duly authenticated 
46.15 	under oath by the laboratory analyst making the determination or examination, shall be 
46.16 	prima facie evidence in all courts of the matters and facts contained in the report.
46.17 		Subd. 3.Aiding of inspection. Subject to rules issued by the office, a representative of 
46.18 	a cannabis business or hemp business shall be given an opportunity to accompany the office 
46.19 	during the physical inspection of any cannabis business or hemp business for the purpose 
46.20 	of aiding such inspection.
46.21 		Subd. 4.Complaints and reports; priority of inspection. (a) The office may conduct 
46.22 	inspections of any licensed cannabis business or hemp business at any time to ensure 
46.23 	compliance with the ownership and operation requirements of this chapter.
46.24 	(b) Any person may report a suspected violation of a safety or health standard. If upon 
46.25 	receipt of such notification the office determines that there are reasonable grounds to believe 
46.26 	that such violation or danger exists, the office shall make a special inspection as soon as 
46.27 	practicable to determine if such danger or violation exists.
46.28 	(c) The office shall prioritize inspections of cannabis businesses or hemp businesses 
46.29 	where there are reasonable grounds to believe that a violation poses imminent danger to the 
46.30 	public or customers.
46.31 	(d) The office shall promptly inspect cannabis businesses or hemp businesses that are 
46.32 	the subject of complaint by a local unit of government.
47.1 		Subd. 5.Violations; administrative orders and penalties. (a) The office may issue an 
47.2 	administrative order to any licensed cannabis business or hemp business that the office 
47.3 	determines has committed a violation of this chapter or rules adopted pursuant to this chapter. 
47.4 	The administrative order may require the business to correct the violation or to cease and 
47.5 	desist from committing the violation. The order must state the deficiencies that constitute 
47.6 	the violation and the time by which the violation must be corrected. If the business believes 
47.7 	that the information in the administrative order is in error, the business may ask the office 
47.8 	to consider the parts of the order that are alleged to be in error. The request must be in 
47.9 	writing, delivered to the office by certified mail within seven days after receipt of the order, 
47.10 	and provide documentation to support the allegation of error. The office must respond to a 
47.11 	request for reconsideration within 15 days after receiving the request. A request for 
47.12 	reconsideration does not stay the correction order unless the office issues a supplemental 
47.13 	order granting additional time. The office's disposition of a request for reconsideration is 
47.14 	final.
47.15 	(b) For each violation of this chapter or rules adopted pursuant to this chapter, the office 
47.16 	may issue to each business a monetary penalty of up to $10,000, an amount that deprives 
47.17 	the business of any economic advantage gained by the violation, or both.
47.18 	(c) An administrative penalty may be recovered in a civil action in the name of the state 
47.19 	brought in the district court of the county where the violation is alleged to have occurred 
47.20 	or the district court where the office is housed.
47.21 	(d) In addition to penalties listed in this subdivision, a person or business who violates 
47.22 	the provisions of this chapter is subject to any applicable criminal penalty.

47.23 	Sec. 19. [342.18] LICENSE SUSPENSION OR REVOCATION; HEARING.
47.24 		Subdivision 1.License revocation and nonrenewal. The office may revoke or not 
47.25 	renew a license when the office has cause to believe that a cannabis business has violated 
47.26 	an ownership or operational requirement in this chapter or rules adopted pursuant to this 
47.27 	chapter. The office must notify the license holder in writing, specifying the grounds for 
47.28 	revocation or nonrenewal and fixing a time of at least 20 days thereafter for a hearing on 
47.29 	the matter.
47.30 		Subd. 2.Hearing; written findings. (a) Before the office revokes or does not renew a 
47.31 	license, the office must provide the license holder with a statement of the complaints made 
47.32 	against the license holder, and the office must hold a hearing to determine whether the office 
47.33 	should revoke the license or deny renewal of the license. The license holder shall receive 
47.34 	notice at least 20 days before the date of the hearing and notice may be served either by 
48.1 	certified mail addressed to the address of the license holder as shown in the license 
48.2 	application or in the manner provided by law for the service of a summons. At the time and 
48.3 	place fixed for the hearing, the office, or any office employee or agent authorized by the 
48.4 	office to conduct the hearing, shall receive evidence, administer oaths, and examine witnesses.
48.5 	(b) After the hearing held pursuant to paragraph (a), or upon the failure of the license 
48.6 	holder to appear at the hearing, the office must take action as is deemed advisable and issue 
48.7 	written findings that the office must mail to the license holder. An action of the office under 
48.8 	this paragraph is subject to judicial review pursuant to chapter 14.
48.9 		Subd. 3.Temporary suspension. The office may temporarily, without hearing, suspend 
48.10 	the license and operating privilege of any business licensed under this chapter for up to 90 
48.11 	days if continuing the operation of the business would threaten the health or safety of any 
48.12 	person. The office may extend the period for an additional 90 days if the office notified the 
48.13 	business that the office intends to revoke or not renew a license and the hearing required 
48.14 	under subdivision 2 has not taken place.

48.15 	Sec. 20. [342.185] DATA PRACTICES; APPLICANTS; LICENSE HOLDERS.
48.16 		Subdivision 1.Not public data. The following data collected, created, or maintained 
48.17 	by the office are classified as nonpublic data, as defined by section 13.02, subdivision 9, or 
48.18 	as private data on individuals, as defined by section 13.02, subdivision 12:
48.19 	(1) application data submitted by an applicant for a cannabis business license, other than 
48.20 	the data listed in subdivision 2;
48.21 	(2) the identity of a complainant who has made a report concerning a license holder or 
48.22 	applicant that appears in inactive complaint data unless the complainant consents to the 
48.23 	disclosure;
48.24 	(3) the nature or content of unsubstantiated complaints when the information is not 
48.25 	maintained in anticipation of legal action;
48.26 	(4) the record of any disciplinary proceeding except as limited by subdivision 4;
48.27 	(5) data identifying retail or wholesale customers of a cannabis business; and
48.28 	(6) data identifying cannabis workers.
48.29 		Subd. 2.Public data on license applicants. (a) The following application data submitted 
48.30 	by an applicant for a cannabis business license are public data:
48.31 	(1) the applicant's name and designated address;
49.1 	(2) data disclosing the ownership and control of the applicant;
49.2 	(3) proof of trade name registration;
49.3 	(4) data showing the legal possession of the premises where the business will operate;
49.4 	(5) data describing whether volatile chemicals will be used in any methods of extraction 
49.5 	or concentration;
49.6 	(6) environmental plans;
49.7 	(7) the type and number of other cannabis business licenses held by the applicant; and
49.8 	(8) the name, address, location, dates, and hours of where any proposed cannabis event 
49.9 	will take place.
49.10 	(b) Scoring and other data generated by the office in its review of an applicant for a 
49.11 	cannabis business license are public data.
49.12 		Subd. 3.Public application data on license holders. Once an applicant for a cannabis 
49.13 	business license becomes a license holder, all of the application data that the license holder 
49.14 	had previously submitted to the office are public data except that the following data remain 
49.15 	classified as nonpublic data or private data on individuals:
49.16 	(1) data identifying retail or wholesale customers of a cannabis business;
49.17 	(2) data identifying cannabis workers;
49.18 	(3) tax returns, bank account statements, and other financial account information;
49.19 	(4) business plans; and
49.20 	(5) security information and trade secret information, as defined by section 13.37.
49.21 		Subd. 4.Public disciplinary data. Minutes, orders for hearings, findings of fact, 
49.22 	conclusions of law, and specification of the final disciplinary action contained in the record 
49.23 	of the disciplinary action are classified as public data. If there is a public hearing concerning 
49.24 	the disciplinary action, the entire record concerning the disciplinary action is public data. 
49.25 	If the license holder and the office agree to resolve a complaint without a hearing, the 
49.26 	agreement and the specific reasons for the agreement are public data.
49.27 		Subd. 5.Data practices administration. (a) The office must establish written procedures 
49.28 	to ensure that only individuals authorized by law may enter, update, or access data maintained 
49.29 	by the office and classified as nonpublic or private data on individuals. An authorized 
49.30 	individual's ability to enter, update, or access not public data must correspond to the official 
49.31 	duties or training level of the individual and to the statutory authorization granting access 
50.1 	for that purpose. All queries and responses, and all actions in which not public data are 
50.2 	entered, updated, accessed, shared, or disseminated, must be recorded in a data audit trail. 
50.3 	Data contained in the audit trail have the same classification as the underlying data tracked 
50.4 	by the audit trail.
50.5 	(b) The office must not share data classified as nonpublic or private data on individuals 
50.6 	under this section or other data identifying an individual applicant or license holder with 
50.7 	any federal agency, federal department, or federal entity unless specifically ordered to do 
50.8 	so by a state or federal court.
50.9 	(c) The office must arrange for an independent audit to verify compliance with this 
50.10 	section. The audit must be completed annually for the first two years following establishment 
50.11 	of the office and biennially thereafter. The results of the audit are public. No later than 30 
50.12 	days following completion of the audit, the office must provide a report summarizing the 
50.13 	audit results to the chairs and ranking minority members of the committees of the house of 
50.14 	representatives and the senate with jurisdiction over commerce and data practices, and the 
50.15 	Legislative Commission on Data Practices and Personal Data Privacy. The report must be 
50.16 	submitted as required under section 3.195, except that printed copies are not required.

50.17 	Sec. 21. [342.19] ADULT-USE CANNABIS BUSINESS; GENERAL OWNERSHIP 
50.18 	DISQUALIFICATIONS AND REQUIREMENTS.
50.19 		Subdivision 1.Criminal history check.  Every license applicant and prospective cannabis 
50.20 	worker must submit a completed criminal history records check consent form, a full set of 
50.21 	classifiable fingerprints, and the required fees to the office. Upon receipt of this information, 
50.22 	the office must submit the completed criminal history records check consent form, full set 
50.23 	of classifiable fingerprints, and required fees to the Bureau of Criminal Apprehension. After 
50.24 	receiving this information, the bureau must conduct a Minnesota criminal history records 
50.25 	check of the person. The bureau may exchange the person's fingerprints with the Federal 
50.26 	Bureau of Investigation to obtain the person's national criminal history record information. 
50.27 	The bureau must return the results of the Minnesota and federal criminal history records 
50.28 	checks to the director to determine if the person is disqualified under this section.
50.29 		Subd. 2.Criminal offenses; disqualifications. (a) No person may hold or receive a 
50.30 	license issued under this chapter or work for a cannabis business if the person has been 
50.31 	convicted of, or received a stay of adjudication for, a violation of a state or federal controlled 
50.32 	substance law that is a felony under Minnesota law or would be a felony if committed in 
50.33 	Minnesota, regardless of the sentence imposed, unless the office determines that the person's 
50.34 	conviction was for the possession or sale of cannabis.
51.1 	(b) A person who has been convicted of, or received a stay of adjudication for, a violation 
51.2 	of Minnesota Statutes 2022, section 152.023, subdivision 1, clause (3), or a state or federal 
51.3 	law in conformity with that provision, for the sale of cannabis to a person under the age of 
51.4 	18 may hold or receive a license issued under this chapter, or work for a cannabis business, 
51.5 	if 20 years have passed since the date the person was convicted or adjudication was stayed.
51.6 	(c) Except as provided in paragraph (a), (b), or (d), a person who has been convicted of, 
51.7 	or received a stay of adjudication for, a violation of a state or federal law that is a felony 
51.8 	under Minnesota law or would be a felony if committed in Minnesota, regardless of the 
51.9 	sentence imposed, may hold or receive a license issued under this chapter, or work for a 
51.10 	cannabis business, if five years have passed since the discharge of the sentence.
51.11 	(d) No license holder or applicant may hold or receive a license issued under this chapter, 
51.12 	or work for a cannabis business, if the person has been convicted of a sale of cannabis in 
51.13 	the first degree under section 152.0264, subdivision 1.
51.14 	(e) A person who has been convicted of sale of cannabis in the second degree under 
51.15 	section 152.0264, subdivision 2, may hold or receive a license issued under this chapter or 
51.16 	work for a cannabis business if ten years have passed since the discharge of the sentence.
51.17 	(f) A person who has been convicted of sale of cannabis in the third degree under section 
51.18 	152.0264, subdivision 3, may hold or receive a license issued under this chapter or work 
51.19 	for a cannabis business if five years have passed since the discharge of the sentence.
51.20 	(g) A person who has been convicted of sale of cannabis in the fourth degree under 
51.21 	section 152.0264, subdivision 4, may hold or receive a license issued under this chapter or 
51.22 	work for a cannabis business if one year has passed since the discharge of the sentence.
51.23 	(h) If the license holder or applicant is a business entity, the disqualifications under this 
51.24 	subdivision apply to every cooperative member or every director, manager, and general 
51.25 	partner of the business entity.
51.26 		Subd. 3.Risk of harm; set aside. The office may set aside a disqualification under 
51.27 	subdivision 2 if the office finds that the person has submitted sufficient information to 
51.28 	demonstrate that the person does not pose a risk of harm to any person served by the 
51.29 	applicant, license holder, or other entities as provided in this chapter.
51.30 		Subd. 4.General requirements. (a) A license holder or applicant must meet each of 
51.31 	the following requirements, if applicable, to hold or receive a license issued under this 
51.32 	chapter:
51.33 	(1) be at least 21 years of age;
52.1 	(2) have completed an application for licensure or application for renewal;
52.2 	(3) have paid the applicable application fee;
52.3 	(4) reside in the state;
52.4 	(5) if the applicant or license holder is a business entity, be incorporated in the state or 
52.5 	otherwise formed or organized under the laws of the state;
52.6 	(6) if the applicant or license holder is a business entity, at least 75 percent of the business 
52.7 	must be owned by Minnesota residents;
52.8 	(7) not be employed by the office or any state agency with regulatory authority under 
52.9 	this chapter or the rules adopted pursuant to this chapter;
52.10 	(8) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph 
52.11 	(c);
52.12 	(9) never have had a license previously issued under this chapter revoked;
52.13 	(10) have filed any previously required tax returns for a cannabis business;
52.14 	(11) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties 
52.15 	due relating to the operation of a cannabis business;
52.16 	(12) have fully and truthfully complied with all information requests of the office relating 
52.17 	to license application and renewal;
52.18 	(13) not be disqualified under subdivision 2;
52.19 	(14) not employ an individual who is disqualified from working for a cannabis business 
52.20 	under this chapter; and
52.21 	(15) meet the ownership and operational requirements for the type of license and, if 
52.22 	applicable, endorsement sought or held.
52.23 	(b) If the license holder or applicant is a business entity, every officer, director, manager, 
52.24 	and general partner of the business entity must meet each of the requirements of this section.

52.25 	Sec. 22. [342.20] CANNABIS BUSINESSES; GENERAL OPERATIONAL 
52.26 	REQUIREMENTS AND PROHIBITIONS.
52.27 		Subdivision 1.Individuals under 21 years of age. (a) A cannabis business may not 
52.28 	employ an individual under 21 years of age and may not contract with an individual under 
52.29 	21 years of age if the individual's scope of work involves the handling of cannabis plants, 
52.30 	cannabis flower, synthetically derived cannabinoids, or cannabis products.
53.1 	(b) A cannabis business may not permit an individual under 21 years of age to enter the 
53.2 	business premises other than entry by a patient enrolled in the registry program.
53.3 	(c) A cannabis business may not sell or give cannabis flower, cannabis products, 
53.4 	lower-potency hemp edibles, or hemp-derived consumer products to an individual under 
53.5 	21 years of age unless the individual is a patient; registered designated caregiver; or parent, 
53.6 	legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical 
53.7 	cannabis flower or medical cannabinoid products.
53.8 		Subd. 2.Use of cannabis flower and cannabis products within a licensed cannabis 
53.9 	business. (a) A cannabis business may not permit an individual who is not an employee to 
53.10 	consume cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
53.11 	consumer products within its licensed premises unless the business is licensed to permit 
53.12 	on-site consumption or the business has an on-site endorsement to a license authorizing the 
53.13 	sale of lower-potency hemp edibles.
53.14 	(b) Except as otherwise provided in this subdivision, a cannabis business may not permit 
53.15 	an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles, 
53.16 	or hemp-derived consumer products within its licensed premises or while the employee is 
53.17 	otherwise engaged in activities within the course and scope of employment.
53.18 	(c) A cannabis business may permit an employee to use medical cannabis flower and 
53.19 	medical cannabinoid products if that individual is a patient.
53.20 	(d) For quality control, employees of a licensed cannabis business may sample cannabis 
53.21 	flower or cannabis products. Employees may not interact directly with customers for at least 
53.22 	three hours after sampling a product. Employees may not consume more than three samples 
53.23 	in a single 24-hour period. All samples must be recorded in the statewide monitoring system.
53.24 		Subd. 3.Restricted access. (a) Except as otherwise provided in this subdivision, a 
53.25 	cannabis business may not permit any individual to enter a restricted area unless the cannabis 
53.26 	business records the individual's name, time of entry, time of exit, and authorization to enter 
53.27 	the restricted area through use of an electronic or manual entry log and the individual:
53.28 	(1) is a cannabis worker employed by or contracted with the cannabis business;
53.29 	(2) is an employee of the office or another enforcement agency;
53.30 	(3) is a contractor of the cannabis business, including but not limited to an electrician, 
53.31 	a plumber, an engineer, or an alarm technician, whose scope of work will not involve the 
53.32 	handling of cannabis flower, cannabis products, lower-potency hemp edibles, or 
53.33 	hemp-derived consumer products and, if the individual is working in an area with immediate 
54.1 	access to cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
54.2 	consumer products, the individual is supervised at all times by a cannabis worker employed 
54.3 	by or contracted with the cannabis business; or
54.4 	(4) has explicit authorization from the office to enter a restricted area and, if the individual 
54.5 	is in an area with immediate access to cannabis flower or cannabis products, the individual 
54.6 	is supervised at all times by a cannabis worker employed by or contracted with the cannabis 
54.7 	business.
54.8 	(b) A cannabis business shall ensure that all areas of entry to restricted areas within its 
54.9 	licensed premises are conspicuously marked and cannot be entered without recording the 
54.10 	individual's name, time of entry, time of exit, and authorization to enter the restricted area.
54.11 		Subd. 4.Ventilation and filtration. A cannabis business must maintain a ventilation 
54.12 	and filtration system sufficient to meet the requirements for odor control established by the 
54.13 	office.
54.14 		Subd. 5.Records. (a) A cannabis business must retain financial records for the current 
54.15 	and previous tax year at the primary business location and must make those records available 
54.16 	for inspection by the office at any time during regular business hours.
54.17 	(b) When applicable, a cannabis business must maintain financial records for the previous 
54.18 	ten tax years and must make those records available for inspection within one business day 
54.19 	of receiving a request for inspection by the office.
54.20 	(c) The office may require a cannabis business to submit to an audit of its business 
54.21 	records. The office may select or approve the auditor and the cannabis business must provide 
54.22 	the auditor with access to all business records. The cost of the audit must be paid by the 
54.23 	cannabis business.
54.24 		Subd. 6.Diversity report. A cannabis business shall provide an annual report on the 
54.25 	status of diversity in the business ownership, management, and employment and in services 
54.26 	for which the business contracts.
54.27 		Subd. 7.Use of statewide monitoring system. (a) A cannabis business must use the 
54.28 	statewide monitoring system for integrated cannabis tracking, inventory, and verification 
54.29 	to track all cannabis plants, cannabis flower, cannabis products, lower-potency hemp edibles, 
54.30 	and hemp-derived consumer products the cannabis business has in its possession to the 
54.31 	point of disposal, transfer, or sale.
54.32 	(b) For the purposes of this subdivision, a cannabis business possesses the cannabis 
54.33 	plants and cannabis flower that the business cultivates from seed or immature plant, if 
55.1 	applicable, or receives from another cannabis business, and possesses the cannabis products, 
55.2 	lower-potency hemp edibles, and hemp-derived consumer products that the business 
55.3 	manufactures or receives from another cannabis business.
55.4 	(c) Sale and transfer of cannabis plants, cannabis flower, cannabis products, 
55.5 	lower-potency hemp edibles, and hemp-derived consumer products must be recorded in the 
55.6 	statewide monitoring system within the time established by rule.
55.7 		Subd. 8.Disposal; loss documentation. (a) A cannabis business must dispose of cannabis 
55.8 	plants, cannabis flower, cannabis products, lower-potency hemp edibles, hemp-derived 
55.9 	consumer products, and synthetically derived cannabinoids that are damaged, have a broken 
55.10 	seal, have been contaminated, or have not been sold by the expiration date on the label.
55.11 	(b) Disposal must be conducted in a manner approved by the office.
55.12 	(c) Disposed products must be documented in the statewide monitoring system.
55.13 	(d) Any lost or stolen products must be reported to local law enforcement and a cannabis 
55.14 	business must log any lost or stolen products in the statewide monitoring system as soon 
55.15 	as the loss is discovered.
55.16 		Subd. 9.Sale of approved products. A cannabis business may only sell cannabis plants, 
55.17 	cannabis flower, cannabis products, and synthetically derived cannabinoids that are approved 
55.18 	by the office and that comply with this chapter and rules adopted pursuant to this chapter 
55.19 	regarding the testing, packaging, and labeling of cannabis plants, cannabis flower, cannabis 
55.20 	products, and synthetically derived cannabinoids.
55.21 		Subd. 10.Security. A cannabis business must maintain and follow a security plan to 
55.22 	deter and prevent the theft or diversion of cannabis plants, cannabis flower, cannabis products, 
55.23 	or hemp-derived consumer products; unauthorized entry into the cannabis business; and the 
55.24 	theft of currency.
55.25 		Subd. 11.Financial relationship. (a) Except for the lawful sale of cannabis plants, 
55.26 	cannabis flower, cannabis products, and synthetically derived cannabinoids in the ordinary 
55.27 	course of business and as otherwise provided in this subdivision, no cannabis business may 
55.28 	offer, give, accept, receive, or borrow money or anything else of value or accept or receive 
55.29 	credit from any other cannabis business. This prohibition applies to offering or receiving a 
55.30 	benefit in exchange for preferential placement by a cannabis retailer, including preferential 
55.31 	placement on the cannabis retailer's shelves, display cases, or website. This prohibition 
55.32 	applies to every cooperative member or every director, manager, and general partner of a 
55.33 	cannabis business.
56.1 	(b) This prohibition does not apply to merchandising credit in the ordinary course of 
56.2 	business for a period not to exceed 30 days or for marketing or consumer education materials 
56.3 	made available in a retail location.
56.4 	(c) This prohibition does not apply to free samples of useable cannabis flower or cannabis 
56.5 	products packaged in a sample jar protected by a plastic or metal mesh screen to allow 
56.6 	customers to smell the cannabis flower or cannabis product before purchase. A sample jar 
56.7 	may not contain more than eight grams of useable cannabis flower, eight grams of a cannabis 
56.8 	concentrate, or an edible cannabis product infused with 100 milligrams of 
56.9 	tetrahydrocannabinol.
56.10 	(d) This prohibition does not apply to free samples of cannabis flower or cannabis 
56.11 	products provided to a cannabis retailer or cannabis wholesaler for the purposes of quality 
56.12 	control and to allow cannabis retailers to determine whether to offer a product for sale. A 
56.13 	sample provided for these purposes may not contain more than eight grams of useable 
56.14 	cannabis flower, eight grams of a cannabis concentrate, or an edible cannabis product infused 
56.15 	with 100 milligrams of tetrahydrocannabinol.
56.16 	(e) This prohibition does not apply to any fee charged by a licensed cannabis event 
56.17 	organizer to a cannabis business for participation in a cannabis event.
56.18 		Subd. 12.Exclusive contracts. A cannabis business may not directly or indirectly make 
56.19 	an agreement with a cannabis retailer that binds the cannabis retailer to purchase the products 
56.20 	of one cannabis cultivator or cannabis manufacturer to the exclusion of the products of other 
56.21 	cannabis cultivators or cannabis manufacturers. A cannabis retailer who is a party to a 
56.22 	violation of this section or who receives the benefits of a violation is equally guilty of a 
56.23 	violation.
56.24 		Subd. 13.Customer privacy. A cannabis business must not share data on retail or 
56.25 	wholesale customers with any federal agency, federal department, or federal entity unless 
56.26 	specifically ordered by a state or federal court.

56.27 	Sec. 23. [342.21] CANNABIS CULTIVATOR LICENSING AND OPERATIONS.
56.28 		Subdivision 1.Authorized actions. A cannabis cultivator license entitles the license 
56.29 	holder to grow cannabis plants within the approved amount of space from seed or immature 
56.30 	plant to mature plant, harvest cannabis flower from a mature plant, package and label 
56.31 	cannabis flower for sale to other cannabis businesses, transport cannabis flower to a cannabis 
56.32 	manufacturer located on the same premises, and perform other actions approved by the 
56.33 	office.
57.1 		Subd. 2.Size limitations. A cannabis cultivator may cultivate up to 15,000 square feet 
57.2 	of plant canopy unless the office, by rule, increases that limit. The office may, by rule, 
57.3 	increase the limit on plant canopy to no more than 30,000 cubic feet if the office determines 
57.4 	that expansion is consistent with the goals identified in section 342.02, subdivision 1. A 
57.5 	cannabis cultivator may not operate multiple tiers of cultivation unless authorized by the 
57.6 	office.
57.7 		Subd. 3.Additional information required. In addition to the information required to 
57.8 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
57.9 	a person, cooperative, or business seeking a cannabis cultivator license must submit the 
57.10 	following information in a form approved by the office:
57.11 	(1) an operating plan demonstrating the proposed size and layout of the cultivation 
57.12 	facility; plans for wastewater and waste disposal for the cultivation facility; plans for 
57.13 	providing electricity, water, and other utilities necessary for the normal operation of the 
57.14 	cultivation facility; and plans for compliance with the applicable building code and federal 
57.15 	and state environmental and workplace safety requirements;
57.16 	(2) a cultivation plan demonstrating the proposed size and layout of the cultivation 
57.17 	facility that will be used exclusively for cultivation including the total amount of plant 
57.18 	canopy; and
57.19 	(3) evidence that the business will comply with the applicable operation requirements 
57.20 	for the license being sought.
57.21 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
57.22 	cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis 
57.23 	cultivator license, medical cannabis producer license, license to grow industrial hemp, and 
57.24 	cannabis event organizer license.
57.25 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
57.26 	cannabis cultivator license may own or operate any other cannabis business or hemp business. 
57.27 	This prohibition does not prevent the transportation of cannabis flower from a cannabis 
57.28 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
57.29 	and located on the same premises.
57.30 	(c) The office by rule may limit the number of cannabis cultivator licenses a person, 
57.31 	cooperative, or business may hold.
58.1 	(d) For purposes of this subdivision, a restriction on the number or type of license a 
58.2 	business may hold applies to every cooperative member or every director, manager, and 
58.3 	general partner of a cannabis business.
58.4 		Subd. 5.Cultivation operations. A cannabis cultivator must comply with the 
58.5 	requirements in section 342.25.
58.6 		Subd. 6.Limitations on health care practitioners. A health care practitioner who 
58.7 	certifies qualifying medical conditions for patients is prohibited from:
58.8 	(1) holding a direct or indirect economic interest in a cannabis cultivator;
58.9 	(2) serving as a cooperative member, director, manager, general partner, or employee 
58.10 	of a cannabis cultivator; or
58.11 	(3) advertising with a cannabis cultivator in any way.
58.12 		Subd. 7.Remuneration. A cannabis cultivator is prohibited from:
58.13 	(1) accepting or soliciting any form of remuneration from a health care practitioner who 
58.14 	certifies qualifying medical conditions for patients; or
58.15 	(2) offering any form of remuneration to a health care practitioner who certifies qualifying 
58.16 	medical conditions for patients.

58.17 	Sec. 24. [342.22] RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.
58.18 		Subdivision 1.Registration required. Before making retail sales to customers or patients, 
58.19 	a cannabis microbusiness with a retail operations endorsement, cannabis mezzobusiness 
58.20 	with a retail operations endorsement, cannabis retailer, medical cannabis retailer, or 
58.21 	lower-potency hemp edible retailer must register with the city, town, or county in which 
58.22 	the retail establishment is located. A county may issue a registration in cases where a city 
58.23 	or town has provided consent for the county to issue the registration for the jurisdiction.
58.24 		Subd. 2.Registration fee. (a) A local unit of government may impose an initial retail 
58.25 	registration fee of up to half the amount of the applicable initial license fee under section 
58.26 	342.11. The local unit of government may also impose a renewal retail registration fee of 
58.27 	up to half the amount of the applicable renewal license fee under section 342.11. The initial 
58.28 	license fee shall include the fee for initial registration and the first annual renewal. Any 
58.29 	renewal fee imposed by the local unit of government shall be charged at the time of the 
58.30 	second renewal and each subsequent annual renewal thereafter.
58.31 	(b) The local unit of government may not charge an application fee.
59.1 	(c) A cannabis business with a cannabis retailer license and a medical cannabis retailer 
59.2 	license for the same location may only be charged a single registration fee.
59.3 	(d) Registration fees are nonrefundable.
59.4 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
59.5 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
59.6 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
59.7 	retailer, or lower-potency hemp edible retailer that:
59.8 	(1) has a valid license issued by the office;
59.9 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
59.10 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
59.11 	compliance check that the local unit of government performs; and
59.12 	(4) if applicable, is current on all property taxes and assessments at the location where 
59.13 	the retail establishment is located.
59.14 	(b) Before issuing a retail registration, the local unit of government may conduct a 
59.15 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
59.16 	compliance with the applicable operation requirements and the limits on the types of cannabis 
59.17 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
59.18 	that may be sold.
59.19 	(c) A local unit of government shall renew the retail registration of a cannabis business 
59.20 	or hemp business when the office renews the license of the cannabis business or hemp 
59.21 	business.
59.22 	(d) A retail registration issued under this section may not be transferred.
59.23 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
59.24 	checks of every cannabis business and hemp business with a retail registration issued by 
59.25 	the local unit of government. The checks shall assess compliance with age verification 
59.26 	requirements, the applicable operation requirements, and the applicable limits on the types 
59.27 	of cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived 
59.28 	consumer products being sold.
59.29 	(b) The local unit of government must conduct unannounced age verification compliance 
59.30 	checks at least once each calendar year. Age verification compliance checks must involve 
59.31 	persons at least 17 years of age, but under the age of 21, who, with the prior written consent 
59.32 	of a parent or guardian if the person is under the age of 18, attempt to purchase adult-use 
60.1 	cannabis flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived 
60.2 	consumer products under the direct supervision of a law enforcement officer or an employee 
60.3 	of the local unit of government.
60.4 	(c) Checks to ensure compliance with the applicable operation requirements and the 
60.5 	limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
60.6 	hemp-derived consumer products that may be sold must be performed at least once each 
60.7 	calendar year and may be performed by a law enforcement officer or an employee of the 
60.8 	local unit of government.
60.9 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
60.10 	a local unit of government determines that a cannabis business or hemp business with a 
60.11 	retail registration issued by the local unit of government is not operating in compliance with 
60.12 	the requirements of this chapter or that the operation of the business poses an immediate 
60.13 	threat to the health or safety of the public, the local unit of government may suspend the 
60.14 	retail registration of the cannabis business or hemp business. The local unit of government 
60.15 	must immediately notify the office of the suspension and shall include a description of the 
60.16 	grounds for the suspension.
60.17 	(b) The office shall review the retail registration suspension and may order reinstatement 
60.18 	of the retail registration or take any action described in section 342.17 or 342.18.
60.19 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
60.20 	the license and operating privilege of the cannabis business or hemp business for a longer 
60.21 	period or revokes the license.
60.22 	(d) The local unit of government may reinstate the retail registration if the local unit of 
60.23 	government determines that any violation has been cured. The local unit of government 
60.24 	must reinstate the retail registration if the office orders reinstatement.
60.25 	(e) No cannabis microbusiness with a retail operations endorsement, cannabis 
60.26 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
60.27 	retailer, or lower-potency hemp edible retailer may make any sale to a customer or patient 
60.28 	without a valid retail registration. A local unit of government may impose a civil penalty 
60.29 	of up to $2,000 for each violation of this paragraph.

60.30 	Sec. 25. [342.23] CANNABIS BUSINESSES AND HEMP BUSINESSES; GENERAL 
60.31 	OPERATIONAL REQUIREMENTS.
60.32 		Subdivision 1.Records. (a) Cannabis businesses and hemp businesses must retain 
60.33 	financial records for the current and previous tax year at the primary business location and 
61.1 	must make those records available for inspection by the office at any time during regular 
61.2 	business hours.
61.3 	(b) When applicable, a cannabis business or hemp business must maintain financial 
61.4 	records for the previous ten tax years and must make those records available for inspection 
61.5 	within one business day of receiving a request for inspection by the office.
61.6 	(c) The office may require a cannabis business or hemp business to submit to an audit 
61.7 	of its business records. The office may select or approve the auditor and the cannabis business 
61.8 	or hemp business must provide the auditor with access to all business records. The cost of 
61.9 	the audit must be paid by the cannabis business or hemp business.
61.10 		Subd. 2.Diversity report. Cannabis businesses and hemp businesses shall provide an 
61.11 	annual report on the status of diversity in the business ownership, management, and 
61.12 	employment and in services for which the business contracts.
61.13 		Subd. 3.Disposal; loss documentation. (a) Cannabis businesses and hemp businesses 
61.14 	must dispose of cannabis plants, cannabis flower, cannabis products, synthetically derived 
61.15 	cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products that are 
61.16 	damaged, have a broken seal, have been contaminated, or have not been sold by the expiration 
61.17 	date on the label.
61.18 	(b) Disposal must be conducted in a manner approved by the office.
61.19 	(c) Disposal of any cannabis plants, cannabis flower, cannabis products, synthetically 
61.20 	derived cannabinoids, and hemp-derived consumer products that are required to be entered 
61.21 	into the statewide monitoring system must be documented in the statewide monitoring 
61.22 	system.
61.23 	(d) Loss or theft of any cannabis plants, cannabis flower, cannabis products, synthetically 
61.24 	derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products 
61.25 	that are required to be entered into the statewide monitoring system must be reported to 
61.26 	local law enforcement and a business must log any such loss or theft in the statewide 
61.27 	monitoring system as soon as the loss or theft is discovered.
61.28 		Subd. 4.Sale of approved products. Cannabis businesses and hemp businesses may 
61.29 	only sell cannabis plants, cannabis flower, cannabis products, synthetically derived 
61.30 	cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products that are 
61.31 	a type approved by the office and that comply with this chapter and rules adopted pursuant 
61.32 	to this chapter regarding the testing, packaging, and labeling of cannabis plants, cannabis 
62.1 	flower, cannabis products, synthetically derived cannabinoids, lower-potency hemp edibles, 
62.2 	and hemp-derived consumer products.
62.3 		Subd. 5.Financial relationship. (a) Except for the lawful sale of cannabis plants, 
62.4 	cannabis flower, cannabis products, synthetically derived cannabinoids, lower-potency 
62.5 	hemp edibles, and hemp-derived consumer products in the ordinary course of business and 
62.6 	as otherwise provided in this subdivision, no cannabis business or hemp business may offer, 
62.7 	give, accept, receive, or borrow money or anything else of value or accept or receive credit 
62.8 	from any other cannabis business. This prohibition applies to offering or receiving a benefit 
62.9 	in exchange for preferential placement by a retailer, including preferential placement on 
62.10 	the retailer's shelves, display cases, or website. This prohibition applies to every cooperative 
62.11 	member or every director, manager, and general partner of a cannabis business or hemp 
62.12 	business.
62.13 	(b) This prohibition does not apply to merchandising credit in the ordinary course of 
62.14 	business for a period not to exceed 30 days.
62.15 	(c) This prohibition does not apply to free samples of useable cannabis flower, cannabis 
62.16 	products, lower-potency hemp edibles, or hemp-derived consumer products packaged in a 
62.17 	sample jar protected by a plastic or metal mesh screen to allow customers to smell the 
62.18 	cannabis flower, cannabis product, lower-potency hemp edible, or hemp-derived consumer 
62.19 	product before purchase. A sample jar may not contain more than eight grams of useable 
62.20 	cannabis flower, eight grams of a cannabis concentrate, an edible cannabis product infused 
62.21 	with 100 milligrams of tetrahydrocannabinol, a lower-potency hemp edible infused with 
62.22 	50 milligrams of tetrahydrocannabinol, or a hemp-derived consumer product with a total 
62.23 	weight of more than eight grams.
62.24 	(d) This prohibition does not apply to free samples of cannabis flower, cannabis products, 
62.25 	lower-potency hemp edibles, or hemp-derived consumer products provided to a retailer or 
62.26 	cannabis wholesaler for the purposes of quality control and to allow retailers to determine 
62.27 	whether to offer a product for sale. A sample provided for these purposes may not contain 
62.28 	more than eight grams of useable cannabis flower, eight grams of a cannabis concentrate, 
62.29 	an edible cannabis product infused with 100 milligrams of tetrahydrocannabinol, a 
62.30 	lower-potency hemp edible infused with 50 milligrams of tetrahydrocannabinol, or a 
62.31 	hemp-derived consumer product with a total weight of more than eight grams.
62.32 	(e) This prohibition does not apply to any fee charged by a licensed cannabis event 
62.33 	organizer to a cannabis business or hemp business for participation in a cannabis event.
63.1 		Subd. 6.Customer privacy. Cannabis businesses and hemp businesses must not share 
63.2 	data on retail or wholesale customers with any federal agency, federal department, or federal 
63.3 	entity unless specifically ordered by a state or federal court.

63.4 	Sec. 26. [342.24] CANNABIS MANUFACTURER LICENSING AND OPERATIONS.
63.5 		Subdivision 1.Authorized actions. A cannabis manufacturer license, consistent with 
63.6 	the specific license endorsement or endorsements, entitles the license holder to:
63.7 	(1) purchase cannabis flower, cannabis products, hemp plant parts, hemp concentrate, 
63.8 	and synthetically derived cannabinoids from a cannabis microbusiness, a cannabis 
63.9 	mezzobusiness, a cannabis cultivator, another cannabis manufacturer, a cannabis wholesaler, 
63.10 	or an industrial hemp grower;
63.11 	(2) accept cannabis flower from unlicensed persons who are at least 21 years of age 
63.12 	provided that the cannabis manufacturer does not accept more than two ounces from an 
63.13 	individual on a single occasion;
63.14 	(3) make cannabis concentrate;
63.15 	(4) make hemp concentrate, including hemp concentrate with a delta-9 
63.16 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
63.17 	(5) manufacture synthetically derived cannabinoids;
63.18 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
63.19 	hemp-derived consumer products for public consumption;
63.20 	(7) package and label adult-use cannabis products, lower-potency hemp edibles, and 
63.21 	hemp-derived consumer products for customers;
63.22 	(8) sell cannabis concentrate, hemp concentrate, synthetically derived cannabinoids, 
63.23 	adult-use cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
63.24 	products to other cannabis businesses; and
63.25 	(9) perform other actions approved by the office.
63.26 		Subd. 2.Size limitations. The office shall, by rule, establish a limit on the manufacturing 
63.27 	of adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
63.28 	products a cannabis manufacturer may perform. The limit must be equivalent to the amount 
63.29 	of cannabis flower that can be harvested from a facility with a plant canopy of 15,000 square 
63.30 	feet in a year, but may be increased to the amount that can be harvested from a facility with 
63.31 	up to 30,000 cubic feet of plant canopy if the office expands the allowable area of cultivation 
63.32 	under section 342.21, subdivision 2.
64.1 		Subd. 3.Additional information required. In addition to the information required to 
64.2 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
64.3 	a person, cooperative, or business seeking a cannabis manufacturer license must submit the 
64.4 	following information in a form approved by the office:
64.5 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
64.6 	diagram of ventilation and filtration systems; plans for wastewater and waste disposal for 
64.7 	the manufacturing facility; plans for providing electricity, water, and other utilities necessary 
64.8 	for the normal operation of the manufacturing facility; and plans for compliance with 
64.9 	applicable building code and federal and state environmental and workplace safety 
64.10 	requirements; and
64.11 	(2) evidence that the business will comply with the applicable operation requirements 
64.12 	for the endorsement being sought.
64.13 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
64.14 	cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis 
64.15 	cultivator license, a medical cannabis processor license, and a cannabis event organizer 
64.16 	license.
64.17 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
64.18 	cannabis manufacturer license may own or operate any other cannabis business or hemp 
64.19 	business. This prohibition does not prevent transportation of cannabis flower from a cannabis 
64.20 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
64.21 	and located on the same premises.
64.22 	(c) The office by rule may limit the number of cannabis manufacturer licenses that a 
64.23 	person or business may hold.
64.24 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
64.25 	a business may hold applies to every cooperative member or every director, manager, and 
64.26 	general partner of a cannabis business.
64.27 		Subd. 5.Limitations on health care practitioners. A health care practitioner who 
64.28 	certifies qualifying medical conditions for patients is prohibited from:
64.29 	(1) holding a direct or indirect economic interest in a cannabis manufacturer;
64.30 	(2) serving as a cooperative member, director, manager, general partner, or employee 
64.31 	of a cannabis manufacturer; or
64.32 	(3) advertising with a cannabis manufacturer in any way.
65.1 		Subd. 6.Remuneration. A cannabis manufacturer is prohibited from:
65.2 	(1) accepting or soliciting any form of remuneration from a health care practitioner who 
65.3 	certifies qualifying medical conditions for patients; or
65.4 	(2) offering any form of remuneration to a health care practitioner who certifies qualifying 
65.5 	medical conditions for patients.
65.6 		Subd. 7.Cultivation operations. A cannabis manufacturer must comply with the 
65.7 	requirements in section 342.25.

65.8 	Sec. 27. [342.25] CULTIVATION OF CANNABIS; GENERAL REQUIREMENTS.
65.9 		Subdivision 1.Applicability. Every cannabis business with a license or endorsement 
65.10 	authorizing the cultivation of cannabis must comply with the requirements of this section.
65.11 		Subd. 2.Cultivation records. A business licensed or authorized to cultivate cannabis 
65.12 	must prepare a cultivation record for each batch of cannabis plants and cannabis flower in 
65.13 	the form required by the office and must maintain each record for at least five years. The 
65.14 	cultivation record must include the quantity and timing, where applicable, of each pesticide, 
65.15 	fertilizer, soil amendment, or plant amendment used to cultivate the batch, as well as any 
65.16 	other information required by the office in rule. The cannabis business must present 
65.17 	cultivation records to the office, the commissioner of agriculture, or the commissioner of 
65.18 	health upon request.
65.19 		Subd. 3.Agricultural chemicals and other inputs. A business licensed or authorized 
65.20 	to cultivate cannabis is subject to rules promulgated by the office in consultation with the 
65.21 	commissioner of agriculture, subject to subdivision 5, governing the use of pesticides, 
65.22 	fertilizers, soil amendments, plant amendments, and other inputs to cultivate cannabis.
65.23 		Subd. 4.Cultivation plan. A business licensed or authorized to cultivate cannabis must 
65.24 	prepare, maintain, and execute an operating plan and a cultivation plan as directed by the 
65.25 	office in rule, which must include but is not limited to:
65.26 	(1) water usage;
65.27 	(2) recycling;
65.28 	(3) solid waste disposal; and
65.29 	(4) a pest management protocol that incorporates integrated pest management principles 
65.30 	to control or prevent the introduction of pests to the cultivation site.
66.1 		Subd. 5.Agricultural chemicals and other inputs; pollinator protection. (a) A business 
66.2 	licensed or authorized to cultivate cannabis must comply with chapters 18B, 18C, 18D, and 
66.3 	any other pesticide, fertilizer, soil amendment, and plant amendment laws and rules enforced 
66.4 	by the commissioner of agriculture.
66.5 	(b) A business licensed or authorized to cultivate cannabis must not apply pesticides 
66.6 	when pollinators are present or allow pesticides to drift to flowering plants that are attractive 
66.7 	to pollinators.
66.8 		Subd. 6.Adulteration prohibited. A business licensed or authorized to cultivate cannabis 
66.9 	must not treat or otherwise adulterate cannabis plants or cannabis flower with any substance 
66.10 	or compound that has the effect or intent of altering the color, appearance, weight, potency, 
66.11 	or odor of the cannabis.
66.12 		Subd. 7.Indoor or outdoor cultivation authorized; security. A business licensed or 
66.13 	authorized to cultivate cannabis may cultivate cannabis plants indoors or outdoors, subject 
66.14 	to the security, fencing, lighting, and any other requirements imposed by the office in rule.
66.15 		Subd. 8.Genetically engineered organism release permit. The commissioner of 
66.16 	agriculture may issue a genetically engineered agriculturally related organism permit under 
66.17 	chapter 18F for cannabis seed or cannabis plants.
66.18 		Subd. 9.Exception. Nothing in this section applies to the cultivation of hemp plants.

66.19 	Sec. 28. [342.26] MANUFACTURE OF CANNABIS PRODUCTS; GENERAL 
66.20 	REQUIREMENTS.
66.21 		Subdivision 1.Applicability. Every cannabis business with a license or endorsement 
66.22 	authorizing the creation of cannabis concentrate and manufacture of cannabis products and 
66.23 	hemp-derived consumer products for public consumption must comply with the requirements 
66.24 	of this section.
66.25 		Subd. 2.All manufacturer operations. (a) Cannabis manufacturing must take place in 
66.26 	an enclosed, locked facility that is used exclusively for the manufacture of cannabis products, 
66.27 	creation of hemp concentrate, creation of synthetically derived cannabinoids, creation of 
66.28 	lower-potency hemp edibles, or creation of hemp-derived consumer products except that a 
66.29 	business that also holds a cannabis cultivator license may operate in a facility that shares 
66.30 	general office space, bathrooms, entryways, and walkways.
66.31 	(b) Cannabis manufacturing must take place on equipment that is used exclusively for 
66.32 	the manufacture of cannabis products, creation of hemp concentrate, creation of synthetically 
67.1 	derived cannabinoids, creation of lower-potency hemp edibles, or creation of hemp-derived 
67.2 	consumer products.
67.3 	(c) A business licensed or authorized to manufacture cannabis products must comply 
67.4 	with all applicable packaging, labeling, and health and safety requirements.
67.5 		Subd. 3.Extraction and concentration. (a) A business licensed or authorized to 
67.6 	manufacture cannabis products that creates cannabis concentrate, hemp concentrate, or 
67.7 	synthetically derived cannabinoids must obtain an endorsement from the office.
67.8 	(b) A business licensed or authorized to manufacture cannabis products must inform the 
67.9 	office of all methods of extraction and concentration that the manufacturer intends to use 
67.10 	and identify the volatile chemicals, if any, that will be involved in the creation of cannabis 
67.11 	concentrate or hemp concentrate. A cannabis manufacturer may not use a method of 
67.12 	extraction and concentration or a volatile chemical without approval by the office.
67.13 	(c) A business licensed or authorized to manufacture cannabis products must inform the 
67.14 	office of all methods of conversion that the manufacturer will use, including any specific 
67.15 	catalysts that the manufacturer will employ, to create synthetically derived cannabinoids 
67.16 	and the molecular nomenclature of all cannabinoids or other chemical compounds that the 
67.17 	manufacturer will create. A business licensed or authorized to manufacture cannabis products 
67.18 	may not use a method of conversion or a catalyst without approval by the office.
67.19 	(d) A business licensed or authorized to manufacture cannabis products must obtain a 
67.20 	certification from an independent third-party industrial hygienist or professional engineer 
67.21 	approving:
67.22 	(1) all electrical, gas, fire suppression, and exhaust systems; and
67.23 	(2) the plan for safe storage and disposal of hazardous substances, including but not 
67.24 	limited to any volatile chemicals.
67.25 	(e) A business licensed or authorized to manufacture cannabis products that manufactures 
67.26 	cannabis concentrate from cannabis flower received from an unlicensed person who is at 
67.27 	least 21 years of age must comply with all health and safety requirements established by 
67.28 	the office. At a minimum, the office shall require the manufacturer to:
67.29 	(1) store the cannabis flower in an area that is segregated from cannabis flower and hemp 
67.30 	plant parts received from a licensed cannabis business;
67.31 	(2) perform the extraction and concentration on equipment that is used exclusively for 
67.32 	extraction or concentration of cannabis flower received from unlicensed individuals;
68.1 	(3) store any cannabis concentrate in an area that is segregated from cannabis concentrate, 
68.2 	hemp concentrate, or synthetically derived cannabinoids derived or manufactured from 
68.3 	cannabis flower or hemp plant parts received from a licensed cannabis business; and
68.4 	(4) provide any cannabis concentrate only to the person who provided the cannabis 
68.5 	flower.
68.6 	(f) Upon the sale of cannabis concentrate, hemp concentrate, or synthetically derived 
68.7 	cannabinoids to any person, cooperative, or business, a business licensed or authorized to 
68.8 	manufacture cannabis products must provide a statement to the buyer that discloses the 
68.9 	method of extraction and concentration or conversion used and any solvents, gases, or 
68.10 	catalysts, including but not limited to any volatile chemicals, involved in that method.
68.11 		Subd. 4.Production of consumer products. (a) A business licensed or authorized to 
68.12 	manufacture cannabis products that produces edible cannabis products or lower-potency 
68.13 	hemp edibles must obtain an edible cannabinoid product handler endorsement from the 
68.14 	office.
68.15 	(b) A business licensed or authorized to manufacture cannabis products must obtain an 
68.16 	endorsement from the office to produce:
68.17 	(1) cannabis products other than edible cannabis products; or
68.18 	(2) hemp-derived consumer products other than lower-potency hemp edibles.
68.19 	(c) All areas within the licensed premises of a business licensed or authorized to 
68.20 	manufacture cannabis products producing cannabis products, lower-potency hemp edibles, 
68.21 	or hemp-derived consumer products must meet the sanitary standards specified in rules 
68.22 	adopted by the office.
68.23 	(d) A business licensed or authorized to manufacture cannabis products may only add 
68.24 	chemicals or compounds approved by the office to cannabis concentrate, hemp concentrate, 
68.25 	or synthetically derived cannabinoids.
68.26 	(e) Upon the sale of any cannabis product, lower-potency hemp edible, or hemp-derived 
68.27 	consumer product to a cannabis business or hemp business, a business licensed or authorized 
68.28 	to manufacture cannabis products must provide a statement to the buyer that discloses the 
68.29 	product's ingredients, including but not limited to any chemicals or compounds and any 
68.30 	major food allergens declared by name.
68.31 	(f) A business licensed or authorized to manufacture cannabis products shall not add 
68.32 	any cannabis flower, cannabis concentrate, synthetically derived cannabinoid, hemp plant 
68.33 	part, or hemp concentrate to a product where the manufacturer of the product holds a 
69.1 	trademark to the product's name, except that a business licensed or authorized to manufacture 
69.2 	cannabis products may use a trademarked food product if the manufacturer uses the product 
69.3 	as a component or as part of a recipe and where the business licensed or authorized to 
69.4 	manufacture cannabis products does not state or advertise to the customer that the final 
69.5 	retail cannabis product, lower-potency hemp edible, or hemp-derived consumer product 
69.6 	contains a trademarked food product.
69.7 		Subd. 5.Exception. Nothing in this section applies to the operations of a lower-potency 
69.8 	hemp edible manufacturer.

69.9 	Sec. 29. [342.27] ADULT-USE CANNABIS RETAILER LICENSING AND 
69.10 	OPERATIONS.
69.11 		Subdivision 1.Authorized actions. A cannabis retailer license entitles the license holder 
69.12 	to:
69.13 	(1) purchase immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
69.14 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products from 
69.15 	cannabis microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis 
69.16 	manufacturers, and cannabis wholesalers;
69.17 	(2) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
69.18 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
69.19 	other products authorized by law to customers; and
69.20 	(3) perform other actions approved by the office.
69.21 		Subd. 2.Size limitations. A cannabis retailer may operate up to five retail locations.
69.22 		Subd. 3.Additional information required. In addition to the information required to 
69.23 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
69.24 	a person, cooperative, or business seeking a cannabis retail license must submit the following 
69.25 	information in a form approved by the office:
69.26 	(1) a list of every retail license held by the applicant and, if the applicant is a business, 
69.27 	every retail license held, either as an individual or as part of another business, by each 
69.28 	officer, director, manager, and general partner of the cannabis business;
69.29 	(2) an operating plan demonstrating the proposed layout of the facility, including a 
69.30 	diagram of ventilation and filtration systems; policies to avoid sales to individuals who are 
69.31 	under 21 years of age; identification of a restricted area for storage; and plans to prevent 
70.1 	the visibility of cannabis flower, cannabis products, lower-potency hemp edibles, and 
70.2 	hemp-derived consumer products to individuals outside the retail location; and
70.3 	(3) evidence that the business will comply with the applicable operation requirements 
70.4 	for the license being sought.
70.5 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
70.6 	cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis 
70.7 	retailer license, and a cannabis event organizer license.
70.8 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
70.9 	cannabis retailer license may own or operate any other cannabis business or hemp business.
70.10 	(c) No person, cooperative, or business may hold a license to own or operate more than 
70.11 	one cannabis retail business in one city and three retail businesses in one county.
70.12 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
70.13 	cooperative, or business may hold.
70.14 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
70.15 	business may hold applies to every cooperative member or every director, manager, and 
70.16 	general partner of a cannabis business.
70.17 		Subd. 5.Municipal or county cannabis store. A city or county may establish, own, 
70.18 	and operate a municipal cannabis store subject to the restrictions in this chapter.
70.19 		Subd. 6.Limitations on health care practitioners. A health care practitioner who 
70.20 	certifies qualifying medical conditions for patients is prohibited from:
70.21 	(1) holding a direct or indirect economic interest in a cannabis retailer;
70.22 	(2) serving as a cooperative member, director, manager, general partner, or employee 
70.23 	of a cannabis retailer; or
70.24 	(3) advertising with a cannabis retailer in any way.
70.25 		Subd. 7.Remuneration. A cannabis retailer is prohibited from:
70.26 	(1) accepting or soliciting any form of remuneration from a health care practitioner who 
70.27 	certifies qualifying medical conditions for patients; or
70.28 	(2) offering any form of remuneration to a health care practitioner who certifies qualifying 
70.29 	medical conditions for patients.

71.1 	Sec. 30. [342.28] RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; 
71.2 	GENERAL REQUIREMENTS.
71.3 		Subdivision 1.Applicability. Every cannabis business with a license or endorsement 
71.4 	authorizing the retail sale of cannabis flower or cannabis products must comply with the 
71.5 	requirements of this section.
71.6 		Subd. 2.Sale of cannabis flower and cannabis products. (a) A cannabis business with 
71.7 	a license or endorsement authorizing the retail sale of cannabis flower or cannabis products 
71.8 	may only sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
71.9 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products to 
71.10 	individuals who are at least 21 years of age.
71.11 	(b) A cannabis business with a license or endorsement authorizing the retail sale of 
71.12 	adult-use cannabis flower or adult-use cannabis products may sell immature cannabis plants 
71.13 	and seedlings, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
71.14 	edibles, and hemp-derived consumer products that:
71.15 	(1) are obtained from a business licensed under this chapter; and
71.16 	(2) meet all applicable packaging and labeling requirements.
71.17 	(c) A cannabis business with a license or endorsement authorizing the retail sale of 
71.18 	cannabis flower or cannabis products may sell up to two ounces of adult-use cannabis flower 
71.19 	or hemp-derived consumer products consisting primarily of hemp plant parts, eight grams 
71.20 	of adult-use cannabis concentrate or hemp-derived consumer products consisting primarily 
71.21 	of hemp concentrate or synthetically derived cannabinoids, and edible cannabis products 
71.22 	and lower-potency hemp edibles infused with 800 milligrams of tetrahydrocannabinol during 
71.23 	a single transaction to a customer.
71.24 	(d) Edible cannabis products and hemp-derived consumer products intended to be eaten 
71.25 	or consumed as a beverage may not include more than ten milligrams of tetrahydrocannabinol 
71.26 	per serving and a single package may not include more than a total of 100 milligrams of 
71.27 	tetrahydrocannabinol. A package may contain multiple servings of ten milligrams of 
71.28 	tetrahydrocannabinol provided that each serving is indicated by scoring, wrapping, or other 
71.29 	indicators designating the individual serving size.
71.30 		Subd. 3.Sale of other products. (a) A cannabis business with a license or endorsement 
71.31 	authorizing the retail sale of cannabis flower or cannabis products may sell cannabis 
71.32 	paraphernalia, including but not limited to childproof packaging containers and other devices 
71.33 	designed to ensure the safe storage and monitoring of cannabis flower, cannabis products, 
72.1 	lower-potency hemp edibles, and hemp-derived consumer products in the home to prevent 
72.2 	access by individuals under 21 years of age.
72.3 	(b) A cannabis business with a license or endorsement authorizing the retail sale of 
72.4 	cannabis flower or cannabis products may sell hemp-derived topical products.
72.5 	(c) A cannabis business with a license or endorsement authorizing the retail sale of 
72.6 	cannabis flower or cannabis products may sell the following products that do not contain 
72.7 	cannabis flower, cannabis concentrate, hemp concentrate, synthetically derived cannabinoids, 
72.8 	or tetrahydrocannabinol:
72.9 	(1) drinks that do not contain alcohol and are packaged in sealed containers labeled for 
72.10 	retail sale;
72.11 	(2) books and videos on the cultivation and use of cannabis flower and products that 
72.12 	contain cannabinoids;
72.13 	(3) magazines and other publications published primarily for information and education 
72.14 	on cannabis plants, cannabis flower, and products that contain cannabinoids;
72.15 	(4) multiple-use bags designed to carry purchased items;
72.16 	(5) clothing marked with the specific name, brand, or identifying logo of the retailer; 
72.17 	and
72.18 	(6) hemp fiber products and products that contain hemp grain.
72.19 		Subd. 4.Age verification. (a) Prior to initiating a sale, an employee of a cannabis 
72.20 	business with a license or endorsement authorizing the retail sale of cannabis flower or 
72.21 	cannabis products must verify that the customer is at least 21 years of age.
72.22 	(b) Proof of age may be established only by one of the following:
72.23 	(1) a valid driver's license or identification card issued by Minnesota, another state, or 
72.24 	a province of Canada and including the photograph and date of birth of the licensed person;
72.25 	(2) a valid Tribal identification card as defined in section 171.072, paragraph (b);
72.26 	(3) a valid passport issued by the United States;
72.27 	(4) a valid instructional permit issued under section 171.05 to a person of legal age to 
72.28 	purchase adult-use cannabis flower or adult-use cannabis products, which includes a 
72.29 	photograph and the date of birth of the person issued the permit; or
72.30 	(5) in the case of a foreign national, a valid passport.
73.1 	(c) A retailer may seize a form of identification listed under paragraph (b) if the cannabis 
73.2 	retailer has reasonable grounds to believe that the form of identification has been altered or 
73.3 	falsified or is being used to violate any law. A retailer that seizes a form of identification 
73.4 	as authorized under this paragraph must deliver it to a law enforcement agency within 24 
73.5 	hours of seizing it.
73.6 		Subd. 5.Display of cannabis flower and products. (a) A cannabis business with a 
73.7 	license or endorsement authorizing the retail sale of cannabis flower or cannabis products 
73.8 	must designate a retail area where customers are permitted. The retail area shall include the 
73.9 	portion of the premises where samples of cannabis flower and cannabis products available 
73.10 	for sale are displayed. All other cannabis flower and cannabis products must be stored in 
73.11 	the secure storage area.
73.12 	(b) A cannabis business with a license or endorsement authorizing the retail sale of 
73.13 	cannabis flower or cannabis products may display one sample of each type of cannabis 
73.14 	flower or cannabis product available for sale. Samples of cannabis flower and cannabis 
73.15 	products must be stored in a sample jar or display case and be accompanied by a label or 
73.16 	notice containing the information required to be affixed to the packaging or container 
73.17 	containing cannabis flower and cannabis products sold to customers. A sample may not 
73.18 	consist of more than eight grams of adult-use cannabis flower or adult-use cannabis 
73.19 	concentrate or an edible cannabis product infused with more than 100 milligrams of 
73.20 	tetrahydrocannabinol. A cannabis retailer may allow customers to smell the cannabis flower 
73.21 	or cannabis product before purchase.
73.22 	(c) A cannabis business with a license or endorsement authorizing the retail sale of 
73.23 	cannabis flower or cannabis products may not sell cannabis flower or cannabis products 
73.24 	used as a sample for display. If the retailer uses display samples of lower-potency hemp 
73.25 	edibles or hemp-derived consumer products, the retailer may not sell the product used as a 
73.26 	sample for display.
73.27 		Subd. 6.Posting of notices. A cannabis business with a license or endorsement 
73.28 	authorizing the retail sale of cannabis flower or cannabis products must post all notices as 
73.29 	required by the office, including but not limited to:
73.30 	(1) information about any product recall;
73.31 	(2) a statement that operating a motor vehicle under the influence of intoxicating 
73.32 	cannabinoids is illegal; and
74.1 	(3) a statement that cannabis flower, cannabis products, lower-potency hemp edibles, 
74.2 	and hemp-derived consumer products are only intended for consumption by individuals 
74.3 	who are at least 21 years of age.
74.4 		Subd. 7.Hours of operation. (a) Except as provided by paragraph (b), a cannabis retailer 
74.5 	may not sell cannabis flower, cannabis products, lower-potency hemp edibles, or 
74.6 	hemp-derived consumer products:
74.7 	(1) on Sundays, except between the hours of 11:00 a.m. and 6:00 p.m.;
74.8 	(2) before 8:00 a.m. or after 10:00 p.m. on Monday through Saturday;
74.9 	(3) on Thanksgiving Day;
74.10 	(4) on Christmas Day, December 25; or
74.11 	(5) after 8:00 p.m. on Christmas Eve, December 24.
74.12 	(b) A city or county may adopt an ordinance to permit sales between 10:00 p.m. and 
74.13 	8:00 a.m. on the days of Monday through Saturday or Sunday before 11:00 a.m. or after 
74.14 	6:00 p.m.
74.15 	(c) A cannabis business with a license or endorsement authorizing the retail sale of 
74.16 	cannabis flower or cannabis products may not be open to the public or sell any other products 
74.17 	at times when it is prohibited from selling cannabis flower, cannabis products, lower-potency 
74.18 	hemp edibles, and hemp-derived consumer products.
74.19 		Subd. 8.Building conditions. (a) A cannabis business with a license or endorsement 
74.20 	authorizing the retail sale of cannabis flower or cannabis products shall maintain compliance 
74.21 	with state and local building, fire, and zoning requirements or regulations.
74.22 	(b) A cannabis business with a license or endorsement authorizing the retail sale of 
74.23 	cannabis flower or cannabis products shall ensure that the licensed premises is maintained 
74.24 	in a clean and sanitary condition, free from infestation by insects, rodents, or other pests.
74.25 		Subd. 9.Security. A cannabis business with a license or endorsement authorizing the 
74.26 	retail sale of cannabis flower or cannabis products shall maintain compliance with security 
74.27 	requirements established by the office, including but not limited to requirements for 
74.28 	maintaining video surveillance records, use of specific locking mechanisms, establishment 
74.29 	of secure entries, and the number of employees working at all times.
74.30 		Subd. 10.Lighting. A cannabis business with a license or endorsement authorizing the 
74.31 	retail sale of cannabis flower or cannabis products must keep all lighting outside and inside 
74.32 	the dispensary in good working order and wattage sufficient for security cameras.
75.1 		Subd. 11.Deliveries. A cannabis business with a license or endorsement authorizing 
75.2 	the retail sale of cannabis flower or cannabis products may only accept deliveries of cannabis 
75.3 	flower, cannabis products, and hemp-derived consumer products into a limited access area. 
75.4 	Deliveries may not be accepted through the public access areas unless otherwise approved 
75.5 	by the office.
75.6 		Subd. 12.Prohibitions. A cannabis business with a license or endorsement authorizing 
75.7 	the retail sale of cannabis flower or cannabis products shall not:
75.8 	(1) sell cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
75.9 	consumer products to a person who is visibly intoxicated;
75.10 	(2) knowingly sell more cannabis flower, cannabis products, lower-potency hemp edibles, 
75.11 	or hemp-derived consumer products than a customer is legally permitted to possess;
75.12 	(3) give away immature cannabis plants or seedlings, cannabis flower, cannabis products, 
75.13 	lower-potency hemp edibles, or hemp-derived consumer products;
75.14 	(4) operate a drive-through window;
75.15 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
75.16 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines; or
75.17 	(6) sell cannabis plants, cannabis flower, or cannabis products if the cannabis retailer 
75.18 	knows that any required security or statewide monitoring systems are not operational.
75.19 		Subd. 13.Adult-use and medical cannabis; co-location. (a) A cannabis business with 
75.20 	a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use 
75.21 	cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis 
75.22 	flower and medical cannabinoid products on a portion of its premises.
75.23 	(b) The portion of the premises in which medical cannabis flower and medical 
75.24 	cannabinoid products are sold must be definite and distinct from all other areas of the 
75.25 	cannabis retailer and must provide an appropriate space for a pharmacist employee of the 
75.26 	medical cannabis retailer to consult with a patient to determine the proper type of medical 
75.27 	cannabis flower and medical cannabinoid products and proper dosage for the patient.
75.28 		Subd. 14.Exception. Nothing in this section applies to the operations of a lower-potency 
75.29 	hemp edible retailer.

76.1 	Sec. 31. [342.29] CANNABIS MICROBUSINESS LICENSING AND OPERATIONS.
76.2 		Subdivision 1.Authorized actions. A cannabis microbusiness license, consistent with 
76.3 	the specific license endorsement or endorsements, entitles the license holder to perform any 
76.4 	or all of the following within the limits established by this section:
76.5 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
76.6 	cannabis flower from mature plants;
76.7 	(2) make cannabis concentrate;
76.8 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
76.9 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
76.10 	(4) manufacture synthetically derived cannabinoids;
76.11 	(5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
76.12 	hemp-derived consumer products for public consumption;
76.13 	(6) purchase immature cannabis plants and seedlings and cannabis flower from another 
76.14 	cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, or a cannabis 
76.15 	wholesaler;
76.16 	(7) purchase hemp plant parts from an industrial hemp grower;
76.17 	(8) purchase cannabis concentrate, hemp concentrate, and synthetically derived 
76.18 	cannabinoids from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis 
76.19 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
76.20 	lower-potency hemp edibles, or hemp-derived consumer products;
76.21 	(9) package and label adult-use cannabis flower, adult-use cannabis products, 
76.22 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
76.23 	(10) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
76.24 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
76.25 	other products authorized by law to other cannabis businesses and to customers;
76.26 	(11) operate an establishment that permits on-site consumption of edible cannabis 
76.27 	products and lower-potency hemp edibles; and
76.28 	(12) perform other actions approved by the office.
76.29 		Subd. 2.Size limitations. (a) A cannabis microbusiness that cultivates cannabis may 
76.30 	cultivate up to 2,000 square feet of plant canopy unless the office, by rule, increases that 
76.31 	limit. The office may, by rule, increase the limit on plant canopy to no more than 5,000 
77.1 	square feet if the office determines that expansion is consistent with the goals identified in 
77.2 	section 342.02, subdivision 1. A cannabis microbusiness may not operate multiple tiers of 
77.3 	cultivation.
77.4 	(b) The office shall, by rule, establish a limit on the manufacturing of cannabis products, 
77.5 	lower-potency hemp edibles, or hemp-derived consumer products that a cannabis 
77.6 	microbusiness manufacturing such products may perform. The limit must be equivalent to 
77.7 	the amount of cannabis flower that can be harvested from a facility with a plant canopy of 
77.8 	2,000 square feet in a year, but may be increased to the amount that can be harvested from 
77.9 	a facility with up to 5,000 square feet of plant canopy if the office expands the allowable 
77.10 	area of cultivation under paragraph (a).
77.11 	(c) A cannabis microbusiness with the appropriate endorsement may operate one retail 
77.12 	location.
77.13 		Subd. 3.Additional information required. In addition to the information required to 
77.14 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
77.15 	a person, cooperative, or business seeking a cannabis microbusiness license must submit 
77.16 	the following information in a form approved by the office:
77.17 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
77.18 	diagram of ventilation and filtration systems; plans for wastewater and waste disposal for 
77.19 	any cultivation or manufacturing activities; plans for providing electricity, water, and other 
77.20 	utilities necessary for the normal operation of any cultivation or manufacturing activities; 
77.21 	plans for compliance with applicable building codes and federal and state environmental 
77.22 	and workplace safety requirements and policies; and plans to avoid sales to unlicensed 
77.23 	cannabis businesses and individuals under 21 years of age;
77.24 	(2) if the applicant is seeking an endorsement to cultivate cannabis plants and harvest 
77.25 	cannabis flower, a cultivation plan demonstrating the proposed size and layout of the 
77.26 	cultivation facility that will be used exclusively for cultivation including the total amount 
77.27 	of plant canopy;
77.28 	(3) if the applicant is seeking an endorsement to create cannabis concentrate, hemp 
77.29 	concentrate, or synthetically derived cannabinoids, information identifying all methods of 
77.30 	extraction, concentration, or conversion that the applicant intends to use and the volatile 
77.31 	chemicals and catalysts, if any, that will be involved in extraction, concentration, or creation; 
77.32 	and
77.33 	(4) evidence that the applicant will comply with the applicable operation requirements 
77.34 	for the license being sought.
78.1 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
78.2 	cannabis microbusiness license may also hold a cannabis event organizer license.
78.3 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
78.4 	cannabis microbusiness license may own or operate any other cannabis business or hemp 
78.5 	business or hold more than one cannabis microbusiness license.
78.6 	(c) For purposes of this subdivision, a restriction on the number or type of license that 
78.7 	a business may hold applies to every cooperative member or every director, manager, and 
78.8 	general partner of a cannabis business.
78.9 		Subd. 5.Cultivation endorsement. A cannabis microbusiness that cultivates cannabis 
78.10 	plants and harvests cannabis flower must comply with the requirements in section 342.25.
78.11 		Subd. 6.Extraction and concentration endorsement. A cannabis microbusiness that 
78.12 	creates cannabis concentrate must comply with the requirements in section 342.26, 
78.13 	subdivisions 2 and 3.
78.14 		Subd. 7.Production of customer products endorsement. A cannabis microbusiness 
78.15 	that manufacturers edible cannabis products, lower-potency hemp products, or hemp-derived 
78.16 	consumer products must comply with the requirements in section 342.26, subdivisions 2 
78.17 	and 4.
78.18 		Subd. 8.Retail operations endorsement. A cannabis microbusiness that operates a 
78.19 	retail location must comply with the requirements in section 342.27.
78.20 		Subd. 9.On-site consumption endorsement. (a) A cannabis microbusiness may permit 
78.21 	on-site consumption of edible cannabis products and lower-potency hemp edibles on a 
78.22 	portion of its premises.
78.23 	(b) The portion of the premises in which on-site consumption is permitted must be 
78.24 	definite and distinct from all other areas of the microbusiness and must be accessed through 
78.25 	a distinct entrance.
78.26 	(c) Edible cannabis products and lower-potency hemp edibles sold for on-site 
78.27 	consumption must comply with this chapter and rules adopted pursuant to this chapter 
78.28 	regarding the testing, packaging, and labeling of cannabis products.
78.29 	(d) Edible cannabinoid products and lower-potency hemp edibles sold for on-site 
78.30 	consumption must be served in the required packaging, but may be removed from the 
78.31 	products' packaging by customers and consumed on site.
79.1 	(e) Food and beverages not otherwise prohibited by this subdivision may be prepared 
79.2 	and sold on site provided that the cannabis microbusiness complies with all relevant state 
79.3 	and local laws, ordinances, licensing requirements, and zoning requirements.
79.4 	(f) A cannabis microbusiness shall ensure that the display and consumption of any edible 
79.5 	cannabis product or lower-potency hemp edible is not visible from outside of the licensed 
79.6 	premises of the business.
79.7 	(g) A cannabis microbusiness may offer recorded or live entertainment provided that 
79.8 	the cannabis microbusiness complies with all relevant state and local laws, ordinances, 
79.9 	licensing requirements, and zoning requirements.
79.10 	(h) A cannabis microbusiness may not:
79.11 	(1) sell an edible cannabis product or a lower-potency hemp edible to an individual who 
79.12 	is under 21 years of age;
79.13 	(2) permit an individual who is under 21 years of age to enter the premises;
79.14 	(3) sell more than one single serving of an edible cannabis product or a lower-potency 
79.15 	hemp edible to a customer;
79.16 	(4) sell an edible cannabis product or a lower-potency hemp edible to a person who is 
79.17 	visibly intoxicated;
79.18 	(5) sell or allow the sale or consumption of alcohol or tobacco on the premises;
79.19 	(6) sell products that are intended to be eaten or consumed as a drink, other than packaged 
79.20 	and labeled edible cannabis products and lower-potency hemp edibles, and that contain 
79.21 	cannabis flower or hemp plant parts or are infused with cannabis concentrate, hemp 
79.22 	concentrate, or synthetically derived cannabinoids;
79.23 	(7) permit edible cannabis products or lower-potency hemp edibles sold in the portion 
79.24 	of the area designated for on-site consumption to be removed from that area;
79.25 	(8) permit adult-use cannabis flower, adult-use cannabis products, hemp-derived consumer 
79.26 	products, or tobacco to be consumed through smoking or a vaporized delivery method on 
79.27 	the premises; or
79.28 	(9) distribute or allow free samples of cannabis flower, cannabis products, lower-potency 
79.29 	hemp edibles, or hemp-derived consumer products.

80.1 	Sec. 32. [342.30] CANNABIS WHOLESALER LICENSING.
80.2 		Subdivision 1.Authorized actions. A cannabis wholesaler license entitles the license 
80.3 	holder to:
80.4 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
80.5 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
80.6 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
80.7 	and cannabis microbusinesses;
80.8 	(2) purchase hemp plant parts from industrial hemp growers;
80.9 	(3) sell immature cannabis plants and seedlings, cannabis flower, cannabis products, 
80.10 	lower-potency hemp edibles, and hemp-derived consumer products to cannabis 
80.11 	microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;
80.12 	(4) sell lower-potency hemp edibles to lower-potency hemp edible retailers;
80.13 	(5) import hemp-derived consumer products and lower-potency hemp edibles that contain 
80.14 	hemp concentrate or synthetically derived cannabinoids that are derived from hemp plants 
80.15 	or hemp plant parts; and
80.16 	(6) perform other actions approved by the office.
80.17 		Subd. 2.Additional information required. In addition to the information required to 
80.18 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
80.19 	a person, cooperative, or business seeking a cannabis wholesaler license must submit the 
80.20 	following information in a form approved by the office:
80.21 	(1) an operating plan demonstrating the proposed layout of the facility including a 
80.22 	diagram of ventilation and filtration systems and policies to avoid sales to unlicensed 
80.23 	cannabis businesses; and
80.24 	(2) evidence that the business will comply with the applicable operation requirements 
80.25 	for the license being sought.
80.26 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
80.27 	cannabis wholesaler license may also hold a cannabis transporter license, a cannabis delivery 
80.28 	service license, and a cannabis event organizer license.
80.29 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
80.30 	cannabis wholesaler license may own or operate any other cannabis business or hemp 
80.31 	business.
81.1 	(c) The office by rule may limit the number of cannabis wholesaler licenses a person or 
81.2 	business may hold.
81.3 	(d) For purposes of this subdivision, a restriction on the number or type of license a 
81.4 	business may hold applies to every cooperative member or every director, manager, and 
81.5 	general partner of a cannabis business.

81.6 	Sec. 33. [342.31] CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.
81.7 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
81.8 	the specific license endorsement or endorsements, entitles the license holder to perform any 
81.9 	or all of the following within the limits established by this section:
81.10 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
81.11 	cannabis flower from mature plants;
81.12 	(2) make cannabis concentrate;
81.13 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
81.14 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
81.15 	(4) manufacture synthetically derived cannabinoids;
81.16 	(5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
81.17 	hemp-derived consumer products for public consumption;
81.18 	(6) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
81.19 	microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, or a cannabis 
81.20 	wholesaler;
81.21 	(7) purchase cannabis concentrate, hemp concentrate, and synthetically derived 
81.22 	cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis 
81.23 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
81.24 	lower-potency hemp edibles, or hemp-derived consumer products;
81.25 	(8) purchase hemp plant parts from a licensed hemp grower;
81.26 	(9) package and label adult-use cannabis flower, adult-use cannabis products, 
81.27 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
81.28 	(10) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
81.29 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
81.30 	other products authorized by law to other cannabis businesses and to customers; and
81.31 	(11) perform other actions approved by the office.
82.1 		Subd. 2.Size limitations. (a) A cannabis mezzobusiness that cultivates cannabis may 
82.2 	cultivate up to 5,000 square feet of plant canopy unless the office, by rule, increases that 
82.3 	limit. The office may, by rule, increase the limit on plant canopy to no more than 15,000 
82.4 	cubic feet if the office determines that expansion is consistent with the goals identified in 
82.5 	section 342.02, subdivision 1. A cannabis mezzobusiness may not operate multiple tiers of 
82.6 	cultivation unless authorized by the office.
82.7 	(b) The office shall, by rule, establish a limit on the manufacturing of cannabis products, 
82.8 	lower-potency hemp edibles, or hemp-derived consumer products a cannabis mezzobusiness 
82.9 	that manufactures such products may perform. The limit must be equivalent to the amount 
82.10 	of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square 
82.11 	feet in a year, but may be increased to the amount that can be harvested from a facility with 
82.12 	up to 15,000 cubic feet of plant canopy if the office expands the allowable area of cultivation 
82.13 	under paragraph (a).
82.14 	(c) A cannabis mezzobusiness with the appropriate endorsement may operate up to three 
82.15 	retail locations.
82.16 		Subd. 3.Additional information required. In addition to the information required to 
82.17 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
82.18 	a person, cooperative, or business seeking a cannabis mezzobusiness license must submit 
82.19 	the following information in a form approved by the office:
82.20 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
82.21 	diagram of ventilation and filtration systems; plans for wastewater and waste disposal for 
82.22 	any cultivation or manufacturing activities; plans for providing electricity, water, and other 
82.23 	utilities necessary for the normal operation of any cultivation or manufacturing activities; 
82.24 	plans for compliance with applicable building codes and federal and state environmental 
82.25 	and workplace safety requirements and policies; and plans to avoid sales to unlicensed 
82.26 	cannabis businesses and individuals under 21 years of age;
82.27 	(2) if the applicant is seeking an endorsement to cultivate cannabis plants and harvest 
82.28 	cannabis flower, a cultivation plan demonstrating the proposed size and layout of the 
82.29 	cultivation facility that will be used exclusively for cultivation including the total amount 
82.30 	of plant canopy;
82.31 	(3) if the applicant is seeking an endorsement to create cannabis concentrate, hemp 
82.32 	concentrate, or synthetically derived cannabinoids, information identifying all methods of 
82.33 	extraction, concentration, or conversion that the applicant intends to use and the volatile 
83.1 	chemicals and catalysts, if any, that will be involved in extraction, concentration, or creation; 
83.2 	and
83.3 	(4) evidence that the applicant will comply with the applicable operation requirements 
83.4 	for the license being sought.
83.5 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
83.6 	cannabis mezzobusiness license may also hold a cannabis event organizer license.
83.7 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
83.8 	cannabis mezzobusiness license may own or operate any other cannabis business or hemp 
83.9 	business or hold more than one cannabis mezzobusiness license.
83.10 	(c) For purposes of this subdivision, a restriction on the number or type of license that 
83.11 	a business may hold applies to every cooperative member or every director, manager, and 
83.12 	general partner of a cannabis business.
83.13 		Subd. 5.Cultivation endorsement. A cannabis mezzobusiness that cultivates cannabis 
83.14 	plants and harvests cannabis flower must comply with the requirements in section 342.25.
83.15 		Subd. 6.Extraction and concentration endorsement. A cannabis mezzobusiness that 
83.16 	creates cannabis concentrate must comply with the requirements in section 342.26, 
83.17 	subdivisions 2 and 3.
83.18 		Subd. 7.Production of customer products endorsement. A cannabis mezzobusiness 
83.19 	that manufacturers edible cannabis products, lower-potency hemp products, or hemp-derived 
83.20 	consumer products must comply with the requirements in section 342.26, subdivisions 2 
83.21 	and 4.
83.22 		Subd. 8.Retail operations endorsement. A cannabis mezzobusiness that operates a 
83.23 	retail location must comply with the requirements in section 342.27.
83.24 		Subd. 9.Co-location. (a) A cannabis mezzobusiness that is also a licensed medical 
83.25 	cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a 
83.26 	portion of its premises.
83.27 	(b) The portion of the premises in which medical cannabis flower and medical 
83.28 	cannabinoid products are sold must be definite and distinct from all other areas of the 
83.29 	cannabis mezzobusiness and must provide an appropriate space for a pharmacist employee 
83.30 	of a medical cannabis retailer to consult with the patient to determine the proper type of 
83.31 	medical cannabis flower and medical cannabinoid products and proper dosage for the patient.

84.1 	Sec. 34. [342.32] CANNABIS WHOLESALER OPERATIONS.
84.2 		Subdivision 1.Separation of products. A cannabis wholesaler must ensure that cannabis 
84.3 	plants, cannabis flower, and cannabis products are physically separated from all other 
84.4 	products, including but not limited to lower-potency hemp edibles and hemp-derived 
84.5 	consumer products, in a manner that prevents any cross-contamination.
84.6 		Subd. 2.Records and labels. A cannabis wholesaler must maintain accurate records 
84.7 	and ensure that appropriate labels remain affixed to cannabis plants, cannabis flower, 
84.8 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products.
84.9 		Subd. 3.Building conditions. (a) A cannabis wholesaler shall maintain compliance 
84.10 	with state and local building, fire, and zoning requirements or regulations.
84.11 	(b) A cannabis wholesaler shall ensure that the licensed premises is maintained in a 
84.12 	clean and sanitary condition, free from infestation by insects, rodents, or other pests.
84.13 		Subd. 4.Sale of other products. A cannabis wholesaler may purchase and sell other 
84.14 	products or items for which the cannabis wholesaler has a license or authorization or that 
84.15 	do not require a license or authorization. Products for which no license or authorization is 
84.16 	required include but are not limited to industrial hemp products, products that contain hemp 
84.17 	grain, hemp-derived topical products, and cannabis paraphernalia, including but not limited 
84.18 	to childproof packaging containers and other devices designed to ensure the safe storage 
84.19 	and monitoring of cannabis flower and cannabis products in the home to prevent access by 
84.20 	individuals under 21 years of age.
84.21 		Subd. 5.Importation of hemp-derived products. (a) A cannabis wholesaler that imports 
84.22 	lower-potency hemp edibles or hemp-derived consumer products, other than hemp-derived 
84.23 	topical products, that are manufactured outside the boundaries of the state of Minnesota 
84.24 	with the intent to sell the products to a cannabis microbusiness, cannabis mezzobusiness, 
84.25 	cannabis retailer, or lower-potency hemp edible retailer must obtain a hemp-derived product 
84.26 	importer endorsement from the office.
84.27 	(b) A cannabis wholesaler with a hemp-derived product importer endorsement may sell 
84.28 	products manufactured outside the boundaries of the state of Minnesota if:
84.29 	(1) the manufacturer is licensed in another jurisdiction and subject to regulations designed 
84.30 	to protect the health and safety of consumers that the office determines are substantially 
84.31 	similar to the regulations in this state; or
85.1 	(2) the cannabis wholesaler establishes, to the satisfaction of the office, that the 
85.2 	manufacturer engages in practices that are substantially similar to the practices required for 
85.3 	licensure of manufacturers in this state.
85.4 	(c) The cannabis wholesaler must enter all relevant information regarding an imported 
85.5 	hemp-derived consumer product into the statewide monitoring system before the product 
85.6 	may be distributed. Relevant information includes information regarding the cultivation, 
85.7 	processing, and testing of the industrial hemp used in the manufacture of the product and 
85.8 	information regarding the testing of the hemp-derived consumer product. If information 
85.9 	regarding the industrial hemp or hemp-derived consumer product was submitted to a 
85.10 	statewide monitoring system used in another state, the office may require submission of 
85.11 	any information provided to that statewide monitoring system and shall assist in the transfer 
85.12 	of data from another state as needed and in compliance with any data classification 
85.13 	established by either state.
85.14 	(d) The office may suspend, revoke, or cancel the endorsement of a distributor who is 
85.15 	prohibited from distributing products containing cannabinoids in any other jurisdiction, 
85.16 	convicted of an offense involving the distribution of products containing cannabinoids in 
85.17 	any other jurisdiction, or found liable for distributing any product that injured customers in 
85.18 	any other jurisdiction. A cannabis wholesaler shall disclose all relevant information related 
85.19 	to actions in another jurisdiction. Failure to disclose relevant information may result in 
85.20 	disciplinary action by the office, including the suspension, revocation, or cancellation of 
85.21 	an endorsement or license.
85.22 	(e) Notwithstanding any law to the contrary, it shall not be a defense in any civil or 
85.23 	criminal action that a licensed wholesaler relied on information on a product label or 
85.24 	otherwise provided by a manufacturer who is not licensed in this state.

85.25 	Sec. 35. [342.33] CANNABIS TRANSPORTER LICENSING.
85.26 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
85.27 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
85.28 	products, synthetically derived cannabinoids, hemp plant parts, hemp concentrate, 
85.29 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
85.30 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
85.31 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers, 
85.32 	medical cannabis processors, and industrial hemp growers to cannabis microbusinesses, 
85.33 	cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
85.34 	wholesalers, cannabis retailers, lower-potency hemp edible product retailers, medical 
86.1 	cannabis processors, and medical cannabis retailers and perform other actions approved by 
86.2 	the office.
86.3 		Subd. 2.Additional information required. In addition to the information required to 
86.4 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
86.5 	a person, cooperative, or business seeking a cannabis transporter license must submit the 
86.6 	following information in a form approved by the office:
86.7 	(1) an appropriate surety bond, certificate of insurance, qualifications as a self-insurer, 
86.8 	or other securities or agreements, in the amount of not less than $300,000, for loss of or 
86.9 	damage to cargo;
86.10 	(2) an appropriate surety bond, certificate of insurance, qualifications as a self-insurer, 
86.11 	or other securities or agreements, in the amount of not less than $1,000,000, for injury to 
86.12 	one or more persons in any one accident and, if an accident has resulted in injury to or 
86.13 	destruction of property, of not less than $100,000 because of such injury to or destruction 
86.14 	of property of others in any one accident;
86.15 	(3) the number and type of equipment the business will use to transport immature cannabis 
86.16 	plants and seedlings, cannabis flower, cannabis products, synthetically derived cannabinoids, 
86.17 	hemp plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived 
86.18 	consumer products;
86.19 	(4) a loading, transporting, and unloading plan;
86.20 	(5) a description of the applicant's experience in the distribution or security business; 
86.21 	and
86.22 	(6) evidence that the business will comply with the applicable operation requirements 
86.23 	for the license being sought.
86.24 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
86.25 	cannabis transporter license may also hold a cannabis wholesaler license, a cannabis delivery 
86.26 	service license, and a cannabis event organizer license.
86.27 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
86.28 	cannabis transporter license may own or operate any other cannabis business.
86.29 	(c) The office by rule may limit the number of cannabis transporter licenses a person or 
86.30 	business may hold.
87.1 	(d) For purposes of this subdivision, restrictions on the number or type of license a 
87.2 	business may hold apply to every cooperative member or every director, manager, and 
87.3 	general partner of a cannabis business.

87.4 	Sec. 36. [342.34] CANNABIS TRANSPORTER OPERATIONS.
87.5 		Subdivision 1.Manifest required. Before transporting immature cannabis plants and 
87.6 	seedlings, cannabis flower, cannabis products, synthetically derived cannabinoids, hemp 
87.7 	plant parts, hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer 
87.8 	products, a cannabis transporter shall obtain a shipping manifest on a form established by 
87.9 	the office. The manifest must be kept with the products at all times and the cannabis 
87.10 	transporter must maintain a copy of the manifest in its records.
87.11 		Subd. 2.Records of transportation. Records of transportation must be kept for a 
87.12 	minimum of three years at the cannabis transporter's place of business and are subject to 
87.13 	inspection upon request by the office or law enforcement agency. Records of transportation 
87.14 	include the following:
87.15 	(1) copies of transportation manifests for all deliveries;
87.16 	(2) a transportation log documenting the chain of custody for each delivery, including 
87.17 	every employee and vehicle used during transportation; and
87.18 	(3) financial records showing payment for transportation services.
87.19 		Subd. 3.Storage compartment. Immature cannabis plants and seedlings, cannabis 
87.20 	flower, cannabis products, synthetically derived cannabinoids, hemp plant parts, hemp 
87.21 	concentrate, lower-potency hemp edibles, and hemp-derived consumer products must be 
87.22 	transported in a locked, safe, and secure storage compartment that is part of the motor vehicle 
87.23 	or in a locked storage container that has a separate key or combination pad. Items being 
87.24 	transported may not be visible from outside the motor vehicle.
87.25 		Subd. 4.Identifying logos or business names prohibited. No vehicle or trailer may 
87.26 	contain an image depicting the types of items being transported, including but not limited 
87.27 	to an image depicting a cannabis or hemp leaf, or a name suggesting that the vehicle is used 
87.28 	in transporting immature cannabis plants and seedlings, cannabis flower, cannabis products, 
87.29 	synthetically derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency 
87.30 	hemp edibles, or hemp-derived consumer products.
87.31 		Subd. 5.Randomized deliveries. A cannabis transporter shall ensure that all delivery 
87.32 	times and routes are randomized.
88.1 		Subd. 6.Multiple employees. All cannabis transporter vehicles transporting immature 
88.2 	cannabis plants and seedlings, cannabis flower, cannabis products, synthetically derived 
88.3 	cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, or 
88.4 	hemp-derived consumer products must be staffed with a minimum of two employees. At 
88.5 	least one delivery team member shall remain with the motor vehicle at all times that the 
88.6 	motor vehicle contains cannabis plants and seedlings, cannabis flower, cannabis products, 
88.7 	synthetically derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency 
88.8 	hemp edibles, or hemp-derived consumer products.
88.9 		Subd. 7.Nonemployee passengers prohibited. Only a cannabis worker employed by 
88.10 	or contracted with the cannabis transporter and who is at least 21 years of age may transport 
88.11 	immature cannabis plants and seedlings, cannabis flower, cannabis products, synthetically 
88.12 	derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles, or 
88.13 	hemp-derived consumer products. All passengers in a vehicle must be cannabis workers 
88.14 	employed by or contracted with the cannabis transporter.
88.15 		Subd. 8.Drivers license required. All drivers must carry a valid driver's license with 
88.16 	the proper endorsements when operating a vehicle transporting immature cannabis plants 
88.17 	and seedlings, cannabis flower, cannabis products, synthetically derived cannabinoids, hemp 
88.18 	plant parts, hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer 
88.19 	products.
88.20 		Subd. 9.Vehicles subject to inspection. Any vehicle assigned for the purposes of 
88.21 	transporting immature cannabis plants and seedlings, cannabis flower, cannabis products, 
88.22 	synthetically derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency 
88.23 	hemp edibles, or hemp-derived consumer products is subject to inspection and may be 
88.24 	stopped or inspected at any licensed cannabis business or while en route during transportation.

88.25 	Sec. 37. [342.35] CANNABIS TESTING FACILITY LICENSING.
88.26 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
88.27 	holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
88.28 	products, hemp plant parts, hemp concentrate, synthetically derived cannabinoids, 
88.29 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
88.30 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
88.31 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
88.32 	cultivators, medical cannabis processors, and industrial hemp growers.
88.33 		Subd. 2.Additional information required. In addition to the information required to 
88.34 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
89.1 	a person, cooperative, or business seeking a cannabis testing facility license must submit 
89.2 	the following information in a form approved by the office:
89.3 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
89.4 	diagram of ventilation and filtration systems and policies to avoid sales to unlicensed 
89.5 	businesses;
89.6 	(2) proof of accreditation by a laboratory accrediting organization approved by the office 
89.7 	that, at a minimum, requires a laboratory to operate formal management systems under the 
89.8 	International Organization for Standardization; and
89.9 	(3) evidence that the business will comply with the applicable operation requirements 
89.10 	for the license being sought.
89.11 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
89.12 	cannabis testing facility license may not own or operate, or be employed by, any other 
89.13 	cannabis business or hemp business.
89.14 	(b) The office by rule may limit the number of cannabis testing facility licenses a person 
89.15 	or business may hold.
89.16 	(c) For purposes of this subdivision, a restriction on the number of licenses a business 
89.17 	may hold applies to every cooperative member or every director, manager, and general 
89.18 	partner of a cannabis business.

89.19 	Sec. 38. [342.36] CANNABIS TESTING FACILITY OPERATIONS.
89.20 		Subdivision 1.Testing services. A cannabis testing facility shall provide some or all 
89.21 	testing services required under section 342.60 and rules adopted pursuant to that section.
89.22 		Subd. 2.Testing protocols. A cannabis testing facility shall follow all testing protocols, 
89.23 	standards, and criteria adopted by rule by the office for the testing of different forms of 
89.24 	cannabis plants and seedlings, cannabis flower, cannabis products, lower-potency hemp 
89.25 	edibles, hemp-derived consumer products, hemp plant parts, hemp concentrate, and 
89.26 	synthetically derived cannabinoids; determining batch size; sampling; testing validity; and 
89.27 	the approval and disapproval of tested items.
89.28 		Subd. 3.Records. Records of all business transactions and testing results; records 
89.29 	required to be maintained pursuant to any applicable standards for accreditation; and records 
89.30 	relevant to testing protocols, standards, and criteria adopted by the office must be kept for 
89.31 	a minimum of three years at the cannabis testing facility's place of business and are subject 
89.32 	to inspection upon request by the office or law enforcement agency.
90.1 		Subd. 4.Disposal of cannabis flower and cannabinoid products. A testing facility 
90.2 	shall dispose of or destroy used, unused, and waste cannabis plants and seedlings, cannabis 
90.3 	flower, cannabis products, lower-potency hemp edibles, hemp-derived consumer products, 
90.4 	hemp plant parts, hemp concentrate, and synthetically derived cannabinoids, pursuant to 
90.5 	rules adopted by the office.

90.6 	Sec. 39. [342.37] CANNABIS EVENT ORGANIZER LICENSING.
90.7 		Subdivision 1.Authorized actions. A cannabis event organizer license entitles the 
90.8 	license holder to organize a temporary cannabis event lasting no more than four days.
90.9 		Subd. 2.Additional information required. (a) In addition to the information required 
90.10 	to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that 
90.11 	section, a person, cooperative, or business seeking a cannabis event organizer license must 
90.12 	submit the following information in a form approved by the office:
90.13 	(1) the type and number of any other cannabis business license held by the applicant;
90.14 	(2) the address and location where the temporary cannabis event will take place;
90.15 	(3) the name of the temporary cannabis event;
90.16 	(4) a diagram of the physical layout of the temporary cannabis event showing where the 
90.17 	event will take place on the grounds; all entrances and exits that will be used by participants 
90.18 	during the event; all cannabis consumption areas; all cannabis retail areas where cannabis 
90.19 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
90.20 	will be sold; the location where cannabis waste will be stored; and any location where 
90.21 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
90.22 	products will be stored;
90.23 	(5) a list of the name, number, and type of cannabis businesses and hemp businesses 
90.24 	that will sell cannabis plants, adult-use cannabis flower, adult-use cannabis products, and 
90.25 	hemp-derived consumer products at the event, which may be supplemented or amended 
90.26 	within 72 hours of the time at which the cannabis event begins;
90.27 	(6) the dates and hours during which the cannabis event will take place;
90.28 	(7) proof of local approval for the cannabis event; and
90.29 	(8) evidence that the business will comply with the applicable operation requirements 
90.30 	for the license being sought.
91.1 	(b) A person, cooperative, or business seeking a cannabis event organizer license may 
91.2 	also disclose whether the person or any officer, director, manager, and general partner of a 
91.3 	cannabis business is serving or has previously served in the military.
91.4 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
91.5 	cannabis event organizer license may not hold a cannabis testing facility license, a 
91.6 	lower-potency hemp edible manufacturer license, or a lower-potency hemp edible retailer 
91.7 	license.
91.8 	(b) The office by rule may limit the number of cannabis event licenses that a person or 
91.9 	business may hold.
91.10 	(c) For purposes of this subdivision, restrictions on the number or type of license that a 
91.11 	business may hold apply to every cooperative member or every director, manager, and 
91.12 	general partner of a cannabis business.

91.13 	Sec. 40. [342.38] CANNABIS EVENT ORGANIZER OPERATIONS.
91.14 		Subdivision 1.Local approval. A cannabis event organizer must receive local approval, 
91.15 	including obtaining any necessary permits or licenses issued by a local unit of government, 
91.16 	before holding a cannabis event.
91.17 		Subd. 2.Charging fees. (a) A cannabis event organizer may charge an entrance fee to 
91.18 	a cannabis event.
91.19 	(b) A cannabis event organizer may charge a fee to a cannabis business or hemp business 
91.20 	in exchange for space to display and sell cannabis plants, adult-use cannabis flower, adult-use 
91.21 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products. Any 
91.22 	fee paid for participation in a cannabis event shall not be based on or tied to the sale of 
91.23 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
91.24 	hemp edibles, or hemp-derived consumer products.
91.25 		Subd. 3.Security. A cannabis event organizer must hire or contract for licensed security 
91.26 	personnel to provide security services at the cannabis event. All security personnel hired or 
91.27 	contracted for shall be at least 21 years of age and present on the licensed event premises 
91.28 	at all times that cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
91.29 	lower-potency hemp edibles, or hemp-derived consumer products are available for sale or 
91.30 	consumption of adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
91.31 	edibles, or hemp-derived consumer products is allowed. The security personnel shall not 
91.32 	consume cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
91.33 	consumer products for at least 24 hours before the event or during the event.
92.1 		Subd. 4.Limited access to event. A cannabis event organizer shall ensure that access 
92.2 	to an event is limited to individuals who are at least 21 years of age. At or near each public 
92.3 	entrance to any area where the sale or consumption of adult-use cannabis flower, adult-use 
92.4 	cannabis products, lower-potency hemp edibles, or hemp-derived consumer products is 
92.5 	allowed, a cannabis event organizer shall maintain a clearly visible and legible sign consisting 
92.6 	of the following statement: "No persons under 21 allowed." The lettering of the sign shall 
92.7 	be not less than one inch in height.
92.8 		Subd. 5.Cannabis waste. A cannabis event organizer shall ensure that all used, unused, 
92.9 	and waste cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
92.10 	lower-potency hemp edibles, and hemp-derived consumer products that are not removed 
92.11 	by a customer, cannabis business, or hemp business are disposed of in a manner approved 
92.12 	by the office.
92.13 		Subd. 6.Transportation of cannabis plants, flower, and products. All transportation 
92.14 	of cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
92.15 	hemp edibles, and hemp-derived consumer products intended for display or sale and all 
92.16 	such items used for display or not sold during the cannabis event must be transported to 
92.17 	and from the cannabis event by a licensed cannabis transporter.
92.18 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
92.19 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and lower-potency 
92.20 	hemp edible retailers, including the cannabis event organizer, may be authorized to sell 
92.21 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
92.22 	hemp edibles, and hemp-derived consumer products to customers at a cannabis event.
92.23 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
92.24 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
92.25 	take place in a retail area as designated in the premises diagram.
92.26 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
92.27 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.28, 
92.28 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
92.29 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
92.30 	products to an individual under 21 years of age.
92.31 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
92.32 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
92.33 	consumer product available for sale. Samples of adult-use cannabis flower and adult-use 
92.34 	cannabis products must be stored in a sample jar or display case and be accompanied by a 
93.1 	label or notice containing the information required to be affixed to the packaging or container 
93.2 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
93.3 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
93.4 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
93.5 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
93.6 	cannabis flower or adult-use cannabis product before purchase.
93.7 	(f) The notice requirements under section 342.28, subdivision 6, apply to authorized 
93.8 	cannabis retailers and licensed cannabis microbusinesses offering cannabis plants, adult-use 
93.9 	cannabis flower, adult-use cannabinoid products, and hemp-derived consumer products for 
93.10 	sale at a cannabis event.
93.11 	(g) Authorized retailers may not:
93.12 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
93.13 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
93.14 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
93.15 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
93.16 	is legally permitted to possess;
93.17 	(3) sell medical cannabis flower or medical cannabinoid products;
93.18 	(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp 
93.19 	edibles, or hemp-derived consumer products; or
93.20 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
93.21 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
93.22 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
93.23 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
93.24 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
93.25 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
93.26 	locked container that is not accessible to the public. Such items being stored at a cannabis 
93.27 	event shall not be left unattended.
93.28 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
93.29 	lower-potency hemp edibles, or hemp-derived consumer products for sale at a cannabis 
93.30 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
93.31 	the testing, packaging, and labeling of those items.
94.1 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
94.2 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
94.3 	system.
94.4 		Subd. 8.Cannabis event on-site consumption. (a) If approved by the local unit of 
94.5 	government, a cannabis event may designate an area for consumption of adult-use cannabis 
94.6 	flower, adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer 
94.7 	products, or any combination of those items.
94.8 	(b) Access to areas where consumption of adult-use cannabis flower, adult-use cannabis 
94.9 	products, lower-potency hemp edibles, or hemp-derived consumer products is allowed shall 
94.10 	be restricted to individuals who are at least 21 years of age.
94.11 	(c) The cannabis event organizer shall ensure that consumption of adult-use cannabis 
94.12 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
94.13 	products within a designated consumption area is not visible from any public place.
94.14 	(d) The cannabis event organizer shall not permit consumption of alcohol or tobacco.
94.15 	(e) The cannabis event organizer shall not permit smoking, according to section 144.413, 
94.16 	of adult-use cannabis flower or cannabis products at any location where smoking is not 
94.17 	permitted under sections 144.413 to 144.417. Nothing in this section prohibits a statutory 
94.18 	or home rule charter city or county from enacting and enforcing more stringent measures 
94.19 	to protect individuals from secondhand smoke or involuntary exposure to aerosol or vapor 
94.20 	from electronic delivery devices.

94.21 	Sec. 41. [342.39] CANNABIS DELIVERY SERVICE LICENSING.
94.22 		Subdivision 1.Authorized actions. A cannabis delivery service license entitles the 
94.23 	license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles, 
94.24 	and hemp-derived consumer products from licensed cannabis retailers, licensed cannabis 
94.25 	microbusinesses with a retail endorsement, cannabis mezzobusinesses with a retail 
94.26 	endorsement, cannabis retailers, and medical cannabis retailers; transport and deliver cannabis 
94.27 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumable 
94.28 	products to customers; and perform other actions approved by the office.
94.29 		Subd. 2.Additional information required. In addition to the information required to 
94.30 	be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, 
94.31 	a person, cooperative, or business seeking a cannabis delivery service license must submit 
94.32 	the following information in a form approved by the office:
95.1 	(1) a list of all vehicles to be used in the delivery of cannabis flower, cannabis products, 
95.2 	lower-potency hemp edibles, and hemp-derived consumer products including:
95.3 	(i) the vehicle make, model, and color;
95.4 	(ii) the vehicle identification number; and
95.5 	(iii) the license plate number;
95.6 	(2) proof of insurance for each vehicle;
95.7 	(3) a business plan demonstrating policies to avoid sales of cannabis flower, cannabis 
95.8 	products, lower-potency hemp edibles, and hemp-derived consumer products to individuals 
95.9 	who are under 21 years of age and plans to prevent the visibility of cannabis flower, cannabis 
95.10 	products, lower-potency hemp edibles, and hemp-derived consumer products to individuals 
95.11 	outside the delivery vehicle; and
95.12 	(4) evidence that the business will comply with the applicable operation requirements 
95.13 	for the license being sought.
95.14 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
95.15 	cannabis delivery service license may also hold a cannabis retailer license, a cannabis 
95.16 	wholesaler license, a cannabis transporter license, a cannabis event organizer license, and 
95.17 	a medical cannabis retailer license subject to the ownership limitations that apply to those 
95.18 	licenses.
95.19 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
95.20 	cannabis delivery service license may own or operate any other cannabis business or hemp 
95.21 	business.
95.22 	(c) The office by rule may limit the number of cannabis delivery service licenses that a 
95.23 	person or business may hold.
95.24 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
95.25 	a business may hold applies to every cooperative member or every director, manager, and 
95.26 	general partner of a cannabis business.

95.27 	Sec. 42. [342.40] CANNABIS DELIVERY SERVICE OPERATIONS.
95.28 		Subdivision 1.Age or registry verification. Prior to completing a delivery, a cannabis 
95.29 	delivery service shall verify that the customer is at least 21 years of age or is enrolled in the 
95.30 	registry program. Section 342.28, subdivision 4, applies to the verification of a customer's 
95.31 	age. Registry verification issued by the Division of Medical Cannabis may be considered 
95.32 	evidence that the person is enrolled in the registry program.
96.1 		Subd. 2.Records. The office by rule shall establish record-keeping requirements for a 
96.2 	cannabis delivery service, including but not limited to proof of delivery to individuals who 
96.3 	are at least 21 years of age or enrolled in the registry program.
96.4 		Subd. 3.Amount to be transported. The office by rule shall establish limits on the 
96.5 	amount of cannabis flower, cannabis products, lower-potency hemp edibles, and 
96.6 	hemp-derived consumer products that a cannabis delivery service may transport.
96.7 		Subd. 4.Statewide monitoring system. Receipt of cannabis flower and cannabis products 
96.8 	by the cannabis delivery service and a delivery to a customer must be recorded in the 
96.9 	statewide monitoring system within the time established by rule.
96.10 		Subd. 5.Storage compartment. Cannabis flower, cannabis products, lower-potency 
96.11 	hemp edibles, and hemp-derived consumer products must be transported in a locked, safe, 
96.12 	and secure storage compartment that is part of the cannabis delivery service vehicle or in a 
96.13 	locked storage container that has a separate key or combination pad. Cannabis flower, 
96.14 	cannabis products, lower-potency hemp edibles, and hemp-derived consumer products may 
96.15 	not be visible from outside the cannabis delivery service vehicle.
96.16 		Subd. 6.Identifying logos or business names prohibited. No cannabis delivery service 
96.17 	vehicle or trailer may contain an image depicting the types of items being transported, 
96.18 	including but not limited to an image depicting a cannabis or hemp leaf, or a name suggesting 
96.19 	that the cannabis delivery service vehicle is used for transporting cannabis flower, cannabis 
96.20 	products, lower-potency hemp edibles, or hemp-derived consumer products.
96.21 		Subd. 7.Nonemployee passengers prohibited. Only a cannabis worker employed by 
96.22 	or contracted with the cannabis delivery service and who is at least 21 years of age may 
96.23 	transport cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
96.24 	consumer products. All passengers in a cannabis delivery service vehicle must be cannabis 
96.25 	workers employed by or contracted with the cannabis delivery service.
96.26 		Subd. 8.Vehicles subject to inspection. Any cannabis delivery service vehicle is subject 
96.27 	to inspection and may be stopped or inspected at any licensed cannabis business or while 
96.28 	en route during transportation.

96.29 	Sec. 43. [342.41] LOWER-POTENCY HEMP EDIBLE RETAILER.
96.30 		Subdivision 1.Sale of lower-potency hemp edibles. (a) A lower-potency hemp edible 
96.31 	retailer may only sell lower-potency hemp edibles to individuals who are at least 21 years 
96.32 	of age.
96.33 	(b) A lower-potency hemp edible retailer may sell lower-potency hemp edibles that:
97.1 	(1) are obtained from a licensed Minnesota cannabis microbusiness, cannabis 
97.2 	mezzobusiness, cannabis manufacturer, cannabis wholesaler, or lower-potency hemp edible 
97.3 	manufacturer; and
97.4 	(2) meet all applicable packaging and labeling requirements.
97.5 		Subd. 2.Sale of other products. A lower-potency hemp edible retailer may sell other 
97.6 	products or items for which the lower-potency hemp edible retailer has a license or 
97.7 	authorization or that do not require a license or authorization.
97.8 		Subd. 3.Age verification. Prior to initiating a sale, an employee of the lower-potency 
97.9 	hemp edible retailer must verify that the customer is at least 21 years of age. Section 342.28, 
97.10 	subdivision 4, applies to the verification of a customer's age.
97.11 		Subd. 4.Compliant products. (a) A lower-potency hemp edible retailer shall ensure 
97.12 	that all lower-potency hemp edibles offered for sale comply with the limits on the amounts 
97.13 	and types of cannabinoids that a lower-potency hemp edible can contain, including but not 
97.14 	limited to the requirement that lower-potency hemp edibles:
97.15 	(1) consist of servings that contain no more than five milligrams of delta-9 
97.16 	tetrahydrocannabinol, 25 milligrams of cannabidiol, 25 milligrams of cannabigerol per 
97.17 	serving, or any combination of those cannabinoids that does not exceed the identified 
97.18 	amounts;
97.19 	(2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids; 
97.20 	and
97.21 	(3) do not contain a synthetically derived cannabinoid other than delta-9 
97.22 	tetrahydrocannabinol.
97.23 	(b) If a lower-potency hemp edible is packaged in a manner that includes more than a 
97.24 	single serving, the lower-potency hemp edible must indicate each serving by scoring, 
97.25 	wrapping, or other indicators that appear on the lower-potency hemp edible designating the 
97.26 	individual serving size. If the lower-potency hemp edible is meant to be consumed as a 
97.27 	beverage or it is not possible to indicate a single serving by scoring or use of another indicator 
97.28 	that appears on the product, the lower-potency hemp edible may not be packaged in a manner 
97.29 	that includes more than a single serving in each container.
97.30 	(c) A single package containing multiple servings of a lower-potency hemp edible must 
97.31 	contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of 
97.32 	cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that 
97.33 	does not exceed the identified amounts.
98.1 		Subd. 5.Prohibitions. A lower-potency hemp edible retailer may not:
98.2 	(1) sell lower-potency hemp edibles to an individual who is under 21 years of age;
98.3 	(2) sell a lower-potency hemp edible to a person who is visibly intoxicated;
98.4 	(3) sell cannabis flower, cannabis products, or hemp-derived consumer products;
98.5 	(4) allow for the dispensing of lower-potency hemp edibles in vending machines; or
98.6 	(5) distribute or allow free samples of lower-potency hemp edibles except when the 
98.7 	business is licensed to permit on-site consumption and samples are consumed within its 
98.8 	licensed premises.
98.9 		Subd. 6.On-site consumption. (a) A lower-potency hemp edible retailer may permit 
98.10 	on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an 
98.11 	on-site consumption endorsement.
98.12 	(b) The office shall issue an on-site consumption endorsement to any lower-potency 
98.13 	hemp edible retailer that also holds an on-sale license issued under chapter 340A.
98.14 	(c) Lower-potency hemp edibles sold for on-site consumption must comply with this 
98.15 	chapter and rules adopted pursuant to this chapter regarding testing.
98.16 	(d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency 
98.17 	hemp edibles that are intended to be consumed as a beverage, must be served in the required 
98.18 	packaging, but may be removed from the product's packaging by customers and consumed 
98.19 	on site.
98.20 	(e) Lower-potency hemp edibles that are intended to be consumed as a beverage may 
98.21 	be served outside of their packaging provided the information that is required to be contained 
98.22 	on the label of a lower-potency hemp edible is posted or otherwise displayed by the 
98.23 	lower-potency hemp edible retailer. Hemp workers who serve beverages under this paragraph 
98.24 	are not required to obtain an edible cannabis product handler endorsement under section 
98.25 	342.07, subdivision 3.
98.26 	(f) Food and beverages not otherwise prohibited by this subdivision may be prepared 
98.27 	and sold on site provided that the lower-potency hemp edible retailer complies with all 
98.28 	relevant state and local laws, ordinances, licensing requirements, and zoning requirements.
98.29 	(g) A lower-potency hemp edible retailer may offer recorded or live entertainment 
98.30 	provided that the lower-potency hemp edible retailer complies with all relevant state and 
98.31 	local laws, ordinances, licensing requirements, and zoning requirements.
99.1 	(h) In addition to the prohibitions under this section, a lower-potency hemp edible retailer 
99.2 	with an on-site consumption endorsement may not:
99.3 	(1) sell lower-potency hemp edibles to a customer who the lower-potency hemp edible 
99.4 	retailer knows or reasonably should know is intoxicated;
99.5 	(2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed 
99.6 	with an alcoholic beverage; or
99.7 	(3) permit lower-potency hemp edibles that have been removed from the product's 
99.8 	packaging to be removed from the premises of the lower-potency hemp edible retailer.
99.9 		Subd. 7.Posting of notices. A lower-potency hemp edible retailer must post all notices 
99.10 	as provided in section 342.28, subdivision 6.
99.11 		Subd. 8.Building conditions. (a) A lower-potency hemp edible retailer shall maintain 
99.12 	compliance with state and local building, fire, and zoning requirements or regulations.
99.13 	(b) A lower-potency hemp edible retailer shall ensure that the licensed premises is 
99.14 	maintained in a clean and sanitary condition, free from infestation by insects, rodents, or 
99.15 	other pests.
99.16 		Subd. 9.Enforcement. The office shall inspect lower-potency hemp edible retailers and 
99.17 	take enforcement action as provided in sections 342.17 and 342.18.

99.18 	Sec. 44. [342.42] MEDICAL CANNABIS BUSINESS LICENSES.
99.19 		Subdivision 1.License types. (a) The office shall issue the following types of medical 
99.20 	cannabis business licenses:
99.21 	(1) medical cannabis cultivator;
99.22 	(2) medical cannabis processor; and
99.23 	(3) medical cannabis retailer.
99.24 	(b) The Division of Medical Cannabis may oversee the licensing and regulation of 
99.25 	medical cannabis businesses.
99.26 		Subd. 2.Multiple licenses; limits. (a) A person, cooperative, or business holding:
99.27 	(1) a medical cannabis cultivator license may also hold a medical cannabis processor 
99.28 	license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event 
99.29 	organizer license subject to the ownership limitations that apply to those licenses;
100.1 	(2) a medical cannabis processor license may also hold a medical cannabis cultivator 
100.2 	license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event 
100.3 	organizer license subject to the ownership limitations that apply to those licenses; or
100.4 	(3) a medical cannabis retailer license may also hold a cannabis retailer license, a cannabis 
100.5 	delivery service license, and a cannabis event organizer license subject to the ownership 
100.6 	limitations that apply to those licenses.
100.7 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
100.8 	medical cannabis license may own or operate any other cannabis business.
100.9 	(c) The office by rule may limit the number of medical cannabis business licenses that 
100.10 	a person or business may hold.
100.11 	(d) For purposes of this subdivision, a restriction on the number of licenses or type of 
100.12 	license that a business may hold applies to every cooperative member or every director, 
100.13 	manager, and general partner of a medical cannabis business.
100.14 		Subd. 3.Limitations on health care practitioners. A health care practitioner who 
100.15 	certifies qualifying medical conditions for patients is prohibited from:
100.16 	(1) holding a direct or indirect economic interest in a medical cannabis business;
100.17 	(2) serving on a board of directors or as an employee of a medical cannabis business; 
100.18 	or
100.19 	(3) advertising with a medical cannabis business in any way.
100.20 		Subd. 4.Remuneration. A medical cannabis business is prohibited from:
100.21 	(1) accepting or soliciting any form of remuneration from a health care practitioner who 
100.22 	certifies qualifying medical conditions for patients; or
100.23 	(2) offering any form of remuneration to a health care practitioner who certifies qualifying 
100.24 	medical conditions for patients.

100.25 	EFFECTIVE DATE. This section is effective January 1, 2024.

100.26 	Sec. 45. [342.43] HEMP BUSINESS LICENSE TYPES; MULTIPLE LICENSES.
100.27 		Subdivision 1.License types. The office shall issue the following types of hemp business 
100.28 	licenses:
100.29 	(1) lower-potency hemp edible manufacturer; and
100.30 	(2) lower-potency hemp edible retailer.
101.1 		Subd. 2.Multiple licenses; limits. (a) A person, cooperative, or business may hold both 
101.2 	a lower-potency hemp edible manufacturer and lower-potency hemp edible retailer license.
101.3 	(b) Nothing in this section prohibits a person, cooperative, or business from holding a 
101.4 	lower-potency hemp edible manufacturer license or a lower-potency hemp edible retailer 
101.5 	license, or both, and also holding a license to cultivate industrial hemp issued pursuant to 
101.6 	chapter 18K.
101.7 	(c) Nothing in this section prohibits a person, cooperative, or business from holding a 
101.8 	lower-potency hemp edible manufacturer license or a lower-potency hemp edible retailer 
101.9 	license, or both, and also holding any other license, including but not limited to a license 
101.10 	to prepare or sell food; sell tobacco, tobacco-related devices, and electronic delivery devices 
101.11 	as defined in section 609.685, subdivision 1; nicotine and lobelia delivery products as 
101.12 	described in section 609.6855; or manufacture or sell alcoholic beverages as defined in 
101.13 	section 340A.101, subdivision 2.
101.14 	(d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer 
101.15 	license or a lower-potency hemp edible retailer license, or both, may not hold a cannabis 
101.16 	business license.

101.17 	Sec. 46. [342.44] MEDICAL CANNABIS BUSINESS APPLICATIONS.
101.18 		Subdivision 1.Information required. In addition to information required to be submitted 
101.19 	under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, 
101.20 	cooperative, or business seeking a medical cannabis business license must submit the 
101.21 	following information in a form approved by the office:
101.22 	(1) for medical cannabis cultivator license applicants:
101.23 	(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; 
101.24 	plans for wastewater and waste disposal for the cultivation facility; plans for providing 
101.25 	electricity, water, and other utilities necessary for the normal operation of the cultivation 
101.26 	facility; and plans for compliance with applicable building code and federal and state 
101.27 	environmental and workplace safety requirements;
101.28 	(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation 
101.29 	facility that will be used exclusively for cultivation for medical cannabis, including the total 
101.30 	amount of plant canopy; and
101.31 	(iii) evidence that the business will comply with the applicable operation requirements 
101.32 	for the license being sought;
102.1 	(2) for medical cannabis processor license applicants:
102.2 	(i) an operating plan demonstrating the proposed layout of the facility, including a 
102.3 	diagram of ventilation and filtration systems; plans for wastewater and waste disposal for 
102.4 	the manufacturing facility; plans for providing electricity, water, and other utilities necessary 
102.5 	for the normal operation of the manufacturing facility; and plans for compliance with 
102.6 	applicable building code and federal and state environmental and workplace safety 
102.7 	requirements;
102.8 	(ii) all methods of extraction and concentration that the applicant intends to use and the 
102.9 	volatile chemicals, if any, that are involved in extraction or concentration;
102.10 	(iii) if the applicant is seeking an endorsement to manufacture products infused with 
102.11 	cannabinoids for consumption by patients enrolled in the registry program, proof of an 
102.12 	edible cannabis product handler endorsement from the office; and
102.13 	(iv) evidence that the applicant will comply with the applicable operation requirements 
102.14 	for the license being sought; or
102.15 	(3) for medical cannabis retailer license applicants:
102.16 	(i) a list of every retail license held by the applicant and, if the applicant is a business, 
102.17 	every retail license held, either as an individual or as part of another business, by each 
102.18 	officer, director, manager, and general partner of the cannabis business;
102.19 	(ii) an operating plan demonstrating the proposed layout of the facility including a 
102.20 	diagram of ventilation and filtration systems, policies to avoid sales to individuals who are 
102.21 	not authorized to receive the distribution of medical cannabis flower or medical cannabinoid 
102.22 	products, identification of a restricted area for storage, and plans to prevent the visibility of 
102.23 	cannabis flower and cannabis products;
102.24 	(iii) if the applicant holds or is applying for a cannabis retailer license, a diagram showing 
102.25 	the portion of the premises in which medical cannabis flower and medical cannabinoid 
102.26 	products will be sold and distributed and identifying an area that is definite and distinct 
102.27 	from all other areas of the cannabis retailer, accessed through a distinct entrance, and contains 
102.28 	an appropriate space for a pharmacist employee of the medical cannabis retailer to consult 
102.29 	with the patient to determine the proper type of medical cannabis flower and medical 
102.30 	cannabinoid products and proper dosage for the patient; and
102.31 	(iv) evidence that the applicant will comply with the applicable operation requirements 
102.32 	for the license being sought.
103.1 		Subd. 2.Segregation of medical cannabis. A person, cooperative, or business seeking 
103.2 	a medical cannabis cultivator license or a medical cannabis processor license and any other 
103.3 	type of cannabis business license, other than a cannabis event organizer license, must identify 
103.4 	the methods that will be used to segregate medical cannabis flower and medical cannabinoid 
103.5 	products from other cannabis flower and cannabis products to avoid cross-contamination.

103.6 	EFFECTIVE DATE. This section is effective January 1, 2024.

103.7 	Sec. 47. [342.45] HEMP BUSINESS LICENSES; APPLICATIONS AND ISSUANCE.
103.8 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
103.9 	subdivision, the provisions of this chapter relating to license applications, license selection 
103.10 	criteria, general ownership disqualifications and requirements, and general operational 
103.11 	requirements do not apply to hemp businesses.
103.12 	(b) The office by rule shall establish forms and procedures for the processing of hemp 
103.13 	licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp 
103.14 	license shall include the following information, if applicable:
103.15 	(1) the name, address, and date of birth of the applicant;
103.16 	(2) the address and legal property description of the business;
103.17 	(3) proof of trade name registration;
103.18 	(4) certification that the applicant will comply with the requirements of this chapter 
103.19 	relating to the ownership and operation of a hemp business;
103.20 	(5) identification of one or more controlling persons or managerial employees as agents 
103.21 	who shall be responsible for dealing with the office on all matters; and
103.22 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
103.23 	for information.
103.24 	(c) An application on behalf of a corporation or association shall be signed by at least 
103.25 	two officers or managing agents of that entity.
103.26 		Subd. 2.Issuance; eligibility; prohibition on transfer. (a) The office may issue a hemp 
103.27 	license to an applicant who:
103.28 	(1) is at least 21 years of age;
103.29 	(2) has completed an application for licensure or application for renewal and has fully 
103.30 	and truthfully complied with all information requests relating to license application and 
103.31 	renewal;
104.1 	(3) has paid the applicable application and license fees pursuant to section 342.11;
104.2 	(4) is not employed by the office or any state agency with regulatory authority over this 
104.3 	chapter; and
104.4 	(5) does not hold any cannabis business license.
104.5 	(b) Licenses must be renewed annually.
104.6 	(c) Licenses may not be transferred.

104.7 	Sec. 48. [342.46] LOWER-POTENCY HEMP EDIBLE MANUFACTURER.
104.8 		Subdivision 1.Authorized actions. A lower-potency hemp edible manufacturer license 
104.9 	entitles the license holder to:
104.10 	(1) purchase hemp plant parts, hemp concentrate, and synthetically derived cannabinoids 
104.11 	from cannabis microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, cannabis 
104.12 	wholesalers, and lower-potency hemp edible manufacturers;
104.13 	(2) purchase hemp plant parts from industrial hemp growers;
104.14 	(3) make hemp concentrate;
104.15 	(4) manufacture synthetically derived cannabinoids;
104.16 	(5) manufacture lower-potency hemp edibles for public consumption;
104.17 	(6) package and label lower-potency hemp edibles for sale to customers;
104.18 	(7) sell hemp concentrate, synthetically derived cannabinoids, and lower-potency hemp 
104.19 	edibles to other cannabis businesses and hemp businesses; and
104.20 	(8) perform other actions approved by the office.
104.21 		Subd. 2.All manufacturer operations. (a) All hemp manufacturing must take place in 
104.22 	a facility and on equipment that meets the applicable health and safety requirements 
104.23 	established by the office, including requirements for cleaning and testing machinery between 
104.24 	production of different products.
104.25 	(b) A lower-potency hemp edible manufacturer must comply with all applicable 
104.26 	packaging, labeling, and testing requirements.
104.27 		Subd. 3.Extraction and concentration. (a) A lower-potency hemp edible manufacturer 
104.28 	that creates hemp concentrate or synthetically derived cannabinoids must obtain an 
104.29 	endorsement from the office.
105.1 	(b) A lower-potency hemp edible manufacturer seeking an endorsement to create hemp 
105.2 	concentrate must inform the office of all methods of extraction and concentration that the 
105.3 	manufacturer intends to use and identify the volatile chemicals, if any, that will be involved 
105.4 	in the creation of hemp concentrate. A lower-potency hemp edible manufacturer may not 
105.5 	use a method of extraction and concentration of a volatile chemical without approval by 
105.6 	the office.
105.7 	(c) A lower-potency hemp edible manufacturer seeking an endorsement to create 
105.8 	synthetically derived cannabinoids must inform the office of all methods of conversion that 
105.9 	the manufacturer will use, including any specific catalysts that the manufacturer will employ, 
105.10 	to create synthetically derived cannabinoids and the molecular nomenclature of all 
105.11 	cannabinoids or other chemical compound that the manufacturer will create. A business 
105.12 	licensed or authorized to manufacture lower-potency hemp edibles may not use a method 
105.13 	of conversion or a catalyst without approval by the office.
105.14 	(d) A lower-potency hemp edible manufacturer must obtain a certification from an 
105.15 	independent third-party industrial hygienist or professional engineer approving:
105.16 	(1) all electrical, gas, fire suppression, and exhaust systems; and
105.17 	(2) the plan for safe storage and disposal of hazardous substances, including but not 
105.18 	limited to any volatile chemicals.
105.19 	(e) Upon the sale of hemp concentrate or synthetically derived cannabinoids to any 
105.20 	person, cooperative, or business, a lower-potency hemp edible manufacturer must provide 
105.21 	a statement to the buyer that discloses the method of extraction and concentration or 
105.22 	conversion used and any solvents, gases, or catalysts, including but not limited to any volatile 
105.23 	chemicals, involved in that method.
105.24 		Subd. 4.Production of consumer products. (a) A lower-potency hemp edible 
105.25 	manufacturer that produces lower-potency hemp edibles must obtain an edible cannabis 
105.26 	product handler endorsement from the office.
105.27 	(b) All areas within the premises of a lower-potency hemp edible manufacturer used for 
105.28 	producing lower-potency hemp edibles must meet the sanitary standards specified in rules 
105.29 	adopted by the office.
105.30 	(c) A lower-potency hemp edible manufacturer may only add chemicals or compounds 
105.31 	approved by the office to hemp concentrate or synthetically derived cannabinoids.
105.32 	(d) Upon the sale of any lower-potency hemp edible to a cannabis business or hemp 
105.33 	business, a lower-potency hemp edible manufacturer must provide a statement to the buyer 
106.1 	that discloses the product's ingredients, including but not limited to any chemicals or 
106.2 	compounds and any major food allergens declared by name.
106.3 	(e) A lower-potency hemp edible manufacturer shall not add any synthetically derived 
106.4 	cannabinoid, hemp plant part, or hemp concentrate to a product where the manufacturer of 
106.5 	the product holds a trademark to the product's name, except that a  lower-potency hemp 
106.6 	edible manufacturer may use a trademarked food product if the manufacturer uses the 
106.7 	product as a component or as part of a recipe and where the  lower-potency hemp edible 
106.8 	manufacturer does not state or advertise to the customer that the final retail lower-potency 
106.9 	hemp edible contains a trademarked food product.
106.10 	(f) A lower-potency hemp edible manufacturer shall not add any cannabis flower, 
106.11 	cannabis concentrate, or any cannabinoid derived from cannabis flower or cannabis 
106.12 	concentrate to a product.

106.13 	Sec. 49. [342.47] MEDICAL CANNABIS CULTIVATORS.
106.14 	(a) A medical cannabis cultivator license entitles the license holder to grow cannabis 
106.15 	plants within the approved amount of space up to 60,000 square feet of plant canopy from 
106.16 	seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package 
106.17 	and label cannabis flower as medical cannabis flower, sell medical cannabis flower to 
106.18 	medical cannabis processors and medical cannabis retailers, transport medical cannabis 
106.19 	flower to a medical cannabis processor located on the same premises, and perform other 
106.20 	actions approved by the office.
106.21 	(b) A medical cannabis cultivator license holder must comply with all requirements of 
106.22 	section 342.25.
106.23 	(c) A medical cannabis cultivator license holder must verify that every batch of medical 
106.24 	cannabis flower has passed safety, potency, and consistency testing at a cannabis testing 
106.25 	facility approved by the office for the testing of medical cannabis flower before the medical 
106.26 	cannabis cultivator may package, label, or sell the medical cannabis flower to any other 
106.27 	entity.
106.28 	(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant 
106.29 	canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 
106.30 	1, 2023.

106.31 	EFFECTIVE DATE. This section is effective January 1, 2024.

107.1 	Sec. 50. [342.48] MEDICAL CANNABIS PROCESSORS.
107.2 	(a) A medical cannabis processor license, consistent with the specific license endorsement 
107.3 	or endorsements, entitles the license holder to:
107.4 	(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, 
107.5 	and hemp concentrate from medical cannabis cultivators and other medical cannabis 
107.6 	processors;
107.7 	(2) purchase hemp plant parts from industrial hemp growers;
107.8 	(3) make cannabis concentrate from medical cannabis flower;
107.9 	(4) make hemp concentrate, including hemp concentrate with a delta-9 
107.10 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
107.11 	(5) manufacture medical cannabinoid products;
107.12 	(6) package and label medical cannabinoid products for sale to other medical cannabis 
107.13 	processors and to medical cannabis retailers; and
107.14 	(7) perform other actions approved by the office.
107.15 	(b) A medical cannabis processor license holder must comply with all requirements of 
107.16 	section 342.26, including requirements to obtain specific license endorsements.
107.17 	(c) A medical cannabis processor license holder must verify that every batch of medical 
107.18 	cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing 
107.19 	facility approved by the office for the testing of medical cannabinoid products before the 
107.20 	medical cannabis processor may package, label, or sell the medical cannabinoid product to 
107.21 	any other entity.

107.22 	EFFECTIVE DATE. This section is effective January 1, 2024.

107.23 	Sec. 51. [342.49] MEDICAL CANNABIS RETAILERS.
107.24 		Subdivision 1.Authorized actions. (a) A medical cannabis retailer license entitles the 
107.25 	license holder to purchase medical cannabis flower and medical cannabinoid products from 
107.26 	medical cannabis cultivators and medical cannabis processors and sell or distribute medical 
107.27 	cannabis flower and medical cannabinoid products to any person authorized to receive 
107.28 	medical cannabis flower or medical cannabinoid products.
107.29 	(b) A medical cannabis retailer license holder must verify that all medical cannabis 
107.30 	flower and medical cannabinoid products have passed safety, potency, and consistency 
107.31 	testing at a cannabis testing facility approved by the office for the testing of medical cannabis 
108.1 	flower and medical cannabinoid products before the medical cannabis retailer may distribute 
108.2 	the medical cannabis flower or medical cannabinoid product to any person authorized to 
108.3 	receive medical cannabis flower or medical cannabinoid products.
108.4 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
108.5 	or medical cannabinoid products, a medical cannabis retailer licensee must:
108.6 	(1) review and confirm the patient's registry verification;
108.7 	(2) verify that the person requesting the distribution of medical cannabis flower or 
108.8 	medical cannabinoid products is the patient, the patient's registered designated caregiver, 
108.9 	or the patient's parent, legal guardian, or spouse using the procedures specified in section 
108.10 	152.11, subdivision 2d;
108.11 	(3) ensure that a pharmacist employee of the medical cannabis retailer has consulted 
108.12 	with the patient if required according to subdivision 3; and
108.13 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid 
108.14 	product that includes recommended dosage requirements and other information as required 
108.15 	by rules adopted by the office.
108.16 	(b) A medical cannabis retailer may not deliver medical cannabis flower or medical 
108.17 	cannabinoid products unless the medical cannabis retailer also holds a cannabis delivery 
108.18 	service license. Delivery of medical cannabis flower and medical cannabinoid products are 
108.19 	subject to the provisions of section 342.40.
108.20 		Subd. 3.Final approval for distribution of medical cannabis flower and medical 
108.21 	cannabinoid products. (a) A cannabis worker who is employed by a medical cannabis 
108.22 	retailer and who is licensed as a pharmacist pursuant to chapter 151 shall be the only person 
108.23 	who may give final approval for the distribution of medical cannabis flower and medical 
108.24 	cannabinoid products. Prior to the distribution of medical cannabis flower or medical 
108.25 	cannabinoid products, a pharmacist employed by the medical cannabis retailer must consult 
108.26 	with the patient to determine the proper type of medical cannabis flower, medical cannabinoid 
108.27 	product, or medical cannabis paraphernalia and proper dosage for the patient after reviewing 
108.28 	the range of chemical compositions of medical cannabis flower or medical cannabinoid 
108.29 	product. For purposes of this subdivision, a consultation may be conducted remotely by 
108.30 	secure videoconference, telephone, or other remote means, as long as:
108.31 	(1) the pharmacist engaging in the consultation is able to confirm the identity of the 
108.32 	patient; and
109.1 	(2) the consultation adheres to patient privacy requirements that apply to health care 
109.2 	services delivered through telemedicine.
109.3 	(b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the 
109.4 	distribution of medical cannabis flower or medical cannabinoid products when a medical 
109.5 	cannabis retailer is distributing medical cannabis flower or medical cannabinoid products 
109.6 	to a patient according to a patient-specific dosage plan established with that medical cannabis 
109.7 	retailer and is not modifying the dosage or product being distributed under that plan. Medical 
109.8 	cannabis flower or medical cannabinoid products distributed under this paragraph must be 
109.9 	distributed by a pharmacy technician employed by the medical cannabis retailer.
109.10 		Subd. 4.90-day supply. A medical cannabis retailer shall not distribute more than a 
109.11 	90-day supply of medical cannabis flower or medical cannabinoid products to a patient, 
109.12 	registered designated caregiver, or parent, legal guardian, or spouse of a patient according 
109.13 	to the dosages established for the individual patient.
109.14 		Subd. 5.Distribution to recipient in a motor vehicle. A medical cannabis retailer  may 
109.15 	distribute medical cannabis flower and medical cannabinoid products to a patient, registered 
109.16 	designated caregiver, or parent, legal guardian, or spouse of a patient who is at a dispensary 
109.17 	location but remains in a motor vehicle, provided that:
109.18 	(1) staff receive payment and distribute medical cannabis flower and medical cannabinoid 
109.19 	products in a designated zone that is as close as feasible to the front door of the facility;
109.20 	(2) the medical cannabis retailer ensures that the receipt of payment and distribution of 
109.21 	medical cannabis flower and medical cannabinoid products are visually recorded by a 
109.22 	closed-circuit television surveillance camera and provides any other necessary security 
109.23 	safeguards;
109.24 	(3) the medical cannabis retailer does not store medical cannabis flower or medical 
109.25 	cannabinoid products outside a restricted access area and staff transport medical cannabis 
109.26 	flower and medical cannabinoid products from a restricted access area to the designated 
109.27 	zone for distribution only after confirming that the patient, designated caregiver, or parent, 
109.28 	guardian, or spouse has arrived in the designated zone;
109.29 	(4) the payment and distribution of medical cannabis flower and medical cannabinoid 
109.30 	products take place only after a pharmacist consultation takes place, if required under 
109.31 	subdivision 3;
109.32 	(5) immediately following distribution of medical cannabis flower or medical cannabinoid 
109.33 	products, staff enter the transaction in the statewide monitoring system; and
110.1 	(6) immediately following distribution of medical cannabis flower and medical 
110.2 	cannabinoid products, staff take the payment received into the facility.
110.3 		Subd. 6.Physical separation required. A medical cannabis retailer that is also a cannabis 
110.4 	retailer must distribute medical cannabis flower and medical cannabinoid products provided 
110.5 	that the portion of the premises in which medical cannabis flower and medical cannabinoid 
110.6 	products are sold is definite and distinct from all other areas of the cannabis retailer, is 
110.7 	accessed through a distinct entrance, and provides an appropriate space for a pharmacist 
110.8 	employee of the medical cannabis retailer to consult with the patient to determine the proper 
110.9 	type of medical cannabis flower and medical cannabinoid products and proper dosage for 
110.10 	the patient.

110.11 	EFFECTIVE DATE. This section is effective January 1, 2024.

110.12 	Sec. 52. [342.50] TRIBAL MEDICAL CANNABIS PROGRAM.
110.13 		Subdivision 1.Tribal medical cannabis program manufacturer transportation. (a) 
110.14 	A Tribal medical cannabis program manufacturer may transport medical cannabis to testing 
110.15 	laboratories in the state and to other Indian lands.
110.16 	(b) A Tribal medical cannabis program manufacturer must staff a motor vehicle used to 
110.17 	transport medical cannabis with at least two employees of the manufacturer. Each employee 
110.18 	in the transport vehicle must carry identification specifying that the employee is an employee 
110.19 	of the manufacturer, and one employee in the transport vehicle must carry a detailed 
110.20 	transportation manifest that includes the place and time of departure, the address of the 
110.21 	destination, and a description and count of the medical cannabis being transported.
110.22 		Subd. 2.Distribution to Tribal medical cannabis program patient. (a) A Tribal 
110.23 	medical cannabis manufacturer may distribute medical cannabis in accordance with section 
110.24 	342.49 to a Tribal medical cannabis program patient.
110.25 	(b) Prior to distribution, the Tribal medical cannabis program patient must provide to 
110.26 	the Tribal medical cannabis manufacturer:
110.27 	(1) a valid medical cannabis registration verification card or equivalent document issued 
110.28 	by a Tribal medical cannabis program that indicates that the Tribal medical cannabis program 
110.29 	patient is authorized to use medical cannabis on Indian lands over which the Tribe has 
110.30 	jurisdiction; and
110.31 	(2) a valid photographic identification card issued by the Tribal medical cannabis 
110.32 	program, a valid driver's license, or a valid state identification card.
111.1 	(c) A manufacturer shall distribute medical cannabis to a Tribal medical cannabis program 
111.2 	patient only in a form allowed under section 342.51, subdivision 8.
111.3 		Subd. 3.Use of statewide monitoring system. A Tribal medical cannabis manufacturer 
111.4 	must use the statewide monitoring system for the tracking of the sale or distribution of 
111.5 	medical cannabis to Tribal medical cannabis program patients. Sale or distribution of medical 
111.6 	cannabis by a Tribal medical cannabis manufacturer must be recorded in the statewide 
111.7 	monitoring system within the time established by rule.
111.8 		Subd. 4.Limitations. All the limitations under section 342.55 apply to Tribal medical 
111.9 	cannabis program patients.
111.10 		Subd. 5.Protections for Tribal medical cannabis program participants. All the 
111.11 	protections under section 342.56 apply to Tribal medical cannabis program patients.

111.12 	EFFECTIVE DATE. This section is effective January 1, 2024.

111.13 	Sec. 53. [342.51] PATIENT REGISTRY PROGRAM.
111.14 		Subdivision 1.Administration. The Division of Medical Cannabis must administer the 
111.15 	medical cannabis registry program.
111.16 		Subd. 2.Application procedure for patients. (a) A patient seeking to enroll in the 
111.17 	registry program must submit to the Division of Medical Cannabis an application established 
111.18 	by the Division of Medical Cannabis and a copy of the certification specified in paragraph 
111.19 	(b) or, if the patient is a veteran who receives care from the United States Department of 
111.20 	Veterans Affairs, the information required pursuant to subdivision 3. The patient must 
111.21 	provide at least the following information in the application:
111.22 	(1) the patient's name, mailing address, and date of birth;
111.23 	(2) the name, mailing address, and telephone number of the patient's health care 
111.24 	practitioner;
111.25 	(3) the name, mailing address, and date of birth of the patient's registered designated 
111.26 	caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, 
111.27 	or spouse will be acting as the patient's caregiver;
111.28 	(4) a disclosure signed by the patient that includes:
111.29 	(i) a statement that, notwithstanding any law to the contrary, the Office of Cannabis 
111.30 	Management, the Division of Medical Cannabis, or an employee of the Office of Cannabis 
111.31 	Management or Division of Medical Cannabis may not be held civilly or criminally liable 
112.1 	for any injury, loss of property, personal injury, or death caused by an act or omission while 
112.2 	acting within the employee's scope of office or employment under this section; and
112.3 	(ii) the patient's acknowledgment that enrollment in the registry program is conditional 
112.4 	on the patient's agreement to meet all other requirements of this section; and
112.5 	(5) all other information required by the Division of Medical Cannabis.
112.6 	(b) As part of the application under this subdivision, a patient must submit a copy of a 
112.7 	certification from the patient's health care practitioner that is dated within 90 days prior to 
112.8 	the submission of the application and that certifies that the patient has been diagnosed with 
112.9 	a qualifying medical condition.
112.10 	(c) A patient's health care practitioner may submit a statement to the Division of Medical 
112.11 	Cannabis declaring that the patient is no longer diagnosed with a qualifying medical 
112.12 	condition. Within 30 days after receipt of a statement from a patient's health care practitioner, 
112.13 	the Division of Medical Cannabis must provide written notice to a patient stating that the 
112.14 	patient's enrollment in the registry program will be revoked in 30 days unless the patient 
112.15 	submits a certification from a health care practitioner that the patient is currently diagnosed 
112.16 	with a qualifying medical condition or, if the patient is a veteran, the patient submits 
112.17 	confirmation that the patient is currently diagnosed with a qualifying medical condition in 
112.18 	a form and manner consistent with the information required for an application made pursuant 
112.19 	to subdivision 3. If the Division of Medical Cannabis revokes a patient's enrollment in the 
112.20 	registry program pursuant to this paragraph, the division must provide notice to the patient 
112.21 	and to the patient's health care practitioner.
112.22 		Subd. 3.Application procedure for veterans. (a) The Division of Medical Cannabis 
112.23 	shall establish an alternative certification procedure for veterans who receive care from the 
112.24 	United States Department of Veterans Affairs to confirm that the veteran has been diagnosed 
112.25 	with a qualifying medical condition.
112.26 	(b) A patient who is also a veteran and is seeking to enroll in the registry program must 
112.27 	submit to the Division of Medical Cannabis an application established by the Division of 
112.28 	Medical Cannabis that includes the information identified in subdivision 2, paragraph (a), 
112.29 	and the additional information required by the Division of Medical Cannabis to certify that 
112.30 	the patient has been diagnosed with a qualifying medical condition.
112.31 		Subd. 4.Enrollment; denial of enrollment; revocation. (a) Within 30 days after the 
112.32 	receipt of an application and certification or other documentation of a diagnosis with a 
112.33 	qualifying medical condition, the Division of Medical Cannabis must approve or deny a 
112.34 	patient's enrollment in the registry program. If the Division of Medical Cannabis approves 
113.1 	a patient's enrollment in the registry program, the office must provide notice to the patient 
113.2 	and to the patient's health care practitioner.
113.3 	(b) A patient's enrollment in the registry program must only be denied if the patient:
113.4 	(1) does not submit a certification from a health care practitioner or, if the patient is a 
113.5 	veteran, the documentation required under subdivision 3 that the patient has been diagnosed 
113.6 	with a qualifying medical condition;
113.7 	(2) has not signed the disclosure required in subdivision 2;
113.8 	(3) does not provide the information required by the Division of Medical Cannabis;
113.9 	(4) provided false information on the application; or
113.10 	(5) at the time of application, is also enrolled in a federally approved clinical trial for 
113.11 	the treatment of a qualifying medical condition with medical cannabis.
113.12 	(c) If the Division of Medical Cannabis denies a patient's enrollment in the registry 
113.13 	program, the Division of Medical Cannabis must provide written notice to a patient of all 
113.14 	reasons for denying enrollment. Denial of enrollment in the registry program is considered 
113.15 	a final decision of the office and is subject to judicial review under chapter 14.
113.16 	(d) A patient's enrollment in the registry program may be revoked only:
113.17 	(1) pursuant to subdivision 2, paragraph (c);
113.18 	(2) upon the death of the patient;
113.19 	(3) if the patient's certifying health care practitioner has filed a declaration under 
113.20 	subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the 
113.21 	patient does not submit another certification within 30 days;
113.22 	(4) if the patient does not comply with subdivision 6; or
113.23 	(5) if the patient intentionally sells or diverts medical cannabis flower or medical 
113.24 	cannabinoid products in violation of this chapter.
113.25 	If a patient's enrollment in the registry program has been revoked due to a violation of 
113.26 	subdivision 6, the patient may apply for enrollment 12 months after the date on which the 
113.27 	patient's enrollment was revoked. The office must process such an application in accordance 
113.28 	with this subdivision.
113.29 		Subd. 5.Registry verification. When a patient is enrolled in the registry program, the 
113.30 	Division of Medical Cannabis must assign the patient a patient registry number and must 
113.31 	issue the patient and the patient's registered designated caregiver, parent, legal guardian, or 
114.1 	spouse, if applicable, a registry verification. The Division of Medical Cannabis must also 
114.2 	make the registry verification available to medical cannabis retailers. The registry verification 
114.3 	must include:
114.4 	(1) the patient's name and date of birth;
114.5 	(2) the patient registry number assigned to the patient; and
114.6 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
114.7 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
114.8 	spouse will act as a caregiver.
114.9 		Subd. 6.Conditions of continued enrollment. As conditions of continued enrollment, 
114.10 	a patient must:
114.11 	(1) continue to receive regularly scheduled treatment for the patient's qualifying medical 
114.12 	condition from the patient's health care practitioner; and
114.13 	(2) report changes in the patient's qualifying medical condition to the patient's health 
114.14 	care practitioner.
114.15 		Subd. 7.Enrollment period. Enrollment in the registry program is permanent.
114.16 		Subd. 8.Medical cannabis flower and medical cannabinoid products; allowable 
114.17 	delivery methods. Medical cannabis flower and medical cannabinoid products may be 
114.18 	delivered in the form of:
114.19 	(1) a liquid, including but not limited to oil;
114.20 	(2) a pill;
114.21 	(3) a vaporized delivery method with the use of liquid or oil;
114.22 	(4) a water-soluble cannabinoid multiparticulate, including granules, powder, and 
114.23 	sprinkles;
114.24 	(5) an orally dissolvable product, including lozenges, gum, mints, buccal tablets, and 
114.25 	sublingual tablets;
114.26 	(6) edible products in the form of gummies and chews;
114.27 	(7) a topical formulation;
114.28 	(8) combustion with the use of dried raw cannabis; or
114.29 	(9) any other method approved by the office.
115.1 		Subd. 9.Registered designated caregiver. (a) The Division of Medical Cannabis must 
115.2 	register a designated caregiver for a patient if the patient requires assistance in administering 
115.3 	medical cannabis flower or medical cannabinoid products or in obtaining medical cannabis 
115.4 	flower, medical cannabinoid products, or medical cannabis paraphernalia from a medical 
115.5 	cannabis retailer.
115.6 	(b) In order to serve as a designated caregiver, a person must:
115.7 	(1) be at least 18 years of age;
115.8 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid 
115.9 	products for purposes of assisting the patient; and
115.10 	(3) agree that if the application is approved, the person will not serve as a registered 
115.11 	designated caregiver for more than six registered patients at one time. Patients who reside 
115.12 	in the same residence count as one patient.
115.13 	(c) The office shall conduct a criminal background check on the designated caregiver 
115.14 	prior to registration to ensure that the person does not have a conviction for a disqualifying 
115.15 	felony offense. Any cost of the background check shall be paid by the person seeking 
115.16 	registration as a designated caregiver. A designated caregiver must have the criminal 
115.17 	background check renewed every two years.
115.18 	(d) Nothing in this section shall be construed to prevent a registered designated caregiver 
115.19 	from being enrolled in the registry program as a patient and possessing and administering 
115.20 	medical cannabis as a patient.
115.21 		Subd. 10.Parents, legal guardians, spouses. A parent, legal guardian, or spouse of a 
115.22 	patient may act as the caregiver for a patient. The parent, legal guardian, or spouse who is 
115.23 	acting as a caregiver must follow all requirements for parents, legal guardians, and spouses 
115.24 	under this chapter. Nothing in this section limits any legal authority that a parent, legal 
115.25 	guardian, or spouse may have for the patient under any other law.
115.26 		Subd. 11.Enrollment fee. (a) The Division of Cannabis Management must collect an 
115.27 	enrollment fee of $40 from a patient enrolled under this section.
115.28 	(b) Revenue collected under this subdivision shall deposit to a dedicated account in the 
115.29 	special revenue fund. The balance of the account shall be appropriated annually to the 
115.30 	administrator of the office for program operations.
115.31 		Subd. 12.Notice of change of name or address. Patients and registered designated 
115.32 	caregivers must notify the Division of Medical Cannabis of any address or name change 
116.1 	within 30 days of the change having occurred. A patient or registered designated caregiver 
116.2 	is subject to a $100 fine for failure to notify the office of the change.

116.3 	EFFECTIVE DATE. This section is effective January 1, 2024.

116.4 	Sec. 54. [342.52] DUTIES OF OFFICE OF CANNABIS MANAGEMENT; 
116.5 	REGISTRY PROGRAM.
116.6 	The office may add an allowable form of medical cannabinoid product, and may add or 
116.7 	modify a qualifying medical condition upon its own initiative, upon a petition from a member 
116.8 	of the public or from the Cannabis Advisory Council or as directed by law. The office must 
116.9 	evaluate all petitions and must make the addition or modification if the office determines 
116.10 	that the addition or modification is warranted by the best available evidence and research. 
116.11 	If the office wishes to add an allowable form or add or modify a qualifying medical condition, 
116.12 	the office must notify the chairs and ranking minority members of the legislative committees 
116.13 	and divisions with jurisdiction over health finance and policy by January 15 of the year in 
116.14 	which the change becomes effective. In this notification, the office must specify the proposed 
116.15 	addition or modification, the reasons for the addition or modification, any written comments 
116.16 	received by the office from the public about the addition or modification, and any guidance 
116.17 	received from the Cannabis Advisory Council. An addition or modification by the office 
116.18 	under this subdivision becomes effective on August 1 of that year unless the legislature by 
116.19 	law provides otherwise.

116.20 	EFFECTIVE DATE. This section is effective January 1, 2024.

116.21 	Sec. 55. [342.53] DUTIES OF DIVISION OF MEDICAL CANNABIS; REGISTRY 
116.22 	PROGRAM.
116.23 		Subdivision 1.Duties related to health care practitioners. The Division of Medical 
116.24 	Cannabis must:
116.25 	(1) provide notice of the registry program to health care practitioners in the state;
116.26 	(2) allow health care practitioners to participate in the registry program if they request 
116.27 	to participate and meet the program's requirements;
116.28 	(3) provide explanatory information and assistance to health care practitioners to 
116.29 	understand the nature of the therapeutic use of medical cannabis within program 
116.30 	requirements;
116.31 	(4) make available to participating health care practitioners a certification form in which 
116.32 	a health care practitioner certifies that a patient has a qualifying medical condition; and
117.1 	(5) supervise the participation of health care practitioners in the registry reporting system 
117.2 	in which health care practitioners report patient treatment and health records information 
117.3 	to the office in a manner that ensures stringent security and record keeping requirements 
117.4 	and that prevents the unauthorized release of private data on individuals as defined in section 
117.5 	13.02.
117.6 		Subd. 2.Duties related to the registry program. The Division of Medical Cannabis 
117.7 	must:
117.8 	(1) administer the registry program according to section 342.51;
117.9 	(2) provide information to patients enrolled in the registry program on the existence of 
117.10 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
117.11 	with medical cannabis flower or medical cannabinoid products as an alternative to enrollment 
117.12 	in the registry program;
117.13 	(3) maintain safety criteria with which patients must comply as a condition of participation 
117.14 	in the registry program to prevent patients from undertaking any task under the influence 
117.15 	of medical cannabis flower or medical cannabinoid products that would constitute negligence 
117.16 	or professional malpractice;
117.17 	(4) review and publicly report on existing medical and scientific literature regarding the 
117.18 	range of recommended dosages for each qualifying medical condition, the range of chemical 
117.19 	compositions of medical cannabis flower and medical cannabinoid products that will likely 
117.20 	be medically beneficial for each qualifying medical condition, and any risks of noncannabis 
117.21 	drug interactions. This information must be updated by December 1 of each year. The office 
117.22 	may consult with an independent laboratory under contract with the office or other experts 
117.23 	in reporting and updating this information; and
117.24 	(5) annually consult with cannabis businesses about medical cannabis that the businesses 
117.25 	cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis 
117.26 	website a list of the medical cannabis flower and medical cannabinoid products offered for 
117.27 	sale by each medical cannabis retailer.
117.28 		Subd. 3.Research. (a) The Division of Medical Cannabis must conduct or contract with 
117.29 	a third party to conduct research and studies using data from health records submitted to 
117.30 	the registry program under section 342.54, subdivision 2, and data submitted to the registry 
117.31 	program under section 342.51, subdivisions 2 and 3. If the division contracts with a third 
117.32 	party for research and studies, the third party must provide the division with access to all 
117.33 	research and study results. The division must submit reports on intermediate or final research 
117.34 	results to the legislature and major scientific journals. All data used by the division or a 
118.1 	third party under this subdivision must be used or reported in an aggregated nonidentifiable 
118.2 	form as part of a scientific peer-reviewed publication of research or in the creation of 
118.3 	summary data, as defined in section 13.02, subdivision 19.
118.4 	(b) The Division of Medical Cannabis may submit medical research based on the data 
118.5 	collected under sections 342.54, subdivision 2, and data collected through the statewide 
118.6 	monitoring system to any federal agency with regulatory or enforcement authority over 
118.7 	medical cannabis to demonstrate the effectiveness of medical cannabis flower or medical 
118.8 	cannabinoid products for treating or alleviating the symptoms of a qualifying medical 
118.9 	condition.

118.10 	EFFECTIVE DATE. This section is effective January 1, 2024.

118.11 	Sec. 56. [342.54] DUTIES OF HEALTH CARE PRACTITIONERS; REGISTRY 
118.12 	PROGRAM.
118.13 		Subdivision 1.Health care practitioner duties before patient enrollment. Before a 
118.14 	patient's enrollment in the registry program, a health care practitioner must:
118.15 	(1) determine, in the health care practitioner's medical judgment, whether a patient has 
118.16 	a qualifying medical condition and, if so determined, provide the patient with a certification 
118.17 	of that diagnosis;
118.18 	(2) advise patients, registered designated caregivers, and parents, legal guardians, and 
118.19 	spouses acting as caregivers of any nonprofit patient support groups or organizations;
118.20 	(3) provide to patients explanatory information from the Division of Medical Cannabis, 
118.21 	including information about the experimental nature of the therapeutic use of medical 
118.22 	cannabis flower and medical cannabinoid products; the possible risks, benefits, and side 
118.23 	effects of the proposed treatment; and the application and other materials from the office;
118.24 	(4) provide to patients a Tennessen warning as required under section 13.04, subdivision 
118.25 	2; and
118.26 	(5) agree to continue treatment of the patient's qualifying medical condition and to report 
118.27 	findings to the Division of Medical Cannabis.
118.28 		Subd. 2.Duties upon patient's enrollment in registry program. Upon receiving 
118.29 	notification from the Division of Medical Cannabis of the patient's enrollment in the registry 
118.30 	program, a health care practitioner must:
118.31 	(1) participate in the patient registry reporting system under the guidance and supervision 
118.32 	of the Division of Medical Cannabis;
119.1 	(2) report to the Division of Medical Cannabis patient health records throughout the 
119.2 	patient's ongoing treatment in a manner determined by the office and in accordance with 
119.3 	subdivision 4;
119.4 	(3) determine on a yearly basis if the patient continues to have a qualifying medical 
119.5 	condition and, if so, issue the patient a new certification of that diagnosis. The patient 
119.6 	assessment conducted under this clause may be conducted via telehealth, as defined in 
119.7 	section 62A.673, subdivision 2; and
119.8 	(4) otherwise comply with requirements established by the Office of Cannabis 
119.9 	Management and the Division of Medical Cannabis.
119.10 		Subd. 3.Participation not required. Nothing in this section requires a health care 
119.11 	practitioner to participate in the registry program.
119.12 		Subd. 4.Data. Data on patients collected by a health care practitioner and reported to 
119.13 	the registry program, including data on patients who are veterans who receive care from 
119.14 	the United States Department of Veterans Affairs, are health records under section 144.291 
119.15 	and are private data on individuals under section 13.02 but may be used or reported in an 
119.16 	aggregated nonidentifiable form as part of a scientific peer-reviewed publication of research 
119.17 	conducted under section 342.53 or in the creation of summary data, as defined in section 
119.18 	13.02, subdivision 19.
119.19 		Subd. 5.Exception.  The requirements of this section do not apply to a patient who is a 
119.20 	veteran who receives care from the United States Department of Veterans Affairs or a health 
119.21 	care practitioner employed by the United States Department of Veterans Affairs. Such a 
119.22 	patient must meet the certification requirements developed pursuant to section 342.51, 
119.23 	subdivision 3, before the patient's enrollment in the registry program. The Division of 
119.24 	Medical Cannabis may establish policies and procedures to obtain medical records and other 
119.25 	relevant data from a health care practitioner employed by the United States Department of 
119.26 	Veterans Affairs, provided that those policies and procedures are consistent with this section.

119.27 	EFFECTIVE DATE. This section is effective January 1, 2024.

119.28 	Sec. 57. [342.55] LIMITATIONS.
119.29 		Subdivision 1.Limitations on consumption; locations of consumption. Nothing in 
119.30 	sections 342.47 to 342.59 permits any person to engage in, and does not prevent the 
119.31 	imposition of any civil, criminal, or other penalties for:
119.32 	(1) undertaking a task under the influence of medical cannabis that would constitute 
119.33 	negligence or professional malpractice;
120.1 	(2) possessing or consuming medical cannabis:
120.2 	(i) on a school bus or van; or
120.3 	(ii) in a correctional facility;
120.4 	(3) vaporizing or smoking medical cannabis:
120.5 	(i) on any form of public transportation;
120.6 	(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would 
120.7 	be inhaled by a minor; or
120.8 	(iii) in any public place, including any indoor or outdoor area used by or open to the 
120.9 	general public or a place of employment, as defined in section 144.413, subdivision 1b; and
120.10 	(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft, 
120.11 	train, or motorboat or working on transportation property, equipment, or facilities while 
120.12 	under the influence of medical cannabis or a medical cannabis product.
120.13 		Subd. 2.Health care facilities. (a) Health care facilities licensed under chapter 144A; 
120.14 	hospice providers licensed under chapter 144A; boarding care homes or supervised living 
120.15 	facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities 
120.16 	owned, controlled, managed, or under common control with hospitals licensed under chapter 
120.17 	144; and other health care facilities licensed by the commissioner of health or the 
120.18 	commissioner of human services may adopt reasonable restrictions on the use of medical 
120.19 	cannabis flower or medical cannabinoid products by a patient enrolled in the registry program 
120.20 	who resides at or is actively receiving treatment or care at the facility. The restrictions may 
120.21 	include a provision that the facility must not store or maintain a patient's supply of medical 
120.22 	cannabis flower or medical cannabinoid products on behalf of the patient; that a patient 
120.23 	store the patient's supply of medical cannabis flower or medicinal cannabinoid products in 
120.24 	a locked container accessible only to the patient, the patient's designated caregiver, or the 
120.25 	patient's parent, legal guardian, or spouse; that the facility is not responsible for providing 
120.26 	medical cannabis for patients; and that medical cannabis flower or medical cannabinoid 
120.27 	products are used only in a location specified by the facility or provider. Nothing in this 
120.28 	subdivision requires facilities and providers listed in this subdivision to adopt such 
120.29 	restrictions.
120.30 	(b) No facility or provider listed in this subdivision may unreasonably limit a patient's 
120.31 	access to or use of medical cannabis flower or medical cannabinoid products to the extent 
120.32 	that such use is authorized under sections 342.47 to 342.59. No facility or provider listed 
120.33 	in this subdivision may prohibit a patient access to or use of medical cannabis flower or 
121.1 	medical cannabinoid products due solely to the fact that cannabis is a Schedule I drug 
121.2 	pursuant to the federal Uniform Controlled Substances Act. If a federal regulatory agency, 
121.3 	the United States Department of Justice, or the federal Centers for Medicare and Medicaid 
121.4 	Services takes one of the following actions, a facility or provider may suspend compliance 
121.5 	with this paragraph until the regulatory agency, the United States Department of Justice, or 
121.6 	the federal Centers for Medicare and Medicaid Services notifies the facility or provider that 
121.7 	it may resume permitting the use of medical cannabis flower or medical cannabinoid products 
121.8 	within the facility or in the provider's service setting:
121.9 	(1) a federal regulatory agency or the United States Department of Justice initiates 
121.10 	enforcement action against a facility or provider related to the facility's compliance with 
121.11 	the medical cannabis program; or
121.12 	(2) a federal regulatory agency, the United States Department of Justice, or the federal 
121.13 	Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification 
121.14 	to the facility or provider that expressly prohibits the use of medical cannabis in health care 
121.15 	facilities or otherwise prohibits compliance with the medical cannabis program.
121.16 	(c) An employee or agent of a facility or provider listed in this subdivision or a person 
121.17 	licensed under chapter 144E is not violating this chapter or chapter 152 for the possession 
121.18 	of medical cannabis flower or medical cannabinoid products while carrying out employment 
121.19 	duties, including providing or supervising care to a patient enrolled in the registry program, 
121.20 	or distribution of medical cannabis flower or medical cannabinoid products to a patient 
121.21 	enrolled in the registry program who resides at or is actively receiving treatment or care at 
121.22 	the facility or from the provider with which the employee or agent is affiliated.
121.23 		Subd. 3.Child care facilities. A proprietor of a family or group family day care program 
121.24 	must disclose to parents or guardians of children cared for on the premises of the family or 
121.25 	group family day care program, if the proprietor permits the smoking or use of medical 
121.26 	cannabis on the premises, outside of its hours of operation. Disclosure must include posting 
121.27 	on the premises a conspicuous written notice and orally informing parents or guardians.

121.28 	EFFECTIVE DATE. This section is effective January 1, 2024.

121.29 	Sec. 58. [342.56] PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.
121.30 		Subdivision 1.Presumption. There is a presumption that a patient enrolled in the registry 
121.31 	program is engaged in the authorized use of medical cannabis flower and medical cannabinoid 
121.32 	products. This presumption may be rebutted by evidence that the patient's use of medical 
121.33 	cannabis flower or medical cannabinoid products was not for the purpose of treating or 
122.1 	alleviating the patient's qualifying medical condition or symptoms associated with the 
122.2 	patient's qualifying medical condition.
122.3 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.55, the following 
122.4 	are not violations of this chapter or chapter 152:
122.5 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
122.6 	medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting 
122.7 	patient to whom medical cannabis is distributed under section 342.49, subdivision 5;
122.8 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
122.9 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
122.10 	spouse of a patient enrolled in the registry program; or
122.11 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
122.12 	cannabis paraphernalia by any person while carrying out duties required under sections 
122.13 	342.47 to 342.59.
122.14 	(b) The Office of Cannabis Management, members of the Cannabis Advisory Council, 
122.15 	Office of Cannabis Management employees, agents or contractors of the Office of Cannabis 
122.16 	Management, and health care practitioners participating in the registry program are not 
122.17 	subject to any civil penalties or disciplinary action by the Board of Medical Practice, the 
122.18 	Board of Nursing, or any business, occupational, or professional licensing board or entity 
122.19 	solely for participating in the registry program either in a professional capacity or as a 
122.20 	patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or 
122.21 	disciplinary action by the Board of Pharmacy when acting in accordance with sections 
122.22 	342.47 to 342.59 either in a professional capacity or as a patient. Nothing in this section 
122.23 	prohibits a professional licensing board from taking action in response to a violation of law.
122.24 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
122.25 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
122.26 	any injury, loss of property, personal injury, or death caused by any act or omission while 
122.27 	acting within the scope of office or employment under sections 342.47 to 342.59.
122.28 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
122.29 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
122.30 	13.09, a violation of this paragraph is a gross misdemeanor.
122.31 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
122.32 	not release data or information about an individual contained in any report or document or 
122.33 	in the registry and must not release data or information obtained about a patient enrolled in 
123.1 	the registry program, except as provided in sections 342.47 to 342.59. Notwithstanding 
123.2 	section 13.09, a violation of this paragraph is a gross misdemeanor.
123.3 	(f) No information contained in a report or document, contained in the registry, or 
123.4 	obtained from a patient under sections 342.47 to 342.59 may be admitted as evidence in a 
123.5 	criminal proceeding, unless:
123.6 	(1) the information is independently obtained; or
123.7 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
123.8 	violation of sections 342.47 to 342.59.
123.9 	(g) Possession of a registry verification or an application for enrollment in the registry 
123.10 	program:
123.11 	(1) does not constitute probable cause or reasonable suspicion;
123.12 	(2) must not be used to support a search of the person or property of the person with a 
123.13 	registry verification or application to enroll in the registry program; and
123.14 	(3) must not subject the person or the property of the person to inspection by any 
123.15 	government agency.
123.16 		Subd. 3.School enrollment; rental property. (a) No school may refuse to enroll a 
123.17 	patient as a pupil or otherwise penalize a patient solely because the patient is enrolled in 
123.18 	the registry program, unless failing to do so would violate federal law or regulations or 
123.19 	cause the school to lose a monetary or licensing-related benefit under federal law or 
123.20 	regulations.
123.21 	(b) No landlord may refuse to lease to a patient or otherwise penalize a patient solely 
123.22 	because the patient is enrolled in the registry program, unless failing to do so would violate 
123.23 	federal law or regulations or cause the landlord to lose a monetary or licensing-related 
123.24 	benefit under federal law or regulations.
123.25 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
123.26 	patient's use of medical cannabis according to sections 342.47 to 342.59 is considered the 
123.27 	equivalent of the authorized use of a medication used at the discretion of a health care 
123.28 	practitioner and does not disqualify a patient from needed medical care.
123.29 		Subd. 5.Employment. (a) Unless a failure to do so would violate federal or state law 
123.30 	or regulations or cause an employer to lose a monetary or licensing-related benefit under 
123.31 	federal law or regulations, an employer may not discriminate against a person in hiring, 
124.1 	termination, or any term or condition of employment, or otherwise penalize a person, if the 
124.2 	discrimination is based on:
124.3 	(1) the person's status as a patient enrolled in the registry program; or
124.4 	(2) a patient's positive drug test for cannabis components or metabolites, unless the 
124.5 	patient used, possessed, sold, transported, or was impaired by medical cannabis flower or 
124.6 	a medical cannabinoid product on work premises, during working hours, or while operating 
124.7 	an employer's machinery, vehicle, or equipment.
124.8 	(b) An employee who is a patient and whose employer requires the employee to undergo 
124.9 	drug testing according to section 181.953 may present the employee's registry verification 
124.10 	as part of the employee's explanation under section 181.953, subdivision 6.
124.11 		Subd. 6.Custody; visitation; parenting time. A person must not be denied custody of 
124.12 	a minor child or visitation rights or parenting time with a minor child based solely on the 
124.13 	person's status as a patient enrolled in the registry program. There must be no presumption 
124.14 	of neglect or child endangerment for conduct allowed under sections 342.47 to 342.59, 
124.15 	unless the person's behavior creates an unreasonable danger to the safety of the minor as 
124.16 	established by clear and convincing evidence.
124.17 		Subd. 7.Action for damages. In addition to any other remedy provided by law, a patient 
124.18 	may bring an action for damages against any person who violates subdivision 3, 4, or 5. A 
124.19 	person who violates subdivision 3, 4, or 5 is liable to a patient injured by the violation for 
124.20 	the greater of the person's actual damages or a civil penalty of $100 and reasonable attorney 
124.21 	fees.
124.22 		Subd. 8.Sanctions restricted for those on parole, supervised release, or conditional 
124.23 	release. (a) This subdivision applies to an individual placed on parole, supervised release, 
124.24 	or conditional release.
124.25 	(b) The commissioner of corrections may not:
124.26 	(1) prohibit an individual from participating in the registry program as a condition of 
124.27 	release; or
124.28 	(2) revoke an individual's parole, supervised release, or conditional release or otherwise 
124.29 	sanction an individual solely:
124.30 	(i) for participating in the registry program; or
124.31 	(ii) for a positive drug test for cannabis components or metabolites.

124.32 	EFFECTIVE DATE. This section is effective January 1, 2024.

125.1 	Sec. 59. [342.57] VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL 
125.2 	PENALTY.
125.3 	A health care practitioner who knowingly refers patients to a medical cannabis business 
125.4 	or to a designated caregiver, who advertises as a retailer or producer of medical cannabis 
125.5 	flower or medical cannabinoid products, or who issues certifications while holding a financial 
125.6 	interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and 
125.7 	may be sentenced to imprisonment for not more than 90 days or to payment of not more 
125.8 	than $1,000, or both.

125.9 	EFFECTIVE DATE. This section is effective January 1, 2024.

125.10 	Sec. 60. [342.58] DATA PRACTICES.
125.11 		Subdivision 1.Data classification. Patient health records maintained by the Office of 
125.12 	Cannabis Management or the Division of Medical Cannabis and government data in patient 
125.13 	health records maintained by a health care practitioner are classified as private data on 
125.14 	individuals, as defined in section 13.02, subdivision 12, or nonpublic data, as defined in 
125.15 	section 13.02, subdivision 9.
125.16 		Subd. 2.Allowable use; prohibited use. Data specified in subdivision 1 may be used 
125.17 	to comply with chapter 13, to comply with a request from the legislative auditor or the state 
125.18 	auditor in the performance of official duties, and for purposes specified in sections 342.47 
125.19 	to 342.59. Data specified in subdivision 1 and maintained by the Office of Cannabis 
125.20 	Management or Division of Medical Cannabis must not be used for any purpose not specified 
125.21 	in sections 342.47 to 342.59 and must not be combined or linked in any manner with any 
125.22 	other list, dataset, or database. Data specified in subdivision 1 must not be shared with any 
125.23 	federal agency, federal department, or federal entity unless specifically ordered to do so by 
125.24 	a state or federal court.

125.25 	EFFECTIVE DATE. This section is effective January 1, 2024.

125.26 	Sec. 61. [342.59] CLINICAL TRIALS.
125.27 	The Division of Medical Cannabis may conduct or award grants to health care providers 
125.28 	or research organizations to conduct clinical trials on the safety and efficacy of using medical 
125.29 	cannabis flower or medical cannabinoid products to treat a specific health condition. A 
125.30 	health care provider or research organization receiving a grant under this section must 
125.31 	provide the office with access to all data collected in a clinical trial funded under this section. 
125.32 	The office may use data from clinical trials conducted or funded under this section as 
126.1 	evidence to approve additional qualifying medical conditions or additional allowable forms 
126.2 	of medical cannabis.

126.3 	EFFECTIVE DATE. This section is effective January 1, 2024.

126.4 	Sec. 62. [342.60] TESTING.
126.5 		Subdivision 1.Testing required. Cannabis businesses and hemp businesses shall not 
126.6 	sell or offer for sale cannabis flower, cannabis products, synthetically derived cannabinoids, 
126.7 	lower-potency hemp edibles, or hemp-derived consumer products to another cannabis 
126.8 	business, hemp business, or to a customer or patient or otherwise transfer cannabis flower, 
126.9 	cannabis products, synthetically derived cannabinoids, lower-potency hemp edibles, or 
126.10 	hemp-derived consumer products to another cannabis business, unless:
126.11 	(1) a representative sample of the batch of cannabis flower, cannabis product, synthetically 
126.12 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product has 
126.13 	been tested according to this section and rules adopted under this chapter;
126.14 	(2) the testing was completed by a cannabis testing facility licensed under this chapter; 
126.15 	and
126.16 	(3) the tested sample of cannabis flower, cannabis product, synthetically derived 
126.17 	cannabinoid, lower-potency hemp edible, or hemp-derived consumer product was found to 
126.18 	meet testing standards established by the office.
126.19 		Subd. 2.Procedures and standards established by office. (a) The office shall by rule 
126.20 	establish procedures governing:
126.21 	(1) the sampling, handling, testing, storage, and transportation of cannabis flower, 
126.22 	cannabis products, synthetically derived cannabinoids, lower-potency hemp edibles, and 
126.23 	hemp-derived consumer products tested under this section;
126.24 	(2) the contaminants for which cannabis flower, cannabis products, synthetically derived 
126.25 	cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products must be 
126.26 	tested;
126.27 	(3) standards for potency and homogeneity testing; and
126.28 	(4) procedures applicable to cannabis businesses, hemp businesses, and cannabis testing 
126.29 	facilities regarding cannabis flower, cannabis products, synthetically derived cannabinoids, 
126.30 	lower-potency hemp edibles, and hemp-derived consumer products that fail to meet the 
126.31 	standards for allowable levels of contaminants established by the office, that fail to meet 
127.1 	the potency limits in this chapter or that do not conform with the content of the cannabinoid 
127.2 	profile listed on the label.
127.3 	(b) All testing required under this section must be performed in a manner that is consistent 
127.4 	with general requirements for testing and calibration activities.
127.5 		Subd. 3.Standards established by Office of Cannabis Management. The office shall 
127.6 	by rule establish standards for allowable levels of contaminants in cannabis flower, cannabis 
127.7 	products, synthetically derived cannabinoids, lower-potency hemp edibles, hemp-derived 
127.8 	consumer products, and growing media. Contaminants for which the office must establish 
127.9 	allowable levels must include but are not limited to residual solvents, foreign material, 
127.10 	microbiological contaminants, heavy metals, pesticide residue, and mycotoxins.
127.11 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
127.12 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
127.13 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
127.14 	hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor shall 
127.15 	make each batch of cannabis flower, cannabis products, synthetically derived cannabinoids, 
127.16 	lower-potency hemp edibles, or hemp-derived consumer products grown, manufactured, or 
127.17 	imported by the cannabis business or hemp business available to a cannabis testing facility.
127.18 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
127.19 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
127.20 	hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor must 
127.21 	disclose all known information regarding pesticides, fertilizers, solvents, or other foreign 
127.22 	materials, including but not limited to catalysts used in creating synthetically derived 
127.23 	cannabinoids, applied or added to the batch of cannabis flower, cannabis products, 
127.24 	synthetically derived cannabinoids, lower-potency hemp edible, or hemp-derived consumer 
127.25 	products subject to testing. Disclosure must be made to the cannabis testing facility and 
127.26 	must include information about all applications by any person, whether intentional or 
127.27 	accidental.
127.28 	(c) The cannabis testing facility shall select one or more representative samples from 
127.29 	each batch, test the samples for the presence of contaminants, and test the samples for 
127.30 	potency and homogeneity and to allow the cannabis flower, cannabis product, synthetically 
127.31 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
127.32 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
127.33 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
127.34 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
128.1 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
128.2 	cannabis business or hemp business any part of the sample that remains after testing.
128.3 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
128.4 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
128.5 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
128.6 	endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis 
128.7 	cultivator, or medical cannabis processor, and the cannabis business or hemp business may 
128.8 	then sell or transfer the batch of cannabis flower, cannabis products, synthetically derived 
128.9 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products from which 
128.10 	the sample was taken to another cannabis business or hemp business, or offer the cannabis 
128.11 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products 
128.12 	for sale to customers or patients. If a sample does not meet the applicable testing standards 
128.13 	or if the testing facility is unable to test for a substance identified pursuant to subdivision 
128.14 	4, paragraph (b), the batch from which the sample was taken shall be subject to procedures 
128.15 	established by the office for such batches, including destruction, remediation, or retesting.
128.16 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
128.17 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
128.18 	hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor must 
128.19 	maintain the test results for cannabis flower, cannabis products, synthetically derived 
128.20 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products grown, 
128.21 	manufactured, or imported by that cannabis business or hemp business for at least five years 
128.22 	after the date of testing.
128.23 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
128.24 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
128.25 	hemp edible manufacturer, medical cannabis cultivator, or medical cannabis processor shall 
128.26 	make test results maintained by that cannabis business or hemp business available for review 
128.27 	by any member of the public upon request. Test results made available to the public must 
128.28 	be in plain language.

128.29 	Sec. 63. [342.61] PACKAGING.
128.30 		Subdivision 1.General. All cannabis flower, cannabis products, lower-potency hemp 
128.31 	edibles, and hemp-derived consumer products sold to customers or patients must be packaged 
128.32 	as required by this section and rules adopted under this chapter.
129.1 		Subd. 2.Packaging requirements. (a) Except as provided in paragraph (b), all cannabis 
129.2 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
129.3 	sold to customers or patients must be:
129.4 	(1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and 
129.5 	opaque; or
129.6 	(2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and 
129.7 	opaque at the final point of sale to a customer.
129.8 	(b) The requirement that packaging be child-resistant does not apply to:
129.9 	(1) a hemp-derived topical product; or
129.10 	(2) a lower-potency hemp edible that:
129.11 	(i) contains nonintoxicating cannabinoids;
129.12 	(ii) does not contain more than a combined total of 0.25 milligrams of intoxicating 
129.13 	cannabinoids; and
129.14 	(iii) does not contain a synthetically derived cannabinoid.
129.15 	(c) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer 
129.16 	product is packaged in a manner that includes more than a single serving, each serving must 
129.17 	be indicated by scoring, wrapping, or other indicators designating the individual serving 
129.18 	size. If the item is a lower-potency hemp edible, any indicator other than individual wrapping 
129.19 	that designates the individual serving size must appear on the lower-potency hemp edible.
129.20 	(d) An edible cannabis product or lower-potency hemp edible containing more than a 
129.21 	single serving must be prepackaged or placed at the final point of sale in packaging or a 
129.22 	container that is resealable.
129.23 		Subd. 3.Packaging prohibitions. (a) Cannabis flower, cannabis products, lower-potency 
129.24 	hemp edibles, or hemp-derived consumer products sold to customers or patients must not 
129.25 	be packaged in a manner that:
129.26 	(1) bears a reasonable resemblance to any commercially available product that does not 
129.27 	contain cannabinoids, whether the manufacturer of the product holds a registered trademark 
129.28 	or has registered the trade dress; or
129.29 	(2) is designed to appeal to persons under 21 years of age.
130.1 	(b) Packaging for cannabis flower, cannabis products, lower-potency hemp edibles, and 
130.2 	hemp-derived consumer products must not contain or be coated with any perfluoroalkyl 
130.3 	substance.
130.4 	(c) Edible cannabis products and lower-potency hemp edibles must not be packaged in 
130.5 	a material that is not approved by the United States Food and Drug Administration for use 
130.6 	in packaging food.

130.7 	Sec. 64. [342.62] LABELING.
130.8 		Subdivision 1.General. All cannabis flower, cannabis products, lower-potency hemp 
130.9 	edibles, and hemp-derived consumer products sold to customers or patients must be labeled 
130.10 	as required by this section and rules adopted under this chapter.
130.11 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
130.12 	products that consist of hemp plant parts sold to customers or patients must have affixed 
130.13 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
130.14 	label that contains at least the following information:
130.15 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
130.16 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower where the 
130.17 	cannabis flower or hemp plant part was cultivated;
130.18 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
130.19 	container;
130.20 	(3) the batch number;
130.21 	(4) the cannabinoid profile;
130.22 	(5) a universal symbol established by the office indicating that the package or container 
130.23 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
130.24 	hemp-derived consumer product;
130.25 	(6) verification that the cannabis flower or hemp plant part was tested according to 
130.26 	section 342.60 and that the cannabis flower or hemp plant part complies with the applicable 
130.27 	standards;
130.28 	(7) the maximum dose, quantity, or consumption that may be considered medically safe 
130.29 	within a 24-hour period;
130.30 	(8) the following statement: "Keep this product out of reach of children."; and
130.31 	(9) any other statements or information required by the office.
131.1 		Subd. 3.Content of label; cannabis products. (a) All cannabis products, lower-potency 
131.2 	hemp edibles, hemp-derived consumer products other than products subject to the 
131.3 	requirements under subdivision 2, medical cannabinoid products, and hemp-derived topical 
131.4 	products sold to customers or patients must have affixed to the packaging or container of 
131.5 	the cannabis product a label that contains at least the following information:
131.6 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
131.7 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower that cultivated 
131.8 	the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp 
131.9 	edible, hemp-derived consumer product, or medical cannabinoid product;
131.10 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
131.11 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
131.12 	processor, or industrial hemp grower that manufactured the cannabis concentrate or 
131.13 	synthetically derived cannabinoid and if different, the name and license number of the 
131.14 	cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, lower-potency 
131.15 	hemp edible manufacturer, or medical cannabis processor that manufactured the cannabinoid 
131.16 	product;
131.17 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
131.18 	hemp-derived consumer product in the package or container;
131.19 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
131.20 	product;
131.21 	(5) the batch number;
131.22 	(6) the serving size;
131.23 	(7) the cannabinoid profile per serving and in total;
131.24 	(8) a list of ingredients;
131.25 	(9) a universal symbol established by the office indicating that the package or container 
131.26 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
131.27 	hemp-derived consumer product;
131.28 	(10) a warning symbol developed by the office in consultation with the commissioner 
131.29 	of health and the Minnesota Poison Control System that:
131.30 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
131.31 	(ii) is in a highly visible color;
132.1 	(iii) includes a visual element that is commonly understood to mean a person should 
132.2 	stop;
132.3 	(iv) indicates that the product is not for children; and
132.4 	(v) includes the phone number of the Minnesota Poison Control System;
132.5 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
132.6 	consumer product, or medical cannabinoid product was tested according to section 342.60 
132.7 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
132.8 	or medical cannabinoid product complies with the applicable standards;
132.9 	(12) the maximum dose, quantity, or consumption that may be considered medically 
132.10 	safe within a 24-hour period;
132.11 	(13) the following statement: "Keep this product out of reach of children."; and
132.12 	(14) any other statements or information required by the office.
132.13 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
132.14 	hemp edibles that are imported into the state provided that those requirements provide 
132.15 	consumers with information that is substantially similar to the information described in 
132.16 	paragraph (a).
132.17 		Subd. 4.Additional content of label; medical cannabis flower and medical 
132.18 	cannabinoid products. In addition to the applicable requirements for labeling under 
132.19 	subdivision 2 or 3, all medical cannabis flower and medical cannabinoid products must 
132.20 	include at least the following information on the label affixed to the packaging or container 
132.21 	of the medical cannabis flower or medical cannabinoid product:
132.22 	(1) the patient's name and date of birth;
132.23 	(2) the name and date of birth of the patient's registered designated caregiver or, if listed 
132.24 	on the registry verification, the name of the patient's parent, legal guardian, or spouse, if 
132.25 	applicable; and
132.26 	(3) the patient's registry identification number.
132.27 		Subd. 5.Content of label; hemp-derived topical products. (a) All hemp-derived topical 
132.28 	products sold to customers must have affixed to the packaging or container of the product 
132.29 	a label that contains at least the following information:
132.30 	(1) the manufacturer name, location, phone number, and website;
133.1 	(2) the name and address of the independent, accredited laboratory used by the 
133.2 	manufacturer to test the product;
133.3 	(3) the net weight or volume of the product in the package or container;
133.4 	(4) the type of topical product;
133.5 	(5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid, 
133.6 	derivative, or extract of hemp, per serving and in total;
133.7 	(6) a list of ingredients;
133.8 	(7) a statement that the product does not claim to diagnose, treat, cure, or prevent any 
133.9 	disease and that the product has not been evaluated or approved by the United States Food 
133.10 	and Drug Administration, unless the product has been so approved; and
133.11 	(8) any other statements or information required by the office.
133.12 	(b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided 
133.13 	through the use of a scannable barcode or matrix barcode that links to a page on a website 
133.14 	maintained by the manufacturer or distributor if that page contains all of the information 
133.15 	required by this subdivision.
133.16 		Subd. 6.Additional information. A cannabis microbusiness, cannabis mezzobusiness, 
133.17 	cannabis retailer, or medical cannabis retailer must provide customers and patients with the 
133.18 	following information by including the information on the label affixed to the packaging 
133.19 	or container of cannabis flower, a cannabis product, or a hemp-derived consumer product; 
133.20 	by posting the information in the premises of the cannabis microbusiness, cannabis 
133.21 	mezzobusiness, cannabis retailer, or medical cannabis retailer; by providing the information 
133.22 	on a separate document or pamphlet provided to customers or patients when the customer 
133.23 	purchases cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
133.24 	hemp-derived consumer product:
133.25 	(1) factual information about impairment effects and the expected timing of impairment 
133.26 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
133.27 	lower-potency hemp edibles, and hemp-derived consumer products;
133.28 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
133.29 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
133.30 	hemp edibles, or hemp-derived consumer products;
134.1 	(3) resources customers and patients may consult to answer questions about cannabis 
134.2 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
134.3 	products, and any side effects and adverse effects;
134.4 	(4) contact information for the poison control center and a safety hotline or website for 
134.5 	customers to report and obtain advice about side effects and adverse effects of cannabis 
134.6 	flower and cannabis products;
134.7 	(5) substance abuse disorder treatment options; and
134.8 	(6) any other information specified by the office.
134.9 	All labels affixed to the packaging of cannabis flower, cannabis products, lower-potency 
134.10 	hemp edibles, and hemp-derived consumer products sold to customers or patients must 
134.11 	include the following warning: "Cannabis can harm your health, and your baby's health if 
134.12 	you are pregnant."

134.13 	Sec. 65. [342.63] ADVERTISEMENT.
134.14 		Subdivision 1.Limitations applicable to all advertisements. No cannabis business, 
134.15 	hemp business, or other person shall publish or cause to be published an advertisement for 
134.16 	cannabis flower, a cannabis business, a hemp business, a cannabis product, a lower-potency 
134.17 	hemp edible, or a hemp-derived consumer product in a manner that:
134.18 	(1) contains false or misleading statements;
134.19 	(2) contains unverified claims about the health or therapeutic benefits or effects of 
134.20 	consuming cannabis or a cannabis product;
134.21 	(3) promotes the overconsumption of cannabis flower, cannabis products, or hemp-derived 
134.22 	consumer products;
134.23 	(4) depicts a person under 21 years of age consuming cannabis flower, a cannabis product, 
134.24 	a lower-potency hemp edible, or a hemp-derived consumer product;
134.25 	(5) includes an image designed or likely to appeal to individuals under 21 years of age, 
134.26 	including cartoons, toys, animals, or children, or any other likeness to images, characters, 
134.27 	or phrases that is designed to be appealing to individuals under 21 years of age or encourage 
134.28 	consumption by individuals under 21 years of age; or
134.29 	(6) does not contain a warning as specified by the office regarding impairment and health 
134.30 	risks, including driving while impaired, side effects, adverse reactions, and pregnancy 
134.31 	complications.
135.1 		Subd. 2.Outdoor advertisements; cannabis business signs. (a) A cannabis business 
135.2 	or hemp business may erect or utilize an outdoor advertisement of a cannabis business, a 
135.3 	hemp business, cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
135.4 	hemp-derived consumer product.
135.5 	(b) A cannabis business may erect up to two fixed outdoor signs on the exterior of the 
135.6 	building or property of the cannabis business or hemp business. A fixed outdoor sign:
135.7 	(1) may contain the name of the cannabis business or hemp business and the address 
135.8 	and nature of the cannabis business or hemp business; and
135.9 	(2) shall not include a logo or an image of any kind.
135.10 	(c) All outdoor advertisements on land adjacent to an interstate or trunk highway must 
135.11 	comply with the requirements of chapter 173.
135.12 		Subd. 3.Audience under 21 years of age. Except as provided in subdivision 2, a 
135.13 	cannabis business, hemp business, or other person shall not publish or cause to be published 
135.14 	an advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis 
135.15 	product, a lower-potency hemp edible, or a hemp-derived consumer product in any print 
135.16 	publication or on radio, television, or any other medium if 30 percent or more of the audience 
135.17 	of that medium is reasonably expected to be individuals who are under 21 years of age, as 
135.18 	determined by reliable, current audience composition data.
135.19 		Subd. 4.Certain unsolicited advertising. A cannabis business, hemp business, or 
135.20 	another person shall not utilize unsolicited pop-up advertisements on the internet to advertise 
135.21 	a cannabis business, a hemp business, cannabis flower, a cannabis product, a lower-potency 
135.22 	hemp edible, or a hemp-derived consumer product.
135.23 		Subd. 5.Advertising using direct, individualized communication or dialogue. Before 
135.24 	a cannabis business, hemp business, or another person may advertise a cannabis business, 
135.25 	a hemp business, cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
135.26 	hemp-derived consumer product through direct, individualized communication or dialogue 
135.27 	controlled by the cannabis business, hemp business, or other person, the cannabis business, 
135.28 	hemp business, or other person must use a method of age affirmation to verify that the 
135.29 	recipient of the direct, individualized communication or dialogue is 21 years of age or older. 
135.30 	For purposes of this subdivision, the method of age affirmation may include user 
135.31 	confirmation, birth date disclosure, or another similar registration method.
135.32 		Subd. 6.Advertising using location-based devices. A cannabis business, hemp business, 
135.33 	or another person shall not advertise a cannabis business, a hemp business, cannabis flower, 
136.1 	a cannabis product, a lower-potency hemp edible, or a hemp-derived consumer product 
136.2 	with advertising directed toward location-based devices, including but not limited to cellular 
136.3 	telephones, unless the owner of the device is 21 years of age or older.
136.4 		Subd. 7.Advertising restrictions for health care practitioners under the medical 
136.5 	cannabis program. (a) A health care practitioner shall not publish or cause to be published 
136.6 	an advertisement that:
136.7 	(1) contains false or misleading statements about the registry program;
136.8 	(2) uses colloquial terms to refer to medical cannabis flower or medical cannabinoid 
136.9 	products, such as pot, weed, or grass;
136.10 	(3) states or implies that the health care practitioner is endorsed by the office, the Division 
136.11 	of Medical Cannabis, or the registry program;
136.12 	(4) includes images of cannabis flower, hemp plant parts, or images of paraphernalia 
136.13 	commonly used to smoke cannabis flower;
136.14 	(5) contains medical symbols that could reasonably be confused with symbols of 
136.15 	established medical associations or groups; or
136.16 	(6) does not contain a warning as specified by the office regarding impairment and health 
136.17 	risks, including driving while impaired, side effects, adverse reactions, and pregnancy 
136.18 	complications.
136.19 	(b) A health care practitioner found by the office to have violated this subdivision is 
136.20 	prohibited from certifying that patients have a qualifying medical condition for purposes 
136.21 	of patient participation in the registry program. A decision by the office that a health care 
136.22 	practitioner has violated this subdivision is a final decision and is not subject to the contested 
136.23 	case procedures in chapter 14.

136.24 	Sec. 66. [342.64] INDUSTRIAL HEMP.
136.25 	Nothing in this chapter shall limit the ability of a person licensed under chapter 18K to 
136.26 	grow industrial hemp for commercial or research purposes, process industrial hemp for 
136.27 	commercial purposes, sell hemp fiber products and hemp grain, manufacture hemp-derived 
136.28 	topical products, or perform any other actions authorized by the commissioner of agriculture. 
136.29 	For purposes of this section, "processing" has the meaning given in section 18K.02, 
136.30 	subdivision 5, and does not include the process of creating synthetically derived cannabinoids.

137.1 	Sec. 67. [342.65] LEGAL ASSISTANCE TO CANNABIS BUSINESSES.
137.2 	An attorney must not be subject to disciplinary action by the Minnesota Supreme Court 
137.3 	or professional responsibility board for providing legal assistance to prospective or licensed 
137.4 	cannabis businesses, hemp businesses, or others for activities that do not violate this chapter 
137.5 	or chapter 152.

137.6 	Sec. 68. [342.66] HEMP-DERIVED TOPICAL PRODUCTS.
137.7 		Subdivision 1.Scope. This section applies to the manufacture, marketing, distribution, 
137.8 	and sale of hemp-derived topical products.
137.9 		Subd. 2.Approved cannabinoids. (a) Products manufactured, marketed, distributed, 
137.10 	and sold under this section may contain cannabidiol or cannabigerol. Except as provided 
137.11 	in paragraph (c), products may not contain any other cannabinoid unless approved by the 
137.12 	office.
137.13 	(b) The office may approve any cannabinoid, other than any tetrahydrocannabinol, and 
137.14 	authorize its use in manufacturing, marketing, distribution, and sales under this section if 
137.15 	the office determines that the cannabinoid is a nonintoxicating cannabinoid.
137.16 	(c) A product manufactured, marketed, distributed, and sold under this section may 
137.17 	contain cannabinoids other than cannabidiol, cannabigerol, or any other cannabinoid approved 
137.18 	by the office provided that the cannabinoids are naturally occurring in hemp plants or hemp 
137.19 	plant parts and the total of all other cannabinoids present in a product does not exceed one 
137.20 	milligram per package.
137.21 		Subd. 3.Approved products. Products sold to consumers under this section may only 
137.22 	be manufactured, marketed, distributed, intended, or generally expected to be used by 
137.23 	applying the product externally to a part of the body of a human or animal.
137.24 		Subd. 4.Labeling. Hemp-derived topical products must meet the labeling requirements 
137.25 	in section 342.62, subdivision 5.
137.26 		Subd. 5.Prohibitions. (a) A product sold to consumers under this section must not be 
137.27 	manufactured, marketed, distributed, or intended:
137.28 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
137.29 	of disease in humans or other animals;
137.30 	(2) to affect the structure or any function of the bodies of humans or other animals;
137.31 	(3) to be consumed by combustion or vaporization of the product and inhalation of 
137.32 	smoke, aerosol, or vapor from the product;
138.1 	(4) to be consumed through chewing; or
138.2 	(5) to be consumed through injection or application to a mucous membrane or nonintact 
138.3 	skin.
138.4 	(b) A product manufactured, marketed, distributed, or sold to consumers under this 
138.5 	section must not:
138.6 	(1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;
138.7 	(2) have been produced, prepared, packed, or held under unsanitary conditions where 
138.8 	the product may have been rendered injurious to health, or where the product may have 
138.9 	been contaminated with filth;
138.10 	(3) be packaged in a container that is composed, in whole or in part, of any poisonous 
138.11 	or deleterious substance that may render the contents injurious to health;
138.12 	(4) contain any additives or excipients that have been found by the United States Food 
138.13 	and Drug Administration to be unsafe for human or animal consumption;
138.14 	(5) contain a cannabinoid or an amount or percentage of cannabinoids that is different 
138.15 	than the information stated on the label;
138.16 	(6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid 
138.17 	approved by the office, in an amount that exceeds the standard established in subdivision 
138.18 	2, paragraph (c); or
138.19 	(7) contain any contaminants for which testing is required by the office in amounts that 
138.20 	exceed the acceptable minimum standards established by the office.
138.21 	(c) No product containing any cannabinoid may be sold to any individual who is under 
138.22 	21 years of age.
138.23 		Subd. 6.Enforcement. The office may enforce this section under the relevant provisions 
138.24 	of section 342.17.

138.25 	Sec. 69. [342.67] CANNABIS INDUSTRY COMMUNITY RENEWAL GRANTS.
138.26 		Subdivision 1.Establishment. The Office of Cannabis Management shall establish 
138.27 	CanRenew, a program to award grants to eligible organizations for investments in 
138.28 	communities where long-term residents are eligible to be social equity applicants.
138.29 		Subd. 2.Definitions. (a) For the purposes of this section, the following terms have the 
138.30 	meanings given.
139.1 	(b) "Community investment" means a project or program designed to improve 
139.2 	community-wide outcomes or experiences and may include efforts targeting economic 
139.3 	development, violence prevention, youth development, or civil legal aid, among others.
139.4 	(c) "Eligible community" means a community where long-term residents are eligible to 
139.5 	be social equity applicants.
139.6 	(d) "Eligible organization" means any organization able to make an investment in a 
139.7 	community where long-term residents are eligible to be social equity applicants and may 
139.8 	include educational institutions, nonprofit organizations, private businesses, community 
139.9 	groups, units of local government, or partnerships between different types of organizations.
139.10 	(e) "Program" means the CanRenew grant program.
139.11 	(f) "Social equity applicant" means a person who meets the qualification requirements 
139.12 	in section 342.15.
139.13 		Subd. 3.Grants to organizations. (a) The office must award grants to eligible 
139.14 	organizations through a competitive grant process.
139.15 	(b) To receive grant money, an eligible organization must submit a written application 
139.16 	to the office, using a form developed by the office, explaining the community investment 
139.17 	the organization wants to make in an eligible community.
139.18 	(c) An eligible organization's grant application must also include:
139.19 	(1) an analysis of the community's need for the proposed investment;
139.20 	(2) a description of the positive impact that the proposed investment is expected to 
139.21 	generate for that community;
139.22 	(3) any evidence of the organization's ability to successfully achieve that positive impact;
139.23 	(4) any evidence of the organization's past success in making similar community 
139.24 	investments;
139.25 	(5) an estimate of the cost of the proposed investment;
139.26 	(6) the sources and amounts of any nonstate funds or in-kind contributions that will 
139.27 	supplement grant money; and
139.28 	(7) any additional information requested by the office.
139.29 	(d) In awarding grants under this subdivision, the office shall give weight to applications 
139.30 	from organizations that demonstrate a history of successful community investments, 
139.31 	particularly in geographic areas that are now eligible communities. The office shall also 
140.1 	give weight to applications where there is demonstrated community support for the proposed 
140.2 	investment. The office shall fund investments in eligible communities throughout the state.
140.3 		Subd. 4.Program outreach. The office shall make extensive efforts to publicize these 
140.4 	grants, including through partnerships with community organizations, particularly those 
140.5 	located in eligible communities.
140.6 		Subd. 5.Reports to the legislature. By January 15, 2024, and each January 15 thereafter, 
140.7 	the office must submit a report to the chairs and ranking minority members of the committees 
140.8 	of the house of representatives and the senate having jurisdiction over community 
140.9 	development that details awards given through the CanRenew program and the use of grant 
140.10 	money, including any measures of successful community impact from the grants.

140.11 	Sec. 70. [342.68] SUBSTANCE USE TREATMENT, RECOVERY, AND 
140.12 	PREVENTION GRANTS.
140.13 		Subdivision 1.Account established; appropriation. A substance use treatment, recovery, 
140.14 	and prevention grant account is created in the special revenue fund. Money in the account, 
140.15 	including interest earned, is appropriated to the office for the purposes specified in this 
140.16 	section.
140.17 		Subd. 2.Acceptance of gifts and grants. Notwithstanding sections 16A.013 to 16A.016, 
140.18 	the office may accept money contributed by individuals and may apply for grants from 
140.19 	charitable foundations to be used for the purposes identified in this section. The money 
140.20 	accepted under this section must be deposited in the substance use treatment, recovery, and 
140.21 	prevention grant account created under subdivision 1.
140.22 		Subd. 3.Disposition of money; grants. (a) Money in the substance use treatment, 
140.23 	recovery, and prevention grant account must be distributed as follows:
140.24 	(1) 75 percent of the money is for grants for recovery programs and substance use 
140.25 	disorder treatment, as defined in section 245G.01, subdivision 24, and may be used for 
140.26 	substance use disorder treatment providers to adopt evidence-based, culturally informed, 
140.27 	and responsive treatment and services. Funds may be used to support the expansion of peer 
140.28 	and recovery specialists, cover housing costs in sober homes for persons with low incomes, 
140.29 	expand co-occurring programming for persons with mental illnesses and substance use 
140.30 	disorders, support first episode psychosis programs, provide harm reduction services, and 
140.31 	provide start-up funding for culturally specific providers of substance use disorder services. 
140.32 	The office shall consult with the commissioner of human services to determine appropriate 
140.33 	provider rate increases or modifications to existing payment methodologies;
141.1 	(2) 20 percent of the money is for grants for substance use disorder prevention; and
141.2 	(3) five percent of the money is for grants to educate pregnant individuals, breastfeeding 
141.3 	individuals, and individuals who may become pregnant on the adverse health effects of 
141.4 	substance use.
141.5 	(b) The office shall consult with the commissioner of human services and the 
141.6 	commissioner of health to develop an appropriate application process, establish grant 
141.7 	requirements, determine what organizations are eligible to receive grants, and establish 
141.8 	reporting requirements for grant recipients.
141.9 		Subd. 4.Reports to the legislature. By January 15, 2024, and each January 15 thereafter, 
141.10 	the office must submit a report to the chairs and ranking minority members of the committees 
141.11 	of the house of representatives and the senate having jurisdiction over health and human 
141.12 	services policy and finance that details grants awarded from the substance use treatment, 
141.13 	recovery, and prevention grant account, including the total amount awarded, total number 
141.14 	of recipients, and geographic distribution of those recipients.

141.15 	Sec. 71. [342.69] CANNABIS GROWER GRANTS.
141.16 		Subdivision 1.Establishment. The office, in consultation with the commissioner of 
141.17 	agriculture, shall establish CanGrow, a program to award grants to (1) eligible organizations 
141.18 	to help farmers navigate the regulatory structure of the legal cannabis industry, and (2) 
141.19 	nonprofit corporations to fund loans to farmers for expansion into the legal cannabis industry.
141.20 		Subd. 2.Definitions. (a) For the purposes of this section, the following terms have the 
141.21 	meanings given.
141.22 	(b) "Eligible organization" means any organization capable of helping farmers navigate 
141.23 	the regulatory structure of the legal cannabis industry, particularly individuals facing barriers 
141.24 	to education or employment, and may include educational institutions, nonprofit 
141.25 	organizations, private businesses, community groups, units of local government, or 
141.26 	partnerships between different types of organizations.
141.27 	(c) "Industry" means the legal cannabis industry in the state of Minnesota.
141.28 	(d) "Program" means the CanGrow grant program.
141.29 	(e) "Social equity applicant" means a person who meets the qualification requirements 
141.30 	in section 342.15.
141.31 		Subd. 3.Technical assistance grants. (a) Grant money awarded to eligible organizations 
141.32 	may be used for both developing technical assistance resources relevant to the regulatory 
142.1 	structure of the legal cannabis industry and for providing such technical assistance or 
142.2 	navigation services to farmers.
142.3 	(b) The office must award grants to eligible organizations through a competitive grant 
142.4 	process.
142.5 	(c) To receive grant money, an eligible organization must submit a written application 
142.6 	to the office, using a form developed by the office, explaining the organization's ability to 
142.7 	assist farmers in navigating the regulatory structure of the legal cannabis industry, particularly 
142.8 	farmers facing barriers to education or employment.
142.9 	(d) An eligible organization's grant application must also include:
142.10 	(1) a description of the proposed technical assistance or navigation services, including 
142.11 	the types of farmers targeted for assistance;
142.12 	(2) any evidence of the organization's past success in providing technical assistance or 
142.13 	navigation services to farmers, particularly farmers who live in areas where long-term 
142.14 	residents are eligible to be social equity applicants;
142.15 	(3) an estimate of the cost of providing the technical assistance;
142.16 	(4) the sources and amounts of any nonstate funds or in-kind contributions that will 
142.17 	supplement grant money, including any amounts that farmers will be charged to receive 
142.18 	assistance; and
142.19 	(5) any additional information requested by the office.
142.20 	(e) In awarding grants under this subdivision, the office shall give weight to applications 
142.21 	from organizations that demonstrate a history of successful technical assistance or navigation 
142.22 	services, particularly for farmers facing barriers to education or employment. The office 
142.23 	shall also give weight to applications where the proposed technical assistance will serve 
142.24 	areas where long-term residents are eligible to be social equity applicants. The office shall 
142.25 	fund technical assistance to farmers throughout the state.
142.26 		Subd. 4.Loan financing grants. (a) The office shall establish a revolving loan account 
142.27 	to make loan financing grants under the CanGrow program.
142.28 	(b) The office must award grants to nonprofit corporations through a competitive grant 
142.29 	process.
142.30 	(c) To receive grant money, a nonprofit corporation must submit a written application 
142.31 	to the office using a form developed by the office.
143.1 	(d) In awarding grants under this subdivision, the office shall give weight to whether 
143.2 	the nonprofit corporation:
143.3 	(1) has a board of directors that includes individuals experienced in agricultural business 
143.4 	development;
143.5 	(2) has the technical skills to analyze projects;
143.6 	(3) is familiar with other available public and private funding sources and economic 
143.7 	development programs;
143.8 	(4) can initiate and implement economic development projects;
143.9 	(5) can establish and administer a revolving loan account; and
143.10 	(6) has established relationships with communities where long-term residents are eligible 
143.11 	to be social equity applicants.
143.12 	The office shall make grants that will help farmers enter the legal cannabis industry 
143.13 	throughout the state.
143.14 	(e) A nonprofit corporation that receives grants under the program must:
143.15 	(1) establish an office-certified revolving loan account for the purpose of making eligible 
143.16 	loans; and
143.17 	(2) enter into an agreement with the office that the office shall fund loans that the 
143.18 	nonprofit corporation makes to farmers entering the legal cannabis industry. The office shall 
143.19 	review existing agreements with nonprofit corporations every five years and may renew or 
143.20 	terminate an agreement based on that review. In making this review, the office shall consider, 
143.21 	among other criteria, the criteria in paragraph (d).
143.22 		Subd. 5.Loans to farmers. (a) The criteria in this subdivision apply to loans made by 
143.23 	nonprofit corporations under the program.
143.24 	(b) A loan must be used to support a farmer in entering the legal cannabis industry. 
143.25 	Priority must be given to loans to businesses owned by farmers who are eligible to be social 
143.26 	equity applicants and businesses located in communities where long-term residents are 
143.27 	eligible to be social equity applicants.
143.28 	(c) Loans must be made to businesses that are not likely to undertake the project for 
143.29 	which loans are sought without assistance from the program.
143.30 	(d) The minimum state contribution to a loan is $2,500 and the maximum is either:
143.31 	(1) $50,000; or
144.1 	(2) $150,000, if state contributions are matched by an equal or greater amount of new 
144.2 	private investment.
144.3 	(e) Loan applications given preliminary approval by the nonprofit corporation must be 
144.4 	forwarded to the office for approval. The office must give final approval for each loan made 
144.5 	by the nonprofit corporation under the program.
144.6 	(f) If the borrower has met lender criteria, including being current with all payments for 
144.7 	a minimum of three years, the office may approve either full or partial forgiveness of interest 
144.8 	or principal amounts.
144.9 		Subd. 6.Revolving loan account administration. (a) The office shall establish a 
144.10 	minimum interest rate for loans or guarantees to ensure that necessary loan administration 
144.11 	costs are covered. The interest rate charged by a nonprofit corporation for a loan under this 
144.12 	section must not exceed the Wall Street Journal prime rate. For a loan under this section, 
144.13 	the nonprofit corporation may charge a loan origination fee equal to or less than one percent 
144.14 	of the loan value. The nonprofit corporation may retain the amount of the origination fee.
144.15 	(b) Loan repayment of principal must be paid to the office for deposit in the revolving 
144.16 	loan account. Loan interest payments must be deposited in a revolving loan account created 
144.17 	by the nonprofit corporation originating the loan being repaid for further distribution or use, 
144.18 	consistent with the criteria of this section.
144.19 	(c) Administrative expenses of the nonprofit corporations with whom the office enters 
144.20 	into agreements, including expenses incurred by a nonprofit corporation in providing 
144.21 	financial, technical, managerial, and marketing assistance to a business receiving a loan 
144.22 	under this section, are eligible program expenses that the office may agree to pay under the 
144.23 	grant agreement.
144.24 		Subd. 7.Program outreach. The office shall make extensive efforts to publicize these 
144.25 	grants, including through partnerships with community organizations, particularly those 
144.26 	located in areas where long-term residents are eligible to be social equity applicants.
144.27 		Subd. 8.Reporting requirements. (a) A nonprofit corporation that receives a grant 
144.28 	under subdivision 4 shall:
144.29 	(1) submit an annual report to the office by January 15 of each year that the nonprofit 
144.30 	corporation participates in the program that includes a description of agricultural businesses 
144.31 	supported by the grant program, an account of loans made during the calendar year, the 
144.32 	program's impact on farmers' ability to expand into the legal cannabis industry, the source 
145.1 	and amount of money collected and distributed by the program, the program's assets and 
145.2 	liabilities, and an explanation of administrative expenses; and
145.3 	(2) provide for an independent annual audit to be performed in accordance with generally 
145.4 	accepted accounting practices and auditing standards and submit a copy of each annual 
145.5 	audit report to the office.
145.6 	(b) By February 15, 2024, and each February 15 thereafter, the office must submit a 
145.7 	report to the chairs and ranking minority members of the committees of the house of 
145.8 	representatives and the senate having jurisdiction over agriculture that details awards given 
145.9 	through the CanGrow program and the use of grant money, including any measures of 
145.10 	success toward helping farmers enter the legal cannabis industry. The report must include 
145.11 	geographic information regarding the issuance of grants and loans under this section, the 
145.12 	repayment rate of loans issued under subdivision 5, and a summary of the amount of loans 
145.13 	forgiven.

145.14 	Sec. 72. [342.70] LAWFUL ACTIVITIES.
145.15 	(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing, 
145.16 	and selling of cannabis flower, cannabis products, synthetically derived cannabinoids, 
145.17 	lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis 
145.18 	business in conformity with the rights granted by a cannabis business license is lawful and 
145.19 	may not be the grounds for the seizure or forfeiture of property, arrest or prosecution, or 
145.20 	search or inspections except as provided by this chapter.
145.21 	(b) A person acting as an agent of a licensed cannabis retailer or licensed cannabis 
145.22 	microbusiness who sells or otherwise transfers cannabis flower, cannabis products, 
145.23 	lower-potency hemp edibles, or hemp-derived consumer products to a person under 21 years 
145.24 	of age is not subject to arrest, prosecution, or forfeiture of property if the person complied 
145.25 	with section 342.28, subdivision 4, and any rules promulgated pursuant to this chapter.

145.26 	Sec. 73. [342.71] CIVIL ACTIONS.
145.27 		Subdivision 1.Right of action. A spouse, child, parent, guardian, employer, or other 
145.28 	person injured in person, property, or means of support or who incurs other pecuniary loss 
145.29 	by an intoxicated person or by the intoxication of another person, has a right of action in 
145.30 	the person's own name for all damages sustained against a person who caused the intoxication 
145.31 	of that person by illegally selling cannabis flower or cannabis products. All damages 
145.32 	recovered by a minor under this section must be paid either to the minor or to the minor's 
145.33 	parent, guardian, or next friend as the court directs.
146.1 		Subd. 2.Actions. All suits for damages under this section must be by civil action in a 
146.2 	court of this state having jurisdiction.
146.3 		Subd. 3.Comparative negligence. Actions under this section are governed by section 
146.4 	604.01.
146.5 		Subd. 4.Defense. It is a defense for the defendant to prove by a preponderance of the 
146.6 	evidence that the defendant reasonably and in good faith relied upon representations of 
146.7 	proof of age in selling, bartering, furnishing, or giving the cannabis or cannabis product.
146.8 		Subd. 5.Common law claims. Nothing in this chapter precludes common law tort claims 
146.9 	against any person 21 years old or older who knowingly provides or furnishes cannabis 
146.10 	flower or cannabis products to a person under the age of 21 years.

146.11 	Sec. 74. [342.73] NUISANCE; ACTION.
146.12 		Subdivision 1.Nuisance. Any use of adult-use cannabis flower which is injurious to 
146.13 	health, indecent or offensive to the senses, or an obstruction to the free use of property so 
146.14 	as to interfere with the comfortable enjoyment of life or property is a nuisance.
146.15 		Subd. 2.Actions; landlord; association. (a) A person who is injuriously affected or 
146.16 	whose personal enjoyment is lessened by a nuisance under subdivision 1 may bring an 
146.17 	action for injunctive relief and the greater of the person's actual damages or a civil penalty 
146.18 	of $250.
146.19 	(b) If a landlord, as defined in section 504B.001, subdivision 7, or an association, as 
146.20 	defined in section 515B.1-103, clause (4), fails to enforce the terms of a lease, governing 
146.21 	document, or policy related to the use of adult-use cannabis flower on the premises or 
146.22 	property, a person who is injuriously affected or whose personal enjoyment is lessened by 
146.23 	a nuisance under subdivision 1 as a result of the failure to enforce the terms may bring an 
146.24 	action against the landlord or association seeking injunctive relief and the greater of the 
146.25 	person's actual damages or a civil penalty of $500.

146.26 	EFFECTIVE DATE. This section is effective July 1, 2023, and applies to causes of 
146.27 	actions accruing on or after that date.

146.28 	Sec. 75. REPORT; TRAFFIC AND TRANSPORTATION ISSUES.
 146.29 	By January 31, 2024, the Office of Cannabis Management must submit a report to the 
146.30 	chairs and ranking minority members of the legislative committees with jurisdiction over 
146.31 	transportation policy and finance. At a minimum, the report must include:
147.1 	(1) a description of all rules adopted that relate to traffic and transportation laws and 
147.2 	cannabis transporter licensing and operations;
147.3 	(2) recommendations on changes to statutes that would codify the rules; and
147.4 	(3) recommendations on how to improve any aspects of this act. The recommendations 
147.5 	must be developed in consultation with the commissioner of transportation, the commissioner 
147.6 	of public safety, the colonel of the State Patrol, and the director of the Office of Traffic 
147.7 	Safety in the Department of Public Safety.

147.8 	Sec. 76. TRANSPORTER LICENSE ESTABLISHMENT.
 147.9 	When establishing the process for issuing transporter licenses and the requirements for 
147.10 	obtaining a transporter license, the Office of Cannabis Management must consult with the 
147.11 	Commissioner of Transportation about best practices for issuing licenses.

147.12 	Sec. 77. INITIAL APPOINTMENTS; FIRST TERMS; FIRST MEETING FOR THE 
147.13 	CANNABIS ADVISORY COUNCIL.
 147.14 		Subdivision 1.Appointments; first terms. Appointing authorities must make the first 
147.15 	appointments to the Cannabis Advisory Council under Minnesota Statutes, section 342.03, 
147.16 	by August 1, 2023. The members appointed under Minnesota Statutes, section 342.03, 
147.17 	subdivision 1, paragraph (a), clauses (14) to (26) and (38), items (i) to (vi), shall serve terms 
147.18 	coterminous with the governor. The members appointed under Minnesota Statutes, section 
147.19 	342.03, subdivision 1, paragraph (a), clauses (27) to (37) and (38), items (vii) to (xi), shall 
147.20 	serve terms that conclude the year after the end of a governor's term.
147.21 		Subd. 2.First meeting. The director of the Office of Cannabis Management shall convene 
147.22 	the first meeting of the Cannabis Advisory Council by September 15, 2023.

147.23 	Sec. 78. EFFECTIVE DATE.
 147.24 	Except as otherwise provided, each section of this article is effective July 1, 2023.

148.1 	ARTICLE 2
148.2 	TAXES

148.3 	Section 1. Minnesota Statutes 2022, section 270B.12, is amended by adding a subdivision 
148.4 	to read:
148.5 		Subd. 4a.Office of Cannabis Management. The commissioner may disclose return 
148.6 	information to the Office of Cannabis Management for the purpose of and to the extent 
148.7 	necessary to administer section 270C.726.

148.8 	EFFECTIVE DATE. This section is effective June 30, 2023.

148.9 	Sec. 2. [270C.726] POSTING OF TAX DELINQUENCY; SALE OF CANNABIS.
148.10 		Subdivision 1.Posting; notice. (a) Pursuant to the authority to disclose under section 
148.11 	270B.12, subdivision 4a, the commissioner shall, by the 15th of each month, submit to the 
148.12 	Office of Cannabis Management a list of all taxpayers subject to the tax imposed by section 
148.13 	295.81 that are required to pay, withhold, or collect the tax imposed by sections 290.02, 
148.14 	290.0922, 290.92, 290.9727, 290.9728, 290.9729, 295.81, or 297A.62 or local sales and 
148.15 	use tax payable to the commissioner, or a local option sales and use tax administered and 
148.16 	collected by the commissioner, and who are ten days or more delinquent in either filing a 
148.17 	tax return or paying the tax.
148.18 	(b) The commissioner is under no obligation to list a taxpayer whose business is inactive. 
148.19 	At least ten days before notifying the Office of Cannabis Management, the commissioner 
148.20 	shall notify the taxpayer of the intended action.
148.21 	(c) The Office of Cannabis Management shall post the list required by this section on 
148.22 	the Office of Cannabis Management website. The list must prominently show the date of 
148.23 	posting. If a taxpayer previously listed files all returns and pays all taxes specified in this 
148.24 	subdivision then due, the commissioner shall notify the Office of Cannabis Management 
148.25 	within two business days.
148.26 		Subd. 2.Sales prohibited. Beginning the third business day after the list is posted, no 
148.27 	cannabis cultivator, cannabis manufacturer, cannabis microbusiness, cannabis mezzobusiness, 
148.28 	cannabis wholesaler, or industrial hemp grower as defined in chapter 342 may sell or deliver 
148.29 	any product to a taxpayer included on the posted list.
148.30 		Subd. 3.Penalty. A cannabis cultivator, cannabis manufacturer, cannabis microbusiness, 
148.31 	cannabis mezzobusiness, cannabis wholesaler, or industrial hemp grower as defined in 
149.1 	chapter 342 who violates subdivision 2 is subject to the penalties provided in sections 342.19 
149.2 	and 342.21.

149.3 	EFFECTIVE DATE. This section is effective June 30, 2023.

149.4 	Sec. 3. Minnesota Statutes 2022, section 273.13, subdivision 24, is amended to read:
149.5 		Subd. 24.Class 3.  Commercial and industrial property and utility real and personal 
149.6 	property is class 3a.
149.7 	(1) Except as otherwise provided, each parcel of commercial, industrial, or utility real 
149.8 	property has a classification rate of 1.5 percent of the first tier of market value, and 2.0 
149.9 	percent of the remaining market value. In the case of contiguous parcels of property owned 
149.10 	by the same person or entity, only the value equal to the first-tier value of the contiguous 
149.11 	parcels qualifies for the reduced classification rate, except that contiguous parcels owned 
149.12 	by the same person or entity shall be eligible for the first-tier value classification rate on 
149.13 	each separate business operated by the owner of the property, provided the business is 
149.14 	housed in a separate structure. For the purposes of this subdivision, the first tier means the 
149.15 	first $150,000 of market value. Real property owned in fee by a utility for transmission line 
149.16 	right-of-way shall be classified at the classification rate for the higher tier.
149.17 	For purposes of this subdivision, parcels are considered to be contiguous even if they 
149.18 	are separated from each other by a road, street, waterway, or other similar intervening type 
149.19 	of property. Connections between parcels that consist of power lines or pipelines do not 
149.20 	cause the parcels to be contiguous. Property owners who have contiguous parcels of property 
149.21 	that constitute separate businesses that may qualify for the first-tier classification rate shall 
149.22 	notify the assessor by July 1, for treatment beginning in the following taxes payable year.
149.23 	(2) All personal property that is: (i) part of an electric generation, transmission, or 
149.24 	distribution system; or (ii) part of a pipeline system transporting or distributing water, gas, 
149.25 	crude oil, or petroleum products; and (iii) not described in clause (3), and all railroad 
149.26 	operating property has a classification rate as provided under clause (1) for the first tier of 
149.27 	market value and the remaining market value. In the case of multiple parcels in one county 
149.28 	that are owned by one person or entity, only one first tier amount is eligible for the reduced 
149.29 	rate.
149.30 	(3) The entire market value of personal property that is: (i) tools, implements, and 
149.31 	machinery of an electric generation, transmission, or distribution system; (ii) tools, 
149.32 	implements, and machinery of a pipeline system transporting or distributing water, gas, 
149.33 	crude oil, or petroleum products; or (iii) the mains and pipes used in the distribution of 
150.1 	steam or hot or chilled water for heating or cooling buildings, has a classification rate as 
150.2 	provided under clause (1) for the remaining market value in excess of the first tier.
150.3 	(4) Real property used for raising, cultivating, processing, or storing cannabis plants, 
150.4 	cannabis flower, or cannabis products for sale has a classification rate as provided under 
150.5 	clause (1) for the first tier of market value and the remaining market value. As used in this 
150.6 	paragraph, "cannabis plant" has the meaning given in section 342.01, subdivision 18, 
150.7 	"cannabis flower" has the meaning given in section 342.01, subdivision 15, and "cannabis 
150.8 	product" has the meaning given in section 342.01, subdivision 19.

150.9 	EFFECTIVE DATE. This section is effective beginning with assessment year 2024 
150.10 	and thereafter.

150.11 	Sec. 4. Minnesota Statutes 2022, section 275.025, subdivision 2, is amended to read:
150.12 		Subd. 2.Commercial-industrial tax capacity. For the purposes of this section, 
150.13 	"commercial-industrial tax capacity" means the tax capacity of all taxable property classified 
150.14 	as class 3 or class 5(1) under section 273.13, excluding:
150.15 	(1) the tax capacity attributable to the first $150,000 of market value of each parcel of 
150.16 	commercial-industrial property as defined under section 273.13, subdivision 24, clauses (1) 
150.17 	and, (2), and (4);
150.18 	(2) electric generation attached machinery under class 3; and
150.19 	(3) property described in section 473.625.
150.20 	County commercial-industrial tax capacity amounts are not adjusted for the captured 
150.21 	net tax capacity of a tax increment financing district under section 469.177, subdivision 2, 
150.22 	the net tax capacity of transmission lines deducted from a local government's total net tax 
150.23 	capacity under section 273.425, or fiscal disparities contribution and distribution net tax 
150.24 	capacities under chapter 276A or 473F. For purposes of this subdivision, the procedures 
150.25 	for determining eligibility for tier 1 under section 273.13, subdivision 24, clauses (1) and 
150.26 	(2), shall apply in determining the portion of a property eligible to be considered within the 
150.27 	first $150,000 of market value.

150.28 	EFFECTIVE DATE. This section is effective beginning with assessment year 2024 
150.29 	and thereafter.

151.1 	Sec. 5. [289A.33] FILING REQUIREMENTS AND DUE DATES; SPECIAL RULES.
151.2 	(a) Upon the request of any cannabis business as defined by section 342.01, subdivision 
151.3 	13, required to collect and remit taxes imposed under section 295.81, chapter 290, or chapter 
151.4 	297A, the commissioner shall waive the requirement that payment of tax must be made 
151.5 	electronically if the failure to pay electronically is because the cannabis business is unable 
151.6 	to secure banking services and the inability to secure the services is due to its engagement 
151.7 	in cannabis-related business allowed under Minnesota law.
151.8 	(b) If, in consultation with the commissioner of commerce, the commissioner determines 
151.9 	that the inability to find banking services is widespread and enforcement of the electronic 
151.10 	payment requirement will significantly impede the ability of cannabis businesses to timely 
151.11 	pay taxes imposed under section 295.81, chapter 290, or chapter 297A, the commissioner 
151.12 	may publish notice on the department website that waives the requirement to pay the tax 
151.13 	electronically. If such notice is published, a cannabis business must file returns and pay 
151.14 	taxes lawfully due in the form and manner prescribed by the commissioner.
151.15 	(c) Nothing in this section relieves a cannabis business from timely filing and paying 
151.16 	taxes.

151.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

151.18 	Sec. 6. Minnesota Statutes 2022, section 290.0132, subdivision 29, is amended to read:
151.19 		Subd. 29.Disallowed section 280E expenses; medical cannabis manufacturers
151.20 	licensees. The amount of expenses of a medical cannabis manufacturer business, as defined 
151.21 	under section 152.22, subdivision 7 342.01, subdivision 52, related to the business of medical 
151.22 	cannabis under sections 152.21 to 152.37 342.47 to 342.59, or a license holder under chapter 
151.23 	342, related to the business of nonmedical cannabis under that chapter, and not allowed for 
151.24 	federal income tax purposes under section 280E of the Internal Revenue Code is a subtraction.

151.25 	EFFECTIVE DATE. This section is effective for taxable years beginning after December 
151.26 	31, 2022.

151.27 	Sec. 7. Minnesota Statutes 2022, section 290.0134, subdivision 19, is amended to read:
151.28 		Subd. 19.Disallowed section 280E expenses; medical cannabis manufacturers
151.29 	licensees. The amount of expenses of a medical cannabis manufacturer business, as defined 
151.30 	under section 152.22, subdivision 7 342.01, subdivision 52, related to the business of medical 
151.31 	cannabis under sections 152.21 to 152.37 342.47 to 342.59, or a license holder under chapter 
152.1 	342, related to the business of nonmedical cannabis under that chapter, and not allowed for 
152.2 	federal income tax purposes under section 280E of the Internal Revenue Code is a subtraction.

152.3 	EFFECTIVE DATE. This section is effective for taxable years beginning after December 
152.4 	31, 2022.

152.5 	Sec. 8. [295.81] CANNABIS GROSS RECEIPTS TAX.
152.6 		Subdivision 1.Definitions. (a) For purposes of this section, the following terms have 
152.7 	the meanings given.
152.8 	(b) "Bundled transaction" means the retail sale of two or more products when the products 
152.9 	are otherwise distinct and identifiable, and the products are sold for one nonitemized price.
152.10 	(c) "Cannabis flower" has the meaning given in section 342.01, subdivision 15.
152.11 	(d) "Cannabis product" has the meaning given in section 342.01, subdivision 19.
152.12 	(e) "Cannabis solution product" means any cartridge, bottle, or other package that contains 
152.13 	a taxable cannabis product in a solution that is consumed or meant to be consumed through 
152.14 	the use of a heating element, power source, electronic circuit, or other electronic, chemical, 
152.15 	or mechanical means that produces vapor or aerosol. A cannabis solution product includes 
152.16 	any electronic delivery system, electronic vaping device, electronic vape pen, electronic 
152.17 	oral device, electronic delivery device, or similar product or device, and any batteries, 
152.18 	heating elements, or other components, parts, or accessories sold with and meant to be used 
152.19 	in the consumption of a solution containing a taxable cannabis product.
152.20 	(f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.31.
152.21 	(g) "Cannabis microbusiness" means a cannabis business licensed under section 342.29.
152.22 	(h) "Cannabis retailer" means a cannabis business licensed under section 342.27.
152.23 	(i) "Commissioner" means the commissioner of revenue.
152.24 	(j) "Gross receipts" means the total amount received, in money or by barter or exchange, 
152.25 	for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts 
152.26 	include but are not limited to delivery charges and packaging costs. Gross receipts do not 
152.27 	include:
152.28 	(1) any taxes imposed directly on the customer that are separately stated on the invoice, 
152.29 	bill of sale, or similar document given to the purchaser; and
152.30 	(2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party 
152.31 	and that are allowed by the seller and taken by a purchaser on a sale.
153.1 	(k) "Hemp-derived consumer product" has the meaning given in section 342.01, 
153.2 	subdivision 35.
153.3 	(l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision 
153.4 	49.
153.5 	(m) "Lower-potency hemp edible retailer" means a cannabis business licensed under 
153.6 	section 342.41, subdivision 1, paragraph (b), clause (1).
153.7 	(n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 53.
153.8 	(o) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision 
153.9 	51.
153.10 	(p) "Medical cannabis paraphernalia" has the meaning given in section 342.01, 
153.11 	subdivision 54.
153.12 	(q) "Retail sale" has the meaning given in section 297A.61, subdivision 4.
153.13 	(r) "Taxable cannabis product" means cannabis flower, cannabis product, cannabis 
153.14 	solution product, hemp-derived consumer product, lower-potency hemp edible, and any 
153.15 	substantially similar product.
153.16 	(s) "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis 
153.17 	product and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness, 
153.18 	and lower-potency hemp edible retailer. Taxable cannabis product retailer includes but is 
153.19 	not limited to a:
153.20 	(1) retailer maintaining a place of business in this state;
153.21 	(2) marketplace provider maintaining a place of business in this state, as defined in 
153.22 	section 297A.66, subdivision 1, paragraph (a);
153.23 	(3) retailer not maintaining a place of business in this state; and
153.24 	(4) marketplace provider not maintaining a place of business in this state, as defined in 
153.25 	section 297A.66, subdivision 1, paragraph (b).
153.26 		Subd. 2.Gross receipts tax imposed. (a) A tax equal to ten percent of gross receipts 
153.27 	from retail sales in Minnesota of taxable cannabis products is imposed on any taxable 
153.28 	cannabis product retailer that sells these products to customers. A taxable cannabis product 
153.29 	retailer may but is not required to collect the tax imposed by this section from the purchaser 
153.30 	as long as the tax is separately stated on the receipt, invoice, bill of sale, or similar document 
153.31 	given to the purchaser.
154.1 	(b) If a product subject to the tax imposed by this section is included in a bundled 
154.2 	transaction, the entire sales price of the bundled transaction is subject to the tax imposed 
154.3 	by this section.
154.4 	(c) The tax imposed under this section is in addition to any other tax imposed on the 
154.5 	sale or use of taxable cannabis products.
154.6 		Subd. 3.Use tax imposed; credit for taxes paid. (a) A person that receives taxable 
154.7 	cannabis products for use or storage in Minnesota, other than from a taxable cannabis product 
154.8 	retailer that paid the tax under subdivision 2, is subject to tax at the rate imposed under 
154.9 	subdivision 2. Liability for the tax is incurred when the person has possession of the taxable 
154.10 	cannabis product in Minnesota. The tax must be remitted to the commissioner in the same 
154.11 	manner prescribed for taxes imposed under chapter 297A.
154.12 	(b) A person that has paid taxes to another state or any subdivision thereof on the same 
154.13 	transaction and is subject to tax under this section is entitled to a credit for the tax legally 
154.14 	due and paid to another state or subdivision thereof to the extent of the lesser of (1) the tax 
154.15 	actually paid to the other state or subdivision thereof, or (2) the amount of tax imposed by 
154.16 	Minnesota on the transaction subject to tax in the other state or subdivision thereof.
154.17 		Subd. 4.Exemptions. (a) The use tax imposed under subdivision 3, paragraph (a), does 
154.18 	not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable 
154.19 	cannabis products have an aggregate cost in any calendar month to the customer of $100 
154.20 	or less and (2) the taxable cannabis products were carried into this state by the customer.
154.21 	(b) The tax imposed under this section does not apply to sales of medical items purchased 
154.22 	by or for the patients enrolled in the registry program, including medical cannabis flower, 
154.23 	medical cannabinoid products, and medical cannabis paraphernalia.
154.24 	(c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed 
154.25 	under chapter 297A are not applicable to the taxes imposed under this section.
154.26 		Subd. 5.Tax collection required. A taxable cannabis product retailer with nexus in 
154.27 	Minnesota, who is not subject to tax under subdivision 2, is required to collect the tax 
154.28 	imposed under subdivision 3 from the purchaser of the taxable cannabis product and give 
154.29 	the purchaser a receipt for the tax paid. The tax collected must be remitted to the 
154.30 	commissioner in the same manner prescribed for the taxes imposed under chapter 297A.
154.31 		Subd. 6.Taxes paid to another state or any subdivision thereof; credit. A taxable 
154.32 	cannabis product retailer that has paid taxes to another state or any subdivision thereof 
154.33 	measured by gross receipts and is subject to tax under this section on the same gross receipts 
155.1 	is entitled to a credit for the tax legally due and paid to another state or any subdivision 
155.2 	thereof to the extent of the lesser of (1) the tax actually paid to the other state or any 
155.3 	subdivision thereof, or (2) the amount of tax imposed by Minnesota on the gross receipts 
155.4 	subject to tax in the other taxing state or any subdivision thereof.
155.5 		Subd. 7.Sourcing of sales. Section 297A.668 applies to the taxes imposed by this 
155.6 	section.
155.7 		Subd. 8.Administration. Unless specifically provided otherwise, the audit, assessment, 
155.8 	refund, penalty, interest, enforcement, collection remedies, appeal, and administrative 
155.9 	provisions of chapters 270C and 289A that are applicable to taxes imposed under chapter 
155.10 	297A, except the requirement to file returns and remit taxes due electronically if the 
155.11 	commissioner waives the requirement pursuant to section 289A.33, apply to the tax imposed 
155.12 	under this section.
155.13 		Subd. 9.Returns; payment of tax. (a) A taxable cannabis product retailer must report 
155.14 	the tax on a return prescribed by the commissioner and must remit the tax in a form and 
155.15 	manner prescribed by the commissioner. The return and the tax must be filed and paid using 
155.16 	the filing cycle and due dates provided for taxes imposed under section 289A.20, subdivision 
155.17 	4, and chapter 297A.
155.18 	(b) Interest must be paid on an overpayment refunded or credited to the taxpayer from 
155.19 	the date of payment of the tax until the date the refund is paid or credited. For purposes of 
155.20 	this subdivision, the date of payment is the due date of the return or the date of actual 
155.21 	payment of the tax, whichever is later.
155.22 		Subd. 10.Deposit of revenues; account established. (a) The commissioner must deposit 
155.23 	the revenues, including penalties and interest, derived from the tax imposed by this section 
155.24 	as follows:
155.25 	(1) 75 percent to the general fund; and
155.26 	(2) 25 percent to the local government cannabis aid account in the special revenue fund.
155.27 	(b) The local government cannabis aid account is established in the special revenue fund.
155.28 		Subd. 11.Personal debt. The tax imposed by this section, and interest and penalties 
155.29 	imposed with respect to it, are a personal debt of the person required to file a return from 
155.30 	the time that the liability for it arises, irrespective of when the time for payment of the 
155.31 	liability occurs. The debt must, in the case of the executor or administrator of the estate of 
155.32 	a decedent and in the case of a fiduciary, be that of the person in the person's official or 
155.33 	fiduciary capacity only, unless the person has voluntarily distributed the assets held in that 
156.1 	capacity without reserving sufficient assets to pay the tax, interest, and penalties, in which 
156.2 	event the person is personally liable for any deficiency.

156.3 	EFFECTIVE DATE. This section is effective for gross receipts received after June 30, 
156.4 	2023.

156.5 	Sec. 9. [295.82] CANNABIS LOCAL TAX PROHIBITED.
156.6 	A political subdivision of this state is prohibited from imposing a tax under this section 
156.7 	solely on the sale of taxable cannabis products as defined under section 295.81, subdivision 
156.8 	1, paragraph (q).

156.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

156.10 	Sec. 10. Minnesota Statutes 2022, section 297A.61, subdivision 3, is amended to read:
156.11 		Subd. 3.Sale and purchase. (a) "Sale" and "purchase" include, but are not limited to, 
156.12 	each of the transactions listed in this subdivision. In applying the provisions of this chapter, 
156.13 	the terms "tangible personal property" and "retail sale" include the taxable services listed 
156.14 	in paragraph (g), clause (6), items (i) to (vi) and (viii), and the provision of these taxable 
156.15 	services, unless specifically provided otherwise. Services performed by an employee for 
156.16 	an employer are not taxable. Services performed by a partnership or association for another 
156.17 	partnership or association are not taxable if one of the entities owns or controls more than 
156.18 	80 percent of the voting power of the equity interest in the other entity. Services performed 
156.19 	between members of an affiliated group of corporations are not taxable. For purposes of 
156.20 	the preceding sentence, "affiliated group of corporations" means those entities that would 
156.21 	be classified as members of an affiliated group as defined under United States Code, title 
156.22 	26, section 1504, disregarding the exclusions in section 1504(b).
156.23 	(b) Sale and purchase include:
156.24 	(1) any transfer of title or possession, or both, of tangible personal property, whether 
156.25 	absolutely or conditionally, for a consideration in money or by exchange or barter; and
156.26 	(2) the leasing of or the granting of a license to use or consume, for a consideration in 
156.27 	money or by exchange or barter, tangible personal property, other than a manufactured 
156.28 	home used for residential purposes for a continuous period of 30 days or more.
156.29 	(c) Sale and purchase include the production, fabrication, printing, or processing of 
156.30 	tangible personal property for a consideration for consumers who furnish either directly or 
156.31 	indirectly the materials used in the production, fabrication, printing, or processing.
157.1 	(d) Sale and purchase include the preparing for a consideration of food. Notwithstanding 
157.2 	section 297A.67, subdivision 2, taxable food includes, but is not limited to, the following:
157.3 	(1) prepared food sold by the retailer;
157.4 	(2) soft drinks;
157.5 	(3) candy; and
157.6 	(4) dietary supplements.
157.7 	(e) A sale and a purchase includes the furnishing for a consideration of electricity, gas, 
157.8 	water, or steam for use or consumption within this state.
157.9 	(f) A sale and a purchase includes the transfer for a consideration of prewritten computer 
157.10 	software whether delivered electronically, by load and leave, or otherwise.
157.11 	(g) A sale and a purchase includes the furnishing for a consideration of the following 
157.12 	services:
157.13 	(1) the privilege of admission to places of amusement, recreational areas, or athletic 
157.14 	events, and the making available of amusement devices, tanning facilities, reducing salons, 
157.15 	steam baths, health clubs, and spas or athletic facilities;
157.16 	(2) lodging and related services by a hotel, rooming house, resort, campground, motel, 
157.17 	or trailer camp, including furnishing the guest of the facility with access to telecommunication 
157.18 	services, and the granting of any similar license to use real property in a specific facility, 
157.19 	other than the renting or leasing of it for a continuous period of 30 days or more under an 
157.20 	enforceable written agreement that may not be terminated without prior notice and including 
157.21 	accommodations intermediary services provided in connection with other services provided 
157.22 	under this clause;
157.23 	(3) nonresidential parking services, whether on a contractual, hourly, or other periodic 
157.24 	basis, except for parking at a meter;
157.25 	(4) the granting of membership in a club, association, or other organization if:
157.26 	(i) the club, association, or other organization makes available for the use of its members 
157.27 	sports and athletic facilities, without regard to whether a separate charge is assessed for use 
157.28 	of the facilities; and
157.29 	(ii) use of the sports and athletic facility is not made available to the general public on 
157.30 	the same basis as it is made available to members.
158.1 	Granting of membership means both onetime initiation fees and periodic membership dues. 
158.2 	Sports and athletic facilities include golf courses; tennis, racquetball, handball, and squash 
158.3 	courts; basketball and volleyball facilities; running tracks; exercise equipment; swimming 
158.4 	pools; and other similar athletic or sports facilities;
158.5 	(5) delivery of aggregate materials by a third party, excluding delivery of aggregate 
158.6 	material used in road construction; and delivery of concrete block by a third party if the 
158.7 	delivery would be subject to the sales tax if provided by the seller of the concrete block. 
158.8 	For purposes of this clause, "road construction" means construction of:
158.9 	(i) public roads;
158.10 	(ii) cartways; and
158.11 	(iii) private roads in townships located outside of the seven-county metropolitan area 
158.12 	up to the point of the emergency response location sign; and
158.13 	(6) services as provided in this clause:
158.14 	(i) laundry and dry cleaning services including cleaning, pressing, repairing, altering, 
158.15 	and storing clothes, linen services and supply, cleaning and blocking hats, and carpet, 
158.16 	drapery, upholstery, and industrial cleaning. Laundry and dry cleaning services do not 
158.17 	include services provided by coin operated facilities operated by the customer;
158.18 	(ii) motor vehicle washing, waxing, and cleaning services, including services provided 
158.19 	by coin operated facilities operated by the customer, and rustproofing, undercoating, and 
158.20 	towing of motor vehicles;
158.21 	(iii) building and residential cleaning, maintenance, and disinfecting services and pest 
158.22 	control and exterminating services;
158.23 	(iv) detective, security, burglar, fire alarm, and armored car services; but not including 
158.24 	services performed within the jurisdiction they serve by off-duty licensed peace officers as 
158.25 	defined in section 626.84, subdivision 1, or services provided by a nonprofit organization 
158.26 	or any organization at the direction of a county for monitoring and electronic surveillance 
158.27 	of persons placed on in-home detention pursuant to court order or under the direction of the 
158.28 	Minnesota Department of Corrections;
158.29 	(v) pet grooming services;
158.30 	(vi) lawn care, fertilizing, mowing, spraying and sprigging services; garden planting 
158.31 	and maintenance; tree, bush, and shrub pruning, bracing, spraying, and surgery; indoor plant 
158.32 	care; tree, bush, shrub, and stump removal, except when performed as part of a land clearing 
159.1 	contract as defined in section 297A.68, subdivision 40; and tree trimming for public utility 
159.2 	lines. Services performed under a construction contract for the installation of shrubbery, 
159.3 	plants, sod, trees, bushes, and similar items are not taxable;
159.4 	(vii) massages, except when provided by a licensed health care facility or professional 
159.5 	or upon written referral from a licensed health care facility or professional for treatment of 
159.6 	illness, injury, or disease; and
159.7 	(viii) the furnishing of lodging, board, and care services for animals in kennels and other 
159.8 	similar arrangements, but excluding veterinary and horse boarding services.
159.9 	(h) A sale and a purchase includes the furnishing for a consideration of tangible personal 
159.10 	property or taxable services by the United States or any of its agencies or instrumentalities, 
159.11 	or the state of Minnesota, its agencies, instrumentalities, or political subdivisions.
159.12 	(i) A sale and a purchase includes the furnishing for a consideration of 
159.13 	telecommunications services, ancillary services associated with telecommunication services, 
159.14 	and pay television services. Telecommunication services include, but are not limited to, the 
159.15 	following services, as defined in section 297A.669: air-to-ground radiotelephone service, 
159.16 	mobile telecommunication service, postpaid calling service, prepaid calling service, prepaid 
159.17 	wireless calling service, and private communication services. The services in this paragraph 
159.18 	are taxed to the extent allowed under federal law.
159.19 	(j) A sale and a purchase includes the furnishing for a consideration of installation if the 
159.20 	installation charges would be subject to the sales tax if the installation were provided by 
159.21 	the seller of the item being installed.
159.22 	(k) A sale and a purchase includes the rental of a vehicle by a motor vehicle dealer to a 
159.23 	customer when (1) the vehicle is rented by the customer for a consideration, or (2) the motor 
159.24 	vehicle dealer is reimbursed pursuant to a service contract as defined in section 59B.02, 
159.25 	subdivision 11.
159.26 	(l) A sale and a purchase includes furnishing for a consideration of specified digital 
159.27 	products or other digital products or granting the right for a consideration to use specified 
159.28 	digital products or other digital products on a temporary or permanent basis and regardless 
159.29 	of whether the purchaser is required to make continued payments for such right. Wherever 
159.30 	the term "tangible personal property" is used in this chapter, other than in subdivisions 10 
159.31 	and 38, the provisions also apply to specified digital products, or other digital products, 
159.32 	unless specifically provided otherwise or the context indicates otherwise.
160.1 	(m) The sale of the privilege of admission under section 297A.61, subdivision 3, 
160.2 	paragraph (g), clause (1), to a place of amusement, recreational area, or athletic event 
160.3 	includes all charges included in the privilege of admission's sales price, without deduction 
160.4 	for amenities that may be provided, unless the amenities are separately stated and the 
160.5 	purchaser of the privilege of admission is entitled to add or decline the amenities, and the 
160.6 	amenities are not otherwise taxable.
160.7 	(n) A sale and purchase includes the transfer for consideration of a taxable cannabis 
160.8 	product as defined in section 295.81, subdivision 1, paragraph (q).

160.9 	EFFECTIVE DATE. This section is effective for sales and purchases made after June 
160.10 	30, 2023.

160.11 	Sec. 11. Minnesota Statutes 2022, section 297A.67, subdivision 2, is amended to read:
160.12 		Subd. 2.Food and food ingredients. Except as otherwise provided in this subdivision, 
160.13 	food and food ingredients are exempt. For purposes of this subdivision, "food" and "food 
160.14 	ingredients" mean substances, whether in liquid, concentrated, solid, frozen, dried, or 
160.15 	dehydrated form, that are sold for ingestion or chewing by humans and are consumed for 
160.16 	their taste or nutritional value. Food and food ingredients exempt under this subdivision do 
160.17 	not include candy, soft drinks, dietary supplements, and prepared foods. Food and food 
160.18 	ingredients do not include alcoholic beverages and, tobacco, taxable cannabis products, 
160.19 	medical cannabis flower, and medical cannabinoid products. For purposes of this subdivision, 
160.20 	"alcoholic beverages" means beverages that are suitable for human consumption and contain 
160.21 	one-half of one percent or more of alcohol by volume. For purposes of this subdivision, 
160.22 	"tobacco" means cigarettes, cigars, chewing or pipe tobacco, or any other item that contains 
160.23 	tobacco. For purposes of this subdivision, "taxable cannabis product" has the meaning given 
160.24 	in section 295.81, subdivision 1, paragraph (q), "medical cannabis flower" has the meaning 
160.25 	given in section 342.01, subdivision 53, and "medical cannabinoid product" has the meaning 
160.26 	given in section 342.01, subdivision 51. For purposes of this subdivision, "dietary 
160.27 	supplements" means any product, other than tobacco, intended to supplement the diet that:
160.28 	(1) contains one or more of the following dietary ingredients:
160.29 	(i) a vitamin;
160.30 	(ii) a mineral;
160.31 	(iii) an herb or other botanical;
160.32 	(iv) an amino acid;
161.1 	(v) a dietary substance for use by humans to supplement the diet by increasing the total 
161.2 	dietary intake; and
161.3 	(vi) a concentrate, metabolite, constituent, extract, or combination of any ingredient 
161.4 	described in items (i) to (v);
161.5 	(2) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form, 
161.6 	or if not intended for ingestion in such form, is not represented as conventional food and is 
161.7 	not represented for use as a sole item of a meal or of the diet; and
161.8 	(3) is required to be labeled as a dietary supplement, identifiable by the supplement facts 
161.9 	box found on the label and as required pursuant to Code of Federal Regulations, title 21, 
161.10 	section 101.36.

161.11 	EFFECTIVE DATE. This section is effective for sales and purchases made after June 
161.12 	30, 2023.

161.13 	Sec. 12. Minnesota Statutes 2022, section 297A.67, subdivision 7, is amended to read:
161.14 		Subd. 7.Drugs; medical devices. (a) Sales of the following drugs and medical devices 
161.15 	for human use are exempt:
161.16 	(1) drugs, including over-the-counter drugs;
161.17 	(2) single-use finger-pricking devices for the extraction of blood and other single-use 
161.18 	devices and single-use diagnostic agents used in diagnosing, monitoring, or treating diabetes;
161.19 	(3) insulin and medical oxygen for human use, regardless of whether prescribed or sold 
161.20 	over the counter;
161.21 	(4) prosthetic devices;
161.22 	(5) durable medical equipment for home use only;
161.23 	(6) mobility enhancing equipment;
161.24 	(7) prescription corrective eyeglasses; and
161.25 	(8) kidney dialysis equipment, including repair and replacement parts.
161.26 	(b) Items purchased in transactions covered by:
161.27 	(1) Medicare as defined under title XVIII of the Social Security Act, United States Code, 
161.28 	title 42, section 1395, et seq.; or
161.29 	(2) Medicaid as defined under title XIX of the Social Security Act, United States Code, 
161.30 	title 42, section 1396, et seq.
162.1 	(c) For purposes of this subdivision:
162.2 	(1) "Drug" means a compound, substance, or preparation, and any component of a 
162.3 	compound, substance, or preparation, other than food and food ingredients, dietary 
162.4 	supplements, taxable cannabis products as defined under section 295.81, subdivision 1, 
162.5 	paragraph (q), or alcoholic beverages that is:
162.6 	(i) recognized in the official United States Pharmacopoeia, official Homeopathic 
162.7 	Pharmacopoeia of the United States, or official National Formulary, and supplement to any 
162.8 	of them;
162.9 	(ii) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; 
162.10 	or
162.11 	(iii) intended to affect the structure or any function of the body.
162.12 	(2) "Durable medical equipment" means equipment, including repair and replacement 
162.13 	parts, including single-patient use items, but not including mobility enhancing equipment, 
162.14 	that:
162.15 	(i) can withstand repeated use;
162.16 	(ii) is primarily and customarily used to serve a medical purpose;
162.17 	(iii) generally is not useful to a person in the absence of illness or injury; and
162.18 	(iv) is not worn in or on the body.
162.19 	For purposes of this clause, "repair and replacement parts" includes all components or 
162.20 	attachments used in conjunction with the durable medical equipment, including repair and 
162.21 	replacement parts which are for single patient use only.
162.22 	(3) "Mobility enhancing equipment" means equipment, including repair and replacement 
162.23 	parts, but not including durable medical equipment, that:
162.24 	(i) is primarily and customarily used to provide or increase the ability to move from one 
162.25 	place to another and that is appropriate for use either in a home or a motor vehicle;
162.26 	(ii) is not generally used by persons with normal mobility; and
162.27 	(iii) does not include any motor vehicle or equipment on a motor vehicle normally 
162.28 	provided by a motor vehicle manufacturer.
162.29 	(4) "Over-the-counter drug" means a drug that contains a label that identifies the product 
162.30 	as a drug as required by Code of Federal Regulations, title 21, section 201.66. The label 
162.31 	must include a "drug facts" panel or a statement of the active ingredients with a list of those 
163.1 	ingredients contained in the compound, substance, or preparation. Over-the-counter drugs 
163.2 	do not include grooming and hygiene products, regardless of whether they otherwise meet 
163.3 	the definition. "Grooming and hygiene products" are soaps, cleaning solutions, shampoo, 
163.4 	toothpaste, mouthwash, antiperspirants, and suntan lotions and sunscreens.
163.5 	(5) "Prescribed" and "prescription" means a direction in the form of an order, formula, 
163.6 	or recipe issued in any form of oral, written, electronic, or other means of transmission by 
163.7 	a duly licensed health care professional.
163.8 	(6) "Prosthetic device" means a replacement, corrective, or supportive device, including 
163.9 	repair and replacement parts, worn on or in the body to:
163.10 	(i) artificially replace a missing portion of the body;
163.11 	(ii) prevent or correct physical deformity or malfunction; or
163.12 	(iii) support a weak or deformed portion of the body.
163.13 	Prosthetic device does not include corrective eyeglasses.
163.14 	(7) "Kidney dialysis equipment" means equipment that:
163.15 	(i) is used to remove waste products that build up in the blood when the kidneys are not 
163.16 	able to do so on their own; and
163.17 	(ii) can withstand repeated use, including multiple use by a single patient, notwithstanding 
163.18 	the provisions of clause (2).
163.19 	(8) A transaction is covered by Medicare or Medicaid if any portion of the cost of the 
163.20 	item purchased in the transaction is paid for or reimbursed by the federal government or 
163.21 	the state of Minnesota pursuant to the Medicare or Medicaid program, by a private insurance 
163.22 	company administering the Medicare or Medicaid program on behalf of the federal 
163.23 	government or the state of Minnesota, or by a managed care organization for the benefit of 
163.24 	a patient enrolled in a prepaid program that furnishes medical services in lieu of conventional 
163.25 	Medicare or Medicaid coverage pursuant to agreement with the federal government or the 
163.26 	state of Minnesota.

163.27 	EFFECTIVE DATE. This section is effective for sales and purchases made after June 
163.28 	30, 2023.

164.1 	Sec. 13. Minnesota Statutes 2022, section 297A.70, subdivision 2, is amended to read:
164.2 		Subd. 2.Sales to government. (a) All sales, except those listed in paragraph (b), to the 
164.3 	following governments and political subdivisions, or to the listed agencies or instrumentalities 
164.4 	of governments and political subdivisions, are exempt:
164.5 	(1) the United States and its agencies and instrumentalities;
164.6 	(2) school districts, local governments, the University of Minnesota, state universities, 
164.7 	community colleges, technical colleges, state academies, the Perpich Minnesota Center for 
164.8 	Arts Education, and an instrumentality of a political subdivision that is accredited as an 
164.9 	optional/special function school by the North Central Association of Colleges and Schools;
164.10 	(3) hospitals and nursing homes owned and operated by political subdivisions of the 
164.11 	state of tangible personal property and taxable services used at or by hospitals and nursing 
164.12 	homes;
164.13 	(4) notwithstanding paragraph (d), the sales and purchases by the Metropolitan Council 
164.14 	of vehicles and repair parts to equip operations provided for in section 473.4051 are exempt 
164.15 	through December 31, 2016;
164.16 	(5) other states or political subdivisions of other states, if the sale would be exempt from 
164.17 	taxation if it occurred in that state; and
164.18 	(6) public libraries, public library systems, multicounty, multitype library systems as 
164.19 	defined in section 134.001, county law libraries under chapter 134A, state agency libraries, 
164.20 	the state library under section 480.09, and the Legislative Reference Library.
164.21 	(b) This exemption does not apply to the sales of the following products and services:
164.22 	(1) building, construction, or reconstruction materials purchased by a contractor or a 
164.23 	subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed 
164.24 	maximum price covering both labor and materials for use in the construction, alteration, or 
164.25 	repair of a building or facility;
164.26 	(2) construction materials purchased by tax exempt entities or their contractors to be 
164.27 	used in constructing buildings or facilities which will not be used principally by the tax 
164.28 	exempt entities;
164.29 	(3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except 
164.30 	for leases entered into by the United States or its agencies or instrumentalities;
164.31 	(4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2), 
164.32 	and prepared food, candy, soft drinks, and alcoholic beverages as defined in section 297A.67, 
165.1 	subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision 
165.2 	1, paragraph (q), except for lodging, prepared food, candy, soft drinks, and alcoholic 
165.3 	beverages, and taxable cannabis products purchased directly by the United States or its 
165.4 	agencies or instrumentalities; or
165.5 	(5) goods or services purchased by a local government as inputs to a liquor store, gas 
165.6 	or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf 
165.7 	course, marina, campground, cafe, or laundromat.
165.8 	(c) As used in this subdivision, "school districts" means public school entities and districts 
165.9 	of every kind and nature organized under the laws of the state of Minnesota, and any 
165.10 	instrumentality of a school district, as defined in section 471.59.
165.11 	(d) For purposes of the exemption granted under this subdivision, "local governments" 
165.12 	has the following meaning:
165.13 	(1) for the period prior to January 1, 2017, local governments means statutory or home 
165.14 	rule charter cities, counties, and townships; and
165.15 	(2) beginning January 1, 2017, local governments means statutory or home rule charter 
165.16 	cities, counties, and townships; special districts as defined under section 6.465; any 
165.17 	instrumentality of a statutory or home rule charter city, county, or township as defined in 
165.18 	section 471.59; and any joint powers board or organization created under section 471.59.

165.19 	EFFECTIVE DATE. This section is effective for sales and purchases made after June 
165.20 	30, 2023.

165.21 	Sec. 14. Minnesota Statutes 2022, section 297A.70, subdivision 4, is amended to read:
165.22 		Subd. 4.Sales to nonprofit groups. (a) All sales, except those listed in paragraph (b), 
165.23 	to the following "nonprofit organizations" are exempt:
165.24 	(1) a corporation, society, association, foundation, or institution organized and operated 
165.25 	exclusively for charitable, religious, or educational purposes if the item purchased is used 
165.26 	in the performance of charitable, religious, or educational functions;
165.27 	(2) any senior citizen group or association of groups that:
165.28 	(i) in general limits membership to persons who are either age 55 or older, or persons 
165.29 	with a physical disability;
165.30 	(ii) is organized and operated exclusively for pleasure, recreation, and other nonprofit 
165.31 	purposes, not including housing, no part of the net earnings of which inures to the benefit 
165.32 	of any private shareholders; and
166.1 	(iii) is an exempt organization under section 501(c) of the Internal Revenue Code; and
166.2 	(3) an organization that qualifies for an exemption for memberships under subdivision 
166.3 	12 if the item is purchased and used in the performance of the organization's mission.
166.4 	For purposes of this subdivision, charitable purpose includes the maintenance of a cemetery 
166.5 	owned by a religious organization.
166.6 	(b) This exemption does not apply to the following sales:
166.7 	(1) building, construction, or reconstruction materials purchased by a contractor or a 
166.8 	subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed 
166.9 	maximum price covering both labor and materials for use in the construction, alteration, or 
166.10 	repair of a building or facility;
166.11 	(2) construction materials purchased by tax-exempt entities or their contractors to be 
166.12 	used in constructing buildings or facilities that will not be used principally by the tax-exempt 
166.13 	entities;
166.14 	(3) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2), 
166.15 	and prepared food, candy, soft drinks, taxable cannabis product as defined under section 
166.16 	295.81, subdivision 1, paragraph (q), and alcoholic beverages as defined in section 297A.67, 
166.17 	subdivision 2, except wine purchased by an established religious organization for sacramental 
166.18 	purposes or as allowed under subdivision 9a; and
166.19 	(4) leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except as 
166.20 	provided in paragraph (c).
166.21 	(c) This exemption applies to the leasing of a motor vehicle as defined in section 297B.01, 
166.22 	subdivision 11, only if the vehicle is:
166.23 	(1) a truck, as defined in section 168.002, a bus, as defined in section 168.002, or a 
166.24 	passenger automobile, as defined in section 168.002, if the automobile is designed and used 
166.25 	for carrying more than nine persons including the driver; and
166.26 	(2) intended to be used primarily to transport tangible personal property or individuals, 
166.27 	other than employees, to whom the organization provides service in performing its charitable, 
166.28 	religious, or educational purpose.
166.29 	(d) A limited liability company also qualifies for exemption under this subdivision if 
166.30 	(1) it consists of a sole member that would qualify for the exemption, and (2) the items 
166.31 	purchased qualify for the exemption.

167.1 	EFFECTIVE DATE. This section is effective for sales and purchases made after June 
167.2 	30, 2023.

167.3 	Sec. 15. Minnesota Statutes 2022, section 297A.70, subdivision 18, is amended to read:
167.4 		Subd. 18.Nursing homes and boarding care homes. (a) All sales, except those listed 
167.5 	in paragraph (b), to a nursing home licensed under section 144A.02 or a boarding care home 
167.6 	certified as a nursing facility under title 19 of the Social Security Act are exempt if the 
167.7 	facility:
167.8 	(1) is exempt from federal income taxation pursuant to section 501(c)(3) of the Internal 
167.9 	Revenue Code; and
167.10 	(2) is certified to participate in the medical assistance program under title 19 of the Social 
167.11 	Security Act, or certifies to the commissioner that it does not discharge residents due to the 
167.12 	inability to pay.
167.13 	(b) This exemption does not apply to the following sales:
167.14 	(1) building, construction, or reconstruction materials purchased by a contractor or a 
167.15 	subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed 
167.16 	maximum price covering both labor and materials for use in the construction, alteration, or 
167.17 	repair of a building or facility;
167.18 	(2) construction materials purchased by tax-exempt entities or their contractors to be 
167.19 	used in constructing buildings or facilities that will not be used principally by the tax-exempt 
167.20 	entities;
167.21 	(3) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2), 
167.22 	and prepared food, candy, soft drinks, and alcoholic beverages as defined in section 297A.67, 
167.23 	subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision 
167.24 	1, paragraph (q); and
167.25 	(4) leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except as 
167.26 	provided in paragraph (c).
167.27 	(c) This exemption applies to the leasing of a motor vehicle as defined in section 297B.01, 
167.28 	subdivision 11, only if the vehicle is:
167.29 	(1) a truck, as defined in section 168.002; a bus, as defined in section 168.002; or a 
167.30 	passenger automobile, as defined in section 168.002, if the automobile is designed and used 
167.31 	for carrying more than nine persons including the driver; and
168.1 	(2) intended to be used primarily to transport tangible personal property or residents of 
168.2 	the nursing home or boarding care home.

168.3 	EFFECTIVE DATE. This section is effective for sales and purchases made after June 
168.4 	30, 2023.

168.5 	Sec. 16. Minnesota Statutes 2022, section 297A.85, is amended to read:
168.6 	297A.85 CANCELLATION OF PERMITS.
168.7 	The commissioner may cancel a permit if one of the following conditions occurs:
168.8 	(1) the permit holder has not filed a sales or use tax return for at least one year;
168.9 	(2) the permit holder has not reported any sales or use tax liability on the permit holder's 
168.10 	returns for at least two years;
168.11 	(3) the permit holder requests cancellation of the permit;
168.12 	(4) the permit is subject to cancellation under section 270C.722, subdivision 2, paragraph 
168.13 	(a); or
168.14 	(5) the permit is subject to cancellation under section 297A.84.; or
168.15 	(6) the permit holder is a taxable cannabis product retailer as defined in section 295.81, 
168.16 	subdivision 1, paragraph (r), other than a lower-potency hemp edible retailer as licensed 
168.17 	under section 342.43, subdivision 1, and its license to sell a taxable cannabis product as 
168.18 	defined in section 295.81, subdivision 1, paragraph (q), has been revoked by the Office of 
168.19 	Cannabis Management.

168.20 	EFFECTIVE DATE. This section is effective June 30, 2023.

168.21 	Sec. 17. Minnesota Statutes 2022, section 297D.01, is amended to read:
168.22 	297D.01 DEFINITIONS.
168.23 		Subdivision 1.Marijuana Illegal cannabis. "Marijuana" "Illegal cannabis" means any 
168.24 	marijuana taxable cannabis product as defined in section 295.81, subdivision 1, paragraph 
168.25 	(q), whether real or counterfeit, as defined in section 152.01, subdivision 9, that is held, 
168.26 	possessed, transported, transferred, sold, or offered to be sold in violation of chapter 342 
168.27 	or Minnesota criminal laws.
168.28 		Subd. 2.Controlled substance. "Controlled substance" means any drug or substance, 
168.29 	whether real or counterfeit, as defined in section 152.01, subdivision 4, that is held, possessed, 
169.1 	transported, transferred, sold, or offered to be sold in violation of Minnesota laws. "Controlled 
169.2 	substance" does not include marijuana illegal cannabis.
169.3 		Subd. 3.Tax obligor or obligor. "Tax obligor" or "obligor" means a person who in 
169.4 	violation of Minnesota law manufactures, produces, ships, transports, or imports into 
169.5 	Minnesota or in any manner acquires or possesses more than 42-1/2 grams of marijuana
169.6 	illegal cannabis, or seven or more grams of any controlled substance, or ten or more dosage 
169.7 	units of any controlled substance which is not sold by weight. A quantity of marijuana illegal 
169.8 	cannabis or other controlled substance is measured by the weight of the substance whether 
169.9 	pure or impure or dilute, or by dosage units when the substance is not sold by weight, in 
169.10 	the tax obligor's possession. A quantity of a controlled substance is dilute if it consists of a 
169.11 	detectable quantity of pure controlled substance and any excipients or fillers.
169.12 		Subd. 4.Commissioner. "Commissioner" means the commissioner of revenue.

169.13 	EFFECTIVE DATE. This section is effective June 30, 2023.

169.14 	Sec. 18. Minnesota Statutes 2022, section 297D.04, is amended to read:
169.15 	297D.04 TAX PAYMENT REQUIRED FOR POSSESSION.
169.16 	No tax obligor may possess any marijuana illegal cannabis or controlled substance upon 
169.17 	which a tax is imposed by section 297D.08 unless the tax has been paid on the marijuana
169.18 	illegal cannabis or other a controlled substance as evidenced by a stamp or other official 
169.19 	indicia.

169.20 	EFFECTIVE DATE. This section is effective June 30, 2023.

169.21 	Sec. 19. Minnesota Statutes 2022, section 297D.06, is amended to read:
169.22 	297D.06 PHARMACEUTICALS.
169.23 	Nothing in this chapter requires persons registered under chapter 151 or otherwise 
169.24 	lawfully in possession of marijuana illegal cannabis or a controlled substance to pay the tax 
169.25 	required under this chapter.

169.26 	EFFECTIVE DATE. This section is effective June 30, 2023.

169.27 	Sec. 20. Minnesota Statutes 2022, section 297D.07, is amended to read:
169.28 	297D.07 MEASUREMENT.
169.29 	For the purpose of calculating the tax under section 297D.08, a quantity of marijuana
169.30 	illegal cannabis or other a controlled substance is measured by the weight of the substance 
170.1 	whether pure or impure or dilute, or by dosage units when the substance is not sold by 
170.2 	weight, in the tax obligor's possession. A quantity of a controlled substance is dilute if it 
170.3 	consists of a detectable quantity of pure controlled substance and any excipients or fillers.

170.4 	EFFECTIVE DATE. This section is effective June 30, 2023.

170.5 	Sec. 21. Minnesota Statutes 2022, section 297D.08, is amended to read:
170.6 	297D.08 TAX RATE.
170.7 	A tax is imposed on marijuana illegal cannabis and controlled substances as defined in 
170.8 	section 297D.01 at the following rates:
170.9 	(1) on each gram of marijuana illegal cannabis, or each portion of a gram, $3.50; and
170.10 	(2) on each gram of controlled substance, or portion of a gram, $200; or
170.11 	(3) on each ten dosage units of a controlled substance that is not sold by weight, or 
170.12 	portion thereof, $400.

170.13 	EFFECTIVE DATE. This section is effective June 30, 2023.

170.14 	Sec. 22. Minnesota Statutes 2022, section 297D.085, is amended to read:
170.15 	297D.085 CREDIT FOR PREVIOUSLY PAID TAXES.
170.16 	If another state or local unit of government has previously assessed an excise tax on the 
170.17 	marijuana illegal cannabis or controlled substances, the taxpayer must pay the difference 
170.18 	between the tax due under section 297D.08 and the tax previously paid. If the tax previously 
170.19 	paid to the other state or local unit of government was equal to or greater than the tax due 
170.20 	under section 297D.08, no tax is due. The burden is on the taxpayer to show that an excise 
170.21 	tax on the marijuana illegal cannabis or controlled substances has been paid to another state 
170.22 	or local unit of government.

170.23 	EFFECTIVE DATE. This section is effective June 30, 2023.

170.24 	Sec. 23. Minnesota Statutes 2022, section 297D.09, subdivision 1a, is amended to read:
170.25 		Subd. 1a.Criminal penalty; sale without affixed stamps. In addition to the tax penalty 
170.26 	imposed, a tax obligor distributing or possessing marijuana illegal cannabis or controlled 
170.27 	substances without affixing the appropriate stamps, labels, or other indicia is guilty of a 
170.28 	crime and, upon conviction, may be sentenced to imprisonment for not more than seven 
170.29 	years or to payment of a fine of not more than $14,000, or both.

170.30 	EFFECTIVE DATE. This section is effective June 30, 2023.

171.1 	Sec. 24. Minnesota Statutes 2022, section 297D.10, is amended to read:
171.2 	297D.10 STAMP PRICE.
171.3 	Official stamps, labels, or other indicia to be affixed to all marijuana illegal cannabis or 
171.4 	controlled substances shall be purchased from the commissioner. The purchaser shall pay 
171.5 	100 percent of face value for each stamp, label, or other indicia at the time of the purchase.

171.6 	EFFECTIVE DATE. This section is effective June 30, 2023.

171.7 	Sec. 25. Minnesota Statutes 2022, section 297D.11, is amended to read:
171.8 	297D.11 PAYMENT DUE.
171.9 		Subdivision 1.Stamps affixed. When a tax obligor purchases, acquires, transports, or 
171.10 	imports into this state marijuana illegal cannabis or controlled substances on which a tax is 
171.11 	imposed by section 297D.08, and if the indicia evidencing the payment of the tax have not 
171.12 	already been affixed, the tax obligor shall have them permanently affixed on the marijuana
171.13 	illegal cannabis or controlled substance immediately after receiving the substance. Each 
171.14 	stamp or other official indicia may be used only once.
171.15 		Subd. 2.Payable on possession. Taxes imposed upon marijuana illegal cannabis or 
171.16 	controlled substances by this chapter are due and payable immediately upon acquisition or 
171.17 	possession in this state by a tax obligor.

171.18 	EFFECTIVE DATE. This section is effective June 30, 2023.

171.19 	Sec. 26. [477A.31] LOCAL GOVERNMENT CANNABIS AID.
171.20 		Subdivision 1.Certification to commissioner of revenue. (a) By July 15, 2024, and 
171.21 	annually thereafter, the commissioner of management and budget must certify to the 
171.22 	commissioner of revenue the balance of the local government cannabis aid account in the 
171.23 	special revenue fund at the close of the previous fiscal year.
171.24 	(b) By June 1, 2024, and annually thereafter, the director of the office of cannabis 
171.25 	management under section 342.02 must certify to the commissioner of revenue the number 
171.26 	of cannabis businesses, as defined under section 342.01, subdivision 13, licensed under 
171.27 	chapter 342 as of the previous January 1, disaggregated by county and city.
171.28 		Subd. 2.Aid to counties. (a) Beginning for aid payable in 2024, the amount available 
171.29 	for aid to counties under this subdivision equals 50 percent of the amount certified in that 
171.30 	year to the commissioner under subdivision 1, paragraph (a).
172.1 	(b) Twenty percent of the amount under paragraph (a) must be distributed equally among 
172.2 	all counties.
172.3 	(c) Eighty percent of the amount under paragraph (a) must be distributed proportionally 
172.4 	to each county according to the number of cannabis businesses located in the county as 
172.5 	compared to the number of cannabis businesses in all counties as of the most recent 
172.6 	certification under subdivision 1, paragraph (b).
172.7 		Subd. 3.Aid to cities. (a) Beginning for aid payable in 2024, the amount available for 
172.8 	aid to cities under this subdivision equals 50 percent of the amount certified in that year to 
172.9 	the commissioner under subdivision 1, paragraph (a).
172.10 	(b) The amount under paragraph (a) must be distributed proportionally to each city 
172.11 	according to the number of cannabis businesses located in the city as compared to the number 
172.12 	of cannabis businesses in all cities as of the most recent certification under subdivision 1, 
172.13 	paragraph (b).
172.14 		Subd. 4.Payment. The commissioner of revenue must compute the amount of aid 
172.15 	payable to each county and city under this section. On or before August 1 of each year, the 
172.16 	commissioner must certify the amount to be paid to each county and city in that year. The 
172.17 	commissioner must pay the full amount of the aid on December 26 annually.
172.18 		Subd. 5.Appropriation. Beginning in fiscal year 2025 and annually thereafter, the 
172.19 	amount in the local government cannabis aid account in the special revenue fund is annually 
172.20 	appropriated to the commissioner of revenue to make the aid payments required under this 
172.21 	section.

172.22 	EFFECTIVE DATE. This section is effective July 1, 2023.

172.23 	ARTICLE 3
172.24 	BUSINESS DEVELOPMENT

172.25 	Section 1. [116J.659] CANNABIS INDUSTRY STARTUP FINANCING GRANTS.
172.26 		Subdivision 1.Establishment. The commissioner of employment and economic 
172.27 	development shall establish CanStartup, a program to award grants to nonprofit corporations 
172.28 	to fund loans to new businesses in the legal cannabis industry and to support job creation 
172.29 	in communities where long-term residents are eligible to be social equity applicants.
172.30 		Subd. 2.Definitions. (a) For the purposes of this section, the following terms have the 
172.31 	meanings given.
172.32 	(b) "Commissioner" means the commissioner of employment and economic development.
173.1 	(c) "Industry" means the legal cannabis industry in the state of Minnesota.
173.2 	(d) "New business" means a legal cannabis business that has been in existence for three 
173.3 	years or less.
173.4 	(e) "Program" means the CanStartup grant program.
173.5 	(f) "Social equity applicant" means a person who meets the qualification requirements 
173.6 	in section 342.15.
173.7 		Subd. 3.Grants. (a) The commissioner shall establish a revolving loan account to make 
173.8 	grants under the CanStartup program.
173.9 	(b) The commissioner must award grants to nonprofit corporations through a competitive 
173.10 	grant process.
173.11 	(c) To receive grant money, a nonprofit corporation must submit a written application 
173.12 	to the commissioner using a form developed by the commissioner.
173.13 	(d) In awarding grants under this subdivision, the commissioner shall give weight to 
173.14 	whether the nonprofit corporation:
173.15 	(1) has a board of directors that includes citizens experienced in business and community 
173.16 	development, new business enterprises, and creating jobs for people facing barriers to 
173.17 	education or employment;
173.18 	(2) has the technical skills to analyze projects;
173.19 	(3) is familiar with other available public and private funding sources and economic 
173.20 	development programs;
173.21 	(4) can initiate and implement economic development projects;
173.22 	(5) can establish and administer a revolving loan account;
173.23 	(6) can work with job referral networks that assist people facing barriers to education 
173.24 	or employment; and
173.25 	(7) has established relationships with communities where long-term residents are eligible 
173.26 	to be social equity applicants.
173.27 	The commissioner shall make grants that will assist a broad range of businesses in the legal 
173.28 	cannabis industry, including the processing and retail sectors.
173.29 	(e) A nonprofit corporation that receives a grant under the program must:
174.1 	(1) establish a commissioner-certified revolving loan account for the purpose of making 
174.2 	eligible loans; and
174.3 	(2) enter into an agreement with the commissioner that the commissioner shall fund 
174.4 	loans that the nonprofit corporation makes to new businesses in the legal cannabis industry. 
174.5 	The commissioner shall review existing agreements with nonprofit corporations every five 
174.6 	years and may renew or terminate an agreement based on that review. In making this review, 
174.7 	the commissioner shall consider, among other criteria, the criteria in paragraph (d).
174.8 		Subd. 4.Loans to businesses. (a) The criteria in this subdivision apply to loans made 
174.9 	by nonprofit corporations under the program.
174.10 	(b) Loans must be used to support a new business in the legal cannabis industry. Priority 
174.11 	must be given to loans to businesses owned by individuals who are eligible to be social 
174.12 	equity applicants and businesses located in communities where long-term residents are 
174.13 	eligible to be social equity applicants.
174.14 	(c) Loans must be made to businesses that are not likely to undertake the project for 
174.15 	which loans are sought without assistance from the program.
174.16 	(d) The minimum state contribution to a loan is $2,500 and the maximum is either:
174.17 	(1) $50,000; or
174.18 	(2) $150,000, if state contributions are matched by an equal or greater amount of new 
174.19 	private investment.
174.20 	(e) Loan applications given preliminary approval by the nonprofit corporation must be 
174.21 	forwarded to the commissioner for approval. The commissioner must give final approval 
174.22 	for each loan made by the nonprofit corporation under the program.
174.23 	(f) A business that receives a loan may apply to renew the loan. Renewal applications 
174.24 	must be made on an annual basis and a business may receive loans for up to six consecutive 
174.25 	years. A nonprofit corporation may renew a loan to a business that is no longer a new 
174.26 	business provided the business would otherwise qualify for an initial loan and is in good 
174.27 	standing with the nonprofit corporation and the commissioner. A nonprofit corporation may 
174.28 	adjust the amount of a renewed loan, or not renew a loan, if the nonprofit corporation 
174.29 	determines that the business is financially stable and is substantially likely to continue the 
174.30 	project for which the loan renewal is sought.
174.31 	(g) If a borrower has met lender criteria, including being current with all payments for 
174.32 	a minimum of three years, the commissioner may approve either full or partial forgiveness 
174.33 	of interest or principal amounts.
175.1 		Subd. 5.Revolving loan account administration. (a) The commissioner shall establish 
175.2 	a minimum interest rate for loans or guarantees to ensure that necessary loan administration 
175.3 	costs are covered. The interest rate charged by a nonprofit corporation for a loan under this 
175.4 	section must not exceed the Wall Street Journal prime rate. For a loan under this section, 
175.5 	the nonprofit corporation may charge a loan origination fee equal to or less than one percent 
175.6 	of the loan value. The nonprofit corporation may retain the amount of the origination fee.
175.7 	(b) Loan repayment of principal must be paid to the commissioner for deposit in the 
175.8 	revolving loan account. Loan interest payments must be deposited in a revolving loan 
175.9 	account created by the nonprofit corporation originating the loan being repaid for further 
175.10 	distribution or use, consistent with the criteria of this section.
175.11 	(c) Administrative expenses of the nonprofit corporations with whom the commissioner 
175.12 	enters into agreements, including expenses incurred by a nonprofit corporation in providing 
175.13 	financial, technical, managerial, and marketing assistance to a business receiving a loan 
175.14 	under this section, are eligible program expenses the commissioner may agree to pay under 
175.15 	the grant agreement.
175.16 		Subd. 6.Program outreach. The commissioner shall make extensive efforts to publicize 
175.17 	this program, including through partnerships with community organizations, particularly 
175.18 	those organizations located in areas where long-term residents are eligible to be social equity 
175.19 	applicants.
175.20 		Subd. 7.Reporting requirements. (a) A nonprofit corporation that receives a grant 
175.21 	shall:
175.22 	(1) submit an annual report to the commissioner by February 1 of each year that the 
175.23 	nonprofit corporation participates in the program that includes a description of businesses 
175.24 	supported by the grant program, an account of loans made during the calendar year, the 
175.25 	program's impact on business creation and job creation, particularly in communities where 
175.26 	long-term residents are eligible to be social equity applicants, the source and amount of 
175.27 	money collected and distributed by the program, the program's assets and liabilities, and an 
175.28 	explanation of administrative expenses; and
175.29 	(2) provide for an independent annual audit to be performed in accordance with generally 
175.30 	accepted accounting practices and auditing standards and submit a copy of each annual 
175.31 	audit report to the commissioner.
175.32 	(b) By March 1, 2024, and each March 1 thereafter, the commissioner must submit a 
175.33 	report to the chairs and ranking minority members of the committees of the house of 
175.34 	representatives and the senate having jurisdiction over economic development that details 
176.1 	awards given through the CanStartup program and the use of grant money, including any 
176.2 	measures of success toward financing new businesses in the legal cannabis industry and 
176.3 	creating jobs in communities where long-term residents are eligible to be social equity 
176.4 	applicants.

176.5 	Sec. 2. [116J.6595] CANNABIS INDUSTRY NAVIGATION GRANTS.
176.6 		Subdivision 1.Establishment. The commissioner of employment and economic 
176.7 	development shall establish CanNavigate, a program to award grants to eligible organizations 
176.8 	to help individuals navigate the regulatory structure of the legal cannabis industry.
176.9 		Subd. 2.Definitions. (a) For the purposes of this section, the following terms have the 
176.10 	meanings given.
176.11 	(b) "Commissioner" means the commissioner of employment and economic development.
176.12 	(c) "Eligible organization" means any organization capable of helping individuals navigate 
176.13 	the regulatory structure of the legal cannabis industry, particularly individuals facing barriers 
176.14 	to education or employment, and may include educational institutions, nonprofit 
176.15 	organizations, private businesses, community groups, units of local government, or 
176.16 	partnerships between different types of organizations.
176.17 	(d) "Industry" means the legal cannabis industry in the state of Minnesota.
176.18 	(e) "Program" means the CanNavigate grant program.
176.19 	(f) "Social equity applicant" means a person who meets the qualification requirements 
176.20 	in section 342.15.
176.21 		Subd. 3.Grants to organizations. (a) Grant money awarded to eligible organizations 
176.22 	may be used for both developing technical assistance resources relevant to the regulatory 
176.23 	structure of the legal cannabis industry and for providing technical assistance or navigation 
176.24 	services to individuals.
176.25 	(b) The commissioner must award grants to eligible organizations through a competitive 
176.26 	grant process.
176.27 	(c) To receive grant money, an eligible organization must submit a written application 
176.28 	to the commissioner, using a form developed by the commissioner, explaining the 
176.29 	organization's ability to assist individuals in navigating the regulatory structure of the legal 
176.30 	cannabis industry, particularly individuals facing barriers to education or employment.
176.31 	(d) An eligible organization's grant application must also include:
177.1 	(1) a description of the proposed technical assistance or navigation services, including 
177.2 	the types of individuals targeted for assistance;
177.3 	(2) any evidence of the organization's past success in providing technical assistance or 
177.4 	navigation services to individuals, particularly individuals who live in areas where long-term 
177.5 	residents are eligible to be social equity applicants;
177.6 	(3) an estimate of the cost of providing the technical assistance;
177.7 	(4) the sources and amounts of any nonstate money or in-kind contributions that will 
177.8 	supplement grant money, including any amounts that individuals will be charged to receive 
177.9 	assistance; and
177.10 	(5) any additional information requested by the commissioner.
177.11 	(e) In awarding grants under this subdivision, the commissioner shall give weight to 
177.12 	applications from organizations that demonstrate a history of successful technical assistance 
177.13 	or navigation services, particularly for individuals facing barriers to education or employment. 
177.14 	The commissioner shall also give weight to applications where the proposed technical 
177.15 	assistance will serve areas where long-term residents are eligible to be social equity 
177.16 	applicants. To the extent practicable, the commissioner shall fund technical assistance for 
177.17 	a variety of sectors in the legal cannabis industry, including both processing and retail 
177.18 	sectors.
177.19 		Subd. 4.Program outreach. The commissioner shall make extensive efforts to publicize 
177.20 	these grants, including through partnerships with community organizations, particularly 
177.21 	those organizations located in areas where long-term residents are eligible to be social equity 
177.22 	applicants.
177.23 		Subd. 5.Reports to the legislature. By January 15, 2024, and each January 15 thereafter, 
177.24 	the commissioner must submit a report to the chairs and ranking minority members of the 
177.25 	committees of the house of representatives and the senate having jurisdiction over economic 
177.26 	development that details awards given through the CanNavigate program and the use of 
177.27 	grant money, including any measures of success toward helping individuals navigate the 
177.28 	regulatory structure of the legal cannabis industry.

177.29 	Sec. 3. [116L.90] CANNABIS INDUSTRY TRAINING GRANTS.
177.30 		Subdivision 1.Establishment. The commissioner of employment and economic 
177.31 	development shall establish CanTrain, a program to award grants to (1) eligible organizations 
177.32 	to train people for work in the legal cannabis industry, and (2) eligible individuals to acquire 
177.33 	such training.
178.1 		Subd. 2.Definitions. (a) For the purposes of this section, the following terms have the 
178.2 	meanings given.
178.3 	(b) "Commissioner" means the commissioner of employment and economic development.
178.4 	(c) "Eligible organization" means any organization capable of providing training relevant 
178.5 	to the legal cannabis industry, particularly for individuals facing barriers to education or 
178.6 	employment, and may include educational institutions, nonprofit organizations, private 
178.7 	businesses, community groups, units of local government, or partnerships between different 
178.8 	types of organizations.
178.9 	(d) "Eligible individual" means a Minnesota resident who is 21 years old or older.
178.10 	(e) "Industry" means the legal cannabis industry in Minnesota.
178.11 	(f) "Program" means the CanTrain grant program.
178.12 	(g) "Social equity applicant" means a person who meets the qualification requirements 
178.13 	in section 342.15.
178.14 		Subd. 3.Grants to organizations. (a) Grant money awarded to eligible organizations 
178.15 	may be used for both developing a training program relevant to the legal cannabis industry 
178.16 	and for providing such training to individuals.
178.17 	(b) The commissioner must award grants to eligible organizations through a competitive 
178.18 	grant process.
178.19 	(c) To receive grant money, an eligible organization must submit a written application 
178.20 	to the commissioner, using a form developed by the commissioner, explaining the 
178.21 	organization's ability to train individuals for successful careers in the legal cannabis industry, 
178.22 	particularly individuals facing barriers to education or employment.
178.23 	(d) An eligible organization's grant application must also include:
178.24 	(1) a description of the proposed training;
178.25 	(2) an analysis of the degree of demand in the legal cannabis industry for the skills gained 
178.26 	through the proposed training;
178.27 	(3) any evidence of the organization's past success in training individuals for successful 
178.28 	careers, particularly in new or emerging industries;
178.29 	(4) an estimate of the cost of providing the proposed training;
179.1 	(5) the sources and amounts of any nonstate funds or in-kind contributions that will 
179.2 	supplement grant money, including any amounts that individuals will be charged to 
179.3 	participate in the training; and
179.4 	(6) any additional information requested by the commissioner.
179.5 	(e) In awarding grants under this subdivision, the commissioner shall give weight to 
179.6 	applications from organizations that demonstrate a history of successful career training, 
179.7 	particularly for individuals facing barriers to education or employment. The commissioner 
179.8 	shall also give weight to applications where the proposed training will:
179.9 	(1) result in an industry-relevant credential; or
179.10 	(2) include opportunities for hands-on or on-site experience in the industry.
179.11 	The commissioner shall fund training for a broad range of careers in the legal cannabis 
179.12 	industry, including both potential business owners and employees and for work in the 
179.13 	growing, processing, and retail sectors of the legal cannabis industry.
179.14 		Subd. 4.Grants to individuals. (a) The commissioner shall award grants of $....... to 
179.15 	eligible individuals to pursue a training program relevant to a career in the legal cannabis 
179.16 	industry.
179.17 	(b) To receive grant money, an eligible individual must submit a written application to 
179.18 	the commissioner, using a form developed by the commissioner, identifying a training 
179.19 	program relevant to the legal cannabis industry and the estimated cost of completing that 
179.20 	training. The application must also indicate whether:
179.21 	(1) the applicant is eligible to be a social equity applicant;
179.22 	(2) the proposed training program results in an industry-relevant credential; and
179.23 	(3) the proposed training program includes opportunities for hands-on or on-site 
179.24 	experience in the industry.
179.25 	The commissioner shall attempt to make the application process simple for individuals to 
179.26 	complete, such as by publishing lists of industry-relevant training programs along with the 
179.27 	training program's estimated cost of completing the training programs and whether the 
179.28 	training programs will result in an industry-relevant credential or include opportunities for 
179.29 	hands-on or on-site experience in the legal cannabis industry.
179.30 	(c) The commissioner must award grants to eligible individuals through a lottery process. 
179.31 	Applicants who have filed complete applications by the deadline set by the commissioner 
179.32 	shall receive one entry in the lottery, plus one additional entry for each of the following:
180.1 	(1) being eligible to be a social equity applicant;
180.2 	(2) seeking to enroll in a training program that results in an industry-relevant credential; 
180.3 	and
180.4 	(3) seeking to enroll in a training program that includes opportunities for hands-on or 
180.5 	on-site experience in the industry.
180.6 	(d) Grant money awarded to eligible individuals shall be used to pay the costs of enrolling 
180.7 	in a training program relevant to the legal cannabis industry, including tuition, fees, and 
180.8 	materials costs. Grant money may also be used to remove external barriers to attending such 
180.9 	a training program, such as the cost of child care, transportation, or other expenses approved 
180.10 	by the commissioner.
180.11 		Subd. 5.Program outreach. The commissioner shall make extensive efforts to publicize 
180.12 	these grants, including through partnerships with community organizations, particularly 
180.13 	those organizations located in areas where long-term residents are eligible to be social equity 
180.14 	applicants.
180.15 		Subd. 6.Reports to the legislature. By January 15, 2024, and each January 15 thereafter, 
180.16 	the commissioner must submit a report to the chairs and ranking minority members of the 
180.17 	committees of the house of representatives and the senate having jurisdiction over workforce 
180.18 	development that describes awards given through the CanTrain program and the use of 
180.19 	grant money, including any measures of success toward training people for successful 
180.20 	careers in the legal cannabis industry.

180.21 	ARTICLE 4
180.22 	CRIMINAL PENALTIES

180.23 	Section 1. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision 
180.24 	to read:
180.25 		Subd. 25.Cannabis product. "Cannabis product" has the meaning given in section 
180.26 	342.01, subdivision 19.

180.27 	Sec. 2. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to 
180.28 	read:
180.29 		Subd. 26.Cannabis concentrate. "Cannabis concentrate" has the meaning given in 
180.30 	section 342.01, subdivision 14.

181.1 	Sec. 3. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to 
181.2 	read:
181.3 		Subd. 27.Cannabis flower. "Cannabis flower" has the meaning given in section 342.01, 
181.4 	subdivision 15.

181.5 	Sec. 4. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to 
181.6 	read:
181.7 		Subd. 28.Edible cannabis product. "Edible cannabis product" has the meaning given 
181.8 	in section 342.01, subdivision 29.

181.9 	Sec. 5. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to 
181.10 	read:
181.11 		Subd. 29.Cannabis plant. "Cannabis plant" has the meaning given in section 342.01, 
181.12 	subdivision 18.

181.13 	Sec. 6. Minnesota Statutes 2022, section 152.01, is amended by adding a subdivision to 
181.14 	read:
181.15 		Subd. 30.Synthetically derived cannabinoid. "Synthetically derived cannabinoid" has 
181.16 	the meaning given in section 342.01, subdivision 67.

181.17 	Sec. 7. Minnesota Statutes 2022, section 152.021, subdivision 2, is amended to read:
181.18 		Subd. 2.Possession crimes. (a) A person is guilty of a controlled substance crime in 
181.19 	the first degree if:
181.20 	(1) the person unlawfully possesses one or more mixtures of a total weight of 50 grams 
181.21 	or more containing cocaine or methamphetamine;
181.22 	(2) the person unlawfully possesses one or more mixtures of a total weight of 25 grams 
181.23 	or more containing cocaine or methamphetamine and:
181.24 	(i) the person or an accomplice possesses on their person or within immediate reach, or 
181.25 	uses, whether by brandishing, displaying, threatening with, or otherwise employing, a 
181.26 	firearm; or
181.27 	(ii) the offense involves two aggravating factors;
181.28 	(3) the person unlawfully possesses one or more mixtures of a total weight of 25 grams 
181.29 	or more containing heroin;
182.1 	(4) the person unlawfully possesses one or more mixtures of a total weight of 500 grams 
182.2 	or more containing a narcotic drug other than cocaine, heroin, or methamphetamine;
182.3 	(5) the person unlawfully possesses one or more mixtures of a total weight of 500 grams 
182.4 	or more containing amphetamine, phencyclidine, or hallucinogen or, if the controlled 
182.5 	substance is packaged in dosage units, equaling 500 or more dosage units; or
182.6 	(6) the person unlawfully possesses one or more mixtures of a total weight of 50 
182.7 	kilograms or more containing marijuana or Tetrahydrocannabinols, or possesses 500 or 
182.8 	more marijuana plants.
182.9 	(b) For the purposes of this subdivision, the weight of fluid used in a water pipe may 
182.10 	not be considered in measuring the weight of a mixture except in cases where the mixture 
182.11 	contains four or more fluid ounces of fluid.

182.12 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
182.13 	committed on or after that date.

182.14 	Sec. 8. Minnesota Statutes 2022, section 152.022, subdivision 1, is amended to read:
182.15 		Subdivision 1.Sale crimes. A person is guilty of controlled substance crime in the 
182.16 	second degree if:
182.17 	(1) on one or more occasions within a 90-day period the person unlawfully sells one or 
182.18 	more mixtures of a total weight of ten grams or more containing a narcotic drug other than 
182.19 	heroin;
182.20 	(2) on one or more occasions within a 90-day period the person unlawfully sells one or 
182.21 	more mixtures of a total weight of three grams or more containing cocaine or 
182.22 	methamphetamine and:
182.23 	(i) the person or an accomplice possesses on their person or within immediate reach, or 
182.24 	uses, whether by brandishing, displaying, threatening with, or otherwise employing, a 
182.25 	firearm; or
182.26 	(ii) the offense involves three aggravating factors;
182.27 	(3) on one or more occasions within a 90-day period the person unlawfully sells one or 
182.28 	more mixtures of a total weight of three grams or more containing heroin;
182.29 	(4) on one or more occasions within a 90-day period the person unlawfully sells one or 
182.30 	more mixtures of a total weight of ten grams or more containing amphetamine, phencyclidine, 
182.31 	or hallucinogen or, if the controlled substance is packaged in dosage units, equaling 50 or 
182.32 	more dosage units;
183.1 	(5) on one or more occasions within a 90-day period the person unlawfully sells one or 
183.2 	more mixtures of a total weight of ten kilograms or more containing marijuana or 
183.3 	Tetrahydrocannabinols;
183.4 	(6) (5) the person unlawfully sells any amount of a Schedule I or II narcotic drug to a 
183.5 	person under the age of 18, or conspires with or employs a person under the age of 18 to 
183.6 	unlawfully sell the substance; or
183.7 	(7) (6) the person unlawfully sells any of the following in a school zone, a park zone, a 
183.8 	public housing zone, or a drug treatment facility:
183.9 	(i) any amount of a Schedule I or II narcotic drug, lysergic acid diethylamide (LSD), 
183.10 	3,4-methylenedioxy amphetamine, or 3,4-methylenedioxymethamphetamine; or
183.11 	(ii) one or more mixtures containing methamphetamine or amphetamine; or.
183.12 	(iii) one or more mixtures of a total weight of five kilograms or more containing marijuana 
183.13 	or Tetrahydrocannabinols.

183.14 	EFFECTIVE DATE. This section is effective January 1, 2024, and applies to crimes 
183.15 	committed on or after that date.

183.16 	Sec. 9. Minnesota Statutes 2022, section 152.022, subdivision 2, is amended to read:
183.17 		Subd. 2.Possession crimes. (a) A person is guilty of controlled substance crime in the 
183.18 	second degree if:
183.19 	(1) the person unlawfully possesses one or more mixtures of a total weight of 25 grams 
183.20 	or more containing cocaine or methamphetamine;
183.21 	(2) the person unlawfully possesses one or more mixtures of a total weight of ten grams 
183.22 	or more containing cocaine or methamphetamine and:
183.23 	(i) the person or an accomplice possesses on their person or within immediate reach, or 
183.24 	uses, whether by brandishing, displaying, threatening with, or otherwise employing, a 
183.25 	firearm; or
183.26 	(ii) the offense involves three aggravating factors;
183.27 	(3) the person unlawfully possesses one or more mixtures of a total weight of six grams 
183.28 	or more containing heroin;
183.29 	(4) the person unlawfully possesses one or more mixtures of a total weight of 50 grams 
183.30 	or more containing a narcotic drug other than cocaine, heroin, or methamphetamine;
184.1 	(5) the person unlawfully possesses one or more mixtures of a total weight of 50 grams 
184.2 	or more containing amphetamine, phencyclidine, or hallucinogen or, if the controlled 
184.3 	substance is packaged in dosage units, equaling 100 or more dosage units; or
184.4 	(6) the person unlawfully possesses one or more mixtures of a total weight of 25 
184.5 	kilograms or more containing marijuana or Tetrahydrocannabinols, or possesses 100 or 
184.6 	more marijuana plants.
184.7 	(b) For the purposes of this subdivision, the weight of fluid used in a water pipe may 
184.8 	not be considered in measuring the weight of a mixture except in cases where the mixture 
184.9 	contains four or more fluid ounces of fluid.

184.10 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
184.11 	committed on or after that date.

184.12 	Sec. 10. Minnesota Statutes 2022, section 152.023, subdivision 1, is amended to read:
184.13 		Subdivision 1.Sale crimes. A person is guilty of controlled substance crime in the third 
184.14 	degree if:
184.15 	(1) the person unlawfully sells one or more mixtures containing a narcotic drug;
184.16 	(2) on one or more occasions within a 90-day period the person unlawfully sells one or 
184.17 	more mixtures containing phencyclidine or hallucinogen, it is packaged in dosage units, 
184.18 	and equals ten or more dosage units;
184.19 	(3) the person unlawfully sells one or more mixtures containing a controlled substance 
184.20 	classified in Schedule I, II, or III, except a Schedule I or II narcotic drug, cannabis flower, 
184.21 	or cannabis products to a person under the age of 18; or
184.22 	(4) the person conspires with or employs a person under the age of 18 to unlawfully sell 
184.23 	one or more mixtures containing a controlled substance listed in Schedule I, II, or III, except 
184.24 	a Schedule I or II narcotic drug; or, cannabis flower, or cannabis products.
184.25 	(5) on one or more occasions within a 90-day period the person unlawfully sells one or 
184.26 	more mixtures of a total weight of five kilograms or more containing marijuana or 
184.27 	Tetrahydrocannabinols.

184.28 	EFFECTIVE DATE. This section is effective January 1, 2024, and applies to crimes 
184.29 	committed on or after that date.

185.1 	Sec. 11. Minnesota Statutes 2022, section 152.023, subdivision 2, is amended to read:
185.2 		Subd. 2.Possession crimes. (a) A person is guilty of controlled substance crime in the 
185.3 	third degree if:
185.4 	(1) on one or more occasions within a 90-day period the person unlawfully possesses 
185.5 	one or more mixtures of a total weight of ten grams or more containing a narcotic drug other 
185.6 	than heroin;
185.7 	(2) on one or more occasions within a 90-day period the person unlawfully possesses 
185.8 	one or more mixtures of a total weight of three grams or more containing heroin;
185.9 	(3) on one or more occasions within a 90-day period the person unlawfully possesses 
185.10 	one or more mixtures containing a narcotic drug, it is packaged in dosage units, and equals 
185.11 	50 or more dosage units;
185.12 	(4) on one or more occasions within a 90-day period the person unlawfully possesses 
185.13 	any amount of a schedule I or II narcotic drug or five or more dosage units of lysergic acid 
185.14 	diethylamide (LSD), 3,4-methylenedioxy amphetamine, or 
185.15 	3,4-methylenedioxymethamphetamine in a school zone, a park zone, a public housing zone, 
185.16 	or a drug treatment facility;
185.17 	(5) on one or more occasions within a 90-day period the person unlawfully possesses 
185.18 	one or more mixtures of a total weight of ten kilograms or more containing marijuana or 
185.19 	Tetrahydrocannabinols:
185.20 	(i) more than ten kilograms of cannabis flower;
185.21 	(ii) more than two kilograms of cannabis concentrate; or
185.22 	(iii) edible cannabis products infused with more than 200 grams of tetrahydrocannabinol; 
185.23 	or
185.24 	(6) the person unlawfully possesses one or more mixtures containing methamphetamine 
185.25 	or amphetamine in a school zone, a park zone, a public housing zone, or a drug treatment 
185.26 	facility.
185.27 	(b) For the purposes of this subdivision, the weight of fluid used in a water pipe may 
185.28 	not be considered in measuring the weight of a mixture except in cases where the mixture 
185.29 	contains four or more fluid ounces of fluid.

185.30 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
185.31 	committed on or after that date.

186.1 	Sec. 12. Minnesota Statutes 2022, section 152.024, subdivision 1, is amended to read:
186.2 		Subdivision 1.Sale crimes. A person is guilty of controlled substance crime in the fourth 
186.3 	degree if:
186.4 	(1) the person unlawfully sells one or more mixtures containing a controlled substance 
186.5 	classified in Schedule I, II, or III, except marijuana or Tetrahydrocannabinols;
186.6 	(2) the person unlawfully sells one or more mixtures containing a controlled substance 
186.7 	classified in Schedule IV or V to a person under the age of 18; or
186.8 	(3) the person conspires with or employs a person under the age of 18 to unlawfully sell 
186.9 	a controlled substance classified in Schedule IV or V; or.
186.10 	(4) the person unlawfully sells any amount of marijuana or Tetrahydrocannabinols in a 
186.11 	school zone, a park zone, a public housing zone, or a drug treatment facility, except a small 
186.12 	amount for no remuneration.

186.13 	EFFECTIVE DATE. This section is effective January 1, 2024, and applies to crimes 
186.14 	committed on or after that date.

186.15 	Sec. 13. Minnesota Statutes 2022, section 152.025, subdivision 1, is amended to read:
186.16 		Subdivision 1.Sale crimes.  A person is guilty of a controlled substance crime in the 
186.17 	fifth degree and upon conviction may be sentenced as provided in subdivision 4 if:
186.18 	(1) the person unlawfully sells one or more mixtures containing marijuana or 
186.19 	tetrahydrocannabinols, except a small amount of marijuana for no remuneration; or
186.20 	(2) the person unlawfully sells one or more mixtures containing a controlled substance 
186.21 	classified in Schedule IV.

186.22 	EFFECTIVE DATE. This section is effective January 1, 2024, and applies to crimes 
186.23 	committed on or after that date.

186.24 	Sec. 14. Minnesota Statutes 2022, section 152.025, subdivision 2, is amended to read:
186.25 		Subd. 2.Possession and other crimes.  A person is guilty of controlled substance crime 
186.26 	in the fifth degree and upon conviction may be sentenced as provided in subdivision 4 if:
186.27 	(1) the person unlawfully possesses one or more mixtures containing a controlled 
186.28 	substance classified in Schedule I, II, III, or IV, except a small amount of marijuana cannabis 
186.29 	flower or cannabis products; or
187.1 	(2) the person procures, attempts to procure, possesses, or has control over a controlled 
187.2 	substance by any of the following means:
187.3 	(i) fraud, deceit, misrepresentation, or subterfuge;
187.4 	(ii) using a false name or giving false credit; or
187.5 	(iii) falsely assuming the title of, or falsely representing any person to be, a manufacturer, 
187.6 	wholesaler, pharmacist, physician, doctor of osteopathic medicine licensed to practice 
187.7 	medicine, dentist, podiatrist, veterinarian, or other authorized person for the purpose of 
187.8 	obtaining a controlled substance.

187.9 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
187.10 	committed on or after that date.

187.11 	Sec. 15. [152.0263] CANNABIS POSSESSION CRIMES.
187.12 		Subdivision 1.Possession of cannabis in the first degree. A person is guilty of cannabis 
187.13 	possession in the first degree and may be sentenced to imprisonment of not more than five 
187.14 	years or to payment of a fine of not more than $10,000, or both, if the person unlawfully 
187.15 	possesses any of the following:
187.16 	(1) more than two pounds but not more than ten kilograms of cannabis flower in any 
187.17 	place other than the person's residence;
187.18 	(2) more than two pounds but not more than ten kilograms of cannabis flower derived 
187.19 	from sources other than the home cultivation of cannabis plants authorized in section 342.09, 
187.20 	subdivision 2, in the person's residence;
187.21 	(3) more than five pounds but not more than ten kilograms of cannabis flower, regardless 
187.22 	of the cannabis' source, in the person's residence;
187.23 	(4) more than 160 grams but not more than two kilograms of cannabis concentrate; or
187.24 	(5) edible cannabis products infused with more than 16 grams but not more than 200 
187.25 	grams of tetrahydrocannabinol.
187.26 		Subd. 2.Possession of cannabis in the second degree. A person is guilty of cannabis 
187.27 	possession in the second degree and may be sentenced to imprisonment of not more than 
187.28 	one year or to payment of a fine of not more than $3,000, or both, if the person unlawfully 
187.29 	possesses any of the following:
187.30 	(1) more than one pound but not more than two pounds of cannabis flower in any place 
187.31 	other than the person's residence;
188.1 	(2) more than 80 grams but not more than 160 grams of cannabis concentrate; or
188.2 	(3) edible cannabis products infused with more than eight grams but not more than 16 
188.3 	grams of tetrahydrocannabinol.
188.4 		Subd. 3.Possession of cannabis in the third degree. A person is guilty of cannabis 
188.5 	possession in the third degree and may be sentenced to imprisonment of not more than 90 
188.6 	days or to payment of a fine of not more than $1,000, or both, if the person unlawfully 
188.7 	possesses any of the following:
188.8 	(1) more than four ounces but not more than one pound of cannabis flower in any place 
188.9 	other than the person's residence;
188.10 	(2) more than 16 grams but not more than 80 grams of cannabis concentrate; or
188.11 	(3) edible cannabis products infused with more than 1,600 milligrams but not more than 
188.12 	eight grams of tetrahydrocannabinol.
188.13 		Subd. 4.Possession of cannabis in the fourth degree. A person is guilty of a petty 
188.14 	misdemeanor if the person unlawfully possesses any of the following:
188.15 	(1) more than two ounces but not more than four ounces of cannabis flower in any place 
188.16 	other than the person's residence;
188.17 	(2) more than eight grams but not more than 16 grams of cannabis concentrate; or
188.18 	(3) edible cannabis products infused with more than 800 milligrams but not more than 
188.19 	1,600 milligrams of tetrahydrocannabinol.
188.20 		Subd. 5.Use of cannabis in a motor vehicle. (a) A person is guilty of a crime and may 
188.21 	be sentenced to imprisonment of not more than 90 days or to payment of a fine of not more 
188.22 	than $1,000, or both, if the person unlawfully uses cannabis flower or cannabis products 
188.23 	while driving, operating, or being in physical control of any motor vehicle, as defined in 
188.24 	section 169A.03, subdivision 15.
188.25 	(b) The State Patrol must increase enforcement of this subdivision annually on April 
188.26 	20. Other law enforcement agencies are encouraged to increase enforcement of this 
188.27 	subdivision annually on April 20.
188.28 		Subd. 6.Use of cannabis in public. A local unit of government may adopt an ordinance 
188.29 	establishing a petty misdemeanor offense for a person who unlawfully uses cannabis flower 
188.30 	or cannabis products in a public place provided that the definition of public place does not 
188.31 	include the following:
188.32 	(1) a private residence, including the person's curtilage or yard;
189.1 	(2) private property not generally accessible by the public, unless the person is explicitly 
189.2 	prohibited from consuming cannabis flower or cannabis products on the property by the 
189.3 	owner of the property; or
189.4 	(3) the premises of an establishment or event licensed to permit on-site consumption.

189.5 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
189.6 	committed on or after that date.

189.7 	Sec. 16. [152.0264] CANNABIS SALE CRIMES.
189.8 		Subdivision 1.Sale of cannabis in the first degree. A person is guilty of the sale of 
189.9 	cannabis in the first degree and may be sentenced to imprisonment of not more than five 
189.10 	years or to payment of a fine of not more than $10,000, or both, if the person unlawfully 
189.11 	sells more than two ounces of cannabis flower, more than eight grams of cannabis 
189.12 	concentrate, or edible cannabis products infused with more than 800 milligrams of 
189.13 	tetrahydrocannabinol:
189.14 	(1) to a minor and the defendant is an adult who is more than 36 months older than the 
189.15 	minor;
189.16 	(2) within ten years of two or more convictions for the unlawful sale of more than two 
189.17 	ounces of cannabis flower, more than eight grams of cannabis concentrate, or edible cannabis 
189.18 	products infused with more than 800 milligrams of tetrahydrocannabinol; or
189.19 	(3) within ten years of a conviction under this subdivision.
189.20 		Subd. 2.Sale of cannabis in the second degree. A person is guilty of sale of cannabis 
189.21 	in the second degree and may be sentenced to imprisonment of not more than one year or 
189.22 	to payment of a fine of not more than $3,000, or both, if the person unlawfully sells more 
189.23 	than two ounces of cannabis flower, more than eight grams of cannabis concentrate, or 
189.24 	edible cannabis products infused with more than 800 milligrams of tetrahydrocannabinol:
189.25 	(1) to a minor and the defendant is an adult who is not more than 36 months older than 
189.26 	the minor;
189.27 	(2) in a school zone, a park zone, a public housing zone, or a drug treatment facility; or
189.28 	(3) within ten years of a conviction for the unlawful sale of more than two ounces of 
189.29 	cannabis flower, more than eight grams of cannabis concentrate, or edible cannabis products 
189.30 	infused with more than 800 milligrams of tetrahydrocannabinol.
190.1 		Subd. 3.Sale of cannabis in the third degree. A person is guilty of sale of cannabis in 
190.2 	the third degree and may be sentenced to imprisonment of not more than 90 days or to 
190.3 	payment of a fine of not more than $1,000, or both, if the person unlawfully sells:
190.4 	(1) more than two ounces of cannabis flower;
190.5 	(2) more than eight grams of cannabis concentrate; or
190.6 	(3) edible cannabis products infused with more than 800 milligrams of 
190.7 	tetrahydrocannabinol.
190.8 		Subd. 4.Sale of cannabis in the fourth degree. (a) A person is guilty of a petty 
190.9 	misdemeanor if the person unlawfully sells:
190.10 	(1) not more than two ounces of cannabis flower;
190.11 	(2) not more than eight grams of cannabis concentrate; or
190.12 	(3) edible cannabis products infused with not more than 800 milligrams of 
190.13 	tetrahydrocannabinol.
190.14 	(b) A sale for no remuneration by an individual over the age of 21 to another individual 
190.15 	over the age of 21 is not an unlawful sale under this subdivision.
190.16 		Subd. 5.Sale of cannabis by a minor. (a) A minor is guilty of a petty misdemeanor if:
190.17 	(1) the minor unlawfully sells cannabis flower, cannabis concentrate, or cannabis 
190.18 	products; and
190.19 	(2) the minor has not previously received a petty misdemeanor disposition or been 
190.20 	adjudicated delinquent for committing an act in violation of this section.
190.21 	(b) A minor sentenced under this subdivision is required to participate in a drug education 
190.22 	program unless the court enters a written finding that a drug education program is 
190.23 	inappropriate. The program must be approved by an area mental health board with a 
190.24 	curriculum approved by the state alcohol and drug abuse authority.
190.25 	(c) A minor who receives a disposition pursuant to this subdivision is required to perform 
190.26 	community service.

190.27 	EFFECTIVE DATE. This section is effective January 1, 2024, and applies to crimes 
190.28 	committed on or after that date.

191.1 	Sec. 17. [152.0265] CANNABIS CULTIVATION CRIMES.
191.2 		Subdivision 1.Cultivation of cannabis in the first degree. A person is guilty of 
191.3 	cultivation of cannabis in the first degree and may be sentenced to imprisonment of not 
191.4 	more than five years or to payment of a fine of not more than $10,000, or both, if the person 
191.5 	unlawfully cultivates more than 23 cannabis plants.
191.6 		Subd. 2.Cultivation of cannabis in the second degree. A person is guilty of cultivation 
191.7 	of cannabis in the second degree and may be sentenced to imprisonment of not more than 
191.8 	one year or to payment of a fine of not more than $3,000, or both, if the person unlawfully 
191.9 	cultivates more than 16 cannabis plants but not more than 23 cannabis plants.

191.10 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
191.11 	committed on or after that date.

191.12 	Sec. 18. [169A.36] OPEN PACKAGE LAW.
191.13 		Subdivision 1.Definitions. As used in this section:
191.14 	(1) "synthetically derived cannabinoid" has the meaning given in section 342.01, 
191.15 	subdivision 67;
191.16 	(2) "cannabis product" has the meaning given in section 342.01, subdivision 2;
191.17 	(3) "cannabis flower" has the meaning given in section 342.01, subdivision 16;
191.18 	(4) "motor vehicle" does not include motorboats in operation or off-road recreational 
191.19 	vehicles except while operated on a roadway or shoulder of a roadway that is not part of a 
191.20 	grant-in-aid trail or trail designated for that vehicle by the commissioner of natural resources; 
191.21 	and
191.22 	(5) "possession" means either that the person had actual possession of the package or 
191.23 	that the person consciously exercised dominion and control over the package.
191.24 		Subd. 2.Use; crime described. It is a crime for a person to use cannabis flower, a 
191.25 	cannabis product, or any product containing a synthetically derived cannabinoid in a motor 
191.26 	vehicle when the vehicle is on a street or highway.
191.27 		Subd. 3.Possession; crime described. It is a crime for a person to have in possession, 
191.28 	while in a private motor vehicle on a street or highway, any cannabis flower, a cannabis 
191.29 	product, or any product containing a synthetically derived cannabinoid that:
191.30 	(1) is in packaging or another container that does not comply with the relevant packaging 
191.31 	requirements in chapter 152 or 342;
192.1 	(2) has been removed from the packaging in which it was sold;
192.2 	(3) is in packaging that has been opened or the seal has been broken; or
192.3 	(4) is in packaging of which the contents have been partially removed.
192.4 		Subd. 4.Liability of nonpresent owner; crime described. It is a crime for the owner 
192.5 	of any private motor vehicle or the driver, if the owner is not present in the motor vehicle, 
192.6 	to keep or allow to be kept in a motor vehicle when the vehicle is on a street or highway 
192.7 	cannabis flower, a cannabis product, or any product containing a synthetically derived 
192.8 	cannabinoid that:
192.9 	(1) is in packaging or another container that does not comply with the relevant packaging 
192.10 	requirements in chapter 152 or 342;
192.11 	(2) has been removed from the packaging in which it was sold;
192.12 	(3) is in packaging that has been opened or the seal has been broken; or
192.13 	(4) is in packaging of which the contents have been partially removed.
192.14 		Subd. 5.Criminal penalty. A person who violates subdivision 2, 3, or 4 is guilty of a 
192.15 	misdemeanor.
192.16 		Subd. 6.Exceptions. (a) This section does not prohibit the possession or consumption 
192.17 	of cannabis flower, a cannabis product, or any other product containing a synthetically 
192.18 	derived cannabinoid by passengers in:
192.19 	(1) a bus that is operated by a motor carrier of passengers as defined in section 221.012, 
192.20 	subdivision 26;
192.21 	(2) a vehicle that is operated for commercial purposes in a manner similar to a bicycle 
192.22 	as defined in section 169.011, subdivision 4, with five or more passengers who provide 
192.23 	pedal power to the drive train of the vehicle; or
192.24 	(3) a vehicle providing limousine service as defined in section 221.84, subdivision 1.
192.25 	(b) Subdivisions 3 and 4 do not apply to: (1) a package that is in the trunk of the vehicle 
192.26 	if the vehicle is equipped with a trunk; or (2) a package that is in another area of the vehicle 
192.27 	not normally occupied by the driver and passengers if the vehicle is not equipped with a 
192.28 	trunk. A utility compartment or glove compartment is deemed to be within the area occupied 
192.29 	by the driver and passengers.

192.30 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
192.31 	committed on or after that date.

193.1 	Sec. 19. Minnesota Statutes 2022, section 609.135, subdivision 1, is amended to read:
193.2 		Subdivision 1.Terms and conditions. (a) Except when a sentence of life imprisonment 
193.3 	is required by law, or when a mandatory minimum sentence is required by section 609.11, 
193.4 	any court may stay imposition or execution of sentence and:
193.5 	(1) may order intermediate sanctions without placing the defendant on probation; or
193.6 	(2) may place the defendant on probation with or without supervision and on the terms 
193.7 	the court prescribes, including intermediate sanctions when practicable. The court may order 
193.8 	the supervision to be under the probation officer of the court, or, if there is none and the 
193.9 	conviction is for a felony or gross misdemeanor, by the commissioner of corrections, or in 
193.10 	any case by some other suitable and consenting person. Unless the court directs otherwise, 
193.11 	state parole and probation agents and probation officers may impose community work 
193.12 	service or probation violation sanctions, consistent with section 243.05, subdivision 1; 
193.13 	sections 244.196 to 244.199; or 401.02, subdivision 5.
193.14 	No intermediate sanction may be ordered performed at a location that fails to observe 
193.15 	applicable requirements or standards of chapter 181A or 182, or any rule promulgated under 
193.16 	them.
193.17 	(b) For purposes of this subdivision, subdivision 6, and section 609.14, the term 
193.18 	"intermediate sanctions" includes but is not limited to incarceration in a local jail or 
193.19 	workhouse, home detention, electronic monitoring, intensive probation, sentencing to service, 
193.20 	reporting to a day reporting center, chemical dependency or mental health treatment or 
193.21 	counseling, restitution, fines, day-fines, community work service, work service in a restorative 
193.22 	justice program, work in lieu of or to work off fines and, with the victim's consent, work in 
193.23 	lieu of or to work off restitution.
193.24 	(c) A court may not stay the revocation of the driver's license of a person convicted of 
193.25 	violating the provisions of section 169A.20.
193.26 	(d) If the court orders a fine, day-fine, or restitution as an intermediate sanction, payment 
193.27 	is due on the date imposed unless the court otherwise establishes a due date or a payment 
193.28 	plan.
193.29 	(e) The court may prohibit a defendant from using adult-use cannabis flower as defined 
193.30 	in section 342.01, subdivision 4, or adult-use cannabis products as defined in section 342.01, 
193.31 	subdivision 2, if the defendant undergoes a chemical use assessment and abstinence is 
193.32 	consistent with a recommended level of care for the defendant in accordance with the criteria 
193.33 	in rules adopted by the commissioner of human services under section 254A.03, subdivision 
194.1 	3. The assessment must be conducted by an assessor qualified under rules adopted by the 
194.2 	commissioner of human services under section 254A.03, subdivision 3. An assessor providing 
194.3 	a chemical use assessment may not have any direct or shared financial interest or referral 
194.4 	relationship resulting in shared financial gain with a treatment provider, except as authorized 
194.5 	under section 254A.19, subdivision 3. If an independent assessor is not available, the 
194.6 	probation officer may use the services of an assessor authorized to perform assessments for 
194.7 	the county social services agency under a variance granted under rules adopted by the 
194.8 	commissioner of human services under section 254A.03, subdivision 3.
194.9 	(f) A court shall not impose an intermediate sanction that has the effect of prohibiting 
194.10 	a person from participating in the registry program as defined in section 342.01, subdivision 
194.11 	63.

194.12 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to sentences 
194.13 	ordered on or after that date.

194.14 	Sec. 20. Minnesota Statutes 2022, section 609.5311, subdivision 1, is amended to read:
194.15 		Subdivision 1.Controlled substances. All controlled substances that were manufactured, 
194.16 	distributed, dispensed, or acquired in violation of chapter 152 or 342 are subject to forfeiture 
194.17 	under this section, except as provided in subdivision 3 and section 609.5316.

194.18 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to violations 
194.19 	committed on or after that date.

194.20 	Sec. 21. Minnesota Statutes 2022, section 609.5314, subdivision 1, is amended to read:
194.21 		Subdivision 1.Property subject to administrative forfeiture. (a) The following are 
194.22 	subject to administrative forfeiture under this section:
194.23 	(1) all money totaling $1,500 or more, precious metals, and precious stones that there 
194.24 	is probable cause to believe represent the proceeds of a controlled substance offense;
194.25 	(2) all money found in proximity to controlled substances when there is probable cause 
194.26 	to believe that the money was exchanged for the purchase of a controlled substance;
194.27 	(3) all conveyance devices containing controlled substances with a retail value of $100 
194.28 	or more if there is probable cause to believe that the conveyance device was used in the 
194.29 	transportation or exchange of a controlled substance intended for distribution or sale; and
194.30 	(4) all firearms, ammunition, and firearm accessories found:
195.1 	(i) in a conveyance device used or intended for use to commit or facilitate the commission 
195.2 	of a felony offense involving a controlled substance;
195.3 	(ii) on or in proximity to a person from whom a felony amount of controlled substance 
195.4 	is seized; or
195.5 	(iii) on the premises where a controlled substance is seized and in proximity to the 
195.6 	controlled substance, if possession or sale of the controlled substance would be a felony 
195.7 	under chapter 152.
195.8 	(b) The Department of Corrections Fugitive Apprehension Unit shall not seize items 
195.9 	listed in paragraph (a), clauses (3) and (4), for the purposes of forfeiture.
195.10 	(c) Money is the property of an appropriate agency and may be seized and recovered by 
195.11 	the appropriate agency if:
195.12 	(1) the money is used by an appropriate agency, or furnished to a person operating on 
195.13 	behalf of an appropriate agency, to purchase or attempt to purchase a controlled substance; 
195.14 	and
195.15 	(2) the appropriate agency records the serial number or otherwise marks the money for 
195.16 	identification.
195.17 	(d) As used in this section, "money" means United States currency and coin; the currency 
195.18 	and coin of a foreign country; a bank check, cashier's check, or traveler's check; a prepaid 
195.19 	credit card; cryptocurrency; or a money order.
195.20 	(e) As used in this section, "controlled substance" does not include cannabis flower as 
195.21 	defined in section 342.01, subdivision 16, or cannabis product as defined in section 342.01, 
195.22 	subdivision 2.

195.23 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
195.24 	committed on or after that date.

195.25 	Sec. 22. Minnesota Statutes 2022, section 609.5316, subdivision 2, is amended to read:
195.26 		Subd. 2.Controlled substances. (a) Controlled substances listed in Schedule I that are 
195.27 	possessed, transferred, sold, or offered for sale in violation of chapter 152 or 342, are 
195.28 	contraband and must be seized and summarily forfeited. Controlled substances listed in 
195.29 	Schedule I that are seized or come into the possession of peace officers, the owners of which 
195.30 	are unknown, are contraband and must be summarily forfeited.
195.31 	(b) Species of plants from which controlled substances in Schedules I and II may be 
195.32 	derived that have been planted or cultivated in violation of chapter 152 or of which the 
196.1 	owners or cultivators are unknown, or that are wild growths, may be seized and summarily 
196.2 	forfeited to the state. The appropriate agency or its authorized agent may seize the plants if 
196.3 	the person in occupancy or in control of land or premises where the plants are growing or 
196.4 	being stored fails to produce an appropriate registration or proof that the person is the holder 
196.5 	of appropriate registration.

196.6 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
196.7 	committed on or after that date.

196.8 	Sec. 23. DWI CONTROLLED SUBSTANCE ROADSIDE TESTING INSTRUMENT 
196.9 	PILOT PROJECT; REPORT REQUIRED.
 196.10 	(a) The commissioner of public safety must design, plan, and implement a pilot project 
196.11 	to study oral fluid roadside testing instruments to determine the presence of a controlled 
196.12 	substance or intoxicating substance in individuals stopped or arrested for driving while 
196.13 	impaired offenses. The pilot project must determine the practicality, accuracy, and efficacy 
196.14 	of these testing instruments and determine and make recommendations on the best instrument 
196.15 	or instruments to pursue in the future.
196.16 	(b) The pilot project must begin on September 1, 2023, and continue until August 31, 
196.17 	2024.
196.18 	(c) The commissioner must consult with law enforcement officials, prosecutors, criminal 
196.19 	defense attorneys, and other interested and knowledgeable parties when designing, 
196.20 	implementing, and evaluating the pilot project.
196.21 	(d) All oral fluid samples obtained for the purpose of this pilot project must be obtained 
196.22 	by a certified drug recognition evaluator and may only be collected with the express voluntary 
196.23 	consent of the person stopped or arrested for suspicion of driving while impaired. Results 
196.24 	of tests conducted under the pilot project are to be used for the purpose of analyzing the 
196.25 	practicality, accuracy, and efficacy of the instrument. Results may not be used to decide 
196.26 	whether an arrest should be made and are not admissible in any legal proceeding.
196.27 	(e) By February 1, 2025, the commissioner must report to the chairs and ranking minority 
196.28 	members of the legislative committees with jurisdiction over public safety on the results of 
196.29 	the pilot project. At a minimum, the report must include information on how accurate the 
196.30 	instruments were when tested against laboratory results, how often participants were found 
196.31 	to have controlled substances or intoxicating substances in their systems, how often there 
196.32 	was commingling of controlled substances or intoxicating substances with alcohol, the types 
196.33 	of controlled substances or intoxicating substances found in participants' systems and which 
197.1 	types were most common, and the number of participants in the project. In addition, the 
197.2 	report must assess the practicality and reliability of using the instruments in the field and 
197.3 	make recommendations on continuing the project permanently.

197.4 	EFFECTIVE DATE. This section is effective the day following final enactment.

197.5 	ARTICLE 5
197.6 	EXPUNGEMENT

197.7 	Section 1. Minnesota Statutes 2022, section 152.18, subdivision 1, is amended to read:
197.8 		Subdivision 1.Deferring prosecution for certain first time drug offenders. (a) A 
197.9 	court may defer prosecution as provided in paragraph (c) for any person found guilty, after 
197.10 	trial or upon a plea of guilty, of a violation of section 152.023, subdivision 2, 152.024, 
197.11 	subdivision 2, 152.025, subdivision 2, or 152.027, subdivision 2, 3, 4, or 6, paragraph (d), 
197.12 	for possession of a controlled substance, who:
197.13 	(1) has not previously participated in or completed a diversion program authorized under 
197.14 	section 401.065;
197.15 	(2) has not previously been placed on probation without a judgment of guilty and 
197.16 	thereafter been discharged from probation under this section; and
197.17 	(3) has not been convicted of a felony violation of this chapter, including a felony-level 
197.18 	attempt or conspiracy, or been convicted by the United States or another state of a similar 
197.19 	offense that would have been a felony under this chapter if committed in Minnesota, unless 
197.20 	ten years have elapsed since discharge from sentence.
197.21 	(b) The court must defer prosecution as provided in paragraph (c) for any person found 
197.22 	guilty of a violation of section 152.025, subdivision 2, who:
197.23 	(1) meets the criteria listed in paragraph (a), clauses (1) to (3); and
197.24 	(2) has not previously been convicted of a felony offense under any state or federal law 
197.25 	or of a gross misdemeanor under section 152.025.
197.26 	(c) In granting relief under this section, the court shall, without entering a judgment of 
197.27 	guilty and with the consent of the person, defer further proceedings and place the person 
197.28 	on probation upon such reasonable conditions as it may require and for a period, not to 
197.29 	exceed the maximum sentence provided for the violation. The court may give the person 
197.30 	the opportunity to attend and participate in an appropriate program of education regarding 
197.31 	the nature and effects of alcohol and drug abuse as a stipulation of probation. Upon violation 
197.32 	of a condition of the probation, the court may enter an adjudication of guilt and proceed as 
198.1 	otherwise provided. The court may, in its discretion, dismiss the proceedings against the 
198.2 	person and discharge the person from probation before the expiration of the maximum 
198.3 	period prescribed for the person's probation. If during the period of probation the person 
198.4 	does not violate any of the conditions of the probation, then upon expiration of the period 
198.5 	the court shall discharge the person and dismiss the proceedings against that person. 
198.6 	Discharge and dismissal under this subdivision shall be without court adjudication of guilt, 
198.7 	but a not public record of it shall be retained by the Bureau of Criminal Apprehension for 
198.8 	the purpose of use by the courts in determining the merits of subsequent proceedings against 
198.9 	the person. The not public record may also be opened only upon court order for purposes 
198.10 	of a criminal investigation, prosecution, or sentencing. Upon receiving notice that the 
198.11 	proceedings were dismissed, the Bureau of Criminal Apprehension shall notify the arresting 
198.12 	or citing law enforcement agency and direct that agency to seal the agency's records related 
198.13 	to the dismissed charge. Upon request by law enforcement, prosecution, or corrections 
198.14 	authorities, the bureau shall notify the requesting party of the existence of the not public 
198.15 	record and the right to seek a court order to open it pursuant to this section. The court shall 
198.16 	forward a record of any discharge and dismissal under this subdivision to the bureau which 
198.17 	shall make and maintain the not public record of it as provided under this subdivision. The 
198.18 	discharge or dismissal shall not be deemed a conviction for purposes of disqualifications 
198.19 	or disabilities imposed by law upon conviction of a crime or for any other purpose.
198.20 	For purposes of this subdivision, "not public" has the meaning given in section 13.02, 
198.21 	subdivision 8a.

198.22 	Sec. 2. Minnesota Statutes 2022, section 609A.01, is amended to read:
198.23 	609A.01 EXPUNGEMENT OF CRIMINAL RECORDS.
198.24 	This chapter provides the grounds and procedures for expungement of criminal records 
198.25 	under section 13.82; 152.18, subdivision 1; 299C.11, where a petition is authorized under 
198.26 	section 609A.02, subdivision 3; expungement is automatic under section 609A.05; 
198.27 	expungement is considered by a panel under section 609A.06; or other applicable law. The 
198.28 	remedy available is limited to a court order sealing the records and prohibiting the disclosure 
198.29 	of their existence or their opening except under court order or statutory authority. Nothing 
198.30 	in this chapter authorizes the destruction of records or their return to the subject of the 
198.31 	records.

198.32 	EFFECTIVE DATE. This section is effective January 1, 2025.

199.1 	Sec. 3. Minnesota Statutes 2022, section 609A.03, subdivision 5, is amended to read:
199.2 		Subd. 5.Nature of remedy; standard. (a) Except as otherwise provided by paragraph 
199.3 	(b), expungement of a criminal record under this section is an extraordinary remedy to be 
199.4 	granted only upon clear and convincing evidence that it would yield a benefit to the petitioner 
199.5 	commensurate with the disadvantages to the public and public safety of:
199.6 	(1) sealing the record; and
199.7 	(2) burdening the court and public authorities to issue, enforce, and monitor an 
199.8 	expungement order.
199.9 	(b) Except as otherwise provided by this paragraph, if the petitioner is petitioning for 
199.10 	the sealing of a criminal record under section 609A.02, subdivision 3, paragraph (a), clause 
199.11 	(1) or (2), the court shall grant the petition to seal the record unless the agency or jurisdiction 
199.12 	whose records would be affected establishes by clear and convincing evidence that the 
199.13 	interests of the public and public safety outweigh the disadvantages to the petitioner of not 
199.14 	sealing the record.
199.15 	(c) In making a determination under this subdivision, the court shall consider:
199.16 	(1) the nature and severity of the underlying crime, the record of which would be sealed;
199.17 	(2) the risk, if any, the petitioner poses to individuals or society;
199.18 	(3) the length of time since the crime occurred;
199.19 	(4) the steps taken by the petitioner toward rehabilitation following the crime;
199.20 	(5) aggravating or mitigating factors relating to the underlying crime, including the 
199.21 	petitioner's level of participation and context and circumstances of the underlying crime;
199.22 	(6) the reasons for the expungement, including the petitioner's attempts to obtain 
199.23 	employment, housing, or other necessities;
199.24 	(7) the petitioner's criminal record;
199.25 	(8) the petitioner's record of employment and community involvement;
199.26 	(9) the recommendations of interested law enforcement, prosecutorial, and corrections 
199.27 	officials;
199.28 	(10) the recommendations of victims or whether victims of the underlying crime were 
199.29 	minors;
200.1 	(11) the amount, if any, of restitution outstanding, past efforts made by the petitioner 
200.2 	toward payment, and the measures in place to help ensure completion of restitution payment 
200.3 	after expungement of the record if granted; and
200.4 	(12) other factors deemed relevant by the court.
200.5 	(d) Notwithstanding section 13.82, 13.87, or any other law to the contrary, if the court 
200.6 	issues an expungement order it may require that the criminal record be sealed, the existence 
200.7 	of the record not be revealed, and the record not be opened except as required under 
200.8 	subdivision 7. Records must not be destroyed or returned to the subject of the record.
200.9 	(e) Information relating to a criminal history record of an employee, former employee, 
200.10 	or tenant that has been expunged before the occurrence of the act giving rise to the civil 
200.11 	action may not be introduced as evidence in a civil action against a private employer or 
200.12 	landlord or its employees or agents that is based on the conduct of the employee, former 
200.13 	employee, or tenant.

200.14 	EFFECTIVE DATE. This section is effective January 1, 2025, and applies to crimes 
200.15 	committed on or after that date.

200.16 	Sec. 4. Minnesota Statutes 2022, section 609A.03, subdivision 9, is amended to read:
200.17 		Subd. 9.Stay of order; appeal. An expungement order issued under this section shall 
200.18 	be stayed automatically for 60 days after the order is filed and, if the order is appealed, 
200.19 	during the appeal period. A person or an agency or jurisdiction whose records would be 
200.20 	affected by the order may appeal the order within 60 days of service of notice of filing of 
200.21 	the order. An agency or jurisdiction or its officials or employees need not file a cost bond 
200.22 	or supersedeas bond in order to further stay the proceedings or file an appeal.

200.23 	EFFECTIVE DATE. This section is effective January 1, 2025.

200.24 	Sec. 5. [609A.05] AUTOMATIC EXPUNGEMENT OF CERTAIN CANNABIS 
200.25 	OFFENSES.
200.26 		Subdivision 1.Eligibility; dismissal, exoneration, or conviction of nonfelony cannabis 
200.27 	offenses. (a) A person is eligible for expungement:
200.28 	(1) upon the dismissal and discharge of proceedings against a person under section 
200.29 	152.18, subdivision 1, for violation of section 152.024, 152.025, or 152.027 for possession 
200.30 	of marijuana or tetrahydrocannabinols;
201.1 	(2) if the person was convicted of or received a stayed sentence for a violation of section 
201.2 	152.027, subdivision 3 or 4;
201.3 	(3) if the person was arrested for possession of marijuana or tetrahydrocannabinols and 
201.4 	all charges were dismissed after a case was filed, unless the dismissal was based on a finding 
201.5 	that the defendant was incompetent to proceed; or
201.6 	(4) if all pending actions or proceedings involving the possession of marijuana or 
201.7 	tetrahydrocannabinols were resolved in favor of the person.
201.8 	(b) For purposes of this section:
201.9 	(1) a verdict of not guilty by reason of mental illness is not a resolution in favor of the 
201.10 	person; and
201.11 	(2) an action or proceeding is resolved in favor of the person if the person received an 
201.12 	order under section 590.11 determining that the person is eligible for compensation based 
201.13 	on exoneration.
201.14 		Subd. 2.Bureau of Criminal Apprehension to identify eligible individuals. (a) The 
201.15 	Bureau of Criminal Apprehension shall identify bureau records that qualify for expungement 
201.16 	pursuant to subdivision 1.
201.17 	(b) The Bureau of Criminal Apprehension shall notify the judicial branch of:
201.18 	(1) the name and date of birth of each person whose case is eligible for an order of 
201.19 	expungement; and
201.20 	(2) the court file number of the eligible case.
201.21 		Subd. 3.Expungement relief; notification requirements. (a) The Bureau of Criminal 
201.22 	Apprehension shall grant expungement relief to each qualifying person and seal the bureau's 
201.23 	records without requiring an application, petition, or motion. The bureau shall seal records 
201.24 	related to an expungement within 60 days after the bureau sent notice of the expungement 
201.25 	to the judicial branch pursuant to subdivision 2, paragraph (b), unless an order of the judicial 
201.26 	branch prohibits sealing the records or additional information establishes that the records 
201.27 	are not eligible for expungement.
201.28 	(b) Nonpublic criminal records maintained by the bureau and subject to a grant of 
201.29 	expungement relief must display a notation stating "expungement relief granted pursuant 
201.30 	to section 609A.05."
201.31 	(c) The bureau shall inform the judicial branch of all cases that are granted expungement 
201.32 	relief pursuant to this section. The bureau may notify the judicial branch using electronic 
202.1 	means and may notify the judicial branch immediately or in a monthly report. Upon receiving 
202.2 	notice of an expungement, the judicial branch shall seal all related records, including records 
202.3 	of the person's arrest, indictment, trial, verdict, and dismissal or discharge of the case. Upon 
202.4 	receiving notice of an expungement, the judicial branch shall issue any order necessary to 
202.5 	seal related records.
202.6 	(d) The bureau shall inform each arresting or citing law enforcement agency or 
202.7 	prosecutorial office with records affected by the grant of expungement relief issued pursuant 
202.8 	to paragraph (a) that expungement has been granted. The bureau shall notify each agency 
202.9 	or office of an expungement within 60 days after the bureau sent notice of the expungement 
202.10 	to the judicial branch. The bureau may notify each agency or office using electronic means. 
202.11 	Upon receiving notification of an expungement, an agency or office shall seal all records 
202.12 	related to the expungement, including the records of the person's arrest, indictment, trial, 
202.13 	verdict, and dismissal or discharge of the case. Notice must also clearly state that persons 
202.14 	who are noncitizens may need copies of these records for immigration purposes, explain 
202.15 	how they can obtain these copies after expungement or other granted relief, and state that 
202.16 	a noncitizen should consult with an immigration attorney.
202.17 	(e) Data on a person whose offense has been expunged under this subdivision, including 
202.18 	any notice sent pursuant to paragraph (d), are private data on individuals as defined in section 
202.19 	13.02, subdivision 12.
202.20 	(f) In any subsequent prosecution of a person with a prior expunged criminal record, a 
202.21 	prosecutor may include the person's expunged criminal record in a complaint or other 
202.22 	charging document if permitted by applicable law and the rules of criminal procedure.
202.23 	(g) The subject whose record qualifies for expungement shall be given access to copies 
202.24 	of the records of arrest, conviction, or incarceration for any purposes, including immigration 
202.25 	purposes.
202.26 	(h) Relief granted under this subdivision shall not impact the ability of a petitioner to 
202.27 	file for relief under section 590.01.

202.28 	EFFECTIVE DATE. This section is effective January 1, 2025.

202.29 	Sec. 6. [609A.06] EXPUNGEMENT AND RESENTENCING OF FELONY 
202.30 	CANNABIS OFFENSES.
202.31 		Subdivision 1.Cannabis Expungement Board. (a) The Cannabis Expungement Board 
202.32 	is created with the powers and duties established by law.
202.33 	(b) The Cannabis Expungement Board is composed of the following members:
203.1 	(1) the chief justice of the supreme court or a designee;
203.2 	(2) the attorney general or a designee;
203.3 	(3) one public defender, appointed by the governor upon recommendation of the state 
203.4 	public defender;
203.5 	(4) the commissioner of one department of the state government as defined in section 
203.6 	15.01, appointed by the governor; and
203.7 	(5) one public member with experience as an advocate for victim's rights, appointed by 
203.8 	the governor.
203.9 	(c) The Cannabis Expungement Board shall have the following powers and duties:
203.10 	(1) to obtain and review the records, including but not limited to all matters, files, 
203.11 	documents, and papers incident to the arrest, indictment, information, trial, appeal, or 
203.12 	dismissal and discharge, which relate to a charge for possession of a controlled substance;
203.13 	(2) to determine whether a person committed an act involving the possession of cannabis 
203.14 	flower or cannabis products that would either be a lesser offense or no longer be a crime 
203.15 	after August 1, 2023;
203.16 	(3) to determine whether a person's conviction should be vacated, charges should be 
203.17 	dismissed, and records should be expunged, or whether the person should be resentenced 
203.18 	to a lesser offense; and
203.19 	(4) to notify the judicial branch of individuals eligible for an expungement or resentencing 
203.20 	to a lesser offense.
203.21 	(d) The Cannabis Expungement Board shall complete the board's work by June 30, 2028.
203.22 		Subd. 2.Eligibility; possession of cannabis. (a) A person is eligible for an expungement 
203.23 	or resentencing to a lesser offense if:
203.24 	(1) the person was convicted of, or adjudication was stayed for, a violation of any of the 
203.25 	following involving the possession of marijuana or tetrahydrocannabinols:
203.26 	(i) section 152.021, subdivision 2, clause (6);
203.27 	(ii) section 152.022, subdivision 2, clause (6);
203.28 	(iii) section 152.023, subdivision 2, clause (5); or
203.29 	(iv) section 152.025, subdivision 2, clause (1).
204.1 	(2) the offense did not involve a dangerous weapon, the intentional infliction of bodily 
204.2 	harm on another, an attempt to inflict bodily harm on another, or an act committed with the 
204.3 	intent to cause fear in another of immediate bodily harm or death;
204.4 	(3) the act on which the charge was based would either be a lesser offense or no longer 
204.5 	be a crime after August 1, 2023; and
204.6 	(4) the person did not appeal the sentence, any appeal was denied, or the deadline to file 
204.7 	an appeal has expired.
204.8 	(b) For purposes of this subdivision, a "lesser offense" means a nonfelony offense if the 
204.9 	person was charged with a felony.
204.10 		Subd. 3.Bureau of Criminal Apprehension to identify eligible records. (a) The 
204.11 	Bureau of Criminal Apprehension shall identify convictions and sentences where adjudication 
204.12 	was stayed that qualify for review under subdivision 2, paragraph (a), clause (1).
204.13 	(b) The Bureau of Criminal Apprehension shall notify the Cannabis Expungement Board 
204.14 	of:
204.15 	(1) the name and date of birth of a person whose record is eligible for review; and
204.16 	(2) the court file number of the eligible conviction or stay of adjudication.
204.17 		Subd. 4.Access to records. The Cannabis Expungement Board shall have free access 
204.18 	to records, including but not limited to all matters, files, documents, and papers incident to 
204.19 	the arrest, indictment, information, trial, appeal, or dismissal and discharge that relate to a 
204.20 	charge and conviction or stay of adjudication for possession of a controlled substance held 
204.21 	by law enforcement agencies, prosecuting authorities, and court administrators. The Cannabis 
204.22 	Expungement Board may issue subpoenas for and compel the production of books, records, 
204.23 	accounts, documents, and papers. If any person fails or refuses to produce any books, records, 
204.24 	accounts, documents, or papers material in the matter under consideration after having been 
204.25 	lawfully required by order or subpoena, any judge of the district court in any county of the 
204.26 	state where the order or subpoena was made returnable, on application of the commissioner 
204.27 	of management and budget or commissioner of administration, as the case may be, shall 
204.28 	compel obedience or punish disobedience as for contempt, as in the case of disobedience 
204.29 	of a similar order or subpoena issued by such court.
204.30 		Subd. 5.Meetings; anonymous identifier. (a) The Cannabis Expungement Board shall 
204.31 	hold meetings at least monthly and shall hold a meeting whenever the board takes formal 
204.32 	action on a review of a conviction or stay of adjudication for an offense involving the 
205.1 	possession of marijuana or tetrahydrocannabinols. All board meetings shall be open to the 
205.2 	public and subject to chapter 13D.
205.3 	(b) Any victim of a crime being reviewed and any law enforcement agency may submit 
205.4 	an oral or written statement at the meeting, giving a recommendation on whether a person's 
205.5 	record should be expunged or the person should be resentenced to a lesser offense. The 
205.6 	board must consider the victim's and the law enforcement agency's statement when making 
205.7 	the board's decision.
205.8 	(c) Section 13D.05 governs the board's treatment of not public data, as defined by section 
205.9 	13.02, subdivision 8a, discussed at open meetings of the board. Notwithstanding section 
205.10 	13.03, subdivision 11, the board shall assign an anonymous, unique identifier to each victim 
205.11 	of a crime and person whose conviction or stay of adjudication the board reviews. The 
205.12 	identifier shall be used in any discussion in a meeting open to the public and on any records 
205.13 	available to the public to protect the identity of the person whose records are being 
205.14 	considered.
205.15 		Subd. 6.Review and determination. (a) The Cannabis Expungement Board shall review 
205.16 	all available records to determine whether the conviction or stay of adjudication is eligible 
205.17 	for an expungement or resentencing to a lesser offense. An expungement under this section 
205.18 	is presumed to be in the public interest unless there is clear and convincing evidence that 
205.19 	an expungement or resentencing to a lesser offense would create a risk to public safety.
205.20 	(b) If the Cannabis Expungement Board determines that an expungement is in the public 
205.21 	interest, the board shall determine whether a person's conviction should be vacated and 
205.22 	charges should be dismissed.
205.23 	(c) If the Cannabis Expungement Board determines that an expungement is in the public 
205.24 	interest, the board shall determine whether the limitations under section 609A.03, subdivision 
205.25 	5a, apply.
205.26 	(d) If the Cannabis Expungement Board determines that an expungement is in the public 
205.27 	interest, the board shall determine whether the limitations under section 609A.03, subdivision 
205.28 	7a, paragraph (b), clause (4) or (5), apply.
205.29 	(e) If the Cannabis Expungement Board determines that an expungement is not in the 
205.30 	public interest, the board shall determine whether the person is eligible for resentencing to 
205.31 	a lesser offense.
205.32 	(f) In making a determination under this subdivision, the Cannabis Expungement Board 
205.33 	shall consider:
206.1 	(1) the nature and severity of the underlying crime, including but not limited to the total 
206.2 	amount of marijuana or tetrahydrocannabinols possessed by the person and whether the 
206.3 	offense involved a dangerous weapon, the intentional infliction of bodily harm on another, 
206.4 	an attempt to inflict bodily harm on another, or an act committed with the intent to cause 
206.5 	fear in another of immediate bodily harm or death;
206.6 	(2) whether an expungement or resentencing the person a lesser offense would increase 
206.7 	the risk, if any, the person poses to other individuals or society;
206.8 	(3) if the person is under sentence, whether an expungement or resentencing to a lesser 
206.9 	offense would result in the release of the person and whether release earlier than the date 
206.10 	that the person would be released under the sentence currently being served would present 
206.11 	a danger to the public or would be compatible with the welfare of society;
206.12 	(4) aggravating or mitigating factors relating to the underlying crime, including the 
206.13 	person's level of participation and the context and circumstances of the underlying crime;
206.14 	(5) statements from victims and law enforcement, if any;
206.15 	(6) if an expungement or resentencing the person to a lesser offense is considered, 
206.16 	whether there is good cause to restore the person's right to possess firearms and ammunition;
206.17 	(7) if an expungement is considered, whether an expunged record of a conviction or stay 
206.18 	of adjudication may be opened for purposes of a background study under section 245C.08;
206.19 	(8) if an expungement is considered, whether an expunged record of a conviction or stay 
206.20 	of adjudication may be opened for purposes of a background check required under section 
206.21 	122A.18, subdivision 8; and
206.22 	(9) other factors deemed relevant by the Cannabis Expungement Board.
206.23 	(g) The affirmative vote of three members is required for action taken at any meeting.
206.24 		Subd. 7.Notice to judicial branch and offenders. (a) The Cannabis Expungement 
206.25 	Board shall identify any conviction or stay of adjudication that qualifies for an order of 
206.26 	expungement or resentencing to a lesser offense and notify the judicial branch of:
206.27 	(1) the name and date of birth of a person whose conviction or stay of adjudication is 
206.28 	eligible for an order of expungement or resentencing to a lesser offense;
206.29 	(2) the case number of the eligible conviction or stay of adjudication;
206.30 	(3) whether the person is eligible for an expungement;
207.1 	(4) if the person is eligible for an expungement, whether the person's conviction should 
207.2 	be vacated and charges should be dismissed;
207.3 	(5) if the person is eligible for an expungement, whether the limitations under section 
207.4 	609A.03, subdivision 7a, clause (4) or (5), apply; and
207.5 	(6) if the person is eligible for resentencing to a lesser offense, the lesser sentence to be 
207.6 	imposed.
207.7 	(b) The Cannabis Expungement Board shall make a reasonable and good faith effort to 
207.8 	notify any person whose conviction or stay of adjudication qualifies for an order of 
207.9 	expungement that the offense qualifies and notice is being sent to the judicial branch. Notice 
207.10 	sent pursuant to this paragraph shall inform the person that, following the order of 
207.11 	expungement, any records of an arrest, conviction, or incarceration should not appear on 
207.12 	any background check or study.
207.13 		Subd. 8.Data classification. All data collected, created, received, maintained, or 
207.14 	disseminated by the Cannabis Expungement Board in which each victim of a crime and 
207.15 	person whose conviction or stay of adjudication that the Cannabis Expungement Board 
207.16 	reviews is or can be identified as the subject of the data is classified as private data on 
207.17 	individuals, as defined by section 13.02, subdivision 12.
207.18 		Subd. 9.Order of expungement. (a) Upon receiving notice that an offense qualifies 
207.19 	for expungement, the court shall issue an order sealing all records relating to an arrest, 
207.20 	indictment or information, trial, verdict, or dismissal and discharge for an offense described 
207.21 	in subdivision 1. If the Cannabis Expungement Board determined that the person's conviction 
207.22 	should be vacated and charges should be dismissed, the order shall vacate and dismiss the 
207.23 	charges.
207.24 	(b) If the Cannabis Expungement Board determined that there is good cause to restore 
207.25 	the person's right to possess firearms and ammunition, the court shall issue an order pursuant 
207.26 	to section 609.165, subdivision 1d.
207.27 	(c) If the Cannabis Expungement Board determined that an expunged record of a 
207.28 	conviction or stay of adjudication may not be opened for purposes of a background study 
207.29 	under section 245C.08, the court shall direct the order specifically to the commissioner of 
207.30 	human services.
207.31 	(d) If the Cannabis Expungement Board determined that an expunged record of a 
207.32 	conviction or stay of adjudication may not be opened for purposes of a background check 
208.1 	required under section 122A.18, subdivision 8, the court shall direct the order specifically 
208.2 	to the Professional Educator Licensing and Standards Board.
208.3 	(e) The court administrator shall send a copy of an expungement order issued under this 
208.4 	section to each agency and jurisdiction whose records are affected by the terms of the order 
208.5 	and send a letter to the last known address of the person whose offense has been expunged 
208.6 	identifying each agency to which the order was sent.
208.7 	(f) Data on the person whose offense has been expunged in a letter sent under this 
208.8 	subdivision are private data on individuals as defined in section 13.02.
208.9 		Subd. 10.Resentencing. (a) If the Cannabis Expungement Board determined that a 
208.10 	person is eligible for resentencing to a lesser offense and the person is currently under 
208.11 	sentence, the court shall proceed as if the appellate court directed a reduction of the conviction 
208.12 	to an offense of lesser degree pursuant to rule 28.02, subdivision 12 of the Rules of Criminal 
208.13 	Procedure.
208.14 	(b) If the Cannabis Expungement Board determined that a person is eligible for 
208.15 	resentencing to a lesser offense and the person completed or has been discharged from the 
208.16 	sentence, the court may issue an order amending the conviction to an offense of lesser degree 
208.17 	without holding a hearing.

208.18 	EFFECTIVE DATE. This section is effective January 1, 2025.

208.19 	Sec. 7. [609A.07] RESTORATION OF FIREARMS RIGHTS.
208.20 	Any person who is prohibited from possessing a firearm or ammunition based on a prior 
208.21 	adjudication or conviction for a cannabis-related offense who receives an expungement or 
208.22 	other relief under section 609A.05 or 609A.06 shall have their right to possess firearms and 
208.23 	ammunition restored if the person is otherwise eligible to possess the item.

208.24 	ARTICLE 6
208.25 	MISCELLANEOUS PROVISIONS

208.26 	Section 1. [3.9224] MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.
208.27 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
208.28 	meanings given.
208.29 	(b) "Indian Tribe" means a Tribe, band, nation, or other federally recognized group or 
208.30 	community of Indians located within the geographical boundaries of the state of Minnesota.
209.1 	(c) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision 
209.2 	51.
209.3 	(d) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 53.
209.4 		Subd. 2.Negotiations authorized. Following a public hearing, the governor or the 
209.5 	governor's designated representatives are authorized to negotiate in good faith a compact 
209.6 	with an Indian Tribe regulating medical cannabis flower and medical cannabinoid products. 
209.7 	The attorney general is the legal counsel for the governor or the governor's representatives 
209.8 	in regard to negotiating a compact under this section. If the governor appoints designees to 
209.9 	negotiate under this subdivision, the designees must include at least two members of the 
209.10 	senate and two members of the house of representatives, two of whom must be the chairs 
209.11 	of the senate and house of representatives standing committees with jurisdiction over health 
209.12 	policy.
209.13 		Subd. 3.Terms of compact; rights of parties. (a) A compact agreed to under this 
209.14 	section may address any issues related to medical cannabis flower and medical cannabinoid 
209.15 	products that affect the interests of both the state and Indian Tribe or otherwise have an 
209.16 	impact on Tribal-state relations. At a minimum, a compact agreed to on behalf of the state 
209.17 	under this section must address:
209.18 	(1) the enforcement of criminal and civil laws;
209.19 	(2) the regulation of the commercial production, processing, sale or distribution, and 
209.20 	possession of medical cannabis flower and medical cannabinoid products;
209.21 	(3) medical and pharmaceutical research involving medical cannabis flower and medical 
209.22 	cannabinoid products;
209.23 	(4) the taxation of medical cannabis flower and medical cannabinoid products, including 
209.24 	establishing an appropriate amount and method of revenue sharing;
209.25 	(5) the immunities of an Indian Tribe or preemption of state law regarding the production, 
209.26 	processing, or sale or distribution of medical cannabis flower and medical cannabinoid 
209.27 	products; and
209.28 	(6) the method of resolution for disputes involving the compact, including the use of 
209.29 	mediation or other alternative dispute resolution processes and procedures.
209.30 	(b) In addressing the issues identified under paragraph (a), the governor or the governor's 
209.31 	designated representatives shall only enter into agreements that:
209.32 	(1) provide for the preservation of public health and safety;
210.1 	(2) ensure the security of production, processing, retail, and research facilities on Tribal 
210.2 	land; and
210.3 	(3) establish provisions regulating business involving medical cannabis flower and 
210.4 	medical cannabinoid products that pass between Tribal land and non-Tribal land in the state.
210.5 		Subd. 4.Assessments and charges. Notwithstanding any law to the contrary, any 
210.6 	compact agreed to under this section shall establish all taxes, fees, assessments, and other 
210.7 	charges related to the production, processing, sale or distribution, and possession of medical 
210.8 	cannabis flower and medical cannabinoid products.
210.9 		Subd. 5.Civil and criminal immunities. The following acts, when performed by a 
210.10 	validly licensed medical cannabis retailer or an employee of a medical cannabis retailer 
210.11 	operated by an Indian Tribe pursuant to a compact entered into under this section, do not 
210.12 	constitute a criminal or civil offense under state law:
210.13 	(1) the cultivation of cannabis flower, as defined in section 342.01, subdivision 15;
210.14 	(2) the possession, purchase, and receipt of medical cannabis flower and medical 
210.15 	cannabinoid products that are properly packaged and labeled as authorized under a compact 
210.16 	entered into pursuant to this section; and
210.17 	(3) the delivery, distribution, and sale of medical cannabis flower and medical cannabinoid 
210.18 	products as authorized under a compact entered into pursuant to this section and that takes 
210.19 	place on the premises of a medical cannabis retailer on Tribal land to any person 21 years 
210.20 	of age or older.
210.21 		Subd. 6.Publication; report. (a) The governor shall post any compact entered into 
210.22 	under this section on a publicly accessible website.
210.23 	(b) The governor, the attorney general, and the governor's designated representatives 
210.24 	shall report to the legislative committees having jurisdiction over health, taxation, and 
210.25 	commerce annually. This report shall contain information on compacts negotiated and an 
210.26 	outline of prospective negotiations.

210.27 	Sec. 2. [3.9228] ADULT-USE CANNABIS; COMPACTS TO BE NEGOTIATED.
210.28 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
210.29 	meanings given.
210.30 	(b) "Indian Tribe" means a Tribe, band, nation, or other federally recognized group or 
210.31 	community of Indians located within the geographical boundaries of the state of Minnesota.
211.1 	(c) "Adult-use cannabis product" has the meaning given in section 342.01, subdivision 
211.2 	4.
211.3 	(d) "Adult-use cannabis flower" has the meaning given in section 342.01, subdivision 
211.4 	3.
211.5 		Subd. 2.Negotiations authorized. Following a public hearing, the governor or the 
211.6 	governor's designated representatives are authorized to negotiate in good faith a compact 
211.7 	with an Indian Tribe regulating adult-use cannabis flower and adult-use cannabis products. 
211.8 	The attorney general is the legal counsel for the governor or the governor's representatives 
211.9 	in regard to negotiating a compact under this section. If the governor appoints designees to 
211.10 	negotiate under this subdivision, the designees must include at least two members of the 
211.11 	senate and two members of the house of representatives, two of whom must be the chairs 
211.12 	of the senate and house of representatives standing committees with jurisdiction over health 
211.13 	policy.
211.14 		Subd. 3.Terms of compact; rights of parties. (a) A compact agreed to under this 
211.15 	section may address any issues related to adult-use cannabis flower and adult-use cannabis 
211.16 	products that affect the interests of both the state and Indian Tribe or otherwise have an 
211.17 	impact on Tribal-state relations. At a minimum, a compact agreed to on behalf of the state 
211.18 	under this section must address:
211.19 	(1) the enforcement of criminal and civil laws;
211.20 	(2) the regulation of the commercial production, processing, sale or distribution, and 
211.21 	possession of adult-use cannabis flower and adult-use cannabis products;
211.22 	(3) medical and pharmaceutical research involving adult-use cannabis flower and 
211.23 	adult-use cannabis products;
211.24 	(4) the taxation of adult-use cannabis flower and adult-use cannabis products, including 
211.25 	establishing an appropriate amount and method of revenue sharing;
211.26 	(5) the immunities of an Indian Tribe or preemption of state law regarding the production, 
211.27 	processing, or sale or distribution of adult-use cannabis flower and adult-use cannabis 
211.28 	products; and
211.29 	(6) the method of resolution for disputes involving the compact, including the use of 
211.30 	mediation or other alternative dispute resolution processes and procedures.
211.31 	(b) In addressing the issues identified under paragraph (a), the governor or the governor's 
211.32 	designee shall only enter into agreements that:
212.1 	(1) provide for the preservation of public health and safety;
212.2 	(2) ensure the security of production, processing, retail, and research facilities on Tribal 
212.3 	land; and
212.4 	(3) establish provisions regulating business involving adult-use cannabis flower and 
212.5 	adult-use cannabis products that pass between Tribal land and non-Tribal land in the state.
212.6 		Subd. 4.Assessments and charges. Notwithstanding any law to the contrary, any 
212.7 	compact agreed to under this section shall establish all taxes, fees, assessments, and other 
212.8 	charges related to the production, processing, sale or distribution, and possession of adult-use 
212.9 	cannabis flower and adult-use cannabis products.
212.10 		Subd. 5.Civil and criminal immunities. The following acts, when performed by a 
212.11 	validly licensed cannabis retailer or an employee of a cannabis retailer operated by an Indian 
212.12 	Tribe pursuant to a compact entered into under this section, do not constitute a criminal or 
212.13 	civil offense under state law:
212.14 	(1) the cultivation of cannabis flower, as defined in section 342.01, subdivision 15;
212.15 	(2) the possession, purchase, and receipt of adult-use cannabis flower and adult-use 
212.16 	cannabis products that are properly packaged and labeled as authorized under a compact 
212.17 	entered into pursuant to this section; and
212.18 	(3) the delivery, distribution, and sale of adult-use cannabis flower and adult-use cannabis 
212.19 	products as authorized under a compact entered into pursuant to this section and that takes 
212.20 	place on the premises of a medical cannabis retailer on Tribal land to any person 21 years 
212.21 	of age or older.
212.22 		Subd. 6.Publication; report. (a) The governor shall post any compact entered into 
212.23 	under this section on a publicly accessible website.
212.24 	(b) The governor, the attorney general, and the governor's designee shall report to the 
212.25 	legislative committees having jurisdiction over health, taxation, and commerce annually. 
212.26 	This report shall contain information on compacts negotiated and an outline of prospective 
212.27 	negotiations.

212.28 	Sec. 3. Minnesota Statutes 2022, section 13.411, is amended by adding a subdivision to 
212.29 	read:
212.30 		Subd. 12.Cannabis businesses. Data submitted to the Office of Cannabis Management 
212.31 	for a cannabis business license and data relating to investigations and disciplinary proceedings 
213.1 	involving cannabis businesses licensed by the Office of Cannabis Management are classified 
213.2 	under section 342.17, subdivision 6.

213.3 	Sec. 4. Minnesota Statutes 2022, section 13.871, is amended by adding a subdivision to 
213.4 	read:
213.5 		Subd. 15.Cannabis Expungement Board records. Data collected, created, received, 
213.6 	maintained, or disseminated by the Cannabis Expungement Board are classified under 
213.7 	section 609A.06, subdivision 8.

213.8 	Sec. 5. Minnesota Statutes 2022, section 16B.2975, subdivision 8, is amended to read:
213.9 		Subd. 8.Canine management. (a) The commissioner may give and convey to a canine's 
213.10 	handler the state's entirety of the right, title, interest, and estate in and to a canine who is 
213.11 	retired from service, with whom the handler trained and worked while the canine was in 
213.12 	service to the state. The handler is solely responsible for all future expenses related to the 
213.13 	retired canine. The commissioner must allow the handler an opportunity to accept the canine 
213.14 	before any other placement options are considered.
213.15 	(b) If the canine's handler does not accept the canine, the agency with ownership of the 
213.16 	canine must determine a home where the canine will be safe and well cared for and inform 
213.17 	the commissioner. The commissioner may give and convey the state's entirety of the right, 
213.18 	title, interest, and estate in and to a canine who is retired from service to the new owner. 
213.19 	The new owner is solely responsible for all future expenses related to the retired canine.

213.20 	Sec. 6. Minnesota Statutes 2022, section 34A.01, is amended by adding a subdivision to 
213.21 	read:
213.22 		Subd. 4a.Food. "Food" means every ingredient used for, entering into the consumption 
213.23 	of, or used or intended for use in the preparation of food, drink, confectionery, or condiment 
213.24 	for humans or other animals, whether simple, mixed, or compound; and articles used as 
213.25 	components of these ingredients, except that edible cannabis products, as defined in section 
213.26 	342.01, subdivision 29, and lower-potency hemp edibles, as defined in section 342.01, 
213.27 	subdivision 49, are not food.

213.28 	EFFECTIVE DATE. This section is effective July 1, 2024.

213.29 	Sec. 7. Minnesota Statutes 2022, section 97B.065, subdivision 1, is amended to read:
213.30 		Subdivision 1.Acts prohibited. (a) A person may not take wild animals with a firearm 
213.31 	or by archery:
214.1 	(1) when the person is under the influence of alcohol;
214.2 	(2) when the person is under the influence of a controlled substance, as defined in section 
214.3 	152.01 169A.03, subdivision 4 6;
214.4 	(3) when the person is under the influence of a combination of any two or more of the 
214.5 	elements in clauses (1) and (2);
214.6 	(4) when the person's alcohol concentration is 0.08 or more;
214.7 	(5) when the person's alcohol concentration as measured within two hours of the time 
214.8 	of taking is 0.08 or more; or
214.9 	(6) when the person is under the influence of an intoxicating substance as defined in 
214.10 	section 169A.03, subdivision 11a, and the person knows or has reason to know that the 
214.11 	substance has the capacity to cause impairment.
214.12 	(b) An owner or other person having charge or control of a firearm or bow may not 
214.13 	authorize or permit an individual the person knows or has reason to believe is under the 
214.14 	influence of alcohol or a controlled substance, as provided under paragraph (a), to possess 
214.15 	the firearm or bow in this state or on a boundary water of this state.
214.16 	(c) A person may not possess a loaded or uncased firearm or an uncased bow afield 
214.17 	under any of the conditions in paragraph (a).

214.18 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
214.19 	committed on or after that date.

214.20 	Sec. 8. Minnesota Statutes 2022, section 97B.066, is amended by adding a subdivision to 
214.21 	read:
214.22 		Subd. 12.Definition. As used in this section, "controlled substance" has the meaning 
214.23 	given in section 169A.03, subdivision 6.

214.24 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
214.25 	committed on or after that date.

214.26 	Sec. 9. [120B.215] EDUCATION ON CANNABIS USE AND SUBSTANCE USE.
214.27 		Subdivision 1.Model program. The commissioner of education, in consultation with 
214.28 	the commissioners of health and human services, local district and school health education 
214.29 	specialists, and other qualified experts, shall identify one or more model programs that may 
214.30 	be used to educate middle school and high school students on the health effects on children 
214.31 	and adolescents of cannabis use and substance use consistent with local standards as required 
215.1 	in section 120B.021, subdivision 1, paragraph (a), clause (6), for elementary and secondary 
215.2 	school students. The commissioner must publish a list of model programs that include 
215.3 	written materials, curriculum resources, and training for instructors by June 1, 2025. A 
215.4 	model program identified by the commissioner must be medically accurate, age and 
215.5 	developmentally appropriate, culturally inclusive, and grounded in science, and must address:
215.6 	(1) the physical and mental health effects of cannabis use and substance use by children,  
215.7 	adolescents, and persons under 25 years of age, including effects on the developing brains 
215.8 	of children, adolescents, and persons under 25 years of age;
215.9 	(2) unsafe or unhealthy behaviors associated with cannabis use and substance use;
215.10 	(3) signs of substance use disorders;
215.11 	(4) treatment options; and
215.12 	(5) healthy coping strategies for children and adolescents.
215.13 		Subd. 2.School programs. (a) Starting in the 2026-2027 school year, a school district 
215.14 	or charter school must implement a comprehensive education program on cannabis use and 
215.15 	substance use for students in middle school and high school. The program must include 
215.16 	instruction on the topics listed in subdivision 1 and must:
215.17 	(1) respect community values and encourage students to communicate with parents, 
215.18 	guardians, and other trusted adults about cannabis use and substance use; and
215.19 	(2) refer students to local resources where students may obtain medically accurate 
215.20 	information about cannabis use and substance use, and treatment for a substance use disorder.
215.21 	(b) District efforts to develop, implement, or improve instruction or curriculum as a 
215.22 	result of the provisions of this section must be consistent with sections 120B.10 and 120B.11.
215.23 		Subd. 3.Parental review. Notwithstanding any law to the contrary, each school district 
215.24 	shall have a procedure for a parent, a guardian, or an adult student 18 years of age or older 
215.25 	to review the content of the instructional materials to be provided to a minor child or to an 
215.26 	adult student pursuant to this section. The district or charter school must allow a parent or 
215.27 	adult student to opt out of instruction under this section with no academic or other penalty 
215.28 	for the student and must inform parents and adult students of this right to opt out.
215.29 		Subd. 4.Youth council. A school district or charter school may establish one or more 
215.30 	youth councils in which student members of the council receive education and training on 
215.31 	cannabis use and substance use and provide peer-to-peer education on these topics.

216.1 	Sec. 10. [144.196] CANNABIS DATA COLLECTION AND BIENNIAL REPORTS.
216.2 		Subdivision 1.General. The commissioner of health shall engage in research and data 
216.3 	collection activities to measure the prevalence of cannabis flower and cannabis product use 
216.4 	in the state by persons under 21 years of age and by persons 21 years of age or older, and 
216.5 	the trends in hospital-treated cannabis poisoning and adverse events. In order to collect data, 
216.6 	the commissioner may modify existing data collection tools used by the department or other 
216.7 	state agencies or may establish one or more new data collection tools.
216.8 		Subd. 2.Statewide assessment; baseline data; updates. (a) The commissioner shall 
216.9 	conduct a statewide assessment to establish a baseline for the prevalence of cannabis flower 
216.10 	and cannabis product use in the state, and the trends in hospital-treated cannabis poisoning 
216.11 	and adverse events broken out by:
216.12 	(1) the current age of the customer;
216.13 	(2) the age at which the customer began consuming cannabis flower or cannabis products;
216.14 	(3) whether the customer consumes cannabis flower or cannabis products, and by type 
216.15 	of cannabis product that the customer consumes, if applicable;
216.16 	(4) the amount of cannabis flower or cannabis product typically consumed at one time;
216.17 	(5) the typical frequency of consumption; and
216.18 	(6) other criteria specified by the commissioner.
216.19 	(b) The initial assessment must be completed by July 1, 2024. The commissioner shall 
216.20 	collect updated data under this subdivision at least every two years thereafter.
216.21 		Subd. 3.Reports. Beginning January 1, 2025, and every two years thereafter, the 
216.22 	commissioner shall issue a public report on the prevalence of cannabis flower use and the 
216.23 	use of cannabis products in the state by persons under age 21 and by persons age 21 or 
216.24 	older, and the trends in hospital-treated cannabis poisoning and adverse events. The report 
216.25 	may include recommendations from the commissioner for changes to this chapter that would 
216.26 	discourage or prevent personal use of cannabis flower or cannabis products by persons 
216.27 	under age 21, that would discourage personal use of cannabis flower or cannabis products 
216.28 	by pregnant or breastfeeding individuals, that would prevent access to cannabis flower or 
216.29 	cannabis products by young children, or that would otherwise promote public health.

216.30 	Sec. 11. [144.197] CANNABIS EDUCATION PROGRAMS.
216.31 		Subdivision 1.Youth education. The commissioner of health, in collaboration with 
216.32 	local health departments, shall conduct a long-term, coordinated education program to raise 
217.1 	public awareness about and address the top three adverse health effects, as determined by 
217.2 	the commissioner, associated with the use of cannabis flower or cannabis products by persons 
217.3 	under age 25. In conducting this education program, the commissioner shall engage and 
217.4 	consult with youth around the state on program content and on methods to effectively 
217.5 	disseminate program information to youth around the state.
217.6 		Subd. 2.Education for pregnant and breastfeeding individuals; individuals who 
217.7 	may become pregnant. The commissioner of health, in consultation with the commissioners 
217.8 	of human services and education, shall conduct a long-term, coordinated program to educate 
217.9 	pregnant individuals, breastfeeding individuals, and individuals who may become pregnant 
217.10 	on the adverse health effects of prenatal exposure to cannabis flower or cannabis products 
217.11 	and on the adverse health effects experienced by infants and children who are exposed to 
217.12 	cannabis flower or cannabis products in breast milk, from secondhand smoke, or by ingesting 
217.13 	cannabis products. This education program must also educate individuals on what constitutes 
217.14 	a substance use disorder, signs of a substance use disorder, and treatment options for persons 
217.15 	with a substance use disorder.
217.16 		Subd. 3.Home visiting programs. The commissioner of health shall provide training, 
217.17 	technical assistance, and education materials to local public health home visiting programs,  
217.18 	Tribal home visiting programs, and child welfare workers regarding the safe and unsafe use 
217.19 	of cannabis flower or cannabis products in homes with infants and young children. Training, 
217.20 	technical assistance, and education materials shall address substance use, the signs of a 
217.21 	substance use disorder, treatment options for persons with a substance use disorder, the 
217.22 	dangers of driving under the influence of cannabis flower or cannabis products, how to 
217.23 	safely consume cannabis flower or cannabis products in homes with infants and young 
217.24 	children, and how to prevent infants and young children from being exposed to cannabis 
217.25 	flower or cannabis products by ingesting cannabis products or through secondhand smoke.
217.26 		Subd. 4.Local and Tribal health departments. The commissioner of health shall 
217.27 	distribute grants to local health departments and Tribal health departments for these 
217.28 	departments to create and disseminate educational materials on cannabis flower and cannabis 
217.29 	products and to provide safe use and prevention training, education, technical assistance, 
217.30 	and community engagement regarding cannabis flower and cannabis products.

217.31 	Sec. 12. Minnesota Statutes 2022, section 169A.03, subdivision 6, is amended to read:
217.32 		Subd. 6.Controlled substance. "Controlled substance" has the meaning given in section 
217.33 	152.01, subdivision 4. The term also includes hemp as defined in section 152.22, subdivision 
217.34 	5a.

218.1 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
218.2 	committed on or after that date. This section expires January 1, 2024.

218.3 	Sec. 13. Minnesota Statutes 2022, section 175.45, subdivision 1, is amended to read:
218.4 		Subdivision 1.Duties; goal. The commissioner of labor and industry shall convene 
218.5 	industry representatives, identify occupational competency standards, and provide technical 
218.6 	assistance to develop dual-training programs. The competency standards shall be identified 
218.7 	for employment in occupations in advanced manufacturing, health care services, information 
218.8 	technology, and agriculture, and the legal cannabis industry. Competency standards are not 
218.9 	rules and are exempt from the rulemaking provisions of chapter 14, and the provisions in 
218.10 	section 14.386 concerning exempt rules do not apply.

218.11 	Sec. 14. Minnesota Statutes 2022, section 181.938, subdivision 2, is amended to read:
218.12 		Subd. 2.Prohibited practice. (a) An employer may not refuse to hire a job applicant 
218.13 	or discipline or discharge an employee because the applicant or employee engages in or has 
218.14 	engaged in the use or enjoyment of lawful consumable products, if the use or enjoyment 
218.15 	takes place off the premises of the employer during nonworking hours. For purposes of this 
218.16 	section, "lawful consumable products" means products whose use or enjoyment is lawful 
218.17 	and which are consumed during use or enjoyment, and includes food, alcoholic or 
218.18 	nonalcoholic beverages, and tobacco, cannabis flower, as defined in section 342.01, 
218.19 	subdivision 15, and cannabis products, as defined in section 342.01, subdivision 19.
218.20 	(b) Cannabis flower and cannabis products are lawful consumable products for the 
218.21 	purpose of Minnesota law, regardless of whether federal or other state law considers cannabis 
218.22 	use, possession, impairment, sale, or transfer to be unlawful. Nothing in this section shall 
218.23 	be construed to limit an employer's ability to discipline or discharge an employee for cannabis 
218.24 	flower or cannabis product use, possession, impairment, sale, or transfer during working 
218.25 	hours, on work premises, or while operating an employer's vehicle, machinery, or equipment, 
218.26 	or if a failure to do so would violate federal or state law or regulations or cause an employer 
218.27 	to lose a monetary or licensing-related benefit under federal law or regulations.

218.28 	Sec. 15. Minnesota Statutes 2022, section 181.950, subdivision 2, is amended to read:
218.29 		Subd. 2.Confirmatory test; confirmatory retest. "Confirmatory test" and "confirmatory 
218.30 	retest" mean a drug or alcohol test or cannabis test that uses a method of analysis allowed 
218.31 	under one of the programs listed in section 181.953, subdivision 1.

219.1 	Sec. 16. Minnesota Statutes 2022, section 181.950, subdivision 4, is amended to read:
219.2 		Subd. 4.Drug. "Drug" means a controlled substance as defined in section 152.01, 
219.3 	subdivision 4, but does not include marijuana, tetrahydrocannabinols, cannabis flower as 
219.4 	defined in section 342.01, subdivision 15, or cannabis products as defined in section 342.01, 
219.5 	subdivision 19.

219.6 	Sec. 17. Minnesota Statutes 2022, section 181.950, subdivision 5, is amended to read:
219.7 		Subd. 5.Drug and alcohol testing. "Drug and alcohol testing," "drug or alcohol testing," 
219.8 	and "drug or alcohol test" mean analysis of a body component sample according to the 
219.9 	standards established under one of the programs listed in section 181.953, subdivision 1, 
219.10 	for the purpose of measuring the presence or absence of drugs, alcohol, or their metabolites 
219.11 	in the sample tested. "Drug and alcohol testing," "drug or alcohol testing," and "drug or 
219.12 	alcohol test" do not include cannabis or cannabis testing, unless stated otherwise.

219.13 	Sec. 18. Minnesota Statutes 2022, section 181.950, is amended by adding a subdivision 
219.14 	to read:
219.15 		Subd. 5a.Cannabis testing. "Cannabis testing" means the analysis of a body component 
219.16 	sample according to the standards established under one of the programs listed in section 
219.17 	181.953, subdivision 1, for the purpose of measuring the presence or absence of cannabis 
219.18 	flower, as defined in section 342.01, subdivision 15, cannabis products, as defined in section 
219.19 	342.01, subdivision 19, or cannabis metabolites in the sample tested. The definitions in this 
219.20 	section apply to cannabis testing unless stated otherwise.

219.21 	Sec. 19. Minnesota Statutes 2022, section 181.950, subdivision 8, is amended to read:
219.22 		Subd. 8.Initial screening test. "Initial screening test" means a drug or alcohol test or 
219.23 	cannabis test which uses a method of analysis under one of the programs listed in section 
219.24 	181.953, subdivision 1.

219.25 	Sec. 20. Minnesota Statutes 2022, section 181.950, subdivision 13, is amended to read:
219.26 		Subd. 13.Safety-sensitive position. "Safety-sensitive position" means a job, including 
219.27 	any supervisory or management position, in which an impairment caused by drug or, alcohol, 
219.28 	or cannabis usage would threaten the health or safety of any person.

220.1 	Sec. 21. Minnesota Statutes 2022, section 181.951, subdivision 4, is amended to read:
220.2 		Subd. 4.Random testing. An employer may request or require employees to undergo
220.3 	cannabis testing or drug and alcohol testing on a random selection basis only if (1) they are 
220.4 	employed in safety-sensitive positions, or (2) they are employed as professional athletes if 
220.5 	the professional athlete is subject to a collective bargaining agreement permitting random 
220.6 	testing but only to the extent consistent with the collective bargaining agreement.

220.7 	Sec. 22. Minnesota Statutes 2022, section 181.951, is amended by adding a subdivision 
220.8 	to read:
220.9 		Subd. 8.Limitations on cannabis testing. (a) An employer must not request or require 
220.10 	a job applicant to undergo cannabis testing solely for the purpose of determining the presence 
220.11 	or absence of cannabis as a condition of employment unless otherwise required by state or 
220.12 	federal law.
220.13 	(b) Unless otherwise required by state or federal law, an employer must not refuse to 
220.14 	hire a job applicant solely because the job applicant submits to a cannabis test authorized 
220.15 	by this section and the results of the test indicate the presence of cannabis.
220.16 	(c) An employer must not request or require an employee or job applicant to undergo 
220.17 	cannabis testing on an arbitrary or capricious basis.
220.18 	(d) An employer may request or require an employee to undergo cannabis testing 
220.19 	conducted by a testing laboratory that participates in one of the programs listed in section 
220.20 	181.953, subdivision 1, if the employer has a reasonable suspicion that while the employee 
220.21 	is working or while the employee is on the employer's premises or operating the employer's 
220.22 	vehicle, machinery, or equipment, the employee:
220.23 	(1) as the result of consuming cannabis flower or a cannabis product, does not possess 
220.24 	that clearness of intellect and control of self that the employee otherwise would have;
220.25 	(2) has violated the employer's written work rules prohibiting cannabis use, possession, 
220.26 	impairment, sale, or transfer, provided that the work rules for cannabis and cannabis testing 
220.27 	are in writing and in a written policy that contains the minimum information required in 
220.28 	section 181.952; or
220.29 	(3) has sustained a personal injury or has a caused a work-related accident as provided 
220.30 	in subdivision 5, clauses (3) and (4).
220.31 	(e) Cannabis testing authorized under paragraph (d) must comply with the safeguards 
220.32 	for testing employees provided in sections 181.953 and 181.954.

221.1 	Sec. 23. Minnesota Statutes 2022, section 181.951, is amended by adding a subdivision 
221.2 	to read:
221.3 		Subd. 9.Cannabis testing exceptions. For the following positions, cannabis and its 
221.4 	metabolites are considered a drug and subject to the drug and alcohol testing provisions in 
221.5 	sections 181.950 to 181.957:
221.6 	(1) a safety-sensitive position, as defined in section 181.950, subdivision 13;
221.7 	(2) a peace officer position, as defined in section 626.84, subdivision 1;
221.8 	(3) a firefighter position, as defined in section 299N.01, subdivision 3;
221.9 	(4) a position requiring face-to-face care, training, education, supervision, counseling, 
221.10 	consultation, or medical assistance to:
221.11 	(i) children;
221.12 	(ii) vulnerable adults, as defined in section 626.5572, subdivision 21; or
221.13 	(iii) patients who receive health care services from a provider for the treatment, 
221.14 	examination, or emergency care of a medical, psychiatric, or mental condition;
221.15 	(5) a position requiring a commercial driver's license or requiring an employee to operate 
221.16 	a motor vehicle for which state or federal law requires drug or alcohol testing of a job 
221.17 	applicant or an employee;
221.18 	(6) a position of employment funded by a federal grant; or
221.19 	(7) any other position for which state or federal law requires testing of a job applicant 
221.20 	or an employee for cannabis.

221.21 	Sec. 24. Minnesota Statutes 2022, section 181.952, is amended by adding a subdivision 
221.22 	to read:
221.23 		Subd. 3.Cannabis policy. (a) Unless otherwise provided by state or federal law, an 
221.24 	employer is not required to permit or accommodate cannabis flower or cannabis product 
221.25 	use, possession, impairment, sale, or transfer while an employee is working or while an 
221.26 	employee is on the employer's premises or operating the employer's vehicle, machinery, or 
221.27 	equipment.
221.28 	(b) An employer may only enact and enforce written work rules prohibiting cannabis 
221.29 	flower and cannabis product use, possession, impairment, sale, or transfer while an employee 
221.30 	is working or while an employee is on the employer's premises or operating the employer's 
222.1 	vehicle, machinery, or equipment in a written policy that contains the minimum information 
222.2 	required by this section.

222.3 	Sec. 25. Minnesota Statutes 2022, section 181.953, is amended to read:
222.4 	181.953 RELIABILITY AND FAIRNESS SAFEGUARDS.
222.5 		Subdivision 1.Use of licensed, accredited, or certified laboratory required. (a) An 
222.6 	employer who requests or requires an employee or job applicant to undergo drug or alcohol 
222.7 	testing or cannabis testing shall use the services of a testing laboratory that meets one of 
222.8 	the following criteria for drug testing:
222.9 	(1) is certified by the National Institute on Drug Abuse as meeting the mandatory 
222.10 	guidelines published at 53 Federal Register 11970 to 11989, April 11, 1988;
222.11 	(2) is accredited by the College of American Pathologists, 325 Waukegan Road, 
222.12 	Northfield, Illinois, 60093-2750, under the forensic urine drug testing laboratory program; 
222.13 	or
222.14 	(3) is licensed to test for drugs by the state of New York, Department of Health, under 
222.15 	Public Health Law, article 5, title V, and rules adopted under that law.
222.16 	(b) For alcohol testing, the laboratory must either be:
222.17 	(1) licensed to test for drugs and alcohol by the state of New York, Department of Health, 
222.18 	under Public Health Law, article 5, title V, and the rules adopted under that law; or
222.19 	(2) accredited by the College of American Pathologists, 325 Waukegan Road, Northfield, 
222.20 	Illinois, 60093-2750, in the laboratory accreditation program.
222.21 		Subd. 3.Laboratory testing, reporting, and sample retention requirements. A testing 
222.22 	laboratory that is not certified by the National Institute on Drug Abuse according to 
222.23 	subdivision 1 shall follow the chain-of-custody procedures prescribed for employers in 
222.24 	subdivision 5. A testing laboratory shall conduct a confirmatory test on all samples that 
222.25 	produced a positive test result on an initial screening test. A laboratory shall disclose to the 
222.26 	employer a written test result report for each sample tested within three working days after 
222.27 	a negative test result on an initial screening test or, when the initial screening test produced 
222.28 	a positive test result, within three working days after a confirmatory test. A test report must 
222.29 	indicate the drugs, alcohol, or drug or alcohol metabolites, or cannabis or cannabis 
222.30 	metabolites tested for and whether the test produced negative or positive test results. A 
222.31 	laboratory shall retain and properly store for at least six months all samples that produced 
222.32 	a positive test result.
223.1 		Subd. 4.Prohibitions on employers. An employer may not conduct drug or alcohol 
223.2 	testing or cannabis testing of its own employees and job applicants using a testing laboratory 
223.3 	owned and operated by the employer; except that, one agency of the state may test the 
223.4 	employees of another agency of the state. Except as provided in subdivision 9, an employer 
223.5 	may not request or require an employee or job applicant to contribute to, or pay the cost of, 
223.6 	drug or alcohol testing or cannabis testing under sections 181.950 to 181.954.
223.7 		Subd. 5.Employer chain-of-custody procedures. An employer shall establish its own 
223.8 	reliable chain-of-custody procedures to ensure proper record keeping, handling, labeling, 
223.9 	and identification of the samples to be tested. The procedures must require the following:
223.10 	(1) possession of a sample must be traceable to the employee from whom the sample is 
223.11 	collected, from the time the sample is collected through the time the sample is delivered to 
223.12 	the laboratory;
223.13 	(2) the sample must always be in the possession of, must always be in view of, or must 
223.14 	be placed in a secured area by a person authorized to handle the sample;
223.15 	(3) a sample must be accompanied by a written chain-of-custody record; and
223.16 	(4) individuals relinquishing or accepting possession of the sample must record the time 
223.17 	the possession of the sample was transferred and must sign and date the chain-of-custody 
223.18 	record at the time of transfer.
223.19 		Subd. 6.Rights of employees and job applicants. (a) Before requesting an employee 
223.20 	or job applicant to undergo drug or alcohol testing or requesting cannabis testing, an employer 
223.21 	shall provide the employee or job applicant with a form, developed by the employer, on 
223.22 	which to acknowledge that the employee or job applicant has seen the employer's drug and 
223.23 	alcohol testing or cannabis testing policy.
223.24 	(b) If an employee or job applicant tests positive for drug use, the employee must be 
223.25 	given written notice of the right to explain the positive test and the employer may request 
223.26 	that the employee or job applicant indicate any over-the-counter or prescription medication 
223.27 	that the individual is currently taking or has recently taken and any other information relevant 
223.28 	to the reliability of, or explanation for, a positive test result.
223.29 	(c) Within three working days after notice of a positive test result on a confirmatory test, 
223.30 	the employee or job applicant may submit information to the employer, in addition to any 
223.31 	information already submitted under paragraph (b), to explain that result, or may request a 
223.32 	confirmatory retest of the original sample at the employee's or job applicant's own expense 
223.33 	as provided under subdivision 9.
224.1 		Subd. 7.Notice of test results. Within three working days after receipt of a test result 
224.2 	report from the testing laboratory, an employer shall inform in writing an employee or job 
224.3 	applicant who has undergone drug or alcohol testing or cannabis testing of (1) a negative 
224.4 	test result on an initial screening test or of a negative or positive test result on a confirmatory 
224.5 	test and (2) the right provided in subdivision 8. In the case of a positive test result on a 
224.6 	confirmatory test, the employer shall also, at the time of this notice, inform the employee 
224.7 	or job applicant in writing of the rights provided in subdivisions 6, paragraph (b), 9, and 
224.8 	either subdivision 10 or 11, whichever applies.
224.9 		Subd. 8.Right to test result report. An employee or job applicant has the right to 
224.10 	request and receive from the employer a copy of the test result report on any drug or alcohol 
224.11 	test or cannabis test.
224.12 		Subd. 9.Confirmatory retests. An employee or job applicant may request a confirmatory 
224.13 	retest of the original sample at the employee's or job applicant's own expense after notice 
224.14 	of a positive test result on a confirmatory test. Within five working days after notice of the 
224.15 	confirmatory test result, the employee or job applicant shall notify the employer in writing 
224.16 	of the employee's or job applicant's intention to obtain a confirmatory retest. Within three 
224.17 	working days after receipt of the notice, the employer shall notify the original testing 
224.18 	laboratory that the employee or job applicant has requested the laboratory to conduct the 
224.19 	confirmatory retest or transfer the sample to another laboratory licensed under subdivision 
224.20 	1 to conduct the confirmatory retest. The original testing laboratory shall ensure that the 
224.21 	chain-of-custody procedures in subdivision 3 are followed during transfer of the sample to 
224.22 	the other laboratory. The confirmatory retest must use the same drug or, alcohol, or cannabis
224.23 	threshold detection levels as used in the original confirmatory test. If the confirmatory retest 
224.24 	does not confirm the original positive test result, no adverse personnel action based on the 
224.25 	original confirmatory test may be taken against the employee or job applicant.
224.26 		Subd. 10.Limitations on employee discharge, discipline, or discrimination. (a) An 
224.27 	employer may not discharge, discipline, discriminate against, or request or require 
224.28 	rehabilitation of an employee on the basis of a positive test result from an initial screening 
224.29 	test that has not been verified by a confirmatory test.
224.30 	(b) In addition to the limitation under paragraph (a), an employer may not discharge an 
224.31 	employee for whom a positive test result on a confirmatory test was the first such result for 
224.32 	the employee on a drug or alcohol test or cannabis test requested by the employer unless 
224.33 	the following conditions have been met:
225.1 	(1) the employer has first given the employee an opportunity to participate in, at the 
225.2 	employee's own expense or pursuant to coverage under an employee benefit plan, either a 
225.3 	drug or, alcohol, or cannabis counseling or rehabilitation program, whichever is more 
225.4 	appropriate, as determined by the employer after consultation with a certified chemical use 
225.5 	counselor or a physician trained in the diagnosis and treatment of substance use disorder; 
225.6 	and
225.7 	(2) the employee has either refused to participate in the counseling or rehabilitation 
225.8 	program or has failed to successfully complete the program, as evidenced by withdrawal 
225.9 	from the program before its completion or by a positive test result on a confirmatory test 
225.10 	after completion of the program.
225.11 	(c) Notwithstanding paragraph (a), an employer may temporarily suspend the tested 
225.12 	employee or transfer that employee to another position at the same rate of pay pending the 
225.13 	outcome of the confirmatory test and, if requested, the confirmatory retest, provided the 
225.14 	employer believes that it is reasonably necessary to protect the health or safety of the 
225.15 	employee, coemployees, or the public. An employee who has been suspended without pay 
225.16 	must be reinstated with back pay if the outcome of the confirmatory test or requested 
225.17 	confirmatory retest is negative.
225.18 	(d) An employer may not discharge, discipline, discriminate against, or request or require 
225.19 	rehabilitation of an employee on the basis of medical history information revealed to the 
225.20 	employer pursuant to subdivision 6 unless the employee was under an affirmative duty to 
225.21 	provide the information before, upon, or after hire.
225.22 	(e) An employee must be given access to information in the employee's personnel file 
225.23 	relating to positive test result reports and other information acquired in the drug and alcohol 
225.24 	testing process or cannabis testing process and conclusions drawn from and actions taken 
225.25 	based on the reports or other acquired information.
225.26 		Subd. 10a.Additional limitations for cannabis. An employer may discipline, discharge, 
225.27 	or take other adverse personnel action against an employee for cannabis flower or cannabis 
225.28 	product use, possession, impairment, sale, or transfer while an employee is working, on the 
225.29 	employer's premises, or operating the employer's vehicle, machinery, or equipment as 
225.30 	follows:
225.31 	(1) if, as the result of consuming cannabis flower or a cannabis product, the employee 
225.32 	does not possess that clearness of intellect and control of self that the employee otherwise 
225.33 	would have;
226.1 	(2) if cannabis testing that the employer requested or required pursuant to section 181.951, 
226.2 	subdivision 8, paragraphs (d) and (e), verifies the presence of cannabis following a 
226.3 	confirmatory test;
226.4 	(3) as provided in the employer's written work rules for cannabis and cannabis testing, 
226.5 	provided that the rules are in writing and in a written policy that contains the minimum 
226.6 	information required by section 181.952; or
226.7 	(4) as otherwise authorized under state or federal law.
226.8 		Subd. 11.Limitation on withdrawal of job offer. If a job applicant has received a job 
226.9 	offer made contingent on the applicant passing drug and alcohol testing, the employer may 
226.10 	not withdraw the offer based on a positive test result from an initial screening test that has 
226.11 	not been verified by a confirmatory test.

226.12 	Sec. 26. Minnesota Statutes 2022, section 181.954, is amended to read:
226.13 	181.954 PRIVACY, CONFIDENTIALITY, AND PRIVILEGE SAFEGUARDS.
226.14 		Subdivision 1.Privacy limitations. A laboratory may only disclose to the employer test 
226.15 	result data regarding the presence or absence of drugs, alcohol, or their metabolites in a 
226.16 	sample tested.
226.17 		Subd. 2.Confidentiality limitations. Test result reports and other information acquired 
226.18 	in the drug or alcohol testing or cannabis testing process are, with respect to private sector 
226.19 	employees and job applicants, private and confidential information, and, with respect to 
226.20 	public sector employees and job applicants, private data on individuals as that phrase is 
226.21 	defined in chapter 13, and may not be disclosed by an employer or laboratory to another 
226.22 	employer or to a third-party individual, governmental agency, or private organization without 
226.23 	the written consent of the employee or job applicant tested.
226.24 		Subd. 3.Exceptions to privacy and confidentiality disclosure 
226.25 	limitations. Notwithstanding subdivisions 1 and 2, evidence of a positive test result on a 
226.26 	confirmatory test may be: (1) used in an arbitration proceeding pursuant to a collective 
226.27 	bargaining agreement, an administrative hearing under chapter 43A or other applicable state 
226.28 	or local law, or a judicial proceeding, provided that information is relevant to the hearing 
226.29 	or proceeding; (2) disclosed to any federal agency or other unit of the United States 
226.30 	government as required under federal law, regulation, or order, or in accordance with 
226.31 	compliance requirements of a federal government contract; and (3) disclosed to a substance 
226.32 	abuse treatment facility for the purpose of evaluation or treatment of the employee.
227.1 		Subd. 4.Privilege. Positive test results from an employer drug or alcohol testing or 
227.2 	cannabis testing program may not be used as evidence in a criminal action against the 
227.3 	employee or job applicant tested.

227.4 	Sec. 27. Minnesota Statutes 2022, section 181.955, is amended to read:
227.5 	181.955 CONSTRUCTION.
227.6 		Subdivision 1.Freedom to collectively bargain. Sections 181.950 to 181.954 shall not 
227.7 	be construed to limit the parties to a collective bargaining agreement from bargaining and 
227.8 	agreeing with respect to a drug and alcohol testing or a cannabis testing policy that meets 
227.9 	or exceeds, and does not otherwise conflict with, the minimum standards and requirements 
227.10 	for employee protection provided in those sections.
227.11 		Subd. 2.Employee protections under existing collective bargaining 
227.12 	agreements. Sections 181.950 to 181.954 shall not be construed to interfere with or diminish 
227.13 	any employee protections relating to drug and alcohol testing or cannabis testing already 
227.14 	provided under collective bargaining agreements in effect on the effective date of those 
227.15 	sections that exceed the minimum standards and requirements for employee protection 
227.16 	provided in those sections.
227.17 		Subd. 3.Professional athletes. Sections 181.950 to 181.954 shall not be construed to 
227.18 	interfere with the operation of a drug and alcohol testing or cannabis testing program if:
227.19 	(1) the drug and alcohol testing program is permitted under a contract between the 
227.20 	employer and employees; and
227.21 	(2) the covered employees are employed as professional athletes.
227.22 	Upon request of the commissioner of labor and industry, the exclusive representative 
227.23 	of the employees and the employer shall certify to the commissioner of labor and industry 
227.24 	that the drug and alcohol testing or cannabis testing program permitted under the contract 
227.25 	should operate without interference from the sections specified in this subdivision. This 
227.26 	subdivision must not be construed to create an exemption from controlled substance crimes 
227.27 	in chapter 152.

227.28 	Sec. 28. Minnesota Statutes 2022, section 181.957, subdivision 1, is amended to read:
227.29 		Subdivision 1.Excluded employees and job applicants. Except as provided under 
227.30 	subdivision 2, the employee and job applicant protections provided under sections 181.950
227.31 	to 181.956 do not apply to employees and job applicants where the specific work performed 
228.1 	requires those employees and job applicants to be subject to drug and alcohol testing or 
228.2 	cannabis testing pursuant to:
228.3 	(1) federal regulations that specifically preempt state regulation of drug and alcohol 
228.4 	testing or cannabis testing with respect to those employees and job applicants;
228.5 	(2) federal regulations or requirements necessary to operate federally regulated facilities;
228.6 	(3) federal contracts where the drug and alcohol testing or cannabis testing is conducted 
228.7 	for security, safety, or protection of sensitive or proprietary data; or
228.8 	(4) state agency rules that adopt federal regulations applicable to the interstate component 
228.9 	of a federally regulated industry, and the adoption of those rules is for the purpose of 
228.10 	conforming the nonfederally regulated intrastate component of the industry to identical 
228.11 	regulation.

228.12 	Sec. 29. Minnesota Statutes 2022, section 192A.555, is amended to read:
228.13 	192A.555 DRIVING WHILE UNDER THE INFLUENCE OR RECKLESS 
228.14 	DRIVING.
228.15 	Any person subject to this code who drives, operates or is in physical control of any 
228.16 	motor vehicle or aircraft while under the influence of an alcoholic beverage or controlled 
228.17 	substance as defined in section 169A.03, subdivision 6, or a combination thereof or whose 
228.18 	blood contains 0.08 percent or more by weight of alcohol or who operates said motor vehicle 
228.19 	or aircraft in a reckless or wanton manner, shall be punished as a court-martial may direct.

228.20 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
228.21 	committed on or after that date.

228.22 	Sec. 30. Minnesota Statutes 2022, section 245C.08, subdivision 1, is amended to read:
228.23 		Subdivision 1.Background studies conducted by Department of Human Services. (a) 
228.24 	For a background study conducted by the Department of Human Services, the commissioner 
228.25 	shall review:
228.26 	(1) information related to names of substantiated perpetrators of maltreatment of 
228.27 	vulnerable adults that has been received by the commissioner as required under section 
228.28 	626.557, subdivision 9c, paragraph (j);
228.29 	(2) the commissioner's records relating to the maltreatment of minors in licensed 
228.30 	programs, and from findings of maltreatment of minors as indicated through the social 
228.31 	service information system;
229.1 	(3) information from juvenile courts as required in subdivision 4 for individuals listed 
229.2 	in section 245C.03, subdivision 1, paragraph (a), when there is reasonable cause;
229.3 	(4) information from the Bureau of Criminal Apprehension, including information 
229.4 	regarding a background study subject's registration in Minnesota as a predatory offender 
229.5 	under section 243.166;
229.6 	(5) except as provided in clause (6), information received as a result of submission of 
229.7 	fingerprints for a national criminal history record check, as defined in section 245C.02, 
229.8 	subdivision 13c, when the commissioner has reasonable cause for a national criminal history 
229.9 	record check as defined under section 245C.02, subdivision 15a, or as required under section 
229.10 	144.057, subdivision 1, clause (2);
229.11 	(6) for a background study related to a child foster family setting application for licensure, 
229.12 	foster residence settings, children's residential facilities, a transfer of permanent legal and 
229.13 	physical custody of a child under sections 260C.503 to 260C.515, or adoptions, and for a 
229.14 	background study required for family child care, certified license-exempt child care, child 
229.15 	care centers, and legal nonlicensed child care authorized under chapter 119B, the 
229.16 	commissioner shall also review:
229.17 	(i) information from the child abuse and neglect registry for any state in which the 
229.18 	background study subject has resided for the past five years;
229.19 	(ii) when the background study subject is 18 years of age or older, or a minor under 
229.20 	section 245C.05, subdivision 5a, paragraph (c), information received following submission 
229.21 	of fingerprints for a national criminal history record check; and
229.22 	(iii) when the background study subject is 18 years of age or older or a minor under 
229.23 	section 245C.05, subdivision 5a, paragraph (d), for licensed family child care, certified 
229.24 	license-exempt child care, licensed child care centers, and legal nonlicensed child care 
229.25 	authorized under chapter 119B, information obtained using non-fingerprint-based data 
229.26 	including information from the criminal and sex offender registries for any state in which 
229.27 	the background study subject resided for the past five years and information from the national 
229.28 	crime information database and the national sex offender registry; and
229.29 	(7) for a background study required for family child care, certified license-exempt child 
229.30 	care centers, licensed child care centers, and legal nonlicensed child care authorized under 
229.31 	chapter 119B, the background study shall also include, to the extent practicable, a name 
229.32 	and date-of-birth search of the National Sex Offender Public website.
230.1 	(b) Except as otherwise provided in this paragraph, notwithstanding expungement by a 
230.2 	court, the commissioner may consider information obtained under paragraph (a), clauses 
230.3 	(3) and (4), unless the commissioner received notice of the petition for expungement and 
230.4 	the court order for expungement is directed specifically to the commissioner. The 
230.5 	commissioner may not consider information obtained under paragraph (a), clauses (3) and 
230.6 	(4), or from any other source that identifies a violation of chapter 152 without determining 
230.7 	if the offense involved the possession of marijuana or tetrahydrocannabinol and, if so, 
230.8 	whether the person received a grant of expungement or order of expungement, or the person 
230.9 	was resentenced to a lesser offense. If the person received a grant of expungement or order 
230.10 	of expungement, the commissioner may not consider information related to that violation 
230.11 	but may consider any other relevant information arising out of the same incident.
230.12 	(c) The commissioner shall also review criminal case information received according 
230.13 	to section 245C.04, subdivision 4a, from the Minnesota court information system that relates 
230.14 	to individuals who have already been studied under this chapter and who remain affiliated 
230.15 	with the agency that initiated the background study.
230.16 	(d) When the commissioner has reasonable cause to believe that the identity of a 
230.17 	background study subject is uncertain, the commissioner may require the subject to provide 
230.18 	a set of classifiable fingerprints for purposes of completing a fingerprint-based record check 
230.19 	with the Bureau of Criminal Apprehension. Fingerprints collected under this paragraph 
230.20 	shall not be saved by the commissioner after they have been used to verify the identity of 
230.21 	the background study subject against the particular criminal record in question.
230.22 	(e) The commissioner may inform the entity that initiated a background study under 
230.23 	NETStudy 2.0 of the status of processing of the subject's fingerprints.

230.24 	Sec. 31. Minnesota Statutes 2022, section 256.01, subdivision 18c, is amended to read:
230.25 		Subd. 18c.Drug convictions. (a) The state court administrator shall provide a report 
230.26 	every six months by electronic means to the commissioner of human services, including 
230.27 	the name, address, date of birth, and, if available, driver's license or state identification card 
230.28 	number, date of the sentence, effective date of the sentence, and county in which the 
230.29 	conviction occurred, of each person convicted of a felony under chapter 152, except for 
230.30 	convictions under section 152.0263 or 152.0264, during the previous six months.
230.31 	(b) The commissioner shall determine whether the individuals who are the subject of 
230.32 	the data reported under paragraph (a) are receiving public assistance under chapter 256D 
230.33 	or 256J, and if the an individual is receiving assistance under chapter 256D or 256J, the 
231.1 	commissioner shall instruct the county to proceed under section 256D.024 or 256J.26, 
231.2 	whichever is applicable, for this individual.
231.3 	(c) The commissioner shall not retain any data received under paragraph (a) or (d) that 
231.4 	does not relate to an individual receiving publicly funded assistance under chapter 256D or 
231.5 	256J.
231.6 	(d) In addition to the routine data transfer under paragraph (a), the state court 
231.7 	administrator shall provide a onetime report of the data fields under paragraph (a) for 
231.8 	individuals with a felony drug conviction under chapter 152 dated from July 1, 1997, until 
231.9 	the date of the data transfer. The commissioner shall perform the tasks identified under 
231.10 	paragraph (b) related to this data and shall retain the data according to paragraph (c).

231.11 	Sec. 32. Minnesota Statutes 2022, section 256B.0625, subdivision 13d, is amended to 
231.12 	read:
231.13 		Subd. 13d.Drug formulary. (a) The commissioner shall establish a drug formulary. Its 
231.14 	establishment and publication shall not be subject to the requirements of the Administrative 
231.15 	Procedure Act, but the Formulary Committee shall review and comment on the formulary 
231.16 	contents.
231.17 	(b) The formulary shall not include:
231.18 	(1) drugs, active pharmaceutical ingredients, or products for which there is no federal 
231.19 	funding;
231.20 	(2) over-the-counter drugs, except as provided in subdivision 13;
231.21 	(3) drugs or active pharmaceutical ingredients when used for the treatment of impotence 
231.22 	or erectile dysfunction;
231.23 	(4) drugs or active pharmaceutical ingredients for which medical value has not been 
231.24 	established;
231.25 	(5) drugs from manufacturers who have not signed a rebate agreement with the 
231.26 	Department of Health and Human Services pursuant to section 1927 of title XIX of the 
231.27 	Social Security Act; and
231.28 	(6) medical cannabis flower as defined in section 152.22, subdivision 6 342.01, 
231.29 	subdivision 53, or medical cannabinoid products as defined in section 342.01, subdivision  
231.30 	51.
231.31 	(c) If a single-source drug used by at least two percent of the fee-for-service medical 
231.32 	assistance recipients is removed from the formulary due to the failure of the manufacturer 
232.1 	to sign a rebate agreement with the Department of Health and Human Services, the 
232.2 	commissioner shall notify prescribing practitioners within 30 days of receiving notification 
232.3 	from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was 
232.4 	not signed.

232.5 	Sec. 33. Minnesota Statutes 2022, section 256D.024, subdivision 1, is amended to read:
232.6 		Subdivision 1.Person convicted of drug offenses. (a) If an applicant or recipient has 
232.7 	been convicted of a drug offense after July 1, 1997, except for convictions related to cannabis, 
232.8 	marijuana, or tetrahydrocannabinols, the assistance unit is ineligible for benefits under this 
232.9 	chapter until five years after the applicant has completed terms of the court-ordered sentence, 
232.10 	unless the person is participating in a drug treatment program, has successfully completed 
232.11 	a drug treatment program, or has been assessed by the county and determined not to be in 
232.12 	need of a drug treatment program. Persons subject to the limitations of this subdivision who 
232.13 	become eligible for assistance under this chapter shall be subject to random drug testing as 
232.14 	a condition of continued eligibility and shall lose eligibility for benefits for five years 
232.15 	beginning the month following:
232.16 	(1) any positive test result for an illegal controlled substance under chapter 152; or
232.17 	(2) discharge of sentence after conviction for another drug felony.
232.18 	(b) For the purposes of this subdivision, "drug offense" means a conviction that occurred 
232.19 	after July 1, 1997, of sections 152.021 to 152.025, 152.0261, 152.0262, or 152.096. Drug 
232.20 	offense also means a conviction in another jurisdiction of the possession, use, or distribution 
232.21 	of a controlled substance, or conspiracy to commit any of these offenses, if the offense 
232.22 	occurred after July 1, 1997, and the conviction is a felony offense in that jurisdiction, or in 
232.23 	the case of New Jersey, a high misdemeanor for a crime that would be a felony if committed 
232.24 	in Minnesota.

232.25 	Sec. 34. Minnesota Statutes 2022, section 256D.024, subdivision 3, is amended to read:
232.26 		Subd. 3.Fleeing felons. An individual who is fleeing to avoid prosecution, or custody, 
232.27 	or confinement after conviction for a crime that is a felony under the laws of the jurisdiction 
232.28 	from which the individual flees, or in the case of New Jersey, is a high misdemeanor, would 
232.29 	be a felony if committed in Minnesota, is ineligible to receive benefits under this chapter.

232.30 	Sec. 35. Minnesota Statutes 2022, section 256J.26, subdivision 1, is amended to read:
232.31 		Subdivision 1.Person convicted of drug offenses. (a) An individual who has been 
232.32 	convicted of a felony level drug offense committed during the previous ten years from the 
233.1 	date of application or recertification, except for convictions related to cannabis, marijuana, 
233.2 	or tetrahydrocannabinols, is subject to the following:
233.3 	(1) Benefits for the entire assistance unit must be paid in vendor form for shelter and 
233.4 	utilities during any time the applicant is part of the assistance unit.
233.5 	(2) The convicted applicant or participant shall be subject to random drug testing as a 
233.6 	condition of continued eligibility and following any positive test for an illegal controlled 
233.7 	substance under chapter 152 is subject to the following sanctions:
233.8 	(i) for failing a drug test the first time, the residual amount of the participant's grant after 
233.9 	making vendor payments for shelter and utility costs, if any, must be reduced by an amount 
233.10 	equal to 30 percent of the MFIP standard of need for an assistance unit of the same size. 
233.11 	When a sanction under this subdivision is in effect, the job counselor must attempt to meet 
233.12 	with the person face-to-face. During the face-to-face meeting, the job counselor must explain 
233.13 	the consequences of a subsequent drug test failure and inform the participant of the right to 
233.14 	appeal the sanction under section 256J.40. If a face-to-face meeting is not possible, the 
233.15 	county agency must send the participant a notice of adverse action as provided in section 
233.16 	256J.31, subdivisions 4 and 5, and must include the information required in the face-to-face 
233.17 	meeting; or
233.18 	(ii) for failing a drug test two times, the participant is permanently disqualified from 
233.19 	receiving MFIP assistance, both the cash and food portions. The assistance unit's MFIP 
233.20 	grant must be reduced by the amount which would have otherwise been made available to 
233.21 	the disqualified participant. Disqualification under this item does not make a participant 
233.22 	ineligible for the Supplemental Nutrition Assistance Program (SNAP). Before a 
233.23 	disqualification under this provision is imposed, the job counselor must attempt to meet 
233.24 	with the participant face-to-face. During the face-to-face meeting, the job counselor must 
233.25 	identify other resources that may be available to the participant to meet the needs of the 
233.26 	family and inform the participant of the right to appeal the disqualification under section 
233.27 	256J.40. If a face-to-face meeting is not possible, the county agency must send the participant 
233.28 	a notice of adverse action as provided in section 256J.31, subdivisions 4 and 5, and must 
233.29 	include the information required in the face-to-face meeting.
233.30 	(3) A participant who fails a drug test the first time and is under a sanction due to other 
233.31 	MFIP program requirements is considered to have more than one occurrence of 
233.32 	noncompliance and is subject to the applicable level of sanction as specified under section 
233.33 	256J.46, subdivision 1, paragraph (d).
234.1 	(b) Applicants requesting only SNAP benefits or participants receiving only SNAP 
234.2 	benefits, who have been convicted of a drug offense that occurred after July 1, 1997, except 
234.3 	for convictions related to cannabis, marijuana, or tetrahydrocannabinols, may, if otherwise 
234.4 	eligible, receive SNAP benefits if the convicted applicant or participant is subject to random 
234.5 	drug testing as a condition of continued eligibility. Following a positive test for an illegal 
234.6 	controlled substance under chapter 152, the applicant is subject to the following sanctions:
234.7 	(1) for failing a drug test the first time, SNAP benefits shall be reduced by an amount 
234.8 	equal to 30 percent of the applicable SNAP benefit allotment. When a sanction under this 
234.9 	clause is in effect, a job counselor must attempt to meet with the person face-to-face. During 
234.10 	the face-to-face meeting, a job counselor must explain the consequences of a subsequent 
234.11 	drug test failure and inform the participant of the right to appeal the sanction under section 
234.12 	256J.40. If a face-to-face meeting is not possible, a county agency must send the participant 
234.13 	a notice of adverse action as provided in section 256J.31, subdivisions 4 and 5, and must 
234.14 	include the information required in the face-to-face meeting; and
234.15 	(2) for failing a drug test two times, the participant is permanently disqualified from 
234.16 	receiving SNAP benefits. Before a disqualification under this provision is imposed, a job 
234.17 	counselor must attempt to meet with the participant face-to-face. During the face-to-face 
234.18 	meeting, the job counselor must identify other resources that may be available to the 
234.19 	participant to meet the needs of the family and inform the participant of the right to appeal 
234.20 	the disqualification under section 256J.40. If a face-to-face meeting is not possible, a county 
234.21 	agency must send the participant a notice of adverse action as provided in section 256J.31, 
234.22 	subdivisions 4 and 5, and must include the information required in the face-to-face meeting.
234.23 	(c) For the purposes of this subdivision, "drug offense" means an offense that occurred 
234.24 	during the previous ten years from the date of application or recertification of sections 
234.25 	152.021 to 152.025, 152.0261, 152.0262, 152.096, or 152.137. Drug offense also means a 
234.26 	conviction in another jurisdiction of the possession, use, or distribution of a controlled 
234.27 	substance, or conspiracy to commit any of these offenses, if the offense occurred during 
234.28 	the previous ten years from the date of application or recertification and the conviction is 
234.29 	a felony offense in that jurisdiction, or in the case of New Jersey, a high misdemeanor for 
234.30 	a crime that would be a felony if committed in Minnesota.

234.31 	Sec. 36. Minnesota Statutes 2022, section 256J.26, subdivision 3, is amended to read:
234.32 		Subd. 3.Fleeing felons. An individual who is fleeing to avoid prosecution, or custody, 
234.33 	or confinement after conviction for a crime that is a felony under the laws of the jurisdiction 
235.1 	from which the individual flees, or in the case of New Jersey, is a high misdemeanor, would 
235.2 	be a felony if committed in Minnesota, is disqualified from receiving MFIP.

235.3 	Sec. 37. [340A.4022] RETAIL LICENSE NOT PROHIBITED; LOWER-POTENCY 
235.4 	HEMP EDIBLE RETAILER.
235.5 	(a) Nothing in this chapter:
235.6 	(1) prohibits the issuance of a retail license or permit to a person also holding a 
235.7 	lower-potency hemp edible retailer license;
235.8 	(2) allows any agreement between a licensing authority and retail license or permit holder 
235.9 	that prohibits the license or permit holder from also holding a lower-potency hemp edible 
235.10 	retailer license; or
235.11 	(3) allows the revocation or suspension of a retail license or permit, or the imposition 
235.12 	of a penalty on a retail license or permit holder, due to the retail license or permit holder 
235.13 	also holding a lower-potency hemp edible retailer license.
235.14 	(b) For purposes of this section, "lower-potency hemp edible retailer license" means a 
235.15 	license issued by the Office of Cannabis Management under section 342.41.

235.16 	Sec. 38. Minnesota Statutes 2022, section 340A.412, subdivision 14, is amended to read:
235.17 		Subd. 14.Exclusive liquor stores. (a) Except as otherwise provided in this subdivision, 
235.18 	an exclusive liquor store may sell only the following items:
235.19 	(1) alcoholic beverages;
235.20 	(2) tobacco products;
235.21 	(3) ice;
235.22 	(4) beverages, either liquid or powder, specifically designated for mixing with intoxicating 
235.23 	liquor;
235.24 	(5) soft drinks;
235.25 	(6) liqueur-filled candies;
235.26 	(7) food products that contain more than one-half of one percent alcohol by volume;
235.27 	(8) cork extraction devices;
235.28 	(9) books and videos on the use of alcoholic beverages;
236.1 	(10) magazines and other publications published primarily for information and education 
236.2 	on alcoholic beverages;
236.3 	(11) multiple-use bags designed to carry purchased items;
236.4 	(12) devices designed to ensure safe storage and monitoring of alcohol in the home, to 
236.5 	prevent access by underage drinkers;
236.6 	(13) home brewing equipment;
236.7 	(14) clothing marked with the specific name, brand, or identifying logo of the exclusive 
236.8 	liquor store, and bearing no other name, brand, or identifying logo;
236.9 	(15) citrus fruit; and
236.10 	(16) glassware.; and
236.11 	(17) lower-potency hemp edibles as defined in section 342.01, subdivision 49.
236.12 	(b) An exclusive liquor store that has an on-sale, or combination on-sale and off-sale 
236.13 	license may sell food for on-premise consumption when authorized by the municipality 
236.14 	issuing the license.
236.15 	(c) An exclusive liquor store may offer live or recorded entertainment.

236.16 	EFFECTIVE DATE. This section is effective July 1, 2024.

236.17 	Sec. 39. Minnesota Statutes 2022, section 609.2111, is amended to read:
236.18 	609.2111 DEFINITIONS.
236.19 	(a) For purposes of sections 609.2111 to 609.2114, the terms defined in this subdivision 
236.20 	have the meanings given them.
236.21 	(b) "Motor vehicle" has the meaning given in section 609.52, subdivision 1, and includes 
236.22 	attached trailers.
236.23 	(c) "Controlled substance" has the meaning given in section 152.01 169A.03, subdivision 
236.24 	4 6.
236.25 	(d) "Intoxicating substance" has the meaning given in section 169A.03, subdivision 11a.
236.26 	(e) "Qualified prior driving offense" includes a prior conviction:
236.27 	(1) for a violation of section 169A.20 under the circumstances described in section 
236.28 	169A.24 or 169A.25;
237.1 	(2) under section 609.2112, subdivision 1, paragraph (a), clauses (2) to (6); 609.2113, 
237.2 	subdivision 1, clauses (2) to (6); 2, clauses (2) to (6); or 3, clauses (2) to (6); or 609.2114, 
237.3 	subdivision 1, paragraph (a), clauses (2) to (6); or 2, clauses (2) to (6);
237.4 	(3) under Minnesota Statutes 2012, section 609.21, subdivision 1, clauses (2) to (6); or
237.5 	(4) under Minnesota Statutes 2006, section 609.21, subdivision 1, clauses (2) to (6); 2, 
237.6 	clauses (2) to (6); 2a, clauses (2) to (6); 2b, clauses (2) to (6); 3, clauses (2) to (6); or 4, 
237.7 	clauses (2) to (6).

237.8 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
237.9 	committed on or after that date.

237.10 	Sec. 40. Minnesota Statutes 2022, section 609B.425, subdivision 2, is amended to read:
237.11 		Subd. 2.Benefit eligibility. (a) A person convicted of a drug offense after July 1, 1997, 
237.12 	except for convictions related to cannabis, marijuana, or tetrahydrocannabinols, is ineligible 
237.13 	for general assistance benefits and Supplemental Security Income under chapter 256D until:
237.14 	(1) five years after completing the terms of a court-ordered sentence; or
237.15 	(2) unless the person is participating in a drug treatment program, has successfully 
237.16 	completed a program, or has been determined not to be in need of a drug treatment program.
237.17 	(b) A person who becomes eligible for assistance under chapter 256D is subject to 
237.18 	random drug testing and shall lose eligibility for benefits for five years beginning the month 
237.19 	following:
237.20 	(1) any positive test for an illegal controlled substance under chapter 152; or
237.21 	(2) discharge of sentence for conviction of another drug felony.
237.22 	(c) Parole violators and fleeing felons are ineligible for benefits and persons fraudulently 
237.23 	misrepresenting eligibility are also ineligible to receive benefits for ten years.

237.24 	Sec. 41. Minnesota Statutes 2022, section 609B.435, subdivision 2, is amended to read:
237.25 		Subd. 2.Drug offenders; random testing; sanctions. A person who is an applicant for 
237.26 	benefits from the Minnesota family investment program or MFIP, the vehicle for temporary 
237.27 	assistance for needy families or TANF, and who has been convicted of a drug offense, 
237.28 	except for convictions related to cannabis, marijuana, or tetrahydrocannabinols, shall be 
237.29 	subject to certain conditions, including random drug testing, in order to receive MFIP 
237.30 	benefits. Following any positive test for a controlled substance under chapter 152, the 
237.31 	convicted applicant or participant is subject to the following sanctions:
238.1 	(1) a first time drug test failure results in a reduction of benefits in an amount equal to 
238.2 	30 percent of the MFIP standard of need; and
238.3 	(2) a second time drug test failure results in permanent disqualification from receiving 
238.4 	MFIP assistance.
238.5 	A similar disqualification sequence occurs if the applicant is receiving Supplemental Nutrition 
238.6 	Assistance Program (SNAP) benefits.

238.7 	Sec. 42. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
238.8 	to read:
238.9 		Subd. 13.Adult-use cannabis flower. "Adult-use cannabis flower" has the meaning 
238.10 	given in section 342.01, subdivision 4.

238.11 	Sec. 43. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
238.12 	to read:
238.13 		Subd. 14.Adult-use cannabis product. "Adult-use cannabis product" has the meaning 
238.14 	given in section 342.01, subdivision 2.

238.15 	Sec. 44. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
238.16 	to read:
238.17 		Subd. 15.Medical cannabis flower. "Medical cannabis flower" has the meaning given 
238.18 	in section 342.01, subdivision 53.

238.19 	Sec. 45. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
238.20 	to read:
238.21 		Subd. 16.Medical cannabinoid product. "Medical cannabinoid product" has the 
238.22 	meaning given in section 342.01, subdivision 51.

238.23 	Sec. 46. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
238.24 	to read:
238.25 		Subd. 17.Patient. "Patient" has the meaning given in section 342.01, subdivision 58.

239.1 	Sec. 47. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
239.2 	to read:
239.3 		Subd. 18.Qualifying medical condition. "Qualifying medical condition" has the meaning 
239.4 	given in section 342.01, subdivision 61.

239.5 	Sec. 48. Minnesota Statutes 2022, section 624.712, is amended by adding a subdivision 
239.6 	to read:
239.7 		Subd. 19.Registry or registry program. "Registry" or "registry program" has the 
239.8 	meaning given in section 342.01, subdivision 63.

239.9 	Sec. 49. Minnesota Statutes 2022, section 624.713, subdivision 1, is amended to read:
239.10 		Subdivision 1.Ineligible persons. The following persons shall not be entitled to possess 
239.11 	ammunition or a pistol or semiautomatic military-style assault weapon or, except for clause 
239.12 	(1), any other firearm:
239.13 	(1) a person under the age of 18 years except that a person under 18 may possess 
239.14 	ammunition designed for use in a firearm that the person may lawfully possess and may 
239.15 	carry or possess a pistol or semiautomatic military-style assault weapon (i) in the actual 
239.16 	presence or under the direct supervision of the person's parent or guardian, (ii) for the 
239.17 	purpose of military drill under the auspices of a legally recognized military organization 
239.18 	and under competent supervision, (iii) for the purpose of instruction, competition, or target 
239.19 	practice on a firing range approved by the chief of police or county sheriff in whose 
239.20 	jurisdiction the range is located and under direct supervision; or (iv) if the person has 
239.21 	successfully completed a course designed to teach marksmanship and safety with a pistol 
239.22 	or semiautomatic military-style assault weapon and approved by the commissioner of natural 
239.23 	resources;
239.24 	(2) except as otherwise provided in clause (9), a person who has been convicted of, or 
239.25 	adjudicated delinquent or convicted as an extended jurisdiction juvenile for committing, in 
239.26 	this state or elsewhere, a crime of violence. For purposes of this section, crime of violence 
239.27 	includes crimes in other states or jurisdictions which would have been crimes of violence 
239.28 	as herein defined if they had been committed in this state;
239.29 	(3) a person who is or has ever been committed in Minnesota or elsewhere by a judicial 
239.30 	determination that the person is mentally ill, developmentally disabled, or mentally ill and 
239.31 	dangerous to the public, as defined in section 253B.02, to a treatment facility, or who has 
239.32 	ever been found incompetent to stand trial or not guilty by reason of mental illness, unless 
240.1 	the person's ability to possess a firearm and ammunition has been restored under subdivision 
240.2 	4;
240.3 	(4) a person who has been convicted in Minnesota or elsewhere of a misdemeanor or 
240.4 	gross misdemeanor violation of chapter 152, unless three years have elapsed since the date 
240.5 	of conviction and, during that time, the person has not been convicted of any other such 
240.6 	violation of chapter 152 or a similar law of another state; or a person who is or has ever 
240.7 	been committed by a judicial determination for treatment for the habitual use of a controlled 
240.8 	substance or marijuana, as defined in sections 152.01 and 152.02, unless the person's ability 
240.9 	to possess a firearm and ammunition has been restored under subdivision 4;
240.10 	(5) a person who has been committed to a treatment facility in Minnesota or elsewhere 
240.11 	by a judicial determination that the person is chemically dependent as defined in section 
240.12 	253B.02, unless the person has completed treatment or the person's ability to possess a 
240.13 	firearm and ammunition has been restored under subdivision 4. Property rights may not be 
240.14 	abated but access may be restricted by the courts;
240.15 	(6) a peace officer who is informally admitted to a treatment facility pursuant to section 
240.16 	253B.04 for chemical dependency, unless the officer possesses a certificate from the head 
240.17 	of the treatment facility discharging or provisionally discharging the officer from the 
240.18 	treatment facility. Property rights may not be abated but access may be restricted by the 
240.19 	courts;
240.20 	(7) a person, including a person under the jurisdiction of the juvenile court, who has 
240.21 	been charged with committing a crime of violence and has been placed in a pretrial diversion 
240.22 	program by the court before disposition, until the person has completed the diversion program 
240.23 	and the charge of committing the crime of violence has been dismissed;
240.24 	(8) except as otherwise provided in clause (9), a person who has been convicted in 
240.25 	another state of committing an offense similar to the offense described in section 609.224, 
240.26 	subdivision 3, against a family or household member or section 609.2242, subdivision 3, 
240.27 	unless three years have elapsed since the date of conviction and, during that time, the person 
240.28 	has not been convicted of any other violation of section 609.224, subdivision 3, or 609.2242, 
240.29 	subdivision 3, or a similar law of another state;
240.30 	(9) a person who has been convicted in this state or elsewhere of assaulting a family or 
240.31 	household member and who was found by the court to have used a firearm in any way 
240.32 	during commission of the assault is prohibited from possessing any type of firearm or 
240.33 	ammunition for the period determined by the sentencing court;
240.34 	(10) a person who:
241.1 	(i) has been convicted in any court of a crime punishable by imprisonment for a term 
241.2 	exceeding one year;
241.3 	(ii) is a fugitive from justice as a result of having fled from any state to avoid prosecution 
241.4 	for a crime or to avoid giving testimony in any criminal proceeding;
241.5 	(iii) is an unlawful user of any controlled substance as defined in chapter 152. The use 
241.6 	of medical cannabis flower or medical cannabinoid products by a patient enrolled in the 
241.7 	registry program or the use of adult-use cannabis flower or adult-use cannabis products by 
241.8 	a person 21 years of age or older does not constitute the unlawful use of a controlled 
241.9 	substance under this item;
241.10 	(iv) has been judicially committed to a treatment facility in Minnesota or elsewhere as 
241.11 	a person who is mentally ill, developmentally disabled, or mentally ill and dangerous to the 
241.12 	public, as defined in section 253B.02;
241.13 	(v) is an alien who is illegally or unlawfully in the United States;
241.14 	(vi) has been discharged from the armed forces of the United States under dishonorable 
241.15 	conditions;
241.16 	(vii) has renounced the person's citizenship having been a citizen of the United States; 
241.17 	or
241.18 	(viii) is disqualified from possessing a firearm under United States Code, title 18, section 
241.19 	922(g)(8) or (9), as amended through March 1, 2014;
241.20 	(11) a person who has been convicted of the following offenses at the gross misdemeanor 
241.21 	level, unless three years have elapsed since the date of conviction and, during that time, the 
241.22 	person has not been convicted of any other violation of these sections: section 609.229
241.23 	(crimes committed for the benefit of a gang); 609.2231, subdivision 4 (assaults motivated 
241.24 	by bias); 609.255 (false imprisonment); 609.378 (neglect or endangerment of a child); 
241.25 	609.582, subdivision 4 (burglary in the fourth degree); 609.665 (setting a spring gun); 609.71
241.26 	(riot); or 609.749 (harassment or stalking). For purposes of this paragraph, the specified 
241.27 	gross misdemeanor convictions include crimes committed in other states or jurisdictions 
241.28 	which would have been gross misdemeanors if conviction occurred in this state;
241.29 	(12) a person who has been convicted of a violation of section 609.224 if the court 
241.30 	determined that the assault was against a family or household member in accordance with 
241.31 	section 609.2242, subdivision 3 (domestic assault), unless three years have elapsed since 
241.32 	the date of conviction and, during that time, the person has not been convicted of another 
241.33 	violation of section 609.224 or a violation of a section listed in clause (11); or
242.1 	(13) a person who is subject to an order for protection as described in section 260C.201, 
242.2 	subdivision 3, paragraph (d), or 518B.01, subdivision 6, paragraph (g).
242.3 	A person who issues a certificate pursuant to this section in good faith is not liable for 
242.4 	damages resulting or arising from the actions or misconduct with a firearm or ammunition 
242.5 	committed by the individual who is the subject of the certificate.
242.6 	The prohibition in this subdivision relating to the possession of firearms other than 
242.7 	pistols and semiautomatic military-style assault weapons does not apply retroactively to 
242.8 	persons who are prohibited from possessing a pistol or semiautomatic military-style assault 
242.9 	weapon under this subdivision before August 1, 1994.
242.10 	The lifetime prohibition on possessing, receiving, shipping, or transporting firearms and 
242.11 	ammunition for persons convicted or adjudicated delinquent of a crime of violence in clause 
242.12 	(2), applies only to offenders who are discharged from sentence or court supervision for a 
242.13 	crime of violence on or after August 1, 1993.
242.14 	Participation as a patient in the registry program or use of adult-use cannabis flower or 
242.15 	adult-use cannabinoid products by a person 21 years of age or older does not disqualify the 
242.16 	person from possessing firearms and ammunition under this section.
242.17 	For purposes of this section, "judicial determination" means a court proceeding pursuant 
242.18 	to sections 253B.07 to 253B.09 or a comparable law from another state.

242.19 	Sec. 50. Minnesota Statutes 2022, section 624.714, subdivision 6, is amended to read:
242.20 		Subd. 6.Granting and denial of permits. (a) The sheriff must, within 30 days after the 
242.21 	date of receipt of the application packet described in subdivision 3:
242.22 	(1) issue the permit to carry;
242.23 	(2) deny the application for a permit to carry solely on the grounds that the applicant 
242.24 	failed to qualify under the criteria described in subdivision 2, paragraph (b); or
242.25 	(3) deny the application on the grounds that there exists a substantial likelihood that the 
242.26 	applicant is a danger to self or the public if authorized to carry a pistol under a permit.
242.27 	(b) Failure of the sheriff to notify the applicant of the denial of the application within 
242.28 	30 days after the date of receipt of the application packet constitutes issuance of the permit 
242.29 	to carry and the sheriff must promptly fulfill the requirements under paragraph (c). To deny 
242.30 	the application, the sheriff must provide the applicant with written notification and the 
242.31 	specific factual basis justifying the denial under paragraph (a), clause (2) or (3), including 
242.32 	the source of the factual basis. The sheriff must inform the applicant of the applicant's right 
243.1 	to submit, within 20 business days, any additional documentation relating to the propriety 
243.2 	of the denial. Upon receiving any additional documentation, the sheriff must reconsider the 
243.3 	denial and inform the applicant within 15 business days of the result of the reconsideration. 
243.4 	Any denial after reconsideration must be in the same form and substance as the original 
243.5 	denial and must specifically address any continued deficiencies in light of the additional 
243.6 	documentation submitted by the applicant. The applicant must be informed of the right to 
243.7 	seek de novo review of the denial as provided in subdivision 12.
243.8 	(c) Upon issuing a permit to carry, the sheriff must provide a laminated permit card to 
243.9 	the applicant by first class mail unless personal delivery has been made. Within five business 
243.10 	days, the sheriff must submit the information specified in subdivision 7, paragraph (a), to 
243.11 	the commissioner for inclusion solely in the database required under subdivision 15, 
243.12 	paragraph (a). The sheriff must transmit the information in a manner and format prescribed 
243.13 	by the commissioner.
243.14 	(d) Within five business days of learning that a permit to carry has been suspended or 
243.15 	revoked, the sheriff must submit information to the commissioner regarding the suspension 
243.16 	or revocation for inclusion solely in the databases required or permitted under subdivision 
243.17 	15.
243.18 	(e) Notwithstanding paragraphs (a) and (b), the sheriff may suspend the application 
243.19 	process if a charge is pending against the applicant that, if resulting in conviction, will 
243.20 	prohibit the applicant from possessing a firearm.
243.21 	(f) A sheriff shall not deny an application for a permit to carry solely because the applicant 
243.22 	is a patient enrolled in the registry program and uses medical cannabis flower or medical 
243.23 	cannabinoid products for a qualifying medical condition or because the person is 21 years 
243.24 	of age or older and uses adult-use cannabis flower or adult-use cannabis products.

243.25 	Sec. 51. Minnesota Statutes 2022, section 624.7142, subdivision 1, is amended to read:
243.26 		Subdivision 1.Acts prohibited. A person may not carry a pistol on or about the person's 
243.27 	clothes or person in a public place:
243.28 	(1) when the person is under the influence of a controlled substance, as defined in section 
243.29 	152.01 169A.03, subdivision 46;
243.30 	(2) when the person is under the influence of a combination of any two or more of the 
243.31 	elements named in clauses (1) and (4);
244.1 	(3) when the person is under the influence of an intoxicating substance as defined in 
244.2 	section 169A.03, subdivision 11a, and the person knows or has reason to know that the 
244.3 	substance has the capacity to cause impairment;
244.4 	(4) when the person is under the influence of alcohol;
244.5 	(5) when the person's alcohol concentration is 0.10 or more; or
244.6 	(6) when the person's alcohol concentration is less than 0.10, but more than 0.04.; or
244.7 	(7) when the person is enrolled as a patient in the registry program, uses medical cannabis 
244.8 	flower or medical cannabinoid products, and knows or has reason to know that the medical 
244.9 	cannabis flower or medical cannabinoid products used by the person has the capacity to 
244.10 	cause impairment.

244.11 	Sec. 52. Minnesota Statutes 2022, section 624.7143, is amended by adding a subdivision 
244.12 	to read:
244.13 		Subd. 6.Definition. As used in this section, "controlled substance" has the meaning 
244.14 	given in section 169A.03, subdivision 6.

244.15 	EFFECTIVE DATE. This section is effective August 1, 2023, and applies to crimes 
244.16 	committed on or after that date.

244.17 	Sec. 53. Minnesota Statutes 2022, section 624.7151, is amended to read:
244.18 	624.7151 STANDARDIZED FORMS.
244.19 	By December 1, 1992, the commissioner shall adopt statewide standards governing the 
244.20 	form and contents, as required by sections 624.7131 to 624.714, of every application for a 
244.21 	pistol transferee permit, pistol transferee permit, report of transfer of a pistol, application 
244.22 	for a permit to carry a pistol, and permit to carry a pistol that is granted or renewed on or 
244.23 	after January 1, 1993.
244.24 	Every application for a pistol transferee permit, pistol transferee permit, report of transfer 
244.25 	of a pistol, application for a permit to carry a pistol, and permit to carry a pistol that is 
244.26 	received, granted, or renewed by a police chief or county sheriff on or after January 1, 1993, 
244.27 	must meet the statewide standards adopted by the commissioner. Notwithstanding the 
244.28 	previous sentence, neither failure of the Department of Public Safety to adopt standards nor 
244.29 	failure of the police chief or county sheriff to meet them shall delay the timely processing 
244.30 	of applications nor invalidate permits issued on other forms meeting the requirements of 
244.31 	sections 624.7131 to 624.714.
245.1 	Any form used for the purpose of approving or disapproving a person from purchasing, 
245.2 	owning, possessing, or carrying a firearm that inquires about the applicant's use of controlled 
245.3 	substances shall specifically authorize a patient in the registry program to refrain from 
245.4 	reporting the use of medical cannabis flower and medical cannabinoid products and shall 
245.5 	specifically authorize a person 21 years of age or older from refraining from reporting the 
245.6 	use of adult-use cannabis flower or adult-use cannabis products.

245.7 	Sec. 54. [624.7152] LAWFUL CANNABIS USERS.
245.8 	(a) A person may not be denied the right to purchase, own, possess, or carry a firearm 
245.9 	solely on the basis that the person is a patient in the registry program.
245.10 	(b) A person may not be denied the right to purchase, own, possess, or carry a firearm 
245.11 	solely on the basis that the person is 21 years of age or older and uses adult-use cannabis 
245.12 	flower or adult-use cannabis products.
245.13 	(c) A state or local agency may not access a database containing the identities of patients 
245.14 	in the registry program to obtain information for the purpose of approving or disapproving 
245.15 	a person from purchasing, owning, possessing, or carrying a firearm.
245.16 	(d) A state or local agency may not use information gathered from a database containing 
245.17 	the identities of patients in the registry program to obtain information for the purpose of 
245.18 	approving or disapproving a person from purchasing, owning, possessing, or carrying a 
245.19 	firearm.
245.20 	(e) A state or local agency may not inquire about a person's status as a patient in the 
245.21 	registry program for the purpose of approving or disapproving the person from purchasing, 
245.22 	owning, possessing, or carrying a firearm.
245.23 	(f) A state or local agency may not inquire about the use of adult-use cannabis flower 
245.24 	or adult-use cannabis products by a person 21 years of age or older for the purpose of 
245.25 	approving or disapproving the person from purchasing, owning, possessing, or carrying a 
245.26 	firearm.

245.27 	Sec. 55. REPEALER.
 245.28 	(a) Minnesota Rules, parts 4770.0100; 4770.0200; 4770.0300; 4770.0400; 4770.0500; 
245.29 	4770.0600; 4770.0800; 4770.0900; 4770.1000; 4770.1100; 4770.1200; 4770.1300; 
245.30 	4770.1400; 4770.1460; 4770.1500; 4770.1600; 4770.1700; 4770.1800; 4770.1900; 
245.31 	4770.2000; 4770.2100; 4770.2200; 4770.2300; 4770.2400; 4770.2700; 4770.2800; 
245.32 	4770.4000; 4770.4002; 4770.4003; 4770.4004; 4770.4005; 4770.4007; 4770.4008; 
246.1 	4770.4009; 4770.4010; 4770.4012; 4770.4013; 4770.4014; 4770.4015; 4770.4016; 
246.2 	4770.4017; 4770.4018; and 4770.4030, are repealed.
246.3 	(b) Minnesota Statutes 2022, sections 152.22, subdivisions 1, 2, 3, 4, 5, 5a, 5b, 6, 7, 8, 
246.4 	9, 10, 11, 12, 13, and 14; 152.23; 152.24; 152.25, subdivisions 1, 1a, 1b, 1c, 2, 3, and 4; 
246.5 	152.26; 152.261; 152.27, subdivisions 1, 2, 3, 4, 5, 6, and 7; 152.28, subdivisions 1, 2, and 
246.6 	3; 152.29, subdivisions 1, 2, 3, 3a, and 4; 152.30; 152.31; 152.32, subdivisions 1, 2, and 3; 
246.7 	152.33, subdivisions 1, 1a, 2, 3, 4, 5, and 6; 152.34; 152.35; 152.36, subdivisions 1, 1a, 2, 
246.8 	3, 4, and 5; and 152.37, are repealed.
246.9 	(c) Minnesota Statutes 2022, section 152.027, subdivisions 3 and 4, are repealed.
246.10 	(d) Minnesota Statutes 2022, section 152.21, is repealed.
246.11 	(e) Minnesota Statutes 2022, sections 34A.01, subdivision 4; and 151.72, are repealed.

246.12 	EFFECTIVE DATE. Paragraphs (a) and (b) are effective January 1, 2024. Paragraph 
246.13 	(c) is effective August 1, 2023. Paragraph (d) is effective July 1, 2023. Paragraph (e) is 
246.14 	effective July 1, 2024.

246.15 	ARTICLE 7
246.16 	TEMPORARY REGULATION OF CERTAIN PRODUCTS

246.17 	Section 1. Minnesota Statutes 2022, section 34A.01, subdivision 4, is amended to read:
246.18 		Subd. 4.Food. "Food" means every ingredient used for, entering into the consumption 
246.19 	of, or used or intended for use in the preparation of food, drink, confectionery, or condiment 
246.20 	for humans or other animals, whether simple, mixed, or compound; and articles used as 
246.21 	components of these ingredients, except that edible cannabinoid products, as defined in 
246.22 	section 151.72, subdivision 1, paragraph (c) (f), are not food.

246.23 	Sec. 2. Minnesota Statutes 2022, section 144.99, subdivision 1, is amended to read:
246.24 		Subdivision 1.Remedies available. The provisions of chapters 103I and 157 and sections 
246.25 	115.71 to 115.77; 144.12, subdivision 1, paragraphs (1), (2), (5), (6), (10), (12), (13), (14), 
246.26 	and (15); 144.1201 to 144.1204; 144.121; 144.1215; 144.1222; 144.35; 144.381 to 144.385; 
246.27 	144.411 to 144.417; 144.495; 144.71 to 144.74; 144.9501 to 144.9512; 144.97 to 144.98; 
246.28 	144.992; 151.72; 152.22 to 152.37; 326.70 to 326.785; 327.10 to 327.131; and 327.14 to 
246.29 	327.28 and all rules, orders, stipulation agreements, settlements, compliance agreements, 
246.30 	licenses, registrations, certificates, and permits adopted or issued by the department or under 
246.31 	any other law now in force or later enacted for the preservation of public health may, in 
246.32 	addition to provisions in other statutes, be enforced under this section.

247.1 	Sec. 3. Minnesota Statutes 2022, section 151.72, is amended to read:
247.2 	151.72 SALE OF CERTAIN CANNABINOID PRODUCTS.
247.3 		Subdivision 1.Definitions. (a) For the purposes of this section, the following terms have 
247.4 	the meanings given.
247.5 	(a) "Synthetically derived cannabinoid" means a cannabinoid extracted from a hemp 
247.6 	plant or hemp plant parts whose chemical makeup is changed after extraction to create a 
247.7 	different cannabinoid or other chemical compound by applying a catalyst other than heat 
247.8 	or light. Synthetically derived cannabinoid includes but is not limited to any 
247.9 	tetrahydrocannabinol created from cannabidiol.
247.10 	(b) "Batch" means a specific quantity of a specific product containing cannabinoids 
247.11 	derived from hemp, including an edible cannabinoid product, that is manufactured at the 
247.12 	same time and using the same methods, equipment, and ingredients that is uniform and 
247.13 	intended to meet specifications for identity, strength, purity, and composition, and that is 
247.14 	manufactured, packaged, and labeled according to a single batch production record executed 
247.15 	and documented during the same cycle of manufacture and produced by a continuous 
247.16 	process.
247.17 	(b) (c) "Certified hemp" means hemp plants that have been tested and found to meet the 
247.18 	requirements of chapter 18K and the rules adopted thereunder.
247.19 	(d) "Commissioner" means the commissioner of health.
247.20 	(e) "Distributor" means a person who sells, arranges a sale, or delivers a product 
247.21 	containing cannabinoids derived from hemp, including an edible cannabinoid product, that 
247.22 	the person did not manufacture to a retail establishment for sale to consumers. Distributor 
247.23 	does not include a common carrier used only to complete delivery to a retailer.
247.24 	(c) (f) "Edible cannabinoid product" means any product that is intended to be eaten or 
247.25 	consumed as a beverage by humans, contains a cannabinoid in combination with food 
247.26 	ingredients, and is not a drug.
247.27 	(d) (g) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 
247.28 	3.
247.29 	(e) (h) "Label" has the meaning given in section 151.01, subdivision 18.
247.30 	(f) (i) "Labeling" means all labels and other written, printed, or graphic matter that are:
247.31 	(1) affixed to the immediate container in which a product regulated under this section 
247.32 	is sold;
248.1 	(2) provided, in any manner, with the immediate container, including but not limited to 
248.2 	outer containers, wrappers, package inserts, brochures, or pamphlets; or
248.3 	(3) provided on that portion of a manufacturer's website that is linked by a scannable 
248.4 	barcode or matrix barcode.
248.5 	(g) (j) "Matrix barcode" means a code that stores data in a two-dimensional array of 
248.6 	geometrically shaped dark and light cells capable of being read by the camera on a 
248.7 	smartphone or other mobile device.
248.8 	(h) (k) "Nonintoxicating cannabinoid" means substances extracted from certified hemp 
248.9 	plants that do not produce intoxicating effects when consumed by any route of administration.
248.10 	(l) "Artificial cannabinoid" means a substance with a similar chemical structure and 
248.11 	pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp 
248.12 	plants, or hemp plant parts and is instead created or produced by chemical or biochemical 
248.13 	synthesis.
248.14 		Subd. 2.Scope. (a) This section applies to the sale of any product that contains 
248.15 	cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended 
248.16 	for human or animal consumption by any route of administration.
248.17 	(b) This section does not apply to any product dispensed by a registered medical cannabis 
248.18 	manufacturer pursuant to sections 152.22 to 152.37.
248.19 	(c) The board commissioner must have no authority over food products, as defined in 
248.20 	section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from 
248.21 	hemp.
248.22 		Subd. 3.Sale of cannabinoids derived from hemp. (a) Notwithstanding any other 
248.23 	section of this chapter, a product containing nonintoxicating cannabinoids, including an 
248.24 	edible cannabinoid product, may be sold for human or animal consumption only if all of 
248.25 	the requirements of this section are met, provided that a product sold for human or animal 
248.26 	consumption does not contain more than 0.3 percent of any tetrahydrocannabinol and an 
248.27 	edible cannabinoid product does not contain an amount of any tetrahydrocannabinol that 
248.28 	exceeds the limits established in subdivision 5a, paragraph (f).
248.29 	(b) No other substance extracted or otherwise derived from hemp may be sold for human 
248.30 	consumption if the substance is intended:
248.31 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
248.32 	of disease in humans or other animals; or
249.1 	(2) to affect the structure or any function of the bodies of humans or other animals.
249.2 	(c) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise 
249.3 	derived from hemp may be sold to any individual who is under the age of 21.
249.4 	(d) Products that meet the requirements of this section are not controlled substances 
249.5 	under section 152.02.
249.6 		Subd. 4.Testing requirements. (a) A manufacturer of a product regulated under this 
249.7 	section must submit representative samples of each batch of the product to an independent, 
249.8 	accredited laboratory in order to certify that the product complies with the standards adopted 
249.9 	by the board on or before July 1, 2023, or the standards adopted by the commissioner. 
249.10 	Testing must be consistent with generally accepted industry standards for herbal and botanical 
249.11 	substances, and, at a minimum, the testing must confirm that the product:
249.12 	(1) contains the amount or percentage of cannabinoids that is stated on the label of the 
249.13 	product;
249.14 	(2) does not contain more than trace amounts of any mold, residual solvents or other 
249.15 	catalysts, pesticides, fertilizers, or heavy metals; and
249.16 	(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.
249.17 	(b) A manufacturer of a product regulated under this section must disclose all known 
249.18 	information regarding pesticides, fertilizers, solvents, or other foreign materials applied to 
249.19 	industrial hemp or added to industrial hemp during any production or processing stages of 
249.20 	any batch from which a representative sample has been sent for testing, including any 
249.21 	catalysts used to create synthetically derived cannabinoids. Disclosure must be made to the 
249.22 	laboratory performing testing or sampling and, upon request, to the commissioner. Disclosure 
249.23 	must include all information known to the licensee regardless of whether the application or 
249.24 	addition was made intentionally or accidentally, or by the manufacturer or any other person.
249.25 	(b) (c) Upon the request of the board commissioner, the manufacturer of the product 
249.26 	must provide the board commissioner with the results of the testing required in this section.
249.27 	(d) The commissioner may determine that any testing laboratory that does not operate 
249.28 	formal management systems under the International Organization for Standardization is not 
249.29 	an accredited laboratory and require that a representative sample of a batch of the product 
249.30 	be retested by a testing laboratory that meets this requirement.
249.31 	(c) (e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, 
249.32 	or possession of a certificate of analysis for such hemp, does not meet the testing requirements 
249.33 	of this section.
250.1 		Subd. 5.Labeling requirements. (a) A product regulated under this section must bear 
250.2 	a label that contains, at a minimum:
250.3 	(1) the name, location, contact phone number, and website of the manufacturer of the 
250.4 	product;
250.5 	(2) the name and address of the independent, accredited laboratory used by the 
250.6 	manufacturer to test the product; and
250.7 	(3) the batch number; and
250.8 	(3) (4) an accurate statement of the amount or percentage of cannabinoids found in each 
250.9 	unit of the product meant to be consumed.
250.10 	(b) The information in paragraph (a) may be provided on an outer package if the 
250.11 	immediate container that holds the product is too small to contain all of the information.
250.12 	(c) The information required in paragraph (a) may be provided through the use of a 
250.13 	scannable barcode or matrix barcode that links to a page on the manufacturer's website if 
250.14 	that page contains all of the information required by this subdivision.
250.15 	(d) The label must also include a statement stating that the product does not claim to 
250.16 	diagnose, treat, cure, or prevent any disease and has not been evaluated or approved by the 
250.17 	United States Food and Drug Administration (FDA) unless the product has been so approved.
250.18 	(e) The information required by this subdivision must be prominently and conspicuously 
250.19 	placed on the label or displayed on the website in terms that can be easily read and understood 
250.20 	by the consumer.
250.21 	(f) The labeling must not contain any claim that the product may be used or is effective 
250.22 	for the prevention, treatment, or cure of a disease or that it may be used to alter the structure 
250.23 	or function of human or animal bodies, unless the claim has been approved by the FDA.
250.24 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
250.25 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
250.26 	must meet the requirements of this subdivision.
250.27 	(b) An edible cannabinoid product must not:
250.28 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
250.29 	animal, or fruit that appeals to children;
250.30 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
251.1 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
251.2 	commercially available candy or snack food item;
251.3 	(4) be substantively similar to a meat food product; poultry food product as defined in 
251.4 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
251.5 	7;
251.6 	(4) (5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
251.7 	by the United States Food and Drug Administration for use in food;
251.8 	(5) (6) be packaged in a way that resembles the trademarked, characteristic, or 
251.9 	product-specialized packaging of any commercially available food product; or
251.10 	(6) (7) be packaged in a container that includes a statement, artwork, or design that could 
251.11 	reasonably mislead any person to believe that the package contains anything other than an 
251.12 	edible cannabinoid product.
251.13 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
251.14 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
251.15 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
251.16 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
251.17 	that is intended to be consumed as a beverage and which contains no more than a trace 
251.18 	amount of any tetrahydrocannabinol total of 0.25 milligrams of all tetrahydrocannabinols.
251.19 	(d) If an edible cannabinoid product is intended for more than a single use or contains 
251.20 	multiple servings, each serving must be indicated by scoring, wrapping, or other indicators 
251.21 	designating the individual serving size that appear on the edible cannabinoid product.
251.22 	(e) A label containing at least the following information must be affixed to the packaging 
251.23 	or container of all edible cannabinoid products sold to consumers:
251.24 	(1) the serving size;
251.25 	(2) the cannabinoid profile per serving and in total;
251.26 	(3) a list of ingredients, including identification of any major food allergens declared 
251.27 	by name; and
251.28 	(4) the following statement: "Keep this product out of reach of children."
251.29 	(f) An edible cannabinoid product must not contain more than five milligrams of any 
251.30 	tetrahydrocannabinol in a single serving, or more than a total of 50 milligrams of any 
251.31 	tetrahydrocannabinol per package.
252.1 	(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 
252.2 	tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is a 
252.3 	synthetically derived cannabinoid. Edible cannabinoid products are prohibited from 
252.4 	containing any other synthetically derived cannabinoid, including but not limited to THC-P, 
252.5 	THC-O, and HHC, unless the commissioner authorizes use of the synthetically derived 
252.6 	cannabinoid in edible cannabinoid products. Edible cannabinoid products are prohibited 
252.7 	from containing artificial cannabinoids.
252.8 		Subd. 5b.Registration; prohibitions. (a) On or before October 1, 2023, every person 
252.9 	selling edible cannabinoid products to consumers must apply for registration with the 
252.10 	commissioner in a form and manner established by the commissioner. After October 1, 
252.11 	2023, the sale of edible cannabinoid products by a person that is not registered is prohibited.
252.12 	(b) The commissioner shall approve completed registration applications unless the 
252.13 	applicant is operating in violation of this section or the commissioner reasonably believes 
252.14 	that the applicant will operate in violation of this section.
252.15 	(c) The commissioner shall not charge a fee for registration under this subdivision.
252.16 	(d) A registered retailer shall not:
252.17 	(1) permit the on-site consumption of edible cannabinoid products; or
252.18 	(2) provide free samples of edible cannabinoid products, except that a retailer may 
252.19 	provide a single package of an edible cannabinoid product with the purchase of a childproof 
252.20 	packaging container or other device designed to ensure the safe storage and monitoring of 
252.21 	edible cannabinoid products in the home to prevent access by individuals under 21 years 
252.22 	of age.
252.23 		Subd. 5c.Age verification. (a) Prior to initiating a sale of an edible cannabinoid product, 
252.24 	an employee of a retailer must verify that the customer is at least 21 years of age.
252.25 	(b) Proof of age may be established only by one of the following:
252.26 	(1) a valid driver's license or identification card issued by Minnesota, another state, or 
252.27 	a province of Canada and including the photograph and date of birth of the licensed person;
252.28 	(2) a valid Tribal identification card as defined in section 171.072, paragraph (b);
252.29 	(3) a valid passport issued by the United States;
252.30 	(4) a valid instructional permit issued under section 171.05 to a person of legal age to 
252.31 	purchase edible cannabinoid products, which includes a photograph and the date of birth 
252.32 	of the person issued the permit; or
253.1 	(5) in the case of a foreign national, by a valid passport.
253.2 	(c) A registered retailer may seize a form of identification listed under paragraph (b) if 
253.3 	the registered retailer has reasonable grounds to believe that the form of identification has 
253.4 	been altered or falsified or is being used to violate any law. A registered retailer that seizes 
253.5 	a form of identification as authorized under this paragraph must deliver it to a law 
253.6 	enforcement agency within 24 hours of seizing it.
253.7 		Subd. 6.Noncompliant products; enforcement. (a) A product regulated under this 
253.8 	section, including an edible cannabinoid product, shall be considered an adulterated drug
253.9 	a noncompliant product if the product is offered for sale in this state or if the product is 
253.10 	manufactured, imported, distributed, or stored with the intent to be offered for sale in this 
253.11 	state in violation of any provision of this section, including but not limited to if:
253.12 	(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;
253.13 	(2) it has been produced, prepared, packed, or held under unsanitary conditions where 
253.14 	it may have been rendered injurious to health, or where it may have been contaminated with 
253.15 	filth;
253.16 	(3) its container is composed, in whole or in part, of any poisonous or deleterious 
253.17 	substance that may render the contents injurious to health;
253.18 	(4) it contains any food additives, color additives, or excipients that have been found by 
253.19 	the FDA to be unsafe for human or animal consumption;
253.20 	(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different 
253.21 	than the amount or percentage stated on the label;
253.22 	(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is 
253.23 	an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits 
253.24 	established in subdivision 5a, paragraph (f); or
253.25 	(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, 
253.26 	or heavy metals.
253.27 	(b) A product regulated under this section shall be considered a misbranded drug
253.28 	noncompliant product if the product's labeling is false or misleading in any manner or in 
253.29 	violation of the requirements of this section.
253.30 	(c) The board's authority to issue cease and desist orders under section 151.06; to embargo 
253.31 	adulterated and misbranded drugs under section 151.38; and to seek injunctive relief under 
253.32 	section 214.11, extends to any commissioner may assume that any product regulated under 
254.1 	this section that is present in the state, other than a product lawfully possessed for personal 
254.2 	use, has been manufactured, imported, distributed, or stored with the intent to be offered 
254.3 	for sale in this state if a product of the same type and brand was sold in the state on or after 
254.4 	July 1, 2023, or if the product is in the possession of a person who has sold any product in
254.5 	violation of this section.
254.6 	(d) The commissioner may enforce this section, including enforcement against a 
254.7 	manufacturer or distributor of a product regulated under this section, under sections 144.989 
254.8 	to 144.993.
254.9 	(e) The commissioner may enter into an interagency agreement with the Office of 
254.10 	Cannabis Management to perform inspections and take other enforcement actions on behalf 
254.11 	of the commissioner.
254.12 		Subd. 7.Violations; criminal penalties. (a) Notwithstanding section 144.99, subdivision 
254.13 	11, a person who does any of the following regarding a product regulated under this section 
254.14 	is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 
254.15 	one year or to payment of a fine of not more than $3,000, or both:
254.16 	(1) knowingly alters or otherwise falsifies testing results;
254.17 	(2) intentionally alters or falsifies any information required to be included on the label 
254.18 	of an edible cannabinoid product; or
254.19 	(3) intentionally makes a false material statement to the commissioner.
254.20 	(b) Notwithstanding section 144.99, subdivision 11, a person who does any of the 
254.21 	following on the premises of a registered retailer or another business that sells retail goods 
254.22 	to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for 
254.23 	not more than one year or to payment of a fine of not more than $3,000, or both:
254.24 	(1) sells an edible cannabinoid product knowing that the product does not comply with 
254.25 	the limits on the amount or types of cannabinoids that a product may contain;
254.26 	(2) sells an edible cannabinoid product knowing that the product does not comply with 
254.27 	the applicable testing, packaging, or labeling requirements; or
254.28 	(3) sells an edible cannabinoid product to a person under the age of 21, except that it is 
254.29 	an affirmative defense to a charge under this clause if the defendant proves by a 
254.30 	preponderance of the evidence that the defendant reasonably and in good faith relied on 
254.31 	proof of age as described in subdivision 5c.

255.1 	Sec. 4. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
255.2 	read:
255.3 		Subd. 5d.Indian lands. (a) "Indian lands" means all lands within the limits of any Indian 
255.4 	reservation within the boundaries of Minnesota and any lands within the boundaries of 
255.5 	Minnesota, title to which are either held in trust by the United States or over which an Indian 
255.6 	Tribe exercises governmental power.
255.7 	(b) This subdivision expires January 1, 2024.

255.8 	Sec. 5. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
255.9 	read:
255.10 		Subd. 15.Tribal medical cannabis board. (a) "Tribal medical cannabis board" means 
255.11 	an agency established by each federally recognized Tribal government and duly authorized 
255.12 	by that Tribe's governing body to perform regulatory oversight and monitor compliance 
255.13 	with a Tribal medical cannabis program and applicable regulations.
255.14 	(b) This subdivision expires January 1, 2024.

255.15 	Sec. 6. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
255.16 	read:
255.17 		Subd. 16.Tribal medical cannabis program. (a) "Tribal medical cannabis program" 
255.18 	means a program established by a federally recognized Tribal government within the 
255.19 	boundaries of Minnesota regarding the commercial production, processing, sale or 
255.20 	distribution, and possession of medical cannabis and medical cannabis products.
255.21 	(b) This subdivision expires January 1, 2024.

255.22 	Sec. 7. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
255.23 	read:
255.24 		Subd. 17.Tribal medical cannabis program manufacturer. (a) "Tribal medical 
255.25 	cannabis program manufacturer" means an entity designated by a Tribal medical cannabis 
255.26 	board within the boundaries of Minnesota or a federally recognized Tribal government 
255.27 	within the boundaries of Minnesota to engage in production, processing, and sale or 
255.28 	distribution of medical cannabis and medical cannabis products under that Tribe's Tribal 
255.29 	medical cannabis program.
255.30 	(b) This subdivision expires January 1, 2024.

256.1 	Sec. 8. Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to 
256.2 	read:
256.3 		Subd. 18.Tribal medical cannabis program patient. (a) "Tribal medical cannabis 
256.4 	program patient" means a person who possesses a valid registration verification card or 
256.5 	equivalent document that is issued under the laws or regulations of a Tribal nation within 
256.6 	the boundaries of Minnesota and that verifies that the person is enrolled in or authorized to 
256.7 	participate in that Tribal nation's Tribal medical cannabis program.
256.8 	(b) This subdivision expires January 1, 2024.

256.9 	Sec. 9. Minnesota Statutes 2022, section 152.29, subdivision 4, is amended to read:
256.10 		Subd. 4.Report. (a) Each manufacturer shall report to the commissioner on a monthly 
256.11 	basis the following information on each individual patient for the month prior to the report:
256.12 	(1) the amount and dosages of medical cannabis distributed;
256.13 	(2) the chemical composition of the medical cannabis; and
256.14 	(3) the tracking number assigned to any medical cannabis distributed.
256.15 	(b) For transactions involving Tribal medical cannabis program patients, each 
256.16 	manufacturer shall report to the commissioner on a weekly basis the following information 
256.17 	on each individual Tribal medical cannabis program patient for the week prior to the report:
256.18 	(1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis 
256.19 	program patient is enrolled;
256.20 	(2) the amount and dosages of medical cannabis distributed;
256.21 	(3) the chemical composition of the medical cannabis distributed; and
256.22 	(4) the tracking number assigned to the medical cannabis distributed.

256.23 	Sec. 10. Minnesota Statutes 2022, section 152.29, is amended by adding a subdivision to 
256.24 	read:
256.25 		Subd. 5.Distribution to Tribal medical cannabis program patient. (a) A manufacturer 
256.26 	may distribute medical cannabis in accordance with subdivisions 1 to 4 to a Tribal medical 
256.27 	cannabis program patient.
256.28 	(b) Prior to distribution, the Tribal medical cannabis program patient must provide to 
256.29 	the manufacturer:
257.1 	(1) a valid medical cannabis registration verification card or equivalent document issued 
257.2 	by a Tribal medical cannabis program that indicates that the Tribal medical cannabis program 
257.3 	patient is authorized to use medical cannabis on Indian lands over which the Tribe has 
257.4 	jurisdiction; and
257.5 	(2) a valid photographic identification card issued by the Tribal medical cannabis 
257.6 	program, a valid driver's license, or a valid state identification card.
257.7 	(c) A manufacturer shall distribute medical cannabis to a Tribal medical cannabis program 
257.8 	patient only in a form allowed under section 152.22, subdivision 6.
257.9 	(d) This subdivision expires January 1, 2024.

257.10 	Sec. 11. [152.291] TRIBAL MEDICAL CANNABIS PROGRAM MANUFACTURER 
257.11 	TRANSPORTATION.
257.12 	(a) A Tribal medical cannabis program manufacturer may transport medical cannabis 
257.13 	to testing laboratories in the state and to other Indian lands.
257.14 	(b) A Tribal medical cannabis program manufacturer must staff a motor vehicle used to 
257.15 	transport medical cannabis with at least two employees of the manufacturer. Each employee 
257.16 	in the transport vehicle must carry identification specifying that the employee is an employee 
257.17 	of the manufacturer, and one employee in the transport vehicle must carry a detailed 
257.18 	transportation manifest that includes the place and time of departure, the address of the 
257.19 	destination, and a description and count of the medical cannabis being transported.
257.20 	(c) This section expires January 1, 2024.

257.21 	Sec. 12. Minnesota Statutes 2022, section 152.30, is amended to read:
257.22 	152.30 PATIENT DUTIES.
257.23 	(a) A patient shall apply to the commissioner for enrollment in the registry program by 
257.24 	submitting an application as required in section 152.27 and an annual registration fee as 
257.25 	determined under section 152.35.
257.26 	(b) As a condition of continued enrollment, patients shall agree to:
257.27 	(1) continue to receive regularly scheduled treatment for their qualifying medical 
257.28 	condition from their health care practitioner; and
257.29 	(2) report changes in their qualifying medical condition to their health care practitioner.
258.1 	(c) A patient shall only receive medical cannabis from a registered manufacturer or 
258.2 	Tribal medical cannabis program but is not required to receive medical cannabis products 
258.3 	from only a registered manufacturer or Tribal medical cannabis program.

258.4 	Sec. 13. Minnesota Statutes 2022, section 152.32, is amended to read:
258.5 	152.32 PROTECTIONS FOR REGISTRY PROGRAM OR TRIBAL MEDICAL 
258.6 	CANNABIS PROGRAM PARTICIPATION.
258.7 		Subdivision 1.Presumption. (a) There is a presumption that a patient enrolled in the 
258.8 	registry program under sections 152.22 to 152.37or a Tribal medical cannabis program 
258.9 	patient is engaged in the authorized use of medical cannabis.
258.10 	(b) The presumption may be rebutted by evidence that:
258.11 	(1) a patient's conduct related to use of medical cannabis was not for the purpose of 
258.12 	treating or alleviating the patient's qualifying medical condition or symptoms associated 
258.13 	with the patient's qualifying medical condition.; or
258.14 	(2) a Tribal medical cannabis program patient's use of medical cannabis was not for a 
258.15 	purpose authorized by the Tribal medical cannabis program.
258.16 		Subd. 2.Criminal and civil protections. (a) Subject to section 152.23, the following 
258.17 	are not violations under this chapter:
258.18 	(1) use or possession of medical cannabis or medical cannabis products by a patient 
258.19 	enrolled in the registry program, or; possession by a registered designated caregiver or the 
258.20 	parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed 
258.21 	on the registry verification; or use or possession of medical cannabis or medical cannabis 
258.22 	products by a Tribal medical cannabis program patient;
258.23 	(2) possession, dosage determination, or sale of medical cannabis or medical cannabis 
258.24 	products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical 
258.25 	cannabis program manufacturer, employees of a Tribal medical cannabis program 
258.26 	manufacturer, a laboratory conducting testing on medical cannabis, or employees of the 
258.27 	laboratory; and
258.28 	(3) possession of medical cannabis or medical cannabis products by any person while 
258.29 	carrying out the duties required under sections 152.22 to 152.37.
258.30 	(b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and 
258.31 	associated property is not subject to forfeiture under sections 609.531 to 609.5316.
259.1 	(c) The commissioner, members of a Tribal medical cannabis board, the commissioner's 
259.2 	or Tribal medical cannabis board's staff, the commissioner's or Tribal medical cannabis 
259.3 	board's agents or contractors, and any health care practitioner are not subject to any civil or 
259.4 	disciplinary penalties by the Board of Medical Practice, the Board of Nursing, or by any 
259.5 	business, occupational, or professional licensing board or entity, solely for the participation 
259.6 	in the registry program under sections 152.22 to 152.37 or in a Tribal medical cannabis 
259.7 	program. A pharmacist licensed under chapter 151 is not subject to any civil or disciplinary 
259.8 	penalties by the Board of Pharmacy when acting in accordance with the provisions of 
259.9 	sections 152.22 to 152.37. Nothing in this section affects a professional licensing board 
259.10 	from taking action in response to violations of any other section of law.
259.11 	(d) Notwithstanding any law to the contrary, the commissioner, the governor of 
259.12 	Minnesota, or an employee of any state agency may not be held civilly or criminally liable 
259.13 	for any injury, loss of property, personal injury, or death caused by any act or omission 
259.14 	while acting within the scope of office or employment under sections 152.22 to 152.37.
259.15 	(e) Federal, state, and local law enforcement authorities are prohibited from accessing 
259.16 	the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid 
259.17 	search warrant.
259.18 	(f) Notwithstanding any law to the contrary, neither the commissioner nor a public 
259.19 	employee may release data or information about an individual contained in any report, 
259.20 	document, or registry created under sections 152.22 to 152.37 or any information obtained 
259.21 	about a patient participating in the program, except as provided in sections 152.22 to 152.37.
259.22 	(g) No information contained in a report, document, or registry or obtained from a patient 
259.23 	under sections 152.22 to 152.37or from a Tribal medical cannabis program patient may be 
259.24 	admitted as evidence in a criminal proceeding unless independently obtained or in connection 
259.25 	with a proceeding involving a violation of sections 152.22 to 152.37.
259.26 	(h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty 
259.27 	of a gross misdemeanor.
259.28 	(i) An attorney may not be subject to disciplinary action by the Minnesota Supreme 
259.29 	Court, a Tribal court, or the professional responsibility board for providing legal assistance 
259.30 	to prospective or registered manufacturers or others related to activity that is no longer 
259.31 	subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for 
259.32 	providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis 
259.33 	program manufacturer.
260.1 	(j) Possession of a registry verification or application for enrollment in the program by 
260.2 	a person entitled to possess or apply for enrollment in the registry program does The 
260.3 	following do not constitute probable cause or reasonable suspicion, nor and shall it not be 
260.4 	used to support a search of the person or property of the person possessing or applying for 
260.5 	the registry verification or equivalent, or otherwise subject the person or property of the 
260.6 	person to inspection by any governmental agency.:
260.7 	(1) possession of a registry verification or application for enrollment in the registry 
260.8 	program by a person entitled to possess a registry verification or apply for enrollment in 
260.9 	the registry program; or
260.10 	(2) possession of a verification or equivalent issued by a Tribal medical cannabis program 
260.11 	or application for enrollment in a Tribal medical cannabis program by a person entitled to 
260.12 	possess such a verification or application.
260.13 		Subd. 3.Discrimination prohibited. (a) No school or landlord may refuse to enroll or 
260.14 	lease to and may not otherwise penalize a person solely for the person's status as a patient 
260.15 	enrolled in the registry program under sections 152.22 to 152.37 or for the person's status 
260.16 	as a Tribal medical cannabis program patient, unless failing to do so would violate federal 
260.17 	law or regulations or cause the school or landlord to lose a monetary or licensing-related 
260.18 	benefit under federal law or regulations.
260.19 	(b) For the purposes of medical care, including organ transplants, a registry program 
260.20 	enrollee's use of medical cannabis under sections 152.22 to 152.37, or a Tribal medical 
260.21 	cannabis program patient's use of medical cannabis as authorized by the Tribal medical 
260.22 	cannabis program, is considered the equivalent of the authorized use of any other medication 
260.23 	used at the discretion of a physician, advanced practice registered nurse, or physician assistant 
260.24 	and does not constitute the use of an illicit substance or otherwise disqualify a patient from 
260.25 	needed medical care.
260.26 	(c) Unless a failure to do so would violate federal law or regulations or cause an employer 
260.27 	to lose a monetary or licensing-related benefit under federal law or regulations, an employer 
260.28 	may not discriminate against a person in hiring, termination, or any term or condition of 
260.29 	employment, or otherwise penalize a person, if the discrimination is based upon either any
260.30 	of the following:
260.31 	(1) the person's status as a patient enrolled in the registry program under sections 152.22 
260.32 	to 152.37; or
260.33 	(2) the person's status as a Tribal medical cannabis program patient; or
261.1 	(2) (3) a patient's positive drug test for cannabis components or metabolites, unless the 
261.2 	patient used, possessed, or was impaired by medical cannabis on the premises of the place 
261.3 	of employment or during the hours of employment.
261.4 	(d) An employee who is required to undergo employer drug testing pursuant to section 
261.5 	181.953 may present verification of enrollment in the patient registry or of enrollment in a 
261.6 	Tribal medical cannabis program as part of the employee's explanation under section 181.953, 
261.7 	subdivision 6.
261.8 	(e) A person shall not be denied custody of a minor child or visitation rights or parenting 
261.9 	time with a minor child solely based on the person's status as a patient enrolled in the registry 
261.10 	program under sections 152.22 to 152.37, or on the person's status as a Tribal medical 
261.11 	cannabis program patient. There shall be no presumption of neglect or child endangerment 
261.12 	for conduct allowed under sections 152.22 to 152.37 or under a Tribal medical cannabis 
261.13 	program, unless the person's behavior is such that it creates an unreasonable danger to the 
261.14 	safety of the minor as established by clear and convincing evidence.

261.15 	Sec. 14. Minnesota Statutes 2022, section 152.33, subdivision 1, is amended to read:
261.16 		Subdivision 1.Intentional diversion; criminal penalty. In addition to any other 
261.17 	applicable penalty in law, a manufacturer or an agent of a manufacturer who intentionally 
261.18 	transfers medical cannabis to a person other than another registered manufacturer, a patient, 
261.19 	a Tribal medical cannabis program patient, a registered designated caregiver or, if listed on 
261.20 	the registry verification, a parent, legal guardian, or spouse of a patient is guilty of a felony 
261.21 	punishable by imprisonment for not more than two years or by payment of a fine of not 
261.22 	more than $3,000, or both. A person convicted under this subdivision may not continue to 
261.23 	be affiliated with the manufacturer and is disqualified from further participation under 
261.24 	sections 152.22 to 152.37.

261.25 	Sec. 15. Minnesota Statutes 2022, section 340A.412, subdivision 14, is amended to read:
261.26 		Subd. 14.Exclusive liquor stores. (a) Except as otherwise provided in this subdivision, 
261.27 	an exclusive liquor store may sell only the following items:
261.28 	(1) alcoholic beverages;
261.29 	(2) tobacco products;
261.30 	(3) ice;
261.31 	(4) beverages, either liquid or powder, specifically designated for mixing with intoxicating 
261.32 	liquor;
262.1 	(5) soft drinks;
262.2 	(6) liqueur-filled candies;
262.3 	(7) food products that contain more than one-half of one percent alcohol by volume;
262.4 	(8) cork extraction devices;
262.5 	(9) books and videos on the use of alcoholic beverages;
262.6 	(10) magazines and other publications published primarily for information and education 
262.7 	on alcoholic beverages;
262.8 	(11) multiple-use bags designed to carry purchased items;
262.9 	(12) devices designed to ensure safe storage and monitoring of alcohol in the home, to 
262.10 	prevent access by underage drinkers;
262.11 	(13) home brewing equipment;
262.12 	(14) clothing marked with the specific name, brand, or identifying logo of the exclusive 
262.13 	liquor store, and bearing no other name, brand, or identifying logo;
262.14 	(15) citrus fruit; and
262.15 	(16) glassware.; and
262.16 	(17) edible cannabinoid products as defined in section 151.72, subdivision 1, paragraph 
262.17 	(f). This clause expires July 1, 2024.
262.18 	(b) An exclusive liquor store that has an on-sale, or combination on-sale and off-sale 
262.19 	license may sell food for on-premise consumption when authorized by the municipality 
262.20 	issuing the license.
262.21 	(c) An exclusive liquor store may offer live or recorded entertainment.

262.22 	Sec. 16. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT.
 262.23 	(a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 
262.24 	151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, 
262.25 	and registrations related to that section adopted or issued by the Office of Medical Cannabis 
262.26 	or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 
262.27 	contained in Minnesota Statutes, sections 144.989 to 144.993. The commissioner of health 
262.28 	may assign enforcement responsibilities to the Office of Medical Cannabis.
262.29 	(b) The enforcement authority under paragraph (a) shall transfer to the Office of Cannabis 
262.30 	Management at any such time that the powers and duties of the Department of Health, with 
263.1 	respect to the medical cannabis program under Minnesota Statutes 2022, sections 152.22 
263.2 	to 152.37, are transferred to the Office of Cannabis Management. The director of the Office 
263.3 	of Cannabis Management may assign enforcement responsibilities to the Division of Medical 
263.4 	Cannabis.
263.5 	(c) This section shall expire on July 1, 2024.

263.6 	Sec. 17. EFFECTIVE DATE.
 263.7 	This article is effective the day following final enactment.

263.8 	ARTICLE 8
263.9 	SCHEDULING OF MARIJUANA

263.10 	Section 1. Minnesota Statutes 2022, section 152.02, subdivision 2, is amended to read:
263.11 		Subd. 2.Schedule I. (a) Schedule I consists of the substances listed in this subdivision.
263.12 	(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the 
263.13 	following substances, including their analogs, isomers, esters, ethers, salts, and salts of 
263.14 	isomers, esters, and ethers, whenever the existence of the analogs, isomers, esters, ethers, 
263.15 	and salts is possible:
263.16 	(1) acetylmethadol;
263.17 	(2) allylprodine;
263.18 	(3) alphacetylmethadol (except levo-alphacetylmethadol, also known as levomethadyl 
263.19 	acetate);
263.20 	(4) alphameprodine;
263.21 	(5) alphamethadol;
263.22 	(6) alpha-methylfentanyl benzethidine;
263.23 	(7) betacetylmethadol;
263.24 	(8) betameprodine;
263.25 	(9) betamethadol;
263.26 	(10) betaprodine;
263.27 	(11) clonitazene;
263.28 	(12) dextromoramide;
264.1 	(13) diampromide;
264.2 	(14) diethyliambutene;
264.3 	(15) difenoxin;
264.4 	(16) dimenoxadol;
264.5 	(17) dimepheptanol;
264.6 	(18) dimethyliambutene;
264.7 	(19) dioxaphetyl butyrate;
264.8 	(20) dipipanone;
264.9 	(21) ethylmethylthiambutene;
264.10 	(22) etonitazene;
264.11 	(23) etoxeridine;
264.12 	(24) furethidine;
264.13 	(25) hydroxypethidine;
264.14 	(26) ketobemidone;
264.15 	(27) levomoramide;
264.16 	(28) levophenacylmorphan;
264.17 	(29) 3-methylfentanyl;
264.18 	(30) acetyl-alpha-methylfentanyl;
264.19 	(31) alpha-methylthiofentanyl;
264.20 	(32) benzylfentanyl beta-hydroxyfentanyl;
264.21 	(33) beta-hydroxy-3-methylfentanyl;
264.22 	(34) 3-methylthiofentanyl;
264.23 	(35) thenylfentanyl;
264.24 	(36) thiofentanyl;
264.25 	(37) para-fluorofentanyl;
264.26 	(38) morpheridine;
264.27 	(39) 1-methyl-4-phenyl-4-propionoxypiperidine;
265.1 	(40) noracymethadol;
265.2 	(41) norlevorphanol;
265.3 	(42) normethadone;
265.4 	(43) norpipanone;
265.5 	(44) 1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP);
265.6 	(45) phenadoxone;
265.7 	(46) phenampromide;
265.8 	(47) phenomorphan;
265.9 	(48) phenoperidine;
265.10 	(49) piritramide;
265.11 	(50) proheptazine;
265.12 	(51) properidine;
265.13 	(52) propiram;
265.14 	(53) racemoramide;
265.15 	(54) tilidine;
265.16 	(55) trimeperidine;
265.17 	(56) N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl);
265.18 	(57) 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-
265.19 	methylbenzamide(U47700);
265.20 	(58) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide(furanylfentanyl);
265.21 	(59) 4-(4-bromophenyl)-4-dimethylamino-1-phenethylcyclohexanol (bromadol);
265.22 	(60) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (Cyclopropryl 
265.23 	fentanyl);
265.24 	(61) N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) (butyryl fentanyl);
265.25 	(62) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) (MT-45);
265.26 	(63) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl 
265.27 	fentanyl);
265.28 	(64) N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl);
266.1 	(65) N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl);
266.2 	(66) N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide 
266.3 	(para-chloroisobutyryl fentanyl);
266.4 	(67) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl 
266.5 	fentanyl);
266.6 	(68) N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide 
266.7 	(para-methoxybutyryl fentanyl);
266.8 	(69) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil);
266.9 	(70) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl 
266.10 	fentanyl or para-fluoroisobutyryl fentanyl);
266.11 	(71) N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl or 
266.12 	acryloylfentanyl);
266.13 	(72) 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl 
266.14 	fentanyl);
266.15 	(73) N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl 
266.16 	or 2-fluorofentanyl);
266.17 	(74) N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide 
266.18 	(tetrahydrofuranyl fentanyl); and
266.19 	(75) Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, 
266.20 	esters and ethers, meaning any substance not otherwise listed under another federal 
266.21 	Administration Controlled Substance Code Number or not otherwise listed in this section, 
266.22 	and for which no exemption or approval is in effect under section 505 of the Federal Food, 
266.23 	Drug, and Cosmetic Act, United States Code , title 21, section 355, that is structurally related 
266.24 	to fentanyl by one or more of the following modifications:
266.25 	(i) replacement of the phenyl portion of the phenethyl group by any monocycle, whether 
266.26 	or not further substituted in or on the monocycle;
266.27 	(ii) substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, 
266.28 	haloalkyl, amino, or nitro groups;
266.29 	(iii) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, 
266.30 	hydroxyl, halo, haloalkyl, amino, or nitro groups;
267.1 	(iv) replacement of the aniline ring with any aromatic monocycle whether or not further 
267.2 	substituted in or on the aromatic monocycle; or
267.3 	(v) replacement of the N-propionyl group by another acyl group.
267.4 	(c) Opium derivatives. Any of the following substances, their analogs, salts, isomers, 
267.5 	and salts of isomers, unless specifically excepted or unless listed in another schedule, 
267.6 	whenever the existence of the analogs, salts, isomers, and salts of isomers is possible:
267.7 	(1) acetorphine;
267.8 	(2) acetyldihydrocodeine;
267.9 	(3) benzylmorphine;
267.10 	(4) codeine methylbromide;
267.11 	(5) codeine-n-oxide;
267.12 	(6) cyprenorphine;
267.13 	(7) desomorphine;
267.14 	(8) dihydromorphine;
267.15 	(9) drotebanol;
267.16 	(10) etorphine;
267.17 	(11) heroin;
267.18 	(12) hydromorphinol;
267.19 	(13) methyldesorphine;
267.20 	(14) methyldihydromorphine;
267.21 	(15) morphine methylbromide;
267.22 	(16) morphine methylsulfonate;
267.23 	(17) morphine-n-oxide;
267.24 	(18) myrophine;
267.25 	(19) nicocodeine;
267.26 	(20) nicomorphine;
267.27 	(21) normorphine;
267.28 	(22) pholcodine; and
268.1 	(23) thebacon.
268.2 	(d) Hallucinogens. Any material, compound, mixture or preparation which contains any 
268.3 	quantity of the following substances, their analogs, salts, isomers (whether optical, positional, 
268.4 	or geometric), and salts of isomers, unless specifically excepted or unless listed in another 
268.5 	schedule, whenever the existence of the analogs, salts, isomers, and salts of isomers is 
268.6 	possible:
268.7 	(1) methylenedioxy amphetamine;
268.8 	(2) methylenedioxymethamphetamine;
268.9 	(3) methylenedioxy-N-ethylamphetamine (MDEA);
268.10 	(4) n-hydroxy-methylenedioxyamphetamine;
268.11 	(5) 4-bromo-2,5-dimethoxyamphetamine (DOB);
268.12 	(6) 2,5-dimethoxyamphetamine (2,5-DMA);
268.13 	(7) 4-methoxyamphetamine;
268.14 	(8) 5-methoxy-3, 4-methylenedioxyamphetamine;
268.15 	(9) alpha-ethyltryptamine;
268.16 	(10) bufotenine;
268.17 	(11) diethyltryptamine;
268.18 	(12) dimethyltryptamine;
268.19 	(13) 3,4,5-trimethoxyamphetamine;
268.20 	(14) 4-methyl-2, 5-dimethoxyamphetamine (DOM);
268.21 	(15) ibogaine;
268.22 	(16) lysergic acid diethylamide (LSD);
268.23 	(17) mescaline;
268.24 	(18) parahexyl;
268.25 	(19) N-ethyl-3-piperidyl benzilate;
268.26 	(20) N-methyl-3-piperidyl benzilate;
268.27 	(21) psilocybin;
268.28 	(22) psilocyn;
269.1 	(23) tenocyclidine (TPCP or TCP);
269.2 	(24) N-ethyl-1-phenyl-cyclohexylamine (PCE);
269.3 	(25) 1-(1-phenylcyclohexyl) pyrrolidine (PCPy);
269.4 	(26) 1-[1-(2-thienyl)cyclohexyl]-pyrrolidine (TCPy);
269.5 	(27) 4-chloro-2,5-dimethoxyamphetamine (DOC);
269.6 	(28) 4-ethyl-2,5-dimethoxyamphetamine (DOET);
269.7 	(29) 4-iodo-2,5-dimethoxyamphetamine (DOI);
269.8 	(30) 4-bromo-2,5-dimethoxyphenethylamine (2C-B);
269.9 	(31) 4-chloro-2,5-dimethoxyphenethylamine (2C-C);
269.10 	(32) 4-methyl-2,5-dimethoxyphenethylamine (2C-D);
269.11 	(33) 4-ethyl-2,5-dimethoxyphenethylamine (2C-E);
269.12 	(34) 4-iodo-2,5-dimethoxyphenethylamine (2C-I);
269.13 	(35) 4-propyl-2,5-dimethoxyphenethylamine (2C-P);
269.14 	(36) 4-isopropylthio-2,5-dimethoxyphenethylamine (2C-T-4);
269.15 	(37) 4-propylthio-2,5-dimethoxyphenethylamine (2C-T-7);
269.16 	(38) 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1]benzofuran-4-yl)ethanamine 
269.17 	(2-CB-FLY);
269.18 	(39) bromo-benzodifuranyl-isopropylamine (Bromo-DragonFLY);
269.19 	(40) alpha-methyltryptamine (AMT);
269.20 	(41) N,N-diisopropyltryptamine (DiPT);
269.21 	(42) 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT);
269.22 	(43) 4-acetoxy-N,N-diethyltryptamine (4-AcO-DET);
269.23 	(44) 4-hydroxy-N-methyl-N-propyltryptamine (4-HO-MPT);
269.24 	(45) 4-hydroxy-N,N-dipropyltryptamine (4-HO-DPT);
269.25 	(46) 4-hydroxy-N,N-diallyltryptamine (4-HO-DALT);
269.26 	(47) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);
269.27 	(48) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT);
270.1 	(49) 5-methoxy-α-methyltryptamine (5-MeO-AMT);
270.2 	(50) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);
270.3 	(51) 5-methylthio-N,N-dimethyltryptamine (5-MeS-DMT);
270.4 	(52) 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT);
270.5 	(53) 5-methoxy-α-ethyltryptamine (5-MeO-AET);
270.6 	(54) 5-methoxy-N,N-dipropyltryptamine (5-MeO-DPT);
270.7 	(55) 5-methoxy-N,N-diethyltryptamine (5-MeO-DET);
270.8 	(56) 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT);
270.9 	(57) methoxetamine (MXE);
270.10 	(58) 5-iodo-2-aminoindane (5-IAI);
270.11 	(59) 5,6-methylenedioxy-2-aminoindane (MDAI);
270.12 	(60) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe);
270.13 	(61) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe);
270.14 	(62) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe);
270.15 	(63) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
270.16 	(64) 2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine (2C-T-2);
270.17 	(65) N,N-Dipropyltryptamine (DPT);
270.18 	(66) 3-[1-(Piperidin-1-yl)cyclohexyl]phenol (3-HO-PCP);
270.19 	(67) N-ethyl-1-(3-methoxyphenyl)cyclohexanamine (3-MeO-PCE);
270.20 	(68) 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo);
270.21 	(69) 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine (methoxydine, 4-MeO-PCP);
270.22 	(70) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexan-1-one (N-Ethylnorketamine, 
270.23 	ethketamine, NENK);
270.24 	(71) methylenedioxy-N,N-dimethylamphetamine (MDDMA);
270.25 	(72) 3-(2-Ethyl(methyl)aminoethyl)-1H-indol-4-yl (4-AcO-MET); and
270.26 	(73) 2-Phenyl-2-(methylamino)cyclohexanone (deschloroketamine).
270.27 	(e) Peyote. All parts of the plant presently classified botanically as Lophophora williamsii 
270.28 	Lemaire, whether growing or not, the seeds thereof, any extract from any part of the plant, 
271.1 	and every compound, manufacture, salts, derivative, mixture, or preparation of the plant, 
271.2 	its seeds or extracts. The listing of peyote as a controlled substance in Schedule I does not 
271.3 	apply to the nondrug use of peyote in bona fide religious ceremonies of the American Indian 
271.4 	Church, and members of the American Indian Church are exempt from registration. Any 
271.5 	person who manufactures peyote for or distributes peyote to the American Indian Church, 
271.6 	however, is required to obtain federal registration annually and to comply with all other 
271.7 	requirements of law.
271.8 	(f) Central nervous system depressants. Unless specifically excepted or unless listed in 
271.9 	another schedule, any material compound, mixture, or preparation which contains any 
271.10 	quantity of the following substances, their analogs, salts, isomers, and salts of isomers 
271.11 	whenever the existence of the analogs, salts, isomers, and salts of isomers is possible:
271.12 	(1) mecloqualone;
271.13 	(2) methaqualone;
271.14 	(3) gamma-hydroxybutyric acid (GHB), including its esters and ethers;
271.15 	(4) flunitrazepam;
271.16 	(5) 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone (2-MeO-2-deschloroketamine, 
271.17 	methoxyketamine);
271.18 	(6) tianeptine;
271.19 	(7) clonazolam;
271.20 	(8) etizolam;
271.21 	(9) flubromazolam; and
271.22 	(10) flubromazepam.
271.23 	(g) Stimulants. Unless specifically excepted or unless listed in another schedule, any 
271.24 	material compound, mixture, or preparation which contains any quantity of the following 
271.25 	substances, their analogs, salts, isomers, and salts of isomers whenever the existence of the 
271.26 	analogs, salts, isomers, and salts of isomers is possible:
271.27 	(1) aminorex;
271.28 	(2) cathinone;
271.29 	(3) fenethylline;
271.30 	(4) methcathinone;
272.1 	(5) methylaminorex;
272.2 	(6) N,N-dimethylamphetamine;
272.3 	(7) N-benzylpiperazine (BZP);
272.4 	(8) methylmethcathinone (mephedrone);
272.5 	(9) 3,4-methylenedioxy-N-methylcathinone (methylone);
272.6 	(10) methoxymethcathinone (methedrone);
272.7 	(11) methylenedioxypyrovalerone (MDPV);
272.8 	(12) 3-fluoro-N-methylcathinone (3-FMC);
272.9 	(13) methylethcathinone (MEC);
272.10 	(14) 1-benzofuran-6-ylpropan-2-amine (6-APB);
272.11 	(15) dimethylmethcathinone (DMMC);
272.12 	(16) fluoroamphetamine;
272.13 	(17) fluoromethamphetamine;
272.14 	(18) α-methylaminobutyrophenone (MABP or buphedrone);
272.15 	(19) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone);
272.16 	(20) 2-(methylamino)-1-(4-methylphenyl)butan-1-one (4-MEMABP or BZ-6378);
272.17 	(21) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl) pentan-1-one (naphthylpyrovalerone or 
272.18 	naphyrone);
272.19 	(22) (alpha-pyrrolidinopentiophenone (alpha-PVP);
272.20 	(23) (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone (4-Me-PHP or MPHP);
272.21 	(24) 2-(1-pyrrolidinyl)-hexanophenone (Alpha-PHP);
272.22 	(25) 4-methyl-N-ethylcathinone (4-MEC);
272.23 	(26) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP);
272.24 	(27) 2-(methylamino)-1-phenylpentan-1-one (pentedrone);
272.25 	(28) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone);
272.26 	(29) 4-fluoro-N-methylcathinone (4-FMC);
272.27 	(30) 3,4-methylenedioxy-N-ethylcathinone (ethylone);
273.1 	(31) alpha-pyrrolidinobutiophenone (α-PBP);
273.2 	(32) 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB);
273.3 	(33) 1-phenyl-2-(1-pyrrolidinyl)-1-heptanone (PV8);
273.4 	(34) 6-(2-Aminopropyl)-2,3-dihydrobenzofuran (6-APDB);
273.5 	(35) 4-methyl-alpha-ethylaminopentiophenone (4-MEAPP);
273.6 	(36) 4'-chloro-alpha-pyrrolidinopropiophenone (4'-chloro-PPP);
273.7 	(37) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one (dibutylone, bk-DMBDB);
273.8 	(38) 1-(3-chlorophenyl) piperazine (meta-chlorophenylpiperazine or mCPP);
273.9 	(39) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one (N-ethylpentylone, ephylone); 
273.10 	and
273.11 	(40) any other substance, except bupropion or compounds listed under a different 
273.12 	schedule, that is structurally derived from 2-aminopropan-1-one by substitution at the 
273.13 	1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the 
273.14 	compound is further modified in any of the following ways:
273.15 	(i) by substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, 
273.16 	haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring 
273.17 	system by one or more other univalent substituents;
273.18 	(ii) by substitution at the 3-position with an acyclic alkyl substituent;
273.19 	(iii) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or 
273.20 	methoxybenzyl groups; or
273.21 	(iv) by inclusion of the 2-amino nitrogen atom in a cyclic structure.
273.22 	(h) Marijuana, tetrahydrocannabinols, and synthetic cannabinoids. Unless specifically 
273.23 	excepted or unless listed in another schedule, any natural or synthetic material, compound, 
273.24 	mixture, or preparation that contains any quantity of the following substances, their analogs, 
273.25 	isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence 
273.26 	of the isomers, esters, ethers, or salts is possible:
273.27 	(1) marijuana;
273.28 	(2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, except 
273.29 	that tetrahydrocannabinols do not include any material, compound, mixture, or preparation 
273.30 	that qualifies as industrial hemp as defined in section 18K.02, subdivision 3; synthetic 
273.31 	equivalents of the substances contained in the cannabis plant or in the resinous extractives 
274.1 	of the plant; or synthetic substances with similar chemical structure and pharmacological 
274.2 	activity to those substances contained in the plant or resinous extract, including, but not 
274.3 	limited to, 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4 
274.4 	cis or trans tetrahydrocannabinol;
274.5 	(3) (h)SyntheticArtificial cannabinoids, including the following substances:
274.6 	(i) (1) Naphthoylindoles, which are any compounds containing a 3-(1-napthoyl)indole 
274.7 	structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, 
274.8 	alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 
274.9 	2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any 
274.10 	extent and whether or not substituted in the naphthyl ring to any extent. Examples of 
274.11 	naphthoylindoles include, but are not limited to:
274.12 	(A) (i) 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM-678);
274.13 	(B) (ii) 1-Butyl-3-(1-naphthoyl)indole (JWH-073);
274.14 	(C) (iii) 1-Pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081);
274.15 	(D) (iv) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);
274.16 	(E) (v) 1-Propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015);
274.17 	(F) (vi) 1-Hexyl-3-(1-naphthoyl)indole (JWH-019);
274.18 	(G) (vii) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
274.19 	(H) (viii) 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210);
274.20 	(I) (ix) 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
274.21 	(J) (x) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201).
274.22 	(ii) (2) Napthylmethylindoles, which are any compounds containing a 
274.23 	1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the 
274.24 	indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 
274.25 	1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further 
274.26 	substituted in the indole ring to any extent and whether or not substituted in the naphthyl 
274.27 	ring to any extent. Examples of naphthylmethylindoles include, but are not limited to:
274.28 	(A) (i) 1-Pentyl-1H-indol-3-yl-(1-naphthyl)methane (JWH-175);
274.29 	(B) (ii) 1-Pentyl-1H-indol-3-yl-(4-methyl-1-naphthyl)methane (JWH-184).
274.30 	(iii) (3) Naphthoylpyrroles, which are any compounds containing a 3-(1-naphthoyl)pyrrole 
274.31 	structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, 
275.1 	alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 
275.2 	2-(4-morpholinyl)ethyl group whether or not further substituted in the pyrrole ring to any 
275.3 	extent, whether or not substituted in the naphthyl ring to any extent. Examples of 
275.4 	naphthoylpyrroles include, but are not limited to, 
275.5 	(5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone (JWH-307).
275.6 	(iv) (4) Naphthylmethylindenes, which are any compounds containing a 
275.7 	naphthylideneindene structure with substitution at the 3-position of the indene ring by an 
275.8 	alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 
275.9 	1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further 
275.10 	substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring 
275.11 	to any extent. Examples of naphthylemethylindenes include, but are not limited to, 
275.12 	E-1-[1-(1-naphthalenylmethylene)-1H-inden-3-yl]pentane (JWH-176).
275.13 	(v) (5) Phenylacetylindoles, which are any compounds containing a 3-phenylacetylindole 
275.14 	structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, 
275.15 	alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 
275.16 	2-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any 
275.17 	extent, whether or not substituted in the phenyl ring to any extent. Examples of 
275.18 	phenylacetylindoles include, but are not limited to:
275.19 	(A) (i) 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole (RCS-8);
275.20 	(B) (ii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
275.21 	(C) (iii) 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251);
275.22 	(D) (iv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).
275.23 	(vi) (6) Cyclohexylphenols, which are compounds containing a 
275.24 	2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic 
275.25 	ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 
275.26 	1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not substituted 
275.27 	in the cyclohexyl ring to any extent. Examples of cyclohexylphenols include, but are not 
275.28 	limited to:
275.29 	(A) (i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497);
275.30 	(B) (ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol 
275.31 	(Cannabicyclohexanol or CP 47,497 C8 homologue);
275.32 	(C) (iii) 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl] 
275.33 	-phenol (CP 55,940).
276.1 	(vii) (7) Benzoylindoles, which are any compounds containing a 3-(benzoyl)indole 
276.2 	structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, 
276.3 	alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 
276.4 	2-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any 
276.5 	extent and whether or not substituted in the phenyl ring to any extent. Examples of 
276.6 	benzoylindoles include, but are not limited to:
276.7 	(A) (i) 1-Pentyl-3-(4-methoxybenzoyl)indole (RCS-4);
276.8 	(B) (ii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694);
276.9 	(C) (iii) (4-methoxyphenyl-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]methanone 
276.10 	(WIN 48,098 or Pravadoline).
276.11 	(viii) (8) Others specifically named:
276.12 	(A) (i) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) 
276.13 	-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (HU-210);
276.14 	(B) (ii) (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) 
276.15 	-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Dexanabinol or HU-211);
276.16 	(C) (iii) 2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de] 
276.17 	-1,4-benzoxazin-6-yl-1-naphthalenylmethanone (WIN 55,212-2);
276.18 	(D) (iv) (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144);
276.19 	(E) (v) (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone 
276.20 	(XLR-11);
276.21 	(F) (vi) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide 
276.22 	(AKB-48(APINACA));
276.23 	(G) (vii) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 
276.24 	(5-Fluoro-AKB-48);
276.25 	(H) (viii) 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22);
276.26 	(I) (ix) 8-quinolinyl ester-1-(5-fluoropentyl)-1H-indole-3-carboxylic acid (5-Fluoro 
276.27 	PB-22);
276.28 	(J) (x) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole- 3-carboxamide 
276.29 	(AB-PINACA);
276.30 	(K) (xi) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]- 
276.31 	1H-indazole-3-carboxamide (AB-FUBINACA);
277.1 	(L) (xii) N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H- 
277.2 	indazole-3-carboxamide(AB-CHMINACA);
277.3 	(M) (xiii) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3- 
277.4 	methylbutanoate (5-fluoro-AMB);
277.5 	(N) (xiv) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl) methanone (THJ-2201);
277.6 	(O) (xv) (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone) 
277.7 	(FUBIMINA);
277.8 	(P) (xvi) (7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo 
277.9 	[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide (MN-25 or UR-12);
277.10 	(Q) (xvii) (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl) 
277.11 	-1H-indole-3-carboxamide (5-fluoro-ABICA);
277.12 	(R) (xviii) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl) 
277.13 	-1H-indole-3-carboxamide;
277.14 	(S) (xix) N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl) 
277.15 	-1H-indazole-3-carboxamide;
277.16 	(T) (xx) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido) 
277.17 	-3,3-dimethylbutanoate;
277.18 	(U) (xxi) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1 
277.19 	H-indazole-3-carboxamide (MAB-CHMINACA);
277.20 	(V) (xxii)
277.21 	N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indazole-3-carboxamide 
277.22 	(ADB-PINACA);
277.23 	(W) (xxiii) methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate (FUB-AMB);
277.24 	(X) (xxiv)
277.25 	N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-1H-Indazole-
277.26 	3-carboxamide. (APP-CHMINACA);
277.27 	(Y) (xxv) quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FUB-PB-22); and
277.28 	(Z) (xxvi) methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]valinate 
277.29 	(MMB-CHMICA).
277.30 	(ix) (9) Additional substances specifically named:
278.1 	(A) (i) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 
278.2 	H-pyrrolo[2,3-B]pyridine-3-carboxamide (5F-CUMYL-P7AICA);
278.3 	(B) (ii) 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1 H-indazole-3-carboxamide 
278.4 	(4-CN-Cumyl-Butinaca);
278.5 	(C) (iii) naphthalen-1-yl-1-(5-fluoropentyl)-1-H-indole-3-carboxylate (NM2201; 
278.6 	CBL2201);
278.7 	(D) (iv) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1 
278.8 	H-indazole-3-carboxamide (5F-ABPINACA);
278.9 	(E) (v) methyl-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate 
278.10 	(MDMB CHMICA);
278.11 	(F) (vi) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate 
278.12 	(5F-ADB; 5F-MDMB-PINACA); and
278.13 	(G) (vii) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl) 
278.14 	1H-indazole-3-carboxamide (ADB-FUBINACA).
278.15 	(i) A controlled substance analog, to the extent that it is implicitly or explicitly intended 
278.16 	for human consumption.

278.17 	EFFECTIVE DATE. This section is effective the day following final enactment.

278.18 	Sec. 2. Minnesota Statutes 2022, section 152.02, subdivision 4, is amended to read:
278.19 		Subd. 4.Schedule III. (a) Schedule III consists of the substances listed in this subdivision.
278.20 	(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any 
278.21 	material, compound, mixture, or preparation which contains any quantity of the following 
278.22 	substances having a potential for abuse associated with a stimulant effect on the central 
278.23 	nervous system, including its salts, isomers, and salts of such isomers whenever the existence 
278.24 	of such salts, isomers, and salts of isomers is possible within the specific chemical 
278.25 	designation:
278.26 	(1) benzphetamine;
278.27 	(2) chlorphentermine;
278.28 	(3) clortermine;
278.29 	(4) phendimetrazine.
279.1 	(c) Depressants. Unless specifically excepted or unless listed in another schedule, any 
279.2 	material, compound, mixture, or preparation which contains any quantity of the following 
279.3 	substances having a potential for abuse associated with a depressant effect on the central 
279.4 	nervous system:
279.5 	(1) any compound, mixture, or preparation containing amobarbital, secobarbital, 
279.6 	pentobarbital or any salt thereof and one or more other active medicinal ingredients which 
279.7 	are not listed in any schedule;
279.8 	(2) any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or 
279.9 	any salt of any of these drugs and approved by the food and drug administration for marketing 
279.10 	only as a suppository;
279.11 	(3) any substance which contains any quantity of a derivative of barbituric acid, or any 
279.12 	salt of a derivative of barbituric acid, except those substances which are specifically listed 
279.13 	in other schedules;
279.14 	(4) any drug product containing gamma hydroxybutyric acid, including its salts, isomers, 
279.15 	and salts of isomers, for which an application is approved under section 505 of the federal 
279.16 	Food, Drug, and Cosmetic Act;
279.17 	(5) any of the following substances:
279.18 	(i) chlorhexadol;
279.19 	(ii) ketamine, its salts, isomers and salts of isomers;
279.20 	(iii) lysergic acid;
279.21 	(iv) lysergic acid amide;
279.22 	(v) methyprylon;
279.23 	(vi) sulfondiethylmethane;
279.24 	(vii) sulfonenthylmethane;
279.25 	(viii) sulfonmethane;
279.26 	(ix) tiletamine and zolazepam and any salt thereof;
279.27 	(x) embutramide;
279.28 	(xi) Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-Dihydropyridin-3-yl) 
279.29 	benzonitrile].
279.30 	(d) Nalorphine.
280.1 	(e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, 
280.2 	any material, compound, mixture, or preparation containing any of the following narcotic 
280.3 	drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities 
280.4 	as follows:
280.5 	(1) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams 
280.6 	per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
280.7 	(2) not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams 
280.8 	per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic 
280.9 	amounts;
280.10 	(3) not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90 
280.11 	milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized 
280.12 	therapeutic amounts;
280.13 	(4) not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 
280.14 	15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized 
280.15 	therapeutic amounts;
280.16 	(5) not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not 
280.17 	more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients 
280.18 	in recognized therapeutic amounts;
280.19 	(6) not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with 
280.20 	one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
280.21 	(f) Anabolic steroids, human growth hormone, and chorionic gonadotropin.
280.22 	(1) Anabolic steroids, for purposes of this subdivision, means any drug or hormonal 
280.23 	substance, chemically and pharmacologically related to testosterone, other than estrogens, 
280.24 	progestins, corticosteroids, and dehydroepiandrosterone, and includes:
280.25 	(i) 3[beta],17[beta]-dihydroxy-5[alpha]-androstane;
280.26 	(ii) 3[alpha],17[beta]-dihydroxy-5[alpha]-androstane;
280.27 	(iii) androstanedione (5[alpha]-androstan-3,17-dione);
280.28 	(iv) 1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-l-ene;
280.29 	(v) 3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene);
280.30 	(vi) 4-androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene);
280.31 	(vii) 5-androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene);
281.1 	(viii) 1-androstenedione (5[alpha]-androst-1-en-3,17-dione);
281.2 	(ix) 4-androstenedione (androst-4-en-3,17-dione);
281.3 	(x) 5-androstenedione (androst-5-en-3,17-dione);
281.4 	(xi) bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);
281.5 	(xii) boldenone (17[beta]-hydroxyandrost-1,4-diene-3-one);
281.6 	(xiii) boldione (androsta-1,4-diene-3,17-dione);
281.7 	(xiv) calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);
281.8 	(xv) clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one);
281.9 	(xvi) dehydrochloromethyltestosterone 
281.10 	(4-chloro-17[beta]-hydroxy-17[alpha]-methylandrost-1,4-dien-3-one);
281.11 	(xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol);
281.12 	(xviii) [delta]1-dihydrotestosterone- (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);
281.13 	(xix) 4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one);
281.14 	(xx) drostanolone (17[beta]hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one);
281.15 	(xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene);
281.16 	(xxii) fluoxymesterone 
281.17 	(9-fluoro-17[alpha]-methyl-11[beta],17[beta]-dihydroxyandrost-4-en-3-one);
281.18 	(xxiii) formebolone 
281.19 	(2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one);
281.20 	(xxiv) furazabol 
281.21 	(17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan)13[beta]-ethyl-17[beta] 
281.22 	-hydroxygon-4-en-3-one;
281.23 	(xxv) 4-hydroxytestosterone (4,17[beta]-dihydroxyandrost-4-en-3-one);
281.24 	(xxvi) 4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxyestr-4-en-3-one);
281.25 	(xxvii) mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one);
281.26 	(xxviii) mesterolone (1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one);
281.27 	(xxix) methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one);
281.28 	(xxx) methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene);
282.1 	(xxxi) methasterone (2 alpha-17 alpha-dimethyl-5 alpha-androstan-17beta-ol-3-one);
282.2 	(xxxii) methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);
282.3 	(xxxiii) 17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5[alpha]-androstane;
282.4 	(xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5[alpha]-androstane;
282.5 	(xxxv) 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene;
282.6 	(xxxvi) 17[alpha]-methyl-4-hydroxynandrolone 
282.7 	(17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one);
282.8 	(xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one);
282.9 	(xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one);
282.10 	(xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one);
282.11 	(xl) mibolerone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyestr-4-en-3-one);
282.12 	(xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone 
282.13 	(17[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one);
282.14 	(xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one);
282.15 	(xliii) 19-nor-4-androstenediol (3[beta],17[beta]-dihydroxyestr-4-ene;
282.16 	(xliv) 3[alpha],17[beta]-dihydroxyestr-4-ene); 19-nor-5-androstenediol 
282.17 	(3[beta],17[beta]-dihydroxyestr-5-ene;
282.18 	(xlv) 3[alpha],17[beta]-dihydroxyestr-5-ene);
282.19 	(xlvi) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);
282.20 	(xlvii) 19-nor-5-androstenedione (estr-5-en-3,17-dione);
282.21 	(xlviii) norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one);
282.22 	(xlix) norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one);
282.23 	(l) norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one);
282.24 	(li) normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one);
282.25 	(lii) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one);
282.26 	(liii) oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one);
282.27 	(liv) oxymetholone 
282.28 	(17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-5[alpha]-androstan-3-one);
283.1 	(lv) prostanozol (17 beta-hydroxy-5 alpha-androstano[3,2-C]pryazole;
283.2 	(lvi) stanozolol 
283.3 	(17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androst-2-eno[3,2-c]-pyrazole);
283.4 	(lvii) stenbolone (17[beta]-hydroxy-2-methyl-5[alpha]-androst-1-en-3-one);
283.5 	(lviii) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
283.6 	(lix) testosterone (17[beta]-hydroxyandrost-4-en-3-one);
283.7 	(lx) tetrahydrogestrinone 
283.8 	(13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one);
283.9 	(lxi) trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one);
283.10 	(lxii) any salt, ester, or ether of a drug or substance described in this paragraph.
283.11 	Anabolic steroids are not included if they are: (A) expressly intended for administration 
283.12 	through implants to cattle or other nonhuman species; and (B) approved by the United States 
283.13 	Food and Drug Administration for that use;
283.14 	(2) Human growth hormones.
283.15 	(3) Chorionic gonadotropin, except that a product containing chorionic gonadotropin is 
283.16 	not included if it is:
283.17 	(i) expressly intended for administration to cattle or other nonhuman species; and
283.18 	(ii) approved by the United States Food and Drug Administration for that use.
283.19 	(g) Hallucinogenic substances. Dronabinol (syntheticartificial) in sesame oil and 
283.20 	encapsulated in a soft gelatin capsule in a United States Food and Drug Administration 
283.21 	approved product.
283.22 	(h) Any material, compound, mixture, or preparation containing the following narcotic 
283.23 	drug or its salt: buprenorphine.
283.24 	(i) Marijuana, tetrahydrocannabinols, and artificial cannabinoids. Unless specifically 
283.25 	excepted or unless listed in another schedule, any natural or artificial material, compound, 
283.26 	mixture, or preparation that contains any quantity of the following substances, their analogs, 
283.27 	isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence 
283.28 	of the isomers, esters, ethers, or salts is possible:
283.29 	(1) marijuana;
284.1 	(2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, except 
284.2 	that tetrahydrocannabinols do not include any material, compound, mixture, or preparation 
284.3 	that qualifies as industrial hemp as defined in section 18K.02, subdivision 3; artificial 
284.4 	equivalents of the substances contained in the cannabis plant or in the resinous extractives 
284.5 	of the plant; or artificial substances with similar chemical structure and pharmacological 
284.6 	activity to those substances contained in the plant or resinous extract, including but not 
284.7 	limited to 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4 
284.8 	cis or trans tetrahydrocannabinol.

284.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

284.10 	ARTICLE 9
284.11 	APPROPRIATIONS

284.12 	Section 1. APPROPRIATIONS.
 284.13 		Subdivision 1.Office of Cannabis Management. (a) $....... in fiscal year 2024 and 
284.14 	$....... in fiscal year 2025 are appropriated from the general fund to the Cannabis Management 
284.15 	Board for purposes of this act. The base for this appropriation is $....... in fiscal year 2026 
284.16 	and $....... in fiscal year 2027.
284.17 	(b) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
284.18 	in fiscal year 2025 are for rulemaking. The base for this appropriation is $....... in fiscal year 
284.19 	2024 and thereafter.
284.20 	(c) Of the base established in paragraph (a), $....... in fiscal year 2026 and $....... in fiscal 
284.21 	year 2027 are for cannabis industry community renewal grants. Of these amounts, up to 
284.22 	three percent may be used for administrative expenses.
284.23 	(d) Of the base established in paragraph (a), $....... in fiscal year 2026 and $....... in fiscal 
284.24 	year 2027 are for the administration of substance use treatment, recovery, and prevention 
284.25 	grants.
284.26 		Subd. 2.Department of Agriculture. $....... in fiscal year 2024 and $....... in fiscal year 
284.27 	2025 are appropriated from the general fund to the commissioner of agriculture for food 
284.28 	safety and pesticide enforcement lab testing and rulemaking related to changes in cannabis 
284.29 	laws. The base for this appropriation is $....... in fiscal year 2026 and $....... in fiscal year 
284.30 	2027.
284.31 		Subd. 3.Cannabis Expungement Board. $....... in fiscal year 2024 and $....... in fiscal 
284.32 	year 2025 are appropriated from the general fund to the Cannabis Expungement Board for 
285.1 	staffing and other expenses related to reviewing criminal convictions and issuing decisions 
285.2 	related to expungement and resentencing. The base for this appropriation is $....... in fiscal 
285.3 	years 2026, 2027, and 2028. The base in fiscal year 2029 and thereafter is $0.
285.4 		Subd. 4.Department of Commerce. $....... in fiscal year 2024 and $....... in fiscal year 
285.5 	2025 are appropriated from the general fund to the commissioner of commerce for the 
285.6 	purposes of this act. The base for this appropriation is $....... in fiscal year 2026 and $....... 
285.7 	in fiscal year 2027.
285.8 		Subd. 5.Department of Corrections. An appropriation to the commissioner of 
285.9 	corrections for correctional institutions is reduced by $....... in fiscal year 2024 and $....... 
285.10 	in fiscal year 2025. The base for this appropriation is reduced by $....... in fiscal year 2026 
285.11 	and $....... in fiscal year 2027.
285.12 		Subd. 6.Department of Education. $....... in fiscal year 2024 and $....... in fiscal year 
285.13 	2025 are appropriated from the general fund to the commissioner of education for the 
285.14 	purposes of this act.
285.15 		Subd. 7.Department of Employment and Economic Development. (a) $....... in fiscal 
285.16 	year 2024 and $....... in fiscal year 2025 are appropriated from the general fund to the 
285.17 	commissioner of employment and economic development for the CanStartup, CanNavigate, 
285.18 	and CanTrain programs. Any unencumbered balances remaining in the first year do not 
285.19 	cancel but are available for the second year.
285.20 	(b) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
285.21 	in fiscal year 2025 are for the CanStartup program.
285.22 	(c) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
285.23 	in fiscal year 2025 are for the CanNavigate program.
285.24 	(d) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
285.25 	in fiscal year 2025 are for the CanTrain program.
285.26 	(e) Of these amounts, up to four percent may be used for administrative expenses.
285.27 		Subd. 8.Department of Health. (a) $....... in fiscal year 2024 and $....... in fiscal year 
285.28 	2025 are appropriated from the general fund to the commissioner of health for the purposes 
285.29 	of this act. The base for this appropriation is $....... in fiscal year 2026 and $....... in fiscal 
285.30 	year 2027.
285.31 	(b) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
285.32 	in fiscal year 2025 are for education for individuals who are pregnant, breastfeeding, or 
285.33 	who may become pregnant. Of this amount, $....... each year is for media campaign contracts. 
286.1 	The base for this appropriation is $....... in fiscal year 2026 and thereafter. Of the amounts 
286.2 	appropriated in fiscal year 2026 and thereafter, $....... is for media campaign contracts.
286.3 	(c) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
286.4 	in fiscal year 2025 are for data collection and reports. The base for this appropriation is 
286.5 	$....... in fiscal year 2026 and $....... in fiscal year 2027.
286.6 	(d) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
286.7 	in fiscal year 2025 are for testing required by this act. The base for this appropriation is 
286.8 	$....... in fiscal year 2026 and thereafter.
286.9 	(e) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
286.10 	in fiscal year 2025 are for education for youth. Of this amount, $....... each year is for 
286.11 	statewide youth awareness campaign contracts. The base for this appropriation is $....... in 
286.12 	fiscal year 2026 and thereafter. Of the amounts in fiscal year 2026 and thereafter, $....... is 
286.13 	for media campaign contracts.
286.14 	(f) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
286.15 	in fiscal year 2025 are for grants to local health departments for: (1) creation and 
286.16 	dissemination of educational materials on cannabis flower and cannabis products; and (2) 
286.17 	community education, technical assistance, and outreach on prevention and safe use regarding 
286.18 	cannabis flower and cannabis products. The commissioner shall distribute these grants 
286.19 	according to a contract with the Local Public Health Association of Minnesota. Of the 
286.20 	appropriations in this paragraph, the commissioner may withhold up to ten percent for grant 
286.21 	administration and technical assistance to local health departments. The base for this 
286.22 	appropriation is $....... in fiscal year 2026 and thereafter.
286.23 	(g) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
286.24 	in fiscal year 2025 are for grants to Tribal health departments for: (1) creation and 
286.25 	dissemination of educational materials on cannabis flower and cannabis products; and (2) 
286.26 	community education, technical assistance, and outreach on prevention and safe use regarding 
286.27 	cannabis flower and cannabis products. Of the appropriations in this paragraph, the 
286.28 	commissioner may withhold up to ten percent for grant administration and technical 
286.29 	assistance to Tribal health departments. The base for this appropriation is $....... in fiscal 
286.30 	year 2026 and thereafter.
286.31 		Subd. 9.Department of Health; Minnesota poison control system. $....... in fiscal 
286.32 	year 2024 and $....... in fiscal year 2025 are appropriated from the general fund to the 
286.33 	commissioner of health to support the poison control system and award or supplement grants 
286.34 	pursuant to Minnesota Statutes, section 145.93.
287.1 		Subd. 10.Department of Human Services. (a) $....... in fiscal year 2024 and $....... in 
287.2 	fiscal year 2025 are appropriated from the general fund to the commissioner of human 
287.3 	services for the purposes of this act. The base for this appropriation is $....... in fiscal years 
287.4 	2026, 2027, and 2028. The base in fiscal year 2029 and thereafter is $........
287.5 	(b) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
287.6 	in fiscal year 2025 are for the Background Studies Legal Division. The base for this 
287.7 	appropriation is $....... in fiscal years 2026, 2027, and 2028. The base in fiscal year 2029 
287.8 	and thereafter is $0.
287.9 	(c) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 is for 
287.10 	technology system changes. This is a onetime appropriation.
287.11 		Subd. 11.Department of Labor and Industry. $....... in fiscal year 2024 and $....... in 
287.12 	fiscal year 2025 are appropriated from the general fund to the commissioner of labor and 
287.13 	industry to identify occupational competency standards and provide technical assistance 
287.14 	for developing dual-training programs under Minnesota Statutes, section 175.45, for the 
287.15 	legal cannabis industry.
287.16 		Subd. 12.Department of Natural Resources. $....... in fiscal year 2024 is appropriated 
287.17 	from the general fund to the commissioner of natural resources for the purposes of this act. 
287.18 	This is a onetime appropriation.
287.19 		Subd. 13.Office of Higher Education. $....... in fiscal year 2024 and $....... in fiscal 
287.20 	year 2025 are appropriated from the general fund to the commissioner of higher education 
287.21 	for transfer to the dual training account in the special revenue fund under Minnesota Statutes, 
287.22 	section 136A.246, subdivision 10, for grants to employers in the legal cannabis industry. 
287.23 	The commissioner shall give priority to applications from employers who are, or who are 
287.24 	training employees who are, eligible to be social equity applicants under Minnesota Statutes, 
287.25 	section 342.15.
287.26 		Subd. 14.Pollution Control Agency. (a) $....... in fiscal year 2024 and $....... in fiscal 
287.27 	year 2025 are appropriated from the general fund to the commissioner of the Pollution 
287.28 	Control Agency for the purposes of this act. The base for this appropriation is $....... in fiscal 
287.29 	year 2026 and $0 in fiscal year 2027 and thereafter.
287.30 	(b) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
287.31 	in fiscal year 2025 are for rulemaking. The base for this appropriation is $0 in fiscal year 
287.32 	2026 and thereafter.
288.1 	(c) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 is for 
288.2 	wastewater staff. This is a onetime appropriation.
288.3 	(d) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
288.4 	in fiscal year 2025 are for small business assistance staff. The base for this appropriation 
288.5 	is $....... in fiscal year 2026 and $0 in fiscal year 2027 and thereafter.
288.6 		Subd. 15.Department of Public Safety; Bureau of Criminal Apprehension. (a) $....... 
288.7 	in fiscal year 2024 and $....... in fiscal year 2025 are appropriated from the general fund to 
288.8 	the commissioner of public safety for use by the Bureau of Criminal Apprehension. The 
288.9 	base for this appropriation is $....... in fiscal years 2026, 2027, and 2028. The base in fiscal 
288.10 	year 2029 and thereafter is $........
288.11 	(b) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
288.12 	in fiscal year 2025 are for expenses related to identifying and providing records of convictions 
288.13 	for certain offenses involving the possession of cannabis that may be eligible for 
288.14 	expungement and resentencing. The base for this appropriation is $....... in fiscal years 2026, 
288.15 	2027, and 2028. The base in fiscal year 2029 and thereafter is $0.
288.16 	(c) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
288.17 	in fiscal year 2025 are for forensic science services including additional staff, equipment, 
288.18 	and supplies.
288.19 	(d) Of the amount appropriated under paragraph (a), $....... in fiscal year 2024 and $....... 
288.20 	in fiscal year 2025 are for investigation of diversion crimes.
288.21 		Subd. 16.Department of Public Safety; State Patrol. (a) $....... in fiscal year 2024 and 
288.22 	$....... in fiscal year 2025 are appropriated from the general fund to the commissioner of 
288.23 	public safety for use by the Minnesota State Patrol for the purposes of this act, including 
288.24 	identifying and investigating incidents and offenses that involve driving under the influence.
288.25 	(b) $....... in fiscal year 2024 and $....... in fiscal year 2025 are appropriated from the 
288.26 	general fund to the commissioner of public safety for use by the Minnesota State Patrol for 
288.27 	its drug evaluation and classification program for drug recognition evaluator training, 
288.28 	additional phlebotomists, and drug recognition training for peace officers, as defined in 
288.29 	Minnesota Statutes, section 626.84, subdivision 1, paragraph (c).
288.30 	(c) $....... in fiscal year 2024 is appropriated from the general fund to the commissioner 
288.31 	of public safety for the Minnesota State Patrol for the retirement and replacement of canines 
288.32 	and the related canine and trooper training costs. This is a onetime appropriation and is 
288.33 	available until June 30, 2025.
289.1 		Subd. 17.Department of Revenue. $....... in fiscal year 2024 and $....... in fiscal year 
289.2 	2025 are appropriated from the general fund to the commissioner of revenue for the purposes 
289.3 	of this act. The base for this appropriation is $....... in fiscal year 2026 and $....... in fiscal 
289.4 	year 2027.
289.5 		Subd. 18.Supreme court. $....... in fiscal year 2024 and $....... in fiscal year 2025 are 
289.6 	appropriated from the general fund to the supreme court for reviewing records and issuing 
289.7 	orders related to the expungement or resentencing of certain cannabis offenses. The base 
289.8 	for this appropriation is $0 in fiscal year 2026 and thereafter.
289.9 		Subd. 19.Supreme court. $....... in fiscal year 2024 and $....... in fiscal year 2025 are 
289.10 	appropriated from the general fund to the supreme court for treatment court operations.
289.11 		Subd. 20.Substance use treatment, recovery, and prevention grant account. Money 
289.12 	for substance use treatment, recovery, and prevention is transferred from the general fund 
289.13 	to the substance use treatment, recovery, and prevention grant account established under 
289.14 	Minnesota Statutes, section 342.68. The transfer is $....... in fiscal years 2024 and 2025. The 
289.15 	base for this transfer is $....... in fiscal year 2026 and $....... in fiscal year 2027.